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Summary 
This dissertation is concerned with the production of nanofibers and nanoparticles for medical 
and pharmaceutical applications. Sub-micron diameters of electrospun fibers with similar 
magnitude to the fibrils often found within the extra cellular matrix demonstrate great promise 
for tissue engineering and skin grafts. Among the common techinques for the production of 
nanofibers, electrospinning is by far the most simple and cost effective one. Therefore, 
solution electrospinning nowadays gained increasing importance. Melt-electrospinning 
provides an alternative to solution-electrospinning especially for biomedical applications as 
residual solvent toxicity is avoided. Submicron polypropylene fibers are electrospun from 
polymer melts. Fiber diameter is reduced from 35±8 m to 840±190 nm with a viscosity-
reducing additive. Utilization of small quantities of calcium stearate (Ca-stearate) and/or 
magnesium stearate (Mg-stearate) as additive for melt electrospinning enables an alternative 
approach to reduce diameter of melt electrospun polypropylene. Influences of the process 
parameters on structure formation and crystallinity of melt electrospun fibers were 
investigated in collaboration with Prof. Dr. D. A. Ivanov and are discussed. Crystallinity of 
melt-electrospun isotactic polypropylene fibers is expected to influence the mechanical 
properties of the resulting scaffold and is mainly controlled by the applied voltage and nozzle 
to target distance for a certain polymer. Besides mechanical strength and a fibrous structure 
similar to the extra cellular matrix, scaffolds for tissue engineering should provide a suitable 
and supporting environment to cells. Therefore, four simple strategies towards bioactivated 
and biofunctionalized electrospun fibers with minimized unspecific protein adsorption are 
presented. The first three are based on amphiphilic block copolymers and a solvent mixture 
containing a selective solvent for the hydrophilic poly(ethylene glycol) segment leading to 
surface enrichment and hydrophilic fibers. Especially this enrichment of hydrophilic 
poly(ethylene glycol) (PEG) leads to remarkable and unique fiber properties. These 
electrospun fibers with contrasting cell adhesion properties provide non-woven substrates 
with enhanced in vitro acceptance and controllable cell interactions. Firstly, poly(ethylene 
glycol)-block-poly( -caprolactone) (PEG-b-PCL) based block copolymers are synthesized in 
two steps and characterized. A cell-adhesive peptide sequence of fibronectin, GRGDS, is 
covalently coupled to the PEG segment of the copolymer in an additional step and electrospun 
from a methanol/chloroform mixture (25/75, v/v) to form fibrous hydrophilic scaffolds with a 
contact angle of 30°. No attachment of human dermal fibroblasts after 24 h cell culture 
demonstrates that the particular combination of the unfunctionalised material and 
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electrospinning conditions yields protein and cell repellent properties and contrasts the 
GRGDS immobilized mesh showing improved cellular attachment. Secondly, poly(ethylene 
glycol)-block- poly(D,L-lactide) (PEG-b-PDLLA) is synthesized in two steps, with a PEG 
segment of 10 kDa, while the PDLLA block ranged from 20 to 60 kDa. Depending on the 
PEG and PDLLA segment ratio, as well as solvent selection, the hydrophilicity and protein 
adsorption is altered on the electrospun mesh. Furthermore, an -acetal PEG-b-PDLLA is 
synthesized that allowes conjugation of active molecules, resulting in surface 
functionalization of the electrospun fiber. Sessile drop measurements show a reduction in the 
contact angle from 120° for pure poly(D,L-lactide) with increasing PEG/PDLLA ratio. All 
electrospun block PEG-b-PDLLA fibers have hydrophilic properties, with contact angles 
below 45°. Fibers of block copolymers with PDLLA blocks smaller than 39 kDa show no 
adsorption of Bovine Serum Albumin (BSA) or streptavidin, indicating good non-fouling 
properties. Fibroblast adhesion is again contrasting between the unfunctionalized and RGD-
coupled electrospun fabrics, confirming that the surface of the fibers is functionalized. 
Thirdly, promising scaffolds are obtained by solution electrospinning amphiphilic block 
copolymers with three different thiol-reactive end groups from methanol/chloroform. Fibers 
of block copolymers with PDLLA blocks of 30 kDa and 10 kDa PEG blocks show again good 
non-fouling properties and hydrophilicity. Contrasting hydrophobic scaffolds like electrospun 
PDLLA or PLGA, these fibers are easily wetted by cell culture medium. Hydrophilic 3D 
fibrous scaffolds presenting thiol-reactive groups on the fiber surface allow immobilization of 
active molecules and show promising in vitro results. These electrospun scaffolds uniquely 
combine well-defined surface chemistries to immobilize bioactive molecules, homogeneous 
presentation of immobilized ligands, and minimized non-specific adsorption of protein. 
Fourthly, a one-step preparation method of fully synthetic bioactive degradable ECM-mimetic 
scaffolds consisting of hydrophilic fibers is presented. Electrospinning a mixture of 
poly(lactide-co-glycolide) and isocyanate terminated star-poly(ethylene glycol) results in 
fibers consisting of a poly(lactide-co-glycolide)/poly(ethylene glycol) blend showing slow 
degradation and being capable of triggering cell response. This system uniquely combines a 
fiber surface where unspecific protein adsorption and cell adhesion is suppressed, specific 
bioactivation through covalently attached peptide sequences for controlled cell – scaffold 
interaction with a simple production process. In order to achieve scaffolds suitable for 
keratinocyte cell culture a fibronectin fragment, a collagen IV fragment as well as a 
combination of both is immobilized to fiber surfaces, simulating the extra cellular matrix 
found in human skin tissue. Keratinocytes are found to selectively adhere to those fibers 
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modified with the collagen IV segment GEFYFDLRLKGDK or a mixture of 
GEFYFDLRLKGDK and GRGDS (1:1) during the first 24 h. After 6 days the number 
adhering cells on these scaffolds was slightly reduced, whereas the spread and flattened 
morphologies indicated strong adherence. 
The second half of this thesis introduces electrospraying as technique for particle generation, 
drug encapsulation and controlled drug delivery. Electrospraying is used to produce 
biodegradable polymeric micro- and nanoparticles. Particles on the basis of PLGA and 
PDLLA-block-PEG polymers with various molecular weights ranging from 30 to 200 kDa are 
generated and the effects of processing parameters such as polymer concentration, used 
solvent and polymer, feed rate, voltage, configuration specific parameters, and surfactants on 
the particle size as well as their surface morphology shown and discussed. Mainly solution 
parameters determine the formed structures. While solvents like acetone tend to lead to small 
particles with sizes below 1 µm, solvents like dichloromethane form hollow particles between 
1 and 6 µm. Applied voltage, feed rate and nozzle to target distance are identified as another 
set of dependent parameters and show to be as important as the solution parameters as they 
determine the flight time and influence solvent evaporation, size and the dispersity of the 
spray. One combination of voltage and corresponding feed rate at a given nozzle to target 
distance enables the production of quasi-monodisperse particles for a certain polymer/solvent 
system. Besides the generation of monodisperse non-aggregated particles capable of 
pulmonary application, the possibility to modify such particles with amino group containing 
molecules is shown. This simple modification allows generation of fluorescently labeled 
particles and may also allow further immobilization of targeting sequenzes. Furthermore, 
degradation of these electrosprayed particles during a period of 14 days under physiological 
conditions shows great promise for medical and pharmaceutical applications. Such 
electrosprayed microparticles are potential candidates for pulmonary drug delivery. 
Commonly used anti-asthmatics such as fenoterol hydrobromide, salbutamol sulphate, 
salbutamol free base and budesonide are used as model drugs to investigate three different 
encapsulation approaches. Polymer-coated drugs and drug-loaded degradable micro spheres 
in the inhalable size range are generated by electrospraying. Firstly, dispersions of drug 
crystals in polymer solutions are electrosprayed to form microparticles showing a core-shell 
structure. Secondly, solutions containing the dissolved drug and polymer are electrosprayed to 
form matrix-type particles with sizes down to a few hundred nanometers. A variation of the 
latter is electrospraying of emulsions of the drug dissolved in one solvent and the polymer 
dissolved in a second (immiscible) solvent. All approaches were optimized to form particles 
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with diameters between 0.5 and 5 µm. Morphology, surface structure drug loading, and 
release behavior is shown to strongly depend on the composition of the liquid precursor; 
while particle size and size distribution are controlled by process parameters. Dependent on 
the encapsulation approach totally different release behaviors are achieved. While polymer-
coating generally leads to a very fast release and minor retardation, matrix-type particles show 
retardation over several hours or days and controlled release behavior. Moderate burst 
releases (release in the first 30 min) seem promising in order to achieve formulations suitable 
to reduce the delivery frequency. Morphology and release behavior is controlled by variation 
of the polymer composition (e.g. ratio L-lactide, block-length, e.t.c.). Additionally to these 
neutral polymers, positively charged and negatively charged biodegradable and bioresorbable 
polymers based on a poly(vinyl alcohol) (PVA) block and graft copolymers (synthesised in 
the group of Prof. Dr. T. Kissel) are tested for the encapsulation of dexamethasone, 
salbutamol free base and budesonide. Spherical particles with smooth surface morphologies 
made of charged polymers prove to be advantageous for the encapsulation of dexamethasone 
and budesonide. Reduced drug release during the first 30 min as well as enhanced retardation 
can be shown for these formulations. In the case of salbutamol free base uncharged 
hydrophobic polymers like PLGA seem to be advantageous as they present slightly lower 
primary drug release. Formulations in the inhalable size range with drug loadings ranging 
from 3.9 to 8.7% are achieved for all three drugs with some of these showing retarded release 
over 24 h. Particles are redispersable using a commercially available inhalation system and 
cascade impactor experiments illustrate the aerodynamic diameter of such electrosprayed 
particles and their deposition pattern in the human lung. A Fine Particle Fraction containing 
28.35 % of the encapsulated drug is determined by analyzing the deposited particles and 
quantifying the encapsulated drug. These results demonstrate great promise for nanoparticles 
and nanofibers in future medicine and pharmacy generated by electrostatic processes. 
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Chapter 1: Introduction 
The impact of nanotechnology on the field of medicine and pharmaceutics is a multifactorial 
and multilevel concern. Nanomedicine is an offshoot of nanotechnology and refers to highly 
specific medical intervention at the molecular scale for curing diseases or repairing tissues 
[1]. Artificial nanostructures, such as nanoparticles and nanodevices, being of the same size as 
biological entities, can readily interact with biomolecules on both the cell surface and within 
the cell. Novel therapeutic approaches gained increasing importance and will further 
modernize today‘s medicine. Especially cell-based therapeutics is one of the most rapidly 
growing fields in translational medicine. It stands at the intersection of a variety of rapidly 
developing disciplines, including biomaterials, tissue engineering and stem cell biology. Cell-
based therapeutics has great potential to treat both genetic and acquired diseases [1]. Tissue 
engineering is one example of cell-based therapy. Especially nanotechnology provides a 
promising opportunity for tissue engineering as it may enable molecular-level or nanoscale 
control over performance of cells (as desired for modern cell-based therapeutics). To 
understand and explain the importance of nanoscaled objects we have to focus on the complex 
structure of functional tissues and organs found in living organisms. Extra cellular matrix 
(ECM) is the natural scaffold for cells, and has an important role in tissue and organ growth. 
Besides providing physical support for cells native ECM also provides a substrate with 
specific ligands for cell adhesion, migration and regulates cellular proliferation and function 
by providing various growth factors. One (and for shure the most well known) feature of 
native ECM is the nanoscale structure. Therefore, tissue engineering scaffolds require 
fabrication of biomaterials that mimic ECM‘s three dimensional structure with defined shapes 
and complex porous architecture facilitating and promoting tissue regeneration by offering 
adhesive ligands and releasing growth factors. Mimicking the biological microenvironments 
is the straight-forward way for engineering tissues from cells. Cells are inherently sensitive to 
local mesoscale, microscale,
 
and nanoscale patterns of chemistry and topography [2]. In 
general, scaffolds with large surface areas, porous structures, and interconnected pores best 
facilitate cell attachment and tissue growth. Consequently, tissue engineering fabrication 
methods have favored the production of salt-leached foams and electrospinning of fibers to 
generate porous polymeric scaffolds. Among the numerous techniques for the production of 
nanofibers especially electrospinning raised promise for biomedical applications due to its 
simplicity and the capability of creating continuous fibers. Yoshimoto et al. explored the use 
of electrospinning to develop nonwoven for tissue engineering and showed that the cell 
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growth occurred throughout scaffolds, suggesting that electrospun degradable polyester like 
PCL and poly(lactide) has tremendous potential as a scaffold material [3, 4]. Recently, 
electrospinning was adapted to synthesize nonwoven meshes of collagen and collagen-
polyethylene oxide (PEO) fibers producing nontoxic, mechanically robust structures without 
denaturing the collagen fibers [5]. Bioactive polymeric scaffolds, which are a prerequisite for 
the ultimate formation of functional tissues, have been produced by melt spinning and 
electrospinning and seem very promising as this approach exceeds the concept of 
biocompatibility by actively interacting with the living organism [6]. Electrospinning allows 
fiber formation down to the 10 nm scale. One difficulty in nanofiber applications in medicine 
has been in placing and keeping the fiber or/and scaffold at the side of the injury [7]. Vital 
issues of graft acceptance and survival must be addressed in any successful tissue engineering 
therapy. While autologous grafts provide the only current method to ensure immune 
compatibility, cell-seeded allogenic and a cellular xenogenic implants have been successfully 
utilized in a number of applications [9]. Artificial skin is another application for electrospun 
fibers. For patients with extensive full-thickness burns, laboratory expansion of skin cells to 
achieve barrier function can make the difference between life and death, and it was this acute 
need that drove the initiation of tissue engineering in the 1980s [1]. Tissue-engineered skin 
based on electrospun fibers of about 10 µm thicknesses and a packing fraction of 0.1 with 
precultivated keratinocytes, fibroblasts and endothelial cells has now become a reality [10]. 
Nowadays synthetic biomaterials still represent oversimplified mimics of natural ECMs 
lacking the essential natural temporal and spatial complexity. Growing symbiosis of materials 
engineering and cell biology may ultimately result in synthetic materials that contain the 
necessary signals to recapitulate developmental processes in tissue- and organ-specific 
differentiation and morphogenesis [7]. Usually, two-dimensional sheets of randomly arranged 
fibers are created by the process, but Daming Zhang and Jiang Chang have developed an 
approach that could produce three-dimensional fibrous structures. A wide range of structures 
can be made through this approach, providing opportunities for applications in tissue 
engineering, blood-vessel reconstruction and filtration [11]. 
Besides nanofibers which are commonly associated to the extra cellular matrix, nanoscaled 
particles raised hopes for certain medical applications like targeted and controlled drug 
delivery. Reducing objects to nanoscale dimensions is capable of altering both physical 
properties and interactions with living organisms on the cellular level. Ideally, controlled drug 
delivery should be concentrated selectively in the targeted cells or organelles of the body 
before drug release begins following the local real-time demand for therapy [12]. At this 
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stage, colloidal drug carriers including nanoparticles, emulsions, liposomes, and micelles are 
investigated for their therapeutical potential. Generally, common characteristics of all these 
particles are that they can increase the specificity towards cells or tissues and improve 
bioavailability of drugs by increasing their diffusion through biological membranes. 
Additionally, encapsulation of the active molecules protects them against enzymatic 
degradation and denaturation in the case of protein based drugs on their way to the target 
location. The term nanoparticles has been introduced for solid submicron drug delivery 
systems with diameters between 1 nm and 1,000 nm [13, 14, 15]. Several different approaches 
in the fabrication of polymeric nanoparticles include surface modification and sterical 
stabilization [16, 17, 18, 19, 20, 21]. Recently, another technique (electrospraying) for the 
generation of monodisperse nano- and micro-particles attracted the interest of researchers in 
the biomedical and pharmaceutical field. The disruption of a liquid into a spray of charged 
droplets, when subjected to an intense electric field, has attracted considerable interest from 
both a fundamental and applied point of view [22]. Such elctrohydrodynamic (EHD) tip 
streaming or cone-jetting phenomena, which are often referred to as electrospraying, occur 
when a liquid precursor, either pure solvent, polymer solution, polymer/drug solution, or 
certain polymer melts, and is subjected to sufficient electric field [23]. Already in the 90‘s 
electrospraying was used in the production of excipient-free microspheres of cholesterol for 
drug delivery [24]. Up to now several attempts have been made to encapsulate proteins in 
polymeric nanoparticles by electrospraying. A comprehensive investigation was conducted on 
the effects of independent variables organic/aqueous phase volume ratio and Bovine Serum 
Albumin (BSA)/ poly(lactic acid) (PLA) weight ratio on the dependent variables viscosity, 
electrical conductivity, surface tension; the morphologies, sizes, and yields of particles; BSA 
encapsulation efficiency; and in vitro release [25, 26, 27]. A large variety of different drugs 
and polymers have been investigated up to now [28, 29, 30, 31, 32, 33, 34]. Besides the 
generation of solid nanoparticles, the production biphasic Janus particles with nanoscale 
anisotropy [35] has been reported and enables to combine the properties of several materials 
on the surface of one particle in locally seperated areas. In a process similar to the 
electrospraying of a single fluid, Loscertales et al. generated a coaxial jet of two immiscible 
fluids. Jet breakup results in an aerosol of monodisperse compound droplets with the outer 
liquid surrounding or encapsulating the inner one[36]. 
Electrostatic processes are currently gaining increasing importance in nanotechnology as well 
as in medicine and pharmaceutics. In combination with cell-based therapies as tissue 
engineering and for the genertaion of nanoscaled structures for controlled drug delivery 
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electrostatic processes show great promise and cost effective solutions. Even thou today‘s 
developments on the atomistic and nano-scale fabrication have already been predicted by 
Richard Feynman (Nobel Laureate in Physics,1965) since 1959, still today ―there is plenty of 
room at the bottom‖ [37]. 
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Contents of this thesis 
 
This thesis concerns nano- and micro-structures generated by electrostatic processes like 
electrospinning and electrospraying as powerful tools in medical and pharmaceutical 
applications, for specific interaction with living cells in a tissue engineering approach and 
pulmonary drug delivery combined with controlled and retarded drug release. 
 
Chapter 2 gives a brief overview on the history, and theory of electrostatic processes and 
their applications. 
 
Chapter 3 describes the preparation and characterization of melt-electrospun poly(propylene) 
submicron fibers and discusses possibilities to control fiber diameters. 
 
Chapter 4 concerns structure formation and crystallization during electrospinning 
poly(propylene) from melt. 
 
Chapter 5 presents the possibility to generate biofunctionalized poly( -caprolactone)-block-
poly(ethylene glycol) fibers scaffolds for tissue engineering. 
 
Chapter 6 concerns the control of protein adsorption on electrospun poly(D,L-lactide)-block-
poly(ethylene glycol) nanofibers. 
 
Chapter 7 is a study about thiol reactive poly(D,L-lactide)-block-poly(ethylene glycol) fibers 
and their capability to specifically interact with cells. 
 
Chapter 8 describes a simple and versatile method for the production of bioactive electrospun 
fibers consisting of a mixture of isocyanate terminated star shaped poly(ethylene glycol) and 
poly(lactide-co-glycolide). 
 
Chapter 9 presents the response of keratinocytes on different bioactivated electrospun fibers 
based resorbable polymers. 
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Chapter 10 is a study about the influence parameters on the generation of monodisperse 
resorbable particles by electrospraying. 
 
Chapter 11 concerns drug encapsulation by electrospraying for pulmonary drug delivery and 
adjusting their release behavior. 
 
Chapter 12 shows the effect of differently charged polymers on drug encapsulation by 
electrospraying for three different model drugs. 
 
The Appendixes describe the up-scaling of an electrospraying device towards continuous 
collection of dry powders (Appendix A), and a method for the qualitative evaluation of 
protein adsorption on various electrospun fibers (Appendix B). 
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Chapter 2: State of the art 
Electrostatic Processes 
Charges are basically involved in any known spray process such as spindrift, salt water 
droplets emanating from the sea surface [1] as well as water fall droplets [2]. These particles 
are charged due to the natural electric field of the earth (130 V/m). There is a great influence 
of droplet breakup of seawater bubbles bursting on the surface onto electric charging of the 
atmosphere [1]. The droplets are mainly positively charged leaving the earth with a negative 
potential. Droplet breakup is also one reason for charge separation in clouds which is leading 
to lightning in thunderstorms. Unlike the break up of a jet subjected to an external electric 
field into droplets is the opposite effect called ―Lenard effect‖ named after the German 
physicist Phillip von Lenard who discovered the phenomenon charge production due to the 
increased electrical charge density near waterfalls [3]. Practically any droplet production 
process is also generating charges and the amount of charges produced depends on the 
concentration and mobility of free ions in the liquid [4]. On the other hand the productions of 
charged droplets with an external electric field present during the breakup process are more 
evident and effective than natural charging and have been studied extensively. Nowadays 
electrostatic processes have become state of the art in many industrial fields including 
agriculture, varnishing, powder coating, pollution control, filter production and many more. 
Generally all electrostatic spraying (commonly referred to as electrospraying) and 
electrostatic spinning (electrospinning) processes are derived from the same underlying 
physical principles. A wide range of distinctly different morphologies and structures can be 
produced by electrostatic processes ranging from polymeric coatings to particles and 
continuous fibers (see Figure 1). 
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Figure 1: Different morphologies and structures produced by electrostatic processes. 
 
A brief history on electrospraying and electrospinning 
Over 400 years ago, Gilbert [5] was the first to show that a droplet of water on a smooth 
surface can be extended into a cone if a piece of rubbed amber is held at a suitable distance 
from it. In 1745, Bose [6] was the first to describe the process of electro-hydrodynamic 
spraying of fluids. It has also been illustrated in Nollet's work on the life sciences. Sigaud-
Lafond, who succeeded Abbé Nollet (1730-1810) to the chair at the Collège Louis-le-Grand 
reported on experimental investigations on charged liquids [7]. Figure 2 is an very early 
illustration of charged water spraying, extracted from Jacquet de Malzet's 1775 Précis de 
l'électricité. 
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Figure 2: Illustration showing a first experimental set up for the generation of charged 
water droplets. 
 
A few centuries later, in 1882, Raleigh [8] furthered the study by examining thin liquid jets in 
electric fields and their stability criterion. Since then, it has been the focus of many scientists 
to not only understand this process but to develop a method in which to utilize it to its fullest 
extent. Zeleny‘s did the first systematic investigations during the early years of last century 
[9]. His experiments focused on the causes leading to the eventual break-up of the jet once it 
has left the capillary in a high electric field. It was only a matter of time before these 
principles were applied to materials with higher and higher viscosities. In 1934, Anton 
Formhals was the first to patent a procedure that utilized electrostatic means to produce 
micrometer diameter fibers of cellulose acetate from solution [10]. This was only the first of 
several patents by Formhals on the topic of electrospinning and fiber production. Formhals 
modified the existing electrostatic spinning apparatus to allow collection of continuous fibers 
through the used of a drum take-up. For several decades after these patents was issued to 
Formhals, neither a theoretical understanding nor real applications were assigned to this 
process (except for gradual studies on the behavior of the fluid jets in the presence of an 
electric field). Research on electrostatic process made tremendous progress during the second 
half of the last century. The impulse which activated this progress was given by Vonnegut and 
Neubauer [11] who shoed in 1952 that a monodispersity of droplet sizes could be obtained 
within the range of 1.0-0.1 micrometer. This work proved that elctrohydrodynamic spraying 
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was capable of being manipulated within an electric field and as a result, numerous authors 
ventured into the field.  
A few decades later (1969) Sir Geoffrey Taylor [12] published a paper explaining the effect of 
an electric field on the geometry of a viscous liquid droplet suspended at the end of a 
capillary. The formation of a cone shape (Taylor Cone) followed by a jet forming at the apex 
was observed when the applied electric field overcomes the surface tension of the liquid 
droplet. Afterwards, Baumgarten [13] was the first to take the initiative in applying the 
electrostatic atomization techniques to synthetic polymer solutions. The study highlighted the 
effects of solution viscosity, surrounding gas, flow rate, etc. on the fiber diameter and jet 
length. He found that as viscosity of the solution increased, the diameter of the resultant fibers 
increased with a power law of ~0.5. In addition, the effect of electrical conductivity of the 
polymer solution on the spinning mechanism and spinning velocity were also discussed. In 
this study, the stability region of the jet was found to increase with increasing viscosity and 
this also directly affected the diameter of the collected fiber. From this time there is a 
separation between research on electrospraying (at this time still called electrostatic spraying) 
and electrospinning (electrostatic spinning). Therefore, we will first describe the important 
developments for electrospraying and later focus on electrospinning. Hayati and Tadros [14] 
studied the effect of electric field and the environment of pendent drops and the ability to 
form stable jets. They found that the conductivity of the liquid was a major factor in 
determining the onset of the jet disruption. Highly conductive fluids dripped from the 
capillary and when the voltage was increased above a critical value broke into many droplets. 
When using insulating materials, no electrostatic forces built up at the interface. In the case of 
semi-conducting fluids (conductivity in the range of 10-6 – 10-8 Ω-1m-1), it was possible to 
form stable jets erupting from a conical base. When the voltage was increased, the cone height 
decreased and at the same time the angle of the cone decreased. The liquid is flowing through 
the metal capillary exit where the high electric field accelerates the liquid resulting in jets that 
break up into droplets. Depending on liquid properties, applied potential and setup geometry 
different electrospray modes appear. In more recent years, Hayati [15, 16] and, after 1990, 
Grace and Marijnissen [17] have summarized the theoretical understanding of the 
electrospraying process. They went into detail on the effects that flow rate, applied potential, 
capillary size, and fluid properties such as surface tension, fluid conductivity, and viscosity 
have on the modes of the EHD process. In 1998, Jaworek [18] studied the combination of the 
above effects and described the particular modes that can be obtained from them. His work 
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shows the formation of eight different modes of electrospraying. Among these modes the one 
most important for the production of monodisperse sprays is the cone-jet mode. 
The next important progress for electrospinning was made by Larrondo and Manley. 
Extending the concept of electrospinning from solution to melt, Larrondo and Manley [19, 20, 
21] published work describing the production of fibers from a solution of polyethylene in 
paraffin and, perhaps more importantly, molten polypropylene. It was the first time that 
anyone demonstrated fibers can be electrostatically spun from the melt. Up to now, still nearly 
all research has been focused on electrospinning of a polymer solution. As they extended the 
electrospinning concept to processing of melt. An increase in melting temperature decreases 
the viscosity of the polymer due to higher molecular mobility thereby decreases the diameter. 
Up to this point most of the studies were concentrated in the understanding of the electrostatic 
atomization process and development of mathematical models relating the physical variables 
that affect the formation of the droplets and liquid jets. In 1995, electrospinning of fine fibers 
of Kevlar was attempted by Srinivasan and Reneker [22]. Kevlar fibers were dissolved in 
sulfuric acid and electrospun into a grounded water bath where the fibers were formed by 
coagulation. This study was followed by an in depth investigation of the electrospinning of 
nanofibers from polymer solutions and their potential applications were provided in Doshi 
and Reneker‘s paper [23] on the production of fibers from aqueous polyethylene oxide (PEO, 
Mw = 145,000 g/mol) solutions having diameters in the range of 50nm to 5μm. Especially the 
cumulative contributions of Reneker et al. over a period of almost two decades initiated 
today‘s interest in electrospinning as method for the production of nanofibers. Firstly, Doshi 
[23] stated that evaporation of the solvent occurs, which leads to a dramatic reduction in 
diameter, considering that most solutions are around 90% solvent by weight. Another reason 
for the decrease in diameter is proposed to be the instability region which has been attempted 
to be explained by several authors [24, 25, 26, 27, 28, 29, 30, 31]. These researchers state that 
the whipping action is needed in order to accelerate the jet in order to stretch it and 
significantly reduce its diameter. It has been shown by Jäger [32] that as the fiber diameter is 
decreased, the mechanical properties of the fiber increase exponentially as a result of the 
decreased probability of surface flaws. Nanofibers were successfully spun from a whole 
variety of polymer systems such as high performance polymers, liquid crystalline polymers, 
polymers important for textile fibers, electrically conducting polymers, as well as 
biopolymers. Although the process of electrospinning has been known for over half a century, 
the current understanding of the process and those parameters is very limited. 
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Description of the electrospraying and electrospinning process 
Electrospraying and electrospinning are unique approaches using electrostatic forces to 
produce fine particles and fibers. Electrospraying and electrospinning are processes by which 
a polymer solution or melt can be processed into smaller diameter particles and fibers using a 
high potential electric field. This generic description is appropriate as it covers a wide range 
of structures with submicron diameters that are normally produced by both processes. If a 
liquid or melt is subjected to an electrical field of sufficient strength, the shape of a droplet of 
this material will change into a cone and above a certain critical voltage either electrospraying 
or electrospinning will occur. Either a jet is ejected from the apex of the cone under the 
influence of an electric field or droplets can be expelled. If a jet breaks up into droplets 
depends on several parameters. These parameters influence the morphology and obtained 
structure. The parameters can be broadly classified into spinning solution parameters (e.g., 
molecular weight, solution viscosity, solution conductivity and dielectric effect) and 
processing condition parameters (e.g., applied voltage, distance, and type of collector) and 
independent parameters (surrounding atmospheric conditions) and will be discussed in detail 
later. These parameters largely determine whether (and if) electrospraying or electrospinning 
will occur. A process is called electrospraying if an electric force applied to a liquid droplet 
results in the break up of this primary droplet and subsequently generates a spray of finer 
charged droplets. The electrical shear stresses created on the surface of a hemispherical 
droplet protruding from a capillary overcome the surface tension of the droplet and extend the 
droplet into a conical shape (see Figure 3).  
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Figure 3: Liquid droplet at the tip of a capillary distorted to a conical shape with a 
thin jet developing at the apex of the cone [33]. 
 
Subsequently, a resultant jet is released from the capillary that eventually breaks up into tiny 
droplets. These droplets can be smaller then one micrometer in size and are smaller then the 
droplets made from conventional mechanical atomizers. This non mechanical, electrically 
driven technique can be extended to fiber with diameter ranging from less than 100nm to 
several micrometers by varying polymer concentration and spinning parameters if the shape 
of the stable jet is maintained. A high voltage is applied to a polymer solution, and generates a 
high electric field between a polymer fluid and a conducting fiber collection ground surface. 
Traditionally, electrospinning produces nanofibers in a random (non woven) arrangement, but 
several modification of the process to allow collection of aligned fiber bundles have been 
developed. 
When the voltage reaches a critical value, the charge overcomes the surface tension of the 
deformed drop (see Figure 3) of the suspended polymer solution formed on the tip of the 
spinneret, and a jet is produced. The electrically charged jet undergoes a series of electrically 
induced bending instabilities during its passage to the collection surface which results in the 
stretching of the jet. This stretching process is accompanied by the rapid evaporation of the 
solvent molecules, further reducing the diameter of the polymer jet. The generated forces, due 
to the electric field, to which the polymer, either as a melt or solution, is exposed to, are in 
some instances capable of drawing the fiber diameter into the nano regime. The dry fibers are 
accumulated on the surface of the collection plate, resulting in a non-woven mesh of nano-to-
micron diameter fibers. 
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The advantages of these electrostatic processes are their technical simplicity and their easy 
adaptability. The (basic) apparatus used for electrospraying and electrospinning are simple in 
construction, which consist of high voltage electric sources with positive or negative polarity, 
a syringe pump with capillaries or tubes to carry the solution from the syringe or pipette to the 
spinneret, and conducting collectors of various types. Recently more elaborated systems 
working without a syringe in order to increase productivity have been developed [34, 35]. 
These set ups will not be described as they are out of the frame of this chapter. The collector 
can be made of any shape according to the requirements, like a flat plate, rotating drum, etc. A 
schematic of an electrostatic process is shown in Figure 4. 
 
 
Figure 4: Schematic representation of an electrospinning/electrospraying apparatus (r, 
radius of the capillary; R, curvature radius of the electrode used) and Taylor cones. (a) 
Formation of Taylor cone in an applied electric field. (b) Taylor cone ejects fluid jet. 
(c) Surface tension causes cone shape to relax. In the case of electrospinning the jet 
stream starts out in stable straight region, and then becomes unstable, partly owing to 
charge repulsion, typically showing a whipping or spiraling motion [36]. 
 
Many previous researchers have used an apparatus similar to the one given in Figure 4 with 
modifications depending on process conditions to spin or spray a wide variety of fine particles 
and fibers. Polymer solution or the melt that has to be processed is forced through a syringe 
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pump to form a pendant drop of the polymer at the tip of the capillary. High voltage potential 
is applied to the polymer solution inside the syringe through an immersed electrode, thereby 
inducing free charges into the polymer solution. An electrostatic potential (typically up to 
approximately 30 kV) is applied between a spinneret and a collector; both are electrically 
conducting and often separated at a distance of 10–15 cm between the two, as shown 
schematically in Figure 4. A fluid is slowly pumped through the spinneret. The fluid is usually 
a solution, whereby the solvent can evaporate during the spinning process while the jet stream 
travels from the conducting spinneret (held at high electric potential) to the collector (e.g., a 
rotating drum at ground potential, although the polarity between the spinneret and the 
collector could be reversed; i.e., the spinneret could be at ground, and the collector at high 
electric potential). The collector can be covered with a removable substrate for easier 
harvesting of the deposited material. The surface of the fluid droplet held by its own surface 
tension at the spinneret tip gets electrostatically charged. The interactions of the electrical 
charges in the polymer fluid with the external electric field cause the droplet to assume a 
conical shape, known as the Taylor cone, as shown in Figure 4a. The electrode shape and the 
spinneret (capillary) diameter are designed to yield a very high electric field strength with an 
appropriate field gradient at the tip of the cone so that a fluid jet stream can be pulled out; i.e., 
when the surface tension of the fluid can be overcome, the droplet becomes unstable, and a 
liquid jet is ejected (Figure 4b). Subsequently, the surface tension causes the droplet shape to 
relax again, but the liquid jet continues to be ejected in a steady fashion (Figure 4c). The 
traveling liquid jet stream is subject to a variety of forces with opposing effects [23]. 
Electrostatic repulsion of the charges in the jet tends to increase its surface area. In the case of 
a cylindrical object like a fiber, this can be accomplished by reduction of the fiber diameter. 
Thus, the effect of electrostatic repulsion is similar to that of stretching by mechanical 
drawing in conventional fiber spinning. If the liquid is a solution and the solvent gradually 
evaporates, this effect is enhanced. Note that solvent evaporation changes the concentration 
and thus the viscosity of the liquid jet. On the other hand, as in any liquid, the surface tension 
tends to reduce the total surface of the jet, but not by keeping the fiber diameter large. What 
usually occurs is an instability that causes the jet to break up into droplets, each with a 
surface-minimizing spherical shape. This effect is known as Rayleigh instability [8]. Which of 
these two opposing effects prevails depends on the nature and the mechanical properties of 
the fluid, especially its viscosity and surface tension. If the viscosity is sufficiently high and 
the fluid contains long-chain molecules, the fluid jet stream diameter will continuously shrink 
to very small values until the essentially dried filament is eventually deposited onto the 
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collector, and at the same time, the solvent is evaporated along the jet stream pathway. This is 
the situation desired for electrospinning. Low-viscosity liquids cannot pose much resistance 
against the Rayleigh instability and tend to break up into droplets. If there are no chain 
molecules or they are not long enough to prevent a complete break up, discrete spherical 
droplets are formed. These charged droplets repel each other electrostatically and are, thus, 
prevented from coalescing. If there is a solvent involved, it continues to evaporate after the 
break up into droplets. The increasing charge density on the surface of the shrinking droplets 
can cause them to explode into even smaller droplets. This is the situation desired for 
electrospraying. Recently, Long and coworkers have demonstrated that high molecular 
weights are not essential for the electrospinning process if sufficient intermolecular 
interactions can provide a substitute for the interchain connectivity obtained through chain 
entanglements [37]. Using this principle, these researchers were able to electrospin oligomer-
sized phospholipids from lecithin solutions into nonwoven membranes. If the conditions of 
the sample are such that a Rayleigh instability occurs for long-chain molecules that cannot be 
easily broken up into discrete droplets, e.g., when the polymer concentration is above the 
overlap concentration, a ―pearls-on a-string‖ morphology, also known as ―beading,‖ can be 
formed. The occurrence of beading depends on the processing variables [38], especially the 
viscosity and the surface tension and, thus, on the concentration of the polymer solution. Note 
that charge density can be fine-tuned by, for example, salt addition. The strong repulsion due 
to high surface charges may, in principle, also be utilized to initiate a bifurcation process in 
which the jet stream (filament) is spatially separated into subfibers (―splaying‖), but this is 
normally not the case. 
Parameters influencing the electrostatic processes (electrospraying & electrospinning) 
From the previous description of theory, it is clear that the electrospinning process can be 
manipulated by a number of variables. Doshi and Reneker classified the parameters that 
control the process in terms of solution parameters, process parameters, and ambient 
parameters [23]. Solution parameters include the viscosity, conductivity, surface tension, 
polymer molecular weight, dipole moment, and dielectric constant. The effects of the solution 
properties can be difficult to isolate since varying one parameter can generally affect other 
solution properties. Process parameters include the flow rate, electric field strength, distance 
between tip and collector, needle tip design, and collector composition and geometry. 
Ambient parameters include temperature, humidity, and air velocity [39]. 
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Solution parameters 
Viscosity is the measure of resistance to flow. Therefore, it is obvious that viscosity plays a 
major role in electrostatic processes. In electrostatic processes, electrospraying and 
electrospinning, a liquid (pure solvent, solution or melt) is subjected to a high voltage electric 
field, which causes a flow and transport directed by the electric forces. Solution viscosity (as 
controlled by changing the polymer concentration and molecular weight in a given solvent) 
has been found to be one of the biggest determiners of structure and morphology when 
processing a precursor solution or melt. When electrospraying/electrospinning a polymer 
solution, the viscosity largely determines if particles or fibers are obtained and influences 
their size and morphology. The relationship between the polymer viscosity and/or 
concentration on fibers obtained from electrospinning has been studied in a number of 
systems, [40, 41, 38, 42, 43, 44, 45, 46, 47, 48, 49] including many polymers relevant for 
biomaterial applications such as poly(DL-lactic acid) (PDLA), poly(lactic-co-glycolic acid) 
(PLGA), and mainly poly(ethylene oxide) (PEO). Several attempts have been made to 
quantify the minimum polymer concentrations and viscosities required to electrospin fibers. 
Those minimum concentrations needed to prevent the break up of the liquid jet into droplets 
are dependent on the polymer and its molecular weight. Therefore, for different polymers 
different minimum concentrations were identified. For example, Koski et al. found that it was 
possible to spin PVA as long as [η]c > 5 where [η] was the intrinsic viscosity and c was the 
concentration [44], whereas for PEO, it was found that solutions with [η]c > 10 allowed for 
spinning [42]. In later studies the concentrations used for electrospinning have been correlated 
to the entanglements of the polymer chains in solution. McKee et al. found that a 
concentration greater than the entanglement concentration, ce, was required to spin linear and 
branched poly(ethylene terephthalate-co-ethylene isophthalate) (PET-co-PEI) [50]. As 
mentioned previously, the two most important factors that affect the viscosity of the spinning 
solution are the molecular weight and the concentration of the organic or inorganic polymer 
solution used to spin or spray. Here the molecular weight reflects the length of individual 
molecular chains. As the molecular weight of the solution increases, the chain entanglement 
increases and hence, the viscosity increases. Generally, concentrations below 1 time the 
entanglement concentration result in electrospraying, whereas concentrations above result 
either in beads and fibers or at significantly higher concentrations lead to fibers only. 
Solutions with concentrations 2-2.5 times the entanglement concentration yielded uniform, 
bead-free fibers. Recently, Gupta et al. focused on the relation between the entanglement of 
polymer chains and the obtained structures. They synthesized PMMA varying in molecular 
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weight from 12.47 to 365.7 kDa and determined the critical chain overlap concentration, c* 
[48]. They determined that when the solution concentration was less than c* there was 
insufficient chain overlap to form polymer fibers; at all conditions, droplet formation was 
observed. In the semi-dilute region (concentrations between c* and ce), beading was 
occasionally observed. At concentrations approximately double ce, uniform, bead-free fibers 
were obtained. Upon electrospinning, they found as the molecular weight increased, the 
number of beads and droplets was reduced. When the spinning solution leaves the pipette tip 
during electrospinning, the solution is stretched as it travels towards the grounded metal plate. 
During the stretching, the large molecular chains present inside the solution entangle among 
each other and, prevent the spinning solution from breaking up into droplets. The increase in 
the concentration of the molecules present in the spinning solution also causes greater extent 
of chain entanglement and, causes increase in viscosity of the solution. As a result, low 
viscosity or monomeric solutions do not form fibers but generate particles or polymeric 
layers. Many researchers found the diameter of the fibers produced by electrospinning to 
increase with increasing solution concentration [51, 38, 50, 52, 53]. For example, PLLA fibers 
with diameters of 100-300 nm were produced from 1 wt% solutions while 5 wt% solutions 
yielded 800-2400 nm fibers [54]. It was found that an increased fiber diameter correlated 
directly to a decrease in the surface area of electrospun mats [53]. 
Surface tension (SF) is another property that affects the morphology of the electrospun fibers. 
SF has the effect of decreasing the surface area per unit mass of a fluid. Here during 
electrospinning, the solvent present in the spinning solution has a tendency to congregate 
together, and induce the formation of spherical beads in the fibers. As the viscosity of the 
solution is increased, the solvent molecules tend to interact with the polymer molecules rather 
than among each other, hence, reducing the tendency to form beads, thus producing more 
uniform and smooth fibers [43]. PHBV solutions with different surface tensions and similar 
conductivities were obtained using triethylbenzyl ammonium chloride, and it was found that 
beading was affected by the surface tension [55]. The addition of ethanol to PEO and PVA 
solutions lowered the surface tension [43, 45]. In the case of the PEO, the solution containing 
ethanol exhibited less beading. 
The conductivity of the spinning solution also plays a role in the morphology of the fibers. 
The conductivity is increased by addition of small amount of salts or polyelectrolyte into the 
spinning solution. As the charge of the spinning solution is increased, the repulsion of the 
charges on the surface of the fibers causes the fibers to extend and hence, causes a decrease in 
diameter of the collected fibers. Zhang et al. showed that PVA fiber diameters were decreased 
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from 214 ± 19 nm to 159 ± 21 nm when NaCl concentration was increased from 0.05 to 0.2% 
(spinning conditions: solvent = water, voltage = 5 kV, distance to collector = 10 cm, flow rate 
= 0.2 mL/h) [45]. Zong et al. studied the effect of the addition of various salts (NaCl, 
KH2PO4, NaH2PO4) to PDLA solutions [45]. They found that salts with smaller ionic radii 
produced smaller fibers (210 nm) while salts with larger ionic radii yielded larger ones (1000 
nm). They attributed this difference to the higher charge density, and thereby mobility, of ions 
with smaller radii; the higher mobility resulted in increased elongational forces exerted on the 
fiber jet yielding a smaller fiber [40]. 
The dielectric constant of the solvents used in the spinning solution also plays an important 
role in fiber diameter. As the dielectric constant of the solvent increases, the diameter of the 
fibers is found to decrease [42]. It has been found that increasing the solution conductivity or 
charge density can be used to produce more uniform fibers with fewer beads present [56]. 
One approach to increasing solution conductivity has been through the addition of salt; for 
fibers spun from PEO, collagen type I-PEO, polyacrylic acid (PAA), polyamide-6, and 
PDLA, uniformity increased and beading decreased upon the addition of salt. 
Just a few studies focused on the effect of dipole moment and dielectric constant on the 
obtained structures and morphologies. The spinning of polystyrene was studied in 18 different 
solvents, and the only solvents found to be used successfully had high values of dipole 
moment [49]. 
 
Process Parameter 
Other parameters that affect an electrostatic process, especially the structure and morphology 
of the layers, particles, and fibers are the external properties that include the applied voltage, 
flow or feed rate, and the distance between the tip and collector.  
The applied voltage is one of the crucial properties for an electrostatic process. As a certain 
critical voltage is needed in order to form a stable Taylor cone, the applied voltage triggers the 
on-set of any electrospraying or electrospinning process. Additionally, the applied voltage has 
crucial impact on the size of the obtained structure (whether it is the fiber diameter or particle 
size). The high voltage induces the required charges in the precursor solution along with the 
external electric field, which causes an increase in the electrostatic force that overcomes the 
surface tension of the solution and forms particles and fibers. Research has shown that an 
approximate voltage of 6 kV is enough to distort the drop of an aqueous spinning solution at 
the tip of the pipette to form a Taylor Cone during jet initiation [12]. Further increase in 
voltage causes faster jet formation. If the voltage is increased to 30 kV, the Taylor Cone at the 
- Chapter 2 - 
  41 
tip of the syringe recedes, due to the increase in speed of liquid ejection. The rate at which the 
solution reaches the tip of the syringe is termed the feed-rate. 
For a given voltage, there is a corresponding feed rate required for a steady Taylor Cone to be 
maintained. This formation of a stable cone corresponds to the formation of homogeneous and 
monodisperse structures. Grigor‘ve et al. developed a theory for the production of 
monodisperse particles by electrostatic spraying of liquids in 1995 based on the 
thermodynamics of the process in which they conclude that monodispersity can only be 
achieved using the corresponding voltage and flow rate [57]. Therefore, these two can not be 
strictly separated, as they are dependent parameters. Thus if the feed rate is not matched to the 
speed of fiber formation, instability in the fiber formation is noticed, which further causes 
bead formation. An idle situation is such that the speed of jet formation matches the feed rate 
in such a way that the Taylor Cone at the tip of the pipette is not disturbed during the entire 
electrospinning process [31, 58]. Especially for electrospinning just few studies have 
systematically investigated the relationship between solution feed or flow rate on fiber 
morphology and size. In general, it was found that lower flow rates yielded fibers with smaller 
diameters [40]. Flow rates that were too high resulted in beading. 
Varying the distance between the tip and the collector has been examined as another approach 
to controlling the fiber diameters and morphology. Thick and flat fibers are obtained when the 
distance of the tip of the pipette is too close to that of the collector. It has been found that a 
minimum distance is required to allow the fibers sufficient time to dry before reaching the 
collector [59]. This is because the solvents present in the fiber jet do not have enough time to 
evaporate, and hence, the fibers are still wet when deposited on the collector, which causes 
the fibers to blend or stick together. At distances that are either too close or too far, beading 
has been observed [51]. As the spinning distance is increased, the flight time of the jet also 
increases and the fiber diameter decreases. As various designs of 
electrospraying/electrospinning configurations are described in literature, a comprehensive 
review is out of the frame of this chapter. Therefore, we like to focus just on the most 
common nozzle and collector configurations. 
Besides the simple blunt-tip stainless steel capillaries commonly used, several designs and 
configurations of needle tips have been investigated for the electrospinning process. For 
example, Li and Xia developed a coaxial, two-capillary spinneret [60]. They also used this 
spinneret to prepare blends of polymers. Similar nozzle configurations have been extensively 
used for electrospraying as well [61, 62, 63, 64]. More recently, Lahann et al. developed a 
variation of such a two-capillary nozzle, where both capillaries are positioned aside to gain 
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biphasic Janus particles combining the physical properties of both polymers [65]. Using feeds 
consisting of two immiscible liquids, they were able to produce hollow nanofibers. In order to 
up-scale the production of fibers or particles by electrostatic processing, the use of multi-
capillary systems has been investigated. The use of multiple tips was described as a way to 
increase the throughput and production rate of electrospinning of PEO [66]. Similar 
developments in order to achieve increased throughput have been studied for electrospraying. 
Besides these up-scaling approaches, apparatures working without any nozzle are already 
commercially available and allow increased production rates [34, 35]. 
On the other side, the type and shape of the fiber collector plays an important role in obtaining 
non-woven, oriented fibers, nanofiber yarn, fibers in the form of mats, three dimensional 
scaffolds, etc. The most common method used to collect nanofibers is a flat metal plate, 
through which films or mats of nonwoven fibers are obtained. For oriented fibers, either 
rotating conductive cylinders or the ―gap-method‖ are utilized. The fibers are also collected 
on high speed rotating cylindrical collectors, through which aligned and small diameter fibers 
are obtained. Knife edge disc, wire cage rotating drum, and patterned silicon wafer collector 
are some of the other examples of fiber collecting device [67, 68, 69, 70, 71]. 
 
Ambient or independent parameters 
Few studies focused on the effects of ambient parameters like humidity, temperature, 
atmosphere composition and pressure on electrostatic processes. The morphology of the 
electrospun fibers is also affected by the percentage of humidity. The surface of the 
electrospun fibers tends to form pores if the humidity is above a certain percentage. This 
could be attributed to the water on top of the fiber surface. As the humidity increases, the 
pores on the surface of the fibers also increase due to the evaporation of water [72]. Increasing 
the humidity resulted in the appearance of small circular pores on the surface of the fibers; 
increasing the humidity further lead to the pores coalescing. 
Mit-Uppatham et al. spun polyamide-6 fibers at temperatures ranging from 25 to 60°C [73]. 
They found that increasing the temperature yielded fibers with a decreased fiber diameter, and 
they attributed this decline in diameter to the decrease in the viscosity of the polymer 
solutions at increased temperatures. 
Spinning has also been performed under vacuum in order to obtain higher electric fields; 
doing so produced fibers and yarns with larger diameters [74, 75]. 
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Biomedical and pharmaceutical applications of electrostatic processes 
Today, there is a number of ways to produce sprays for various technical and scientific 
applications. Originally, in electrosprays the liquid is disintegrated by the applied electric 
potential only. The motivation for technical application of charged droplets and electrified 
sprays can be found in the possibility to control droplet transport, evaporation and life time by 
applying external electric fields. The advantage for deposition purposes is evident as the 
droplets can be directed to the wanted location of impact by tailoring the external electric 
field. Deposition is one of the main applications due to the intrinsic high deposition efficiency 
[76]. Electrospray painting is an established process e.g. in automotive industry [77]. But as 
variable as electrified sprays are their applications. Controlled particle formation [78], 
application in car engines for fuel injection [79] or medical sprays are under investigation 
[80]. Since the 40s of the last century there is ongoing development of devices for crop 
spraying [81]. Electrostatic force fields are currently exploited for beneficially increasing the 
deposition efficiency of finely divided particulate matter used as inputs in the production and 
processing of food and fiber crops satisfying basic human needs. Today technical 
implementation of reliable dust- and spray-charging methods as well as various systems for 
electrostatic deposition of agricultural particulates has been implemented in order to increase 
yields [82]. Electrostatic precipitators and pesticide sprayers are some of the well known 
applications that work similarly to the electrospinning technique. Fiber production using 
electrostatic forces has invoked glare and attention due to its potential to form fine fibers. 
Electrospun fibers have small pore size and high surface area. There is also evidence of 
sizable static charges in electrospun fibers that could be effectively handled to produce three-
dimensional structures. Polymeric nanofiber matrices have been extensively investigated for 
diversified uses such as filtration, advanced textiles composites, electronics devices, wearable 
electronics, barrier fabrics, wipes, personal care, biomedical and pharmaceutical applications. 
Recently electrospun nanofiber matrices have gained a lot of attention, and are being explored 
as scaffolds in tissue engineering due to their properties that can modulate cellular behavior 
[83]. Nanotopographical features can significantly alter cell behavior. Nanotopographical 
features namely pores, ridges, groves, fibers, nodes and combinations of these features 
influenced cellular adhesion [84], morphology [85, 86], proliferation [87], endocytotic 
activity [87], motility [88] and gene expression [89, 84] of various cell types. Several cellular 
activities such as adhesion, proliferation, migration, differentiation and cell shape are 
influenced by the ECM in which the cells reside [90, 91, 92, 93]. Electrospun nanofiber 
matrices show morphological similarities to the natural ECM, characterized by ultra fine 
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continuous fibers, high surface-to-volume ratio, high porosity and variable pore-size 
distribution similar to the dimensions of basement membranes. Electrospun nanofiber 
matrices present a dynamic system in which the pore size and shape can change when 
compared to other rigid porous structures. Laurencin and coworkers using mercury 
porosimetry determined PLGA nanofibers to have 91.63% porosity, a total pore volume of 
9.69 mL g
−1
, total pore area of 23.54 m2 g
−1
 and a pore diameter ranging from 2 to 465 μm 
[94]. Therefore, there has been tremendous effort to develop new applications based on 
materials produced by electrostatic processes in the biomedical and pharmaceutical field 
ranging from tissue engineering, grafts (blood vessel, tendon, nerve and mussel), anti-
adhesion barrier membranes to scaffolds for the delivery of bioactive agents and drugs. 
 
Tissue engineering 
Tissue engineering has emerged as an alternative treatment to traditional autografts and 
allografts for excessive skin loss. Such an approach involves scaffolds, cells and biological 
factors alone or in combination [95]. Electrospun nanofiber scaffolds due to their high surface 
area-to-volume ratio provide more surface for cell attachment compared to other structures 
from the same material. In addition, nanofiber scaffolds are extensively used as wound 
dressings since they protect the wound area from the loss of fluid and proteins, aid in removal 
of exudates, inhibit exogenous microorganism invasion, and improve appearance [96, 97]. 
Polyurethane nanofiber matrices used as wound dressing materials in a rat skin defect model 
showed increased rate of epithelialization with well-organized dermis which provided good 
support for wound healing [96]. Several polymers of both natural and synthetic origins, alone 
or in combination, were successfully electrospun into nanofiber scaffolds, and evaluated as 
dermal substitutes with cells. Collagen nanofibers play a dominant role in maintaining the 
biological and structural integrity of various tissues and organs, including bone, skin, tendon, 
blood vessels and cartilage. A collagen nanofiber mesh scaffold may have the advantage of 
not only resembling the size scale but also the chemical and biological function of ECM. The 
spinning of collagen types I and III is feasible using 1,1,1,3,3,3 hexafluoro-2-propanol (HFP) 
as a solvent, but might result to a large extend in denaturation and collection of gelatin 
nanofibers [98]. Glutaraldehyde cross-linked collagen type I nanofibers in the diameter range 
of 100–1200 nm showed tensile strengths of 11.44 ± 1.20 MPa close to several commercially 
available wound care products [99]. Relatively, less human keratinocytes and fibroblasts 
adhesion was observed on these cross-linked collagen nanofibers than the nanofiber matrices 
treated with type I collagen or laminin. Such an effect might be due to structural changes 
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induced by denaturation of collagen while processing. However, coating these nanofiber 
matrices with ECM proteins, primarily collagen type I provided bioactivity and resulted in 
best in vitro performance. Collagen coated nanofiber matrices showed faster early-stage 
healing compared to the control group (cotton gauze) in full thickness wounds in a rat model. 
Blended nanofibers of collagen and polycaprolactone (PCL) supported growth, proliferation 
and migration of fibroblasts inside the matrices [100]. Surface modification of PCL nanofiber 
matrices with collagen was achieved using a dip coating method and by a core-shell nanofiber 
fabrication technique. Core-shell nanofibers had a collagen shell and PCL as the wrapped 
core. Collagen coating showed linearly increasing fibroblast density with time as compared to 
PCL nanofibers [101]. Collagen-PCL core-shell nanofibers had comparatively higher cell 
density than the nanofibers coated by dip coating, presumably due to the uniform collagen 
coating on the core-shell structures. Fibroblast adhesion was lower on aligned collagen 
nanofibers but showed higher proliferation when compared with the random collagen 
nanofibers. PLGA-dextran electrospun nanofibers supported fibroblast attachment, 
proliferation, migration and extra cellular matrix deposition within the nanostructures as 
presented. Fibroblasts migrated into these three-dimensional structures and organized into 
dense multi-layered structures resembled dermal architecture [102]. Nanofibers of poly(p-
dioxanone-co-L-lactide)-block-poly( ethylene glycol) with average diameters of 380 nm, 
median pore size 8 μm, porosity >80% and mechanical strength 1.4 MPa supported fibroblast 
adhesion, proliferation and maintained phenotypic shape and guided growth along the 
nanofiber orientation [103]. In an effort to develop a fibroblast-populated three-dimensional 
dermal analogue; blends of PCL/gelatin were electrospun onto a polyurethane dressing [104]. 
The significant number of fibroblasts adhered and proliferated on both the sides of the 
construct and shows great potential in the treatment of dermal wounds through layered 
application. The surface-modified polyamide nanofibers coated with ECM proteins namely 
fibronectin, collagen I and laminin-1 supported primary mouse embryonic fibroblasts 
adhesion and proliferation better than tissue culture polystyrene (TCPS) protein-coated 
surfaces [105]. Co-culture of keratinocytes, fibroblasts and endothelial cells on polystyrene 
nanofiber scaffolds resulted in scaffolds populated with viable cells, even under serum-free 
conditions. Fibroblasts may provide supportive environment for keratinocyte and endothelial 
cell viability under serum-free conditions. Cells presented native spatial three-dimensional 
organization where keratinocytes formed a continuous ‗epidermal‘ layer at the upper air-
facing surface, while fibroblasts and endothelial cells occupied the central and lower regions. 
Nanofiber matrices provide a necessary 3D structure similar to natural ECM and result in 
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better cell performance than 2D substrates. Nanofiber matrices with suitable mechanical 
properties, degradation profile, porosity, 3D architecture, necessary chemical cues and 
increased fibroblast and related cells response is required to produce skin substitutes. 
 
Grafts 
As literature on different grafts, ranging from blood vessel grafts, tendon grafts, nerve grafts 
to mussel grafts, is quite diverse and a detailed summary would be out of the frame of this 
chapter we will discuss some recent examples of electrospun grafts. Electrospinning 
techniques have shown potential to produce tubular scaffolds that would meet the functional 
requirements of native blood vessels. Nanofiber based engineered substitutes mimic the 
dimension scale and the spatial organization of the 3D ECM features of native tissue, and may 
be made suitable for interaction with smooth muscle cells (SMCs) and endothelial cells (ECs) 
[83]. Aligned poly(L-lactide-co-ε-caprolactone), P(LLA-CL) (75:25) nanofibrous scaffolds 
with an average fiber diameter of 500 nm modulate SMC‘s behavior to express contractile 
phenotype, spindle shape, orient and migrate along the aligned nanofibers [106]. These 
aligned scaffolds mimic the nanoscale features, and the oriented cell and fiber architecture 
found in native blood vessels. Additionally, gelatin grafting on polyethylene terephthalate 
(PET) non-woven nanofibrous meshes (200–600 nm average fiber diameter) enabled 
endothelial cells to adopt a well-spread polygonal shaped morphology [107] due to the 
optimized hydrophilicity. Surface adhesion proteins like PECAM, VCAM-1 and ICAM-1 
were highly expressed by ECs on gelatin grafted non-woven nanofiber PET matrices. 
Increased expression of PECAM is indicative of a greater degree of endothelization on this 
scaffold as compared to pure non-woven nanofiber PET matrices [108, 109]. A new 
biomimetic approach towards scaffolds mimicking the hierarchical order of the layer structure 
of native blood vessels has been achieved by electrospinning layer scaffolds consisting of 
randomly oriented and oriented fibers. Yarin et al. fabricated PLA/PCL bilayered tubular 
scaffolds with a PCL inner layer of randomly oriented microfibers and a PLA outer layer 
composed of oriented fibers [31]. The bilayered PLA/PCL scaffolds could withstand 
maximum stress of 4.3 MPa and showed an elastic deformation up to 10% strain, which is 
comparable to native blood vessels. Cellular attachment, spreading and proliferation on these 
scaffolds were investigated using mouse fibroblasts and human venous myofibroblasts. 
Fibroblasts adhered and proliferated better on the outer layer as compared to the inner layer 
over 30 days of cell culture. Another interesting approach towards blood vessel grafts with 
cells integrated homogeneously inside the scaffold structure has been reported by Stankus et 
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al. He used SMCs (derived from rat aorta) suspended in gelatin supplemented media and 
electrosprayed them concurrently with poly(ester urethane) urea (PEUU) to microintegrate the 
cells uniformly throughout the scaffold [110]. These integrated cells exhibited spread 
morphology and significantly higher cellular proliferation after one week as compared with 
TCPS. Under perfusion culture, the cells showed a well-spread morphology and more f-actin 
staining than static culture conditions. Shin et al. investigated electrospun PCL fiber meshes 
suspended on a wire ring supports seeded with neonatal rat cardiomyocyte in vitro [111]. 
After three days the cardiomyocytes start to contract weakly and in an unsynchronized 
fashion. Contractions become stronger and synchronized as time progresses.  
Patients suffering tendon injuries often face problems, such as limited availability of tendon 
autografts, inflammatory risks of allografts, failure of long-term tendon prosthesis and 
restricted reparative potential of injured tendons. Recently, promising results were achieved 
using hybrid nano–microfibrous scaffolds composed of knitted PLGA (90/10) covered with 
randomly oriented electrospun PLGA (65:35). This scaffold seeded with bone-marrow-
derived stromal cells (BMSCs) exhibited higher expression of collagen-I, decorin and 
biglycan [112]. Stromal cells thus retain the potential to differentiate into tendon/ligament 
lineage on this novel nano–microfibrous scaffold. Cells attached and proliferated well on the 
novel scaffold forming cellular aggregates that increased in size and fused with the adjacent 
ones. 
Peripheral nerve injuries resulting from trauma, diseases or tumor surgery require grafts, 
currently mostly autografts taken from a donor side, to bridge the proximal and distal nerve 
ends. Several studies were carried out to see the effect of nanofiber diameter and alignment in 
terms of neurite outgrowth and neural stem cells (NSCs) differentiation. Neurites grew 
radially outward from the ganglia on aligned PLLA fibers and turned to follow the fibers upon 
contact. The neurites on highly aligned substrates were longer compared to randomly 
collected fibers [113]. Surface-modified PLLA electrospun aligned nanofiber matrices with 
ECM proteins and bFGF growth factor simulate the natural ECM environment by providing 
necessary physical and chemical cues [114]. PCL and collagen/PCL (C/PCL 25:75 wt%) 
blend nanofibers both random and aligned nanofiber scaffolds supported cell attachment, 
Schwann cell migration and axonal regeneration [115]. Polyamide electrospun nanofibers in 
the diameter range of 100–800 nm supported neuronal attachment and neurite outgrowth in 
vitro [105]. Surface modification of these nanofibers with neuroactive peptides derived from 
human tenascin-C significantly enhanced neuronal attachment, neurite generation and neurite 
extension in vitro compared to poly-L-lysine controls [105]. Blend nanofibers due to the 
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presence of collagen showed significantly higher cellular activity, and neurites oriented in the 
direction of aligned nanofibers. 
Mature skeletal muscle tissue is composed of multinucleated, post-mitotic fibers that do not 
regenerate the following injury. Adhesion and proliferation of murine myoblast cell line 
(C2C12) on electrospun DegraPol showed no toxicity and excellent cell compatibility [116]. 
In differentiation media, C2C12 cells seeded on Matrigel-coated DegraPol developed into 
elongated, multinucleated, myosin-expressing myotubes. Immunofluorescence microscopy 
shows C2C12 myotubes aligned preferentially along the fiber length as visualized by staining 
of F-actin and myosin heavy chains. These cells seeded onto a gelatin- or fibronectin-coated 
non-woven electrospun PLLA fiber mesh (fiber diameter 500 nm) showed disordered actin 
filament arrangement on randomly oriented fiber mesh; whereas actin fibers were aligned 
along the fiber direction on aligned fiber meshes [117]. 
 
Anti-Adhesion barrier membranes 
Trauma, inflammation, and infection are major factors in the prevalence of postoperative 
adhesions that typically occur in either the digestive or reproductive tracts [36]. Thus, there 
remains a substantial need for the production of a low-cost, highly efficient bioabsorbable 
barrier to prevent postoperative adhesions that will reduce inflammation, prevent infection, 
and inertly degrade away once its function has been fulfilled. Following an invasive surgery 
in a region such as the abdominal wall, it is common to deliver antibiotics either systemically 
or locally in order to prevent infection at the surgery site. Recently, Zong et al. demonstrated 
in a rat model that a drug-loaded (cefoxitin sodium), PLGA-based, electrospun membrane 
completely inhibited any adhesion formation after 28 days [118]. These remarkable results 
were better than for either the PLGA membrane alone or the PLGA-based membrane; the 
latter two membranes have already demonstrated favorable rates of anti-adhesion (22% and 
25%, respectively). The inclusion of antibiotics from this study would suggest that 
contamination and subsequent infection at the wound site would be causes of adhesion 
formation.  
 
Delivery systems for bioactive agents and drugs 
Either biodegradable or non-degradable materials can be used to control whether drug release 
occurs via diffusion alone or diffusion and scaffold degradation. Additionally, due to the 
flexibility in material selection a number of drugs can be delivered including: antibiotics, 
anticancer drugs, proteins, and DNA. Using the various electrostatic processes a number of 
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different drug loading methods can also be utilized including coatings, and matrix 
encapsulated drug. When selecting a material to use in a drug delivery device a number of 
requirements must be met. Biodegradable materials add an extra level of complexity to drug 
delivery devices as compared to non-degradable materials, which tend to release drug 
primarily by diffusion. In a biodegradable system the drug may be released by diffusion as 
well as degradation of the material. This in some cases may lead to dose dumping resulting in 
much higher local drug concentrations. Chew et al. examined the release of -nerve growth 
factor (NGF) stabilized in BSA from a copolymer consisting of -caprolactone and ethyl 
ethylene phosphate (PCLEEP) [119]. Due to its relatively hydrophobic backbone, PCLEEP 
has a slow degradation rate demonstrating a mass loss of less than 10% over a 3-month 
period. Using this system a sustained release of NGF was observed. The release mechanism 
was speculated to be occurring primarily via diffusion. Kenawy et al. examined the release of 
tetracycline hydrochloride from electrospun mats composed of PLA, poly(ethylene-co-vinyl 
acetate) (PEVA), and a 50:50 blend of the two [120]. The electrospun mats were prepared by 
dissolving the polymer and tetracycline hydrochloride in a chloroform/methanol solution, thus 
producing polymer fibers containing embedded drug in a polymer matrix. The authors found 
that both polymer composition and drug loading affected the rate of drug release. PEVA 
demonstrated quicker release than either the 50:50 PEVA/PLA blend or PLA. Recent work 
has examined the possibility of using electrospun matrices as constructs for giving controlled 
release of a number of drugs including antibiotics [121, 122, 123] and anticancer drugs [124, 
125]; as well as proteins [126, 127, 118, 128] and DNA [129, 130] for applications in tissue 
engineering. Kim et al. examined the controlled release of a hydrophilic antibiotic (Mefoxin) 
from electrospun PLGA and PLGA/ PEG-b-PLA/PLA (80:15:5 by wt%) mats [123]. Rather 
than absorbing the antibiotic onto the scaffold after electrospinning, Kim et al. dissolved both 
the polymer and the antibiotic in DMF prior to electrospinning, giving antibiotic embedded 
within the electrospun fibers. The authors observed that the drug loading affected the 
morphology of the electrospun fibers, with solutions containing no drug giving a bead-and-
string morphology and solutions containing 5 wt% drug giving a completely fibrous structure. 
Additionally, the average fiber diameter decreased. The authors attribute this change in 
morphology and fiber diameter to the increased conductivity of the solutions containing drug. 
An in vitro drug release study was conducted and demonstrated that the PLGA/PEG-b-
PLA/PLA blend gave a more sustained release than did the PLGA mat. Incorporating the 
amphiphilic PEG-b-PLA block copolymer allows some of the hydrophilic antibiotic to be 
embedded in the polymer nanofibers. Additionally, both drug-loaded meshes demonstrated 
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greater than 90% inhibition of Staphylococcus aureus growth. Especially targeted and 
controlled delivery of anticancer drugs remains a major challenge for current research in the 
drug delivery field. Xu et al. examined the incorporation of the anticancer drug BCNU into 
electrospun PEG-PLLA mats [158]. Both the polymer and the BCNU were dissolved in 
chloroform and electrospun, giving BCNU embedded in the PEG-PLLA fibers. 
Environmental scanning electron microscope with an EDS accessory was used to demonstrate 
that uniform fibers with relatively smooth surfaces were obtained as well as a uniform drug 
distribution. The average fiber diameters again depended on drug loading. Both the release 
rate and the initial burst release increased with increasing BCNU loading. The effect of 
BCNU release from electrospun PEG-PLLA mats on the growth of rat Glioma C6 cells was 
also examined. While unloaded PEG-PLLA fibers did not have any affect on cell growth, 
BCNU loaded PEG-PLLA mats exhibited anticancer activity over a period of 72 h, while free 
BCNU began to lose its anticancer activity after 48 h. Thus, by embedding the drug in the 
polymer fibers it was protected from degradation and preserved its anticancer activity. Xie 
and Wang also examined the treatment of C6 gliomas by using an electrospun PLGA mat 
with encapsulated Paclitaxel [125]. By varying the processing parameters they were able to 
produce fibers with average diameters ranging from the tens of nanometers to 10 mm. The 
encapsulation efficiency of the Paclitaxel loaded electrospun PLGA mats was more than 90%. 
An in vitro drug release study demonstrated controlled release from both PLGA nano- and 
microfibers over a period of 61 days. Nanofibers had a faster release rate than the microfibers. 
An in vitro cytotoxicity study demonstrated that depending on the drug loading, up to 70% of 
C6 Glioma cells could be killed after 72 h. While drug delivery is often associated with the 
delivery of therapeutic agents for the treatment of some disease state such as cancer, it can 
also apply to the delivery of bioactive agents such as proteins and DNA for tissue engineering 
applications. Liang et al. studied the incorporation of DNA into electrospun PLGA scaffolds 
[130]. Plasmid DNA was condensed in a poor solvent mixture, and was then encapsulated in 
micelles composed of a triblock copolymer (PLA-PEG-PLA) giving encapsulated DNA 
nanoparticles protecting it from degradation during electrospinning. The micelles were then 
dissolved in a solution of DMF with PLGA and electrospun, resulting in the formation of 
PLGA fibers containing encapsulated DNA nanoparticles. An in vitro release study 
demonstrated that approximately 20% of the encapsulated DNA was released after a period of 
one week. Additionally, the authors also examined the encapsulation of DNA in PLGA fibers 
without first forming protective micelles using the PLA-PEG-PLA triblock copolymer. 
MC3T3 cells demonstrated some limited transfection only when the block copolymer was 
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present. This paper shows the importance of protecting biological agents that are incorporated 
into electrospun scaffolds in order to ensure that the agents will retain their bioactivity. 
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Chapter 3: Electrospinning of Polymer Melts - Phenomenological 
Observations 
 
Abstract 
Melt electrospinning is an alternative to solution electrospinning, however melt 
electrospinning has typically resulted in fibers with diameters of tens of microns. In this paper 
we demonstrate that polypropylene fibers can be reduced from 35±8 m in diameter, to 
840±190 nm with a viscosity-reducing additive. Some examples for the possibility to reduce 
the diameter of melt electrospun polypropylene fibers by mixing small amounts of stearates 
are shown. The collected melt electrospun fibers often fused together where they touched, 
allowing the stabilization of relatively thick non-woven felts. 
The melt electrospun collection often included coiled circles and looped patterns of fibers 
approximately 150 to 250 m in diameter. The polymer jet is visible between the collector 
and spinneret for particularly significant lengths, and only undergoes coiling and buckling 
instabilities close to the collector. The frequent fusion points between melt electrospun fibers, 
and a reduction in diameter for the gap method of alignment, indicate that the melt 
electrospun fibers are still slightly molten at collection. 
Introduction 
Electrospinning is a nano- and micro fiber manufacturing technique that has attracted much 
recent interest, resulting in hundreds of published articles and reviews [1, 2]. It is well-known 
that both polymer solutions and polymer melts can be electrospun, however the available 
literature for melt electrospinning is comparatively limited [3-11]. Electrospinning without 
solvents (via the melt) may be appealing for applications and configurations where solvent 
accumulation or toxicity is a concern. Research on melt electrospinning has been restricted so 
far, likely due to the large fibers reported in the earlier literature [3-5] – up to 50 m in 
diameter and typically above 10 m [3-7, 11] (Figure 1). With such large diameter fibers, 
melt electrospinning provided little advantage over established melt spinning techniques to 
produce micron-diameter fibers. The benefits of electrospun nanofibers, namely a large 
surface area to volume ratio (up to 10
3
 times of that of a micro-fiber) and mechanical 
properties (e.g. high bending capacity), require much smaller diameters than those initially 
described in the melt electrospinning literature. Industrially, advanced textiles and filtration 
systems are applications where the efficacy of electrospun fibers has been investigated. 
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However, recent melt electrospinning publications demonstrate that continuous fibers 
approximately one micron in diameter are possible, and therefore provide the benefits of 
nanometer diameter fibers often produced with solution electrospinning [8, 10, 11]. Melt 
electrospinning requires cooling of the polymeric jet, while solution electrospinning relies on 
evaporation of the solvent to produce fibers. It is therefore important during solution 
electrospinning that the evaporated solvent does not accumulate; otherwise, the fiber quality is 
affected. At the research level, electrospinning experiments performed in enclosed 
environments are limited – most configurations are in well-ventilated areas [13-16]. In 
numerous ways, solvent accumulation has dictated the manner in which electrospinning has 
been researched. Electrospinning also attracts particular interest in biomedical applications, 
for the tissue engineering of cell constructs. The sub-micron diameters of electrospun fibers 
are a similar magnitude to the fibrils often found within extra cellular matrix, and initial 
electrospinning experiments for tissue engineering demonstrate great promise [17-22]. 
However, since many tissue-engineers wish to combine various cells and electrospun material 
for clinical use, solvent toxicity is an ongoing concern with solution electrospinning. Volatile 
(and often toxic) solvents often used for preparing electrospun fibers therefore require 
removal before contact with cells, or the living body. Such solvent removal can be readily 
demonstrated where electrospun mats are formed an initial step and then degassed. However, 
for strategies where the simultaneous deposition of cells and fibers (or fibers deposited 
directly onto/into the living body) is desirable, the issue of residual solvent (and therefore 
toxicity) remains. Electrospinning from the polymer melt may allow new approaches to 
certain aspects of electrospinning, particularly overcoming the technical restrictions governed 
by solvent accumulation and toxicity.  
In this chapter we highlight the phenomenological observations of melt electrospinning with 
two different synthetic polymers, and produce sub-micron to micron diameter continuous 
fibers. The transformation from large-diameter fibers – typical of previous melt 
electrospinning schemes – to sub-micron diameter fibers with the use of viscosity-reducing 
additives is shown. One of the polymers, polypropylene, is difficult to dissolve and has 
therefore been restricted in the solution electrospinning literature. The low melting point 
block copolymers used in this chapter have a recent history of biomedical applications, and 
were previously melt electrospun directly onto cells [8]. The phenomenological observations 
and descriptions of the process, using a series of different collection systems will contribute to 
the limited knowledge currently available for melt electrospinning. 
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Experimental 
Materials and Copolymer Synthesis 
All materials and solvents, unless otherwise stated, were purchased from Aldrich Chemicals 
(Milwaukee, USA). Commercially available isotatic polypropylene (Novolen 1100 N) was 
purchased from Bayer AG (Germany), while the Moplen HP 561 S polypropylene was 
acquired from Basel l Polyolefine GmbH (Germany). Novolen polypropylene has a molecular 
weight of 210, 000 g/mol and polydispersity of 3.5. Similar data for Moplen polypropylene 
was not provided; however this particular isotactic polymer has a narrow polydispersity and is 
recommended for extrusion applications. Irgatec CR 76 has been obtained from CIBA (Ciba 
Specialty Chemicals, Switzerland). The 1.5% blend has been produced using a kneader type 
30 EHT with rheometer (Plastograph®/ Brabender® GmbH & Co. KG) and kneading at 
200°C for 5 min.  
Calcium stearate and magnesium stearate were also purchased from Sigma Aldrich. Mixtures 
of 99-99.5 wt% of both poly(propylene)s and 0.5-1 wt% of calcium stearate or 0.5-1 wt% 
magnesium stearate were used in the electrospinning experiments. The blends have been 
produced using again a Plastograph
®
 kneader type 30 EHT with rheometer (Brabender
®
 
GmbH and Co. KG, Duisburg, Germany) and kneading at 200 °C for 5 min. All mixtures 
were cooled down to room temperature. Afterwards, the mixtures were milled using freezer 
mill 6800 (purchased from Haar, Munich, Germany) with liquid nitrogen cooling. 
 
Electrospinning 
The electrospinning collection configurations are schematically drawn in Figures 1. Unless 
otherwise indicated, a high negative voltage of 20 kV (Bertran Series 205B, Hicksville, NY) 
was applied to the spinneret and the fibers collected onto grounded aluminum SEM stubs, 
covered with a sheet of aluminum foil. The collection distance was 10 cm for the low melting 
point polymers [23] and 4 cm for the polymers with a high melting point. The polymer was 
pumped to the spinneret with a flow rate between 0.02 and 0.3 mL/h [23]. In the case of the 
three high melting point polymer systems the melt was pumped to the spinneret with a flow 
rate of 0.05 mL/h. To prevent poor fiber collection associated with the initial polymer jet, an 
aluminum foil cover was placed just over the collector, and mechanically withdrawn after the 
initial 30 s of electrospinning. For the experiments collecting onto SEM stubs, the collection 
time was 60 s after removal of the conductive cover, while dynamic deposition experiments 
involved collection of electrospun fibers for only five seconds on a SEM stub rotating at 2500 
rpm. Microscope slides were held by hand throughout collection and a voltage of 10 kV used. 
- Chapter 3 - 
  61 
Stainless steel tweezers (11002-12, Fine Science Tools, Germany) were used as dual 
collectors and were moved with a syringe pump at a rate of 1cm/min across the centre line of 
the polymer jet at a distance of 10 cm from the spinneret. The conditions for solution 
electrospinning of PCL was performed as previously described [24]. 
 
Figure 1: Schematic of electrospinning collection configurations adopted in this 
article. (A)  A single aluminum SEM stub; (B) a single microscope slide; (C) a single 
aluminum SEM stub, rotating at 2500 rpm, with the axis of rotation parallel to the 
centre line; and (D) dual collector with a tapered distance between collectors [23]. 
 
Heating configurations  
The temperatures investigated for melt electrospinning are 90°C for PEG47-b-PCL95/PCL, 
270°C for the Novolen polypropylene, and 320°C for Moplen polypropylene. Two distinctly 
different heating configurations were utilized, based upon temperature stability, operator 
safety, and technical simplicity. The lower temperature heating system adopts the advantages 
of a highly stable circulatory system to maintain temperature (± 0.2°C) and is schematically 
shown in Figure 2. A 1 mL syringe (Injekt, B-Braun) is filled with the polymer powder and 
heated to the appropriate temperature. Air bubbles are removed by pushing the polymer melt 
back and forwards within the syringe. A flat-tipped stainless 20 G steel spinneret in then 
attached, and the syringe is inserted into the circulator and equilibrated for approximately 20 
min at the appropriate temperature. The higher temperature electrospinning system (shown in 
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Figure 2) contains an electronic controlled heat gun and a second thermometer at the place of 
the syringe to control the temperature of the melt. The warm air current provides an easy-to-
handle and simple heat source, which allows safe work at high temperatures. Glass syringes 
with a flat-tipped stainless 20 G steel spinnerets were filled with solid polymer powder and 
preheated in an electric oven (WTB Binder 115L). Air bubbles were removed as described for 
the low melting polymers. The syringe was set in the electrospinning system and heated for 
25 min, which allows the system to reach an equilibrium temperature. Electrospinning was 
performed immediately after removal of the heat gun, in order to minimize the cooling of the 
syringe and spinneret. Temperatures at the spinneret were determined with a K-type 
thermocouple.  
 
Figure 2: Schematic of the different heating configurations used for melt 
electrospinning for A) low melting point polymers and B) high melting point 
polymers. 
 
Viscosity Measurements 
A controlled stress rheometer (Rheometric Scientific DSR, USA) measured the viscosity of 
the polymer melts, at various temperatures and shear rates. The temperatures were reached 
with an electrically heated cone and plate (4°/25 mm; with a gap of 0.111 mm). The zero-
shear viscosity was calculated using creep analysis of the molten polymer. A heat gun aimed 
at the cone-plate configuration was used in addition to the rheometer heating element to attain 
320°C. 
 
Scanning Electron Microscopy (SEM) and Light Microscopy 
The electrospun material on the aluminum SEM stubs were gold-coated and imaged with a 
Cambridge S360 (Leica, Germany) microscope, or with a Quanta 200 (FEI, United 
Kingdom). The low-diameter fibers from dual collectors were sampled by passing a copper 
grid for a transmission electron microscope (TEM) through the suspended fiber collection. 
The TEM grid was mounted on a SEM stub coated with platinum/gold and imaged in high 
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vacuum mode on the Quanta 200 SEM. An electron beam of 15 kV and a working distance of 
7 to 15 mm were used to image the electrospun material. Fiber diameters were measured 
using SEM (n=30) and representative images of the electrospun fibers are presented. The 
periodic distance of the perpendicular surface structures on fibers of Novolen polypropylene 
was also measured with SEM (n=10). The microscope slides containing fibers from multiple 
jets were either imaged on a stereomicroscope (Leica MZ16F, United Kingdom), altering the 
light to contrast the fibers, or on an inverted light microscope (Zeiss Axio Imager A1, United 
Kingdom). 
 
Results and Discussion 
The polymers and blends used in this chapter are summarized in Table 1. The two parameters 
that significantly affect the quality and dimensions of melt electrospun fibers are the viscosity 
of the polymer melt and the flow rate to the spinneret [8-9]. The viscosity often used for 
solution electrospinning (0.1 – 6 Pa.S) [26-28] is a magnitude lower than for these 
experiments (30 – 75 Pa.S). Conversely, the flow rates for solution electrospinning in 
literature are a magnitude greater than those for melt electrospinning. The low flow rates 
required for melt electrospinning (0.02-0.05 mL/hr) are a disadvantage for industrial 
applications, but are required since greater charges exist in polymeric liquids with lower flow 
rates [29]. The highest quality fibers were electrospun from polymer melts with viscosities 
between 35 and 55 Pa.S. The addition of the viscosity-reducing Irgatec to Novolen 
polypropylene reduced the viscosity from 75 to 33 Pa.S. 
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Table 1. Selected properties and conditions for melt electrospun polymers. Viscosity 
data were measured at the electrospinning temperature. The values for the PEG-block-
PCL polymers are taken from literature [23]. 
 
 
The four different collection systems used are shown in Figure 1. A single collector (Figure 
1a) was used for both polypropylene and poly(ethylene glycol)-block-poly( -
caprolactone)/poly( -caprolactone) (PEG47-b-PCL95/PCL) blends. Melt electrospun PEG47-b-
PCL95/PCL blends were additionally collected onto a microscope slide (Figure 1b), a single 
collector, with the axis of rotation parallel to the centre line (Figure 1c) or onto dual collectors 
(Figure 1d) [23].  
Two distinctly different heating configurations were used for electrospinning the different 
melting-point polymers, based upon temperature stability, operator safety, and technical 
simplicity (Figure 2). For low temperatures (60°C to 90°C), a circulatory system provided a 
very constant temperature (± 0.2°C) to the syringe and spinneret, while at higher temperatures 
a heated flow of air melts the polymers. A heat gun is technically straightforward, avoids 
safety issues involving very high temperature circulation systems, and prevents accidental 
surface contamination of biomaterials with high temperature circulating fluids [30]. A 
potential issue of overheating and undesirable degradation of the low melting point PEG47-b-
PCL95/PCL blends [8] is minimized by the controlled circulating heating system.  
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Electrospun Fiber Morphology 
Melt electrospinning of unmodified polypropylene (both the Moplen HP 561 S and Novolen 
1100N) onto a single collector provided good quality electrospun fibers (Figure 3 & 4a-b); 
albeit with a relatively high fiber diameter – this is consistent with previous observations for 
melt electrospun material [3-5]. The Moplen polypropylene fibers had diameters of 8.6±1.0 
m, and appeared not to fuse with other fibers. Cooling of the polymer jet prior to collection 
was therefore sufficient, even though the spinneret/collector distance (collection distance) is a 
relatively short 4 cm. The Novolen polypropylene electrospun fibers were 35.6±1.7 m in 
diameter but had a very different surface structure to the Moplen polypropylene fibers. While 
melt electrospun Moplen fibers were smooth and uniform (Figure 3), the Novolen 
polypropylene fibers had a surface structure perpendicular to the direction of the fiber (Figure 
4a-b). Given the large diameter of the polypropylene fibers, the surface structure is probably a 
result of extrusion instabilities, or shrinkage due to cooling, with the periodicity of these 
surface structures on the electrospun fibers being 920±70 nm. The inclusion of an additive to 
the Novolen polypropylene (1.5% Irgatec CR 76) actively reduces the polymer chain length 
and therefore viscosity [31, 32]. This additive, which is used for melt blowing applications, 
has a dramatic impact on the diameter of the polypropylene fiber and reduced the fiber 
diameter from 35.6±1.7 m to 840±190 nm; however fusion between the collected fibers was 
significant (Figure 4c-d). The surface of these smaller fibers is smooth, and contrasts with the 
perpendicularly oriented morphology on the surface of pure Novolen polypropylene.  
 
 
Figure 3: SEM images of Moplen polypropylene fibers that were melt electrospun at 
320°C, with a pump rate of 0.05 mL/h and a collection distance of 4 cm. 
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Figure 4: SEM images of (A & B) polypropylene Novolen fibers and (C & D) 
polypropylene Novolen fibers containing IR 76, melt electrospun at 270°C, with a 
pump rate of 0.05 mL/h and a collection distance of 4 cm.  
 
Polypropylene (Novolen) was melt electrospun at 260 °C onto aluminum SEM stubs at a 
voltage of 20 kV (see Figure 5A&B) as well as blends with metal stearates. 
 
Figure 5: SEM micrographs of fibers electrospun from A&B.) polypropylene 
(Novolen), C&D.) polypropylene and 0.5 wt% Ca-stearate, E&F.) polypropylene and 
1 wt% Ca-stearate, G&H.) polypropylene and 0.5 wt% Mg-stearate, I&J.) 
polypropylene and 1 wt% Mg-stearate collected on an aluminum SEM stub. 
 
The blends of Novolen containing 0.5 (Figure 5C&D) or 1 wt% (Figure 5E&F) Ca-stearate 
resulted in fibers with reduced diameters. The fiber diameter decreases with increasing 
quantities of the additive. As second effect, besides the diameter reduction, the appearance of 
particles as undesired side products was observed (see Figure 5E). Figure 5G&H shows the 
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fibers produced during melt electrospinning of a blend of 0.5 wt% Mg-stearate and 99.5 wt% 
polypropylene. Compared to pure polypropylene fibers, these fibers show smaller diameters; 
whereas compared to the Ca-stearate containing sample (or the use of viscosity-breaking 
additives like Irgatec CR76), less diameter reduction was observed. Further increase of Mg-
stearate in the blend led to a significant decrease in sample quality. Fiber variability is highly 
increased using 1 wt% Mg-stearate and 99 wt% polypropylene. Two different fiber 
populations were found (see Figure 5I). Small, highly bended and split fibers coexist beside 
large fibers. The addition of the ionic additives results in more charges on the liquid jet and is 
responsible for an increased stretching. The increased charges can be seen at the earlier on-set 
of the whipping instabilities, respectively the smaller visible portion of the jet. Beside the 
increased charges, which act due to repulsive nature as counter force to the surface tension, 
the metal stearates are surface active and reduce the surface tension. Both effects contribute to 
the observed diameter reduction. 
 
Initial experience with melt electrospinning PEG-b-PCL diblock copolymers included the 
fabrication of very poor quality fibers when using the electrospinning parameters (i.e. flow 
rate, viscosity) commonly adopted for solution electrospinning [9; 26-28]. By blending the 
PEG-b-PCL diblock copolymers with a higher molecular weight homopolymer, PCL, we have 
eliminated poor quality molten fibers from the collected melt electrospun material (Figure 6) 
[23]. The slight fusion of some high quality fibers within the electrospun mats demonstrate 
that the solid electrospun fibers may not fully solidify prior to collection. This is seen in 
Figure 6, where the path of the fiber is noticeably altered at the points where the fibers touch, 
due to contraction of the fiber as it continues to cool on the collector and results in straight 
fibers between the fusion points. The diameter of the fibers from PEG47-b-PCL95/PCL blends 
is 2.0±0.3 m [23]. 
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Figure 6: SEM images of PEG47-b-PCL95/PCL electrospun fibers melt electrospun 
at 90°C, with a pump rate of 0.05 mL/h and a collection distance of 10 cm [23]. 
 
Whilst solution electrospun nanofibrous mats have relatively straight fibers [15-18], circular 
and looped coils were commonly observed with all melt electrospun polymers. These 
different types of coiled electrospun fibers are shown and described in Figure 7. The circular 
and looped fibers in Figures 7a-b and 7d respectively were particularly common, whilst 
helical fibers (Figure 7c) occur only intermittently. Such helical fibers, with small curvature, 
may form with particularly cooled parts of the polymer jets that have a high surface tension. 
The tightly coiled deposition (circular and looping) of the electrospun fibers is an interesting 
phenomenon associated with melt electrospinning.  
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Figure 7: Examples of commonly observed coiled deposition phenomena for melt 
electrospun fibers. Circular coils are deposited and can form for A) Polypropylene 
with Irgatec; or B) PEG47-b-PCL95/PCL [23]. Helical fibers with very short curvature 
are also periodically seen for C) Polypropylene with Irgatec. A different, and very 
common deposition phenomena, is the looped coils that are elongated as shown for 
(D) PEG47-b-PCL95/PCL blends [23]. Such circular and looped coil depositions are not 
abnormality, but are consistently observed for melt electrospun samples. 
 
Taylor Cone Formation 
When a sufficient voltage is applied, the pendant drop of polymer melt is initially distended 
and stretched towards the collector. The quality of the electrospun material for the first 30 
seconds is extremely poor, and creates visibly large collected fibers, or ―impurities‖. This 
portion of the collected material is therefore discarded, and a ―sacrificial collector‖ is used for 
the first 30 seconds of collection. Figure 8 shows a typical photograph of the Taylor cone and 
jet from a polymer melt that result in solid fibers. The visible portion of the jet typically 
extends for 60 to 80% of the collection distance, and can be over 10 cm in length when the 
distance is 15 cm. The Taylor cone was stable for periods up to 10 hours, with no visible 
fluctuations, when flow rates of approximately 0.02 mL/h to 0.05 mL/h were used. A lack of 
poor quality fibers, associated with the first 30 seconds of Taylor cone formation, indicated 
that the Taylor cone was continuous for these long time periods. 
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Figure 8: Photograph of the Taylor cone and polymer jet for melt electrospinning. The 
molten pendant drop has one single Taylor cone that is relatively elongated, while the 
jet is particularly long, and is visible for almost the entire distance to the collector. The 
resulting fibers are solid and 2.0 ±0.3 m in diameter [23]. 
 
Deposition Phenomena of Electrospun fibers 
The visible portion of the jet from solution electrospinning typically, but not always, extends 
for approximately 1 cm from the spinneret before undergoing the instabilities that result in 
diameter reduction and good quality fiber collection [33, 34]. The visible portion of the initial 
jet for a polymer melt extends much further; estimated to be 10 cm with a collection distance 
of 15 cm, and results in solid, electrospun fibers as shown in Figures 6, 7 and 9. The molten 
polymer jet therefore travels the majority of the collection distance before coiling and 
buckling instabilities occur, and the region of fiber deposition is notably focused. This ―late 
coiling‖ phenomenon has also been recently reported with other melt electrospinning systems 
[10]. Elongated jets are also reported with electrostatically drawn glycerol, which has a low 
conductivity compared to commonly used solvents [35]. 
Figure 9 shows the deposition of melt electrospun PEG47-b-PCL95/PCL blends onto a single 
collector [23]. ―Patches‖ of electrospun fibers contrast with the widely deposited fibers 
commonly collected during solution electrospinning [13-21; 26-28]. While the patches of 
electrospun fibers indicate a focused deposition, the depositing fiber ―wanders‖ across the 
collector – this can be seen with the eye during collection. In Figure 9b, a distinctive (circular) 
coiled loop joins the patches of electrospun fibers. The formation of such distinctly white 
―patches‖ of electrospun fibers is visible to the eye; they form in rapid succession in one area 
of the collector, before moving to another area (Figure 9a). The radius of the coils for PEG47-
b-PCL95/PCL blends is approximately 75 to 125 m. Looped coil deposits were also common 
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(Figure 7d) structures. The centre of the patches had high quality electrospun fibers, with 
depths of up to 1 mm (Figure 9c) The fibers also fused where they touched (Figure 9d), as 
previously seen with melt electrospun PEG47-b-PCL95/PCL blends (Figure 6; Figure 7b) [23]. 
As can be seen in Figure 8, the initial visible portion of the jet travels the majority of the 
collection distance; therefore the reduction of the fiber diameter must occur relatively close to 
the previously deposited fibers. As the fiber patches can attain heights of up to 1 mm and the 
polymer is non-conducting, it is likely that a build-up of localized charges initiates this 
―wandering‖ of the position for focused fiber deposition. The fusion of the electrospun fibers 
could assist in achieving such relatively thick patches. 
 
Figure 9: Deposition phenomena of melt electrospun PEG47-b-PCL95/PCL blends. 
Regional ―patches‖ of electrospun fibers are collected, and the collection is magnified 
in images b-d. Coiled loops of fibers join some of these regions (B), while the centre 
of the patches reveals high quality fibers (C) that exhibit some fusion of the fibers (D). 
These patches were up to one millimeter in height [23]. 
 
While multiple jetting on single, grounded metallic collectors was not observed, it was 
common for multiple jetting to occur when microscope slides were used as collectors (Figure 
1b). Simultaneously, multiple fiber jets collect on the glass slide, observed as white, or 
colored, patches. Moving the microscope slide under centerline demonstrated that the 
different jet collections mirror the paths of each other, for both double- and triple-jets (Figure 
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10a & 10b). The distance between the collected fibers of two jets was 3.8±0.5 mm for a 50 
mm spinneret/collector distance. The fiber quality from the multiple jets, however, was not 
identical. While one of the collected jets typically had high quality fibers with a small 
diameter and narrow fiber distribution (Figure 10c; 2.0±0.3 m), the second and third jets 
were larger diameter and of poorer quality (Figure 10e; 4.4±2.2 m). Only one Taylor cone 
was visible during the collection of multiple jets, suggesting splitting of the jet between the 
spinneret and collector [23]. 
 
Figure 10: Photographs of multiple jets from melt electrospun PEG47-block-
PCL95/PCL blends, collected on a microscope slide showing the collections of A) two 
and B) three jets from a single spinneret. The microscope slide was moved by hand, 
and fiber deposition paths of different jets are mirrored. The collected material is 
different from each jet, with high quality fibers (C) collected simultaneously with 
larger, molten fibers (D). A photograph where the collected material from the two jets 
cross paths with each other is shown (E) [23].  
 
To prevent surface charge build-up in a specific region of the collector, we melt electrospun 
fibers onto a rotating collector for five seconds. Figure 11 shows a ring of electrospun fibers 
with a width of 500 m with a collection distance of 15 cm. The coiled fiber deposition is 
stretched by the rotation (2500 rpm) of the collector (Figure 11b&c). Figure 11d shows that 
the collected fibers are again fused together where they are deposited. A similar magnitude of 
focused deposition can be achieved with solution electrospinning; however, the collection 
- Chapter 3 - 
  73 
distance required is only 0.5 mm [36]. Focused deposition may also be achieved with solution 
electrospinning over similar distances to this chapter, using concentric rings with intermediate 
potential applied [37]. In this instance, we achieved similar focused deposition areas as 
Deitzel et al. [37], without the need for concentric rings [23]. 
 
Figure 11: Deposition of PEG47-b-PCL95/PCL electrospun fibers on a collector 
rotating at 2500 rpm (schematically drawn in Figure 2c). A ring of electrospun fibers 
forms due to the focused nature of the deposition (A). The electrospun fibers are coiled 
(B and C) and the periodicity of the coiling is stretched by the angular rotation (C). 
There is also some fusion of the electrospun fibers (D) [23]. 
 
Dual collectors with solution electrospinning results in oriented fibers, and has been termed 
the ―gap method of alignment‖ and results in a suspended collection [25, 38]. Using moving 
stainless steel tweezers as the collector (Figure 1d); the suspended melt electrospun 
collections could be observed over a range of gaps. It was only when the collector gap 
narrowed to 1 mm, near the fused portion of the tweezers, that oriented fibers occurred 
(Figure 12a), while extremely poor suspended collections result at larger gaps. No melt 
electrospun fiber suspensions formed when the collector gap was greater than 10 mm. This 
distance is a magnitude lower than solution electrospun PCL, where collector gaps of up to 10 
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cm result in suspended, oriented, electrospun fibers [25]. The entire tweezers are engulfed 
with solution electrospun PCL fibers (Figure 12b). Melt electrospinning was poor at 
generating oriented fiber suspensions between collectors over significant gaps, probably due 
to the focused nature of deposition, and elongated jet. The melt electrospun PEG47-b-
PCL95/PCL fibers produced with such dual collectors (Figure 12a) had very small diameters 
of 270±100 nm [23]. 
 
Figure 12: Images of suspended electrospun fibers on stainless steel tweezers for (A) 
melt electrospun PEG47-b-PCL95/PCL and (B) solution electrospun PCL. The fibers 
bridge the two metallic parts of the collector, and are covered well with solution 
electrospun fibers (B). Melt electrospun PEG47-b-PCL95/PCL fibers are poor in 
bridging larger gaps, yet have particularly low diameters of 270±100 nm. The scale 
bar for inset image is 500 nm. [23] 
Conclusion 
Micron and sub-micron melt electrospun fibers can be collected with two different synthetic 
polymers, while oriented melt electrospun fibers were 270±100 nm diameter, which is 
currently the lowest diameter reported for a melt electrospun fiber. As cooling is the 
mechanism for fiber jet solidification (as compared to solvent evaporation), extending the 
melt electrospinning to multiple spinnerets may compensate for the low flow rates required 
for high-quality fibers. As shown with polypropylene, the fiber diameter may be adjusted with 
viscosity-reducing additives; greater than a magnitude reduction in the electrospun fiber 
diameter is feasible. Finally, the addition of ions with bulky organic groups and bigger ion 
size to the polymer melt reduces the fiber diameter significantly. In addition, the focused fiber 
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deposition allows specific placing and predictable patterning of the electrospun fiber. The 
phenomenological observations and unique properties exhibited by melt electrospinning 
warrant further investigations into the modeling and mechanisms of the process. 
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Chapter 4: Melt electrospinning of isotactic polypropylene - Influence of 
applied voltage on structure formation 
 
Abstract 
The role of the processing parameters on the structure formation and crystallinity of 
electrospun fibers, especially melt electrospun fibers, have not been sufficiently investigated 
yet. The structure formation and crystallinity in semicrystalline polymers like isotactic 
polypropylene (iPP) influence the mechanical properties of the resulting fibers. The 
understanding of the structure formation process and the governing parameters is necessary to 
optimize fiber properties such as mechanical strength. In this chapter, melt electrospinning of 
iPP has been conducted at three different voltages and different noozle to target distances (at a 
constant electric field strength of 2.5 kV/cm). The fibers were collected onto a rotating 
cylinder in order to obtain oriented fiber bundles. Dependent on the applied voltage and 
corresponding noozle to target distances, significant differences in the fiber diameter have 
been observed. Higher voltages and longer distances led to more stretching and resulted in 
thinner fibers. Wide– and small-angle X-ray scattering were employed to investigate the fiber 
microstructure. All iPP fibers contained a mixture of the crystalline α-phase and smectic 
phase at room temperature. Increasing of the voltage and distance during electrospinning 
resulted in a decrease of crystallinity and increase of the smectic phase fraction. Upon heating 
recrystallization of the smectic phase into the more stable -phase was observed at about 
90°C. Maximum crystallinities were obtained at 145°C independent of the process parameters 
and fiber diameter. Recrystallization was found to be most pronounced for the polypropylene 
fibers produced at 25kV and 10 cm distance, as these showed the lowest crystallinity at room 
temperature. Besides these findings, small-angle X-ray scattering curves allowed to see the 
lamellar stacking for all three acceleration voltages. 
Introduction 
Nanofibers are promising materials for many technological applications such as textiles, 
filtration and bioengineering, just to mention a few. Electrospinning is considered one of the 
simplest and effective methods for fabrication of fibers with diameters ranging from 3 nm to 
500 µm [1, 2, 3]. By using electrospinning, nanofibers can be produced either from the 
polymer solutions or polymer melts. Work on melt electrospinning is relatively scarce in spite 
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of the fact that the most significant limiting factors to economically produce nanofibers are 
the solvent recycling issues and low productivity. Melt electrospinning eliminates both 
problems. It also allows for fibers that are free of potentially harmful solvents, which is 
important for most biomedical applications. Furthermore, melt electrospinning is the only 
choice for electrospinning polymers that do not have proper solvents at room temperature like 
polypropylene, or where toxic and expensive solvents are needed. The main difference to the 
solution electrospinning is the way of fiber forming. Within solution electrospinning fibers are 
formed by evaporation of the solvent, while in the case of melt electrospinning, polymer melt 
is cooled down to form fibers [4] The basic principle of melt electrospinning consists in 
extruding a polymer melt through a small needle due to an electric field of high intensity. The 
charged melt in form of a viscoelastic polymer jet is drawn towards a grounded target for 
collection. During its pathway towards the target, the melt solidifies, and the charged, solid 
polymer fiber is collected on the target. The charges on the fibers eventually dissipate, as they 
become neutralized by the surrounding environment as well as after collection on the 
grounded and conductive target. During electrospinning, the jet undergoes elongation and 
hydrodynamic instability processes, which allow the jet to reach its final diameter. The final 
product of the process is a non-woven composed of small diameter fibers, which can be 
randomly collected or exhibit a certain orientation depending on the used target. The 
crystalline structure of nanofibers produced by solution electrospinning has been addressed by 
several researchers in studies using X-ray diffraction [5]. The crystalline structure of 
electrospun polymer nanofibers has been discussed from the viewpoints of processing 
parameters, solution properties, and size effect. When the diameter of polymer fibers 
decreases from the micrometer to nanometer scale, a question arises on how the crystalline 
structure is formed and how different are these structures in comparison to the crystalline 
structures of the corresponding bulk polymers. Another concern is how the processing 
parameters influence the structure of electrospun fibers. Higher applied voltages may lead to 
higher forces pulling and stretching the jet/fiber. Comparison of the structure and morphology 
of bulk material and fibers electrospun at various applied voltages is expected to reveal these 
differences. Due to its technical importance, isotactic polypropylene (iPP- propose to use 
further on) is one of the most extensively studied semi crystalline polymers of the last decade. 
Therefore it is well suited as a model system to address the effect of the processing conditions 
on the structure formation during the melt electrospinning. A semi crystalline polymer such as 
polypropylene consists of crystalline and amorphous parts. The polymer chains fold back and 
forth to form several nanometer-thick lamellae. In the bulk sample, the crystalline and 
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amorphous layers are first folded and stacked on top of one another held together by 
amorphous tie-molecules to form crystallites. These are then twisted and turned to form 
ribbon like supramolekular aggregates called spherulietes. The ratio of the two regions (i.e., 
amorphous and crystalline) determines many of the polymer properties. Polymers that have 
higher crystallinity show higher yield strength, modulus and hardness. When crystalline 
polymers are stretched, the polymer chains are oriented in the direction of stress and the 
spherulite structure is destroyed. A phenomenon called necking is observed, leading to better 
wear and chemical resistance. The fundamentals of the structure of semi crystalline polymers, 
stacks of layer-like crystallites with thicknesses in the nanometer range embedded in an 
amorphous matrix, were revealed already back in the 1950s. [6]. X-ray diffraction is a non-
destructive method of characterization of materials like polymers. Wide-angle X-ray 
diffraction (WAXD) specifically refers to the analysis of Bragg Peaks scattered to wide 
angles, which (by Bragg's law) implies that they are caused by sub-nanometer sized 
structures. When X-rays are directed in crystalline or semi crystalline polymers they will 
scatter in predictable patterns based upon their internal structure. Wide- and small-angle X-
ray Scattering (SAXS) are similar techniques mainly differing in the sample to detector 
distance, which directly determines the resolution of the measurement. SAXS is capable of 
delivering structural information for the distances ranging from 5 to 50 nm. Semi crystalline 
polymers are ideal objects to be studied by SAXS, because electron density variations of the 
structure (with alternating crystalline and amorphous domains) have a correlation length of 
several hundred Angstroms, which falls in the typical resolution range of SAXS. In a SAXS 
instrument a monochromatic beam of X-rays is brought to a sample from which a fraction of 
the X-rays photons undergoes scattering, while the other simply goes through the sample 
without interacting with it. The scattered X-rays form a scattering pattern which is recorded 
with the help of an X-ray detector. The aim of the present project was to study the structure 
formed during electrospinning of iPP, which, to my knowledge, has never been addressed in 
the past. From the previous morphological studies with (various) other polymers, it was found 
that very different structures can be formed for example as a function of the solution 
electrospinning conditions and post processing of fibers such as cold drawing or annealing. 
Thus, to understand the influence of the process parameter voltage on the structure formed 
during electrospinning and prepare iPP-based fibers with a well-controlled morphology, fibers 
produced at different voltages were monitored with WAXD and SAXS at temperatures 
ranging from 55°C to 180°C. 
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Experimental part 
Materials: 
Commercially available isotactic polypropylene (Novolen 1100 N) was purchased from Bayer 
AG (Germany). Novolen polypropylene has a molecular weight of 210,000 g/mol and 
polydispersity of 3.5 and is recommended for extrusion applications. Irgatec CR 76, a 
viscosity reducing additive, has been obtained from CIBA (Ciba Specialty Chemicals, 
Switzerland). The 1.5% blend has been produced using a kneader type 30 EHT with 
rheometer (Plastograph®/Brabender® GmbH & Co. KG) and kneading at 200°C for 5 min. 
 
Electrospinning: 
The melt electrospinning device was composed of a high voltage supply (Eltex KNH34 
purchased from Eltex Elektrostatic GmbH, Weil am Rhein, Germany), a rotating cylindrical 
target, syringe pump of type HA 11 plus (Harvard Apparatus, purchased from Hugo-Sachs 
Elektronik GmbH, March-Hugstetten, Germany), heating chamber (manufactured by DWI 
workshop) and a heat gun of the electron type (product of Leister, purchased from 
Klappenbach GmbH, Hagen, Germany). The warm air current provides an easy-to-handle and 
simple heat source, which allows safe work at high temperatures. A glass tubing as heating 
chamber around the syringe leads the flow of warm air and allows reproducible heating and 
keeping the temperature constant for the time of the experiment. The electronic controlled 
heat gun and the additional thermometer at the place of the syringe allowed control the 
temperature of the melt while heating and at the same time electrospinning. The polymer 
pellets or powders were filled into 2 ml glass syringes with flat-tipped stainless 20 G steel 
spinnerets, and the polymer was melted at the desired temperature (200°C) inside the heating 
chamber by using the warm air. A high negative voltage was applied to the spinneret and the 
fibers were collected onto a grounded rotating aluminum cylinder (diameter 80 mm, length 
100 mm) at varying distances from the spinneret. The grounded cylinder was rotated at a 
speed of 400 rpm, 1000 rpm and 1500 rpm, respectively. The collector was covered with a 
thin sheet of Teflon foil to allow easy removal of the fibers. The collection distance was 60 
mm, 80 mm, and 100 mm, the applied voltages were altered (15 kV, 20 kV, and 25 kV) in 
order to keep the electric field strength constantly at 2.5 kV/cm. A pump rate of 0.08 mL/h 
was used to produce all samples. After production, the oriented fibers were fixed onto 
stainless steal flat washer (outer diameter: 9 mm, inner diameter: 5 mm) with double faced 
adhesive tape (fixated only on the metal, no adhesive tape over the gap). 
Microscopy: 
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Optical microscope images were taken with an MRc5 camera, an Axioplan2 and a N XBO 75 
lamp (Zeiss, Oberkochen, Germany) microscope. The images were taken using a polarization 
filter (Filter 2/ Zeiss, Germany). The magnification used was 5X. The applied voltages are 
indicated on each picture and a scale bar was introduced to allow comparison. 
 
Small- and Wide-angle X-ray scattering 
Room temperature 2D Wide- angle X-ray scattering (WAXS) experiments were performed on 
the BM26 beamline at the European Synchrotron Facility in Grenoble (France) using X-ray 
photons with an energy of 10keV corresponding to a wavelength of 1.24 Ǻ. 2D WAXS 
patterns were collected in transmission geometry using a Photonic Science Detector.  
Time- and temperature-resolved SAXS and WAXS experiments were performed on the ID02 
beamline of the European Synchrotron Radiation Facility (ESRF, Grenoble) using X-ray 
photons with energy of 12.4keV. 2D SAXS and WAXD patterns were simultaneously 
collected in transmission geometry using a proportional gas detector for SAXS and an 
inclined X-ray photon sensitive CCD camera for WAXS.  
The sample temperature was controlled by a Linkam heating stage mounted in the X-ray 
beam path. The fibers were heated in the range from room temperature to 180°C using a 
heating rate of 10 K/min while a dataset was recorded at each degree. In all cases the s-axis, 
with  
)sin(2
s , 
where θ is the Bragg angle and λ is the wavelength of the X-ray photons, was calibrated using 
silver behenate. Reduction and processing of the 2D and 1D X-ray data was performed using 
home-made routines including 2D-distortion and background correction as well as circular 
and radial image integration capabilities within the IGOR PRO (Wavemetrics Ltd.) 
environment. The raw data were corrected for absorption, parasitic scattering, and the fluid 
like background scattering in accordance with ref [7]. After correction the 2D WAXS Pattern 
were radially integrated to obtain one-dimensional scattering curves. To analyze individual 
oriented fibers by X-ray diffraction, the samples were fixed on special sample holders. The 
dimensions of the sample chamber and its dimensions are given in Figure 1A. In a second 
stage, the data were fitted to the sum of Porod‘s law and the Ruland‘s function representing 
the fluid-like background scattering in the large s-range (0.05–0.1A°). The detailed data 
processing has been described by Ivanov et al. [8]. Briefly, for the experimental setup, the X-
ray beam profile measured in the detector plane was found to be adequately described in its 
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longer dimension by a Gaussian of standard deviation beam = 0:66 cm. We thus 
consistently used the expression of ıPorod(s) given by Koberstein et al. [9]: 
 
with 
 
and 
 
In these equations  represents the root-mean-square (RMS) thickness of the density 
transition layers and Kp is Porod‘s constant. The parameter p is related to the standard 
deviation of the beam profile, sample-to-detector distance (SDD) and the X-ray wavelength: 
 
This parameter allows describing the beam shape in reciprocal space units as: 
 
The fluid-like background scattering was subtracted from ı(s), and these curves were then 
desmeared using a variant of Glatter‘s algorithm [10], taking into account the actual profile of 
the incident beam. The one-dimensional correlation function, 1(r), was obtained by Fourier 
transformation of the Lorentz-corrected desmeared intensity. Given the isotropy of this 
samples, and the lamellar character of semi-crystalline iPP, s
2
 was selected as Lorentz factor. 
The morphological parameters of the lamellar structure of iPP, the long period (L) and 
lamellar thickness (Lc), were obtained from 1(r) using standard approximate relationships 
[11]: 
 
In this equations c,lin stands for linear crystallinity, L is determined from the location of the 
first subsidiary maximum of 1(r), and r0 is the first intercept of the tangent to the linear part 
of the correlation function in the self correlation 1(r)=0) In most 
cases, they provide two values for the linear crystallinity, fc,lin; we selected the smaller value 
as the correct one, in agreement with arguments presented elsewhere [12, 13, 7]. The 
examination of the width distributions of crystalline and amorphous regions was performed 
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by analysis of the interface distribution functions, ‘‘1(r) = d
2
 1(r)/dr
2
; where the derivation is 
performed over 0 < r < 1. For one-dimensional layered systems, these functions can be related 
to a series of interfacial distributions [14]  
 
In this equation, the subscripts of the distribution functions h(r) indicate what phases (c—
crystalline, a—amorphous) should be traversed while calculating the interfacial distance. 
 
Results and Discussion 
The electrospun iPP fibers obtained in this chapter were fixed onto stainless steal flat washer 
(outer diameter: 9 mm, inner diameter: 5 mm) with double faced adhesive tape (fixated only 
on the metal, no adhesive tape over the gap) as shown in Figure 1B.  
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Figure 1: A.) Schematic drawing of the WAXS/SAXS sample holder and B.) an 
oriented electrospun fibers on a ring collector (Outer diameter: 9 mm, inner diameter: 
5 mm). 
 
Depending on the used electrospinning conditions the macroscopic morphology and degree of 
orientation of the fiber samples varied. Figure 2 shows melt-electrospun polypropylene fibers 
produced at 15, 20, and 25 kV (corresponding to 6, 8 and 10 cm). 
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Figure 2: Microscopy images of polypropylene fibers electrospun at a Voltage of A.) 
15 kV (distance: 6 cm, rotation speed: 400 rpm), B.) 20 kV (distance 8 cm, rotation 
speed: 1000 rpm) and C.) 25 kV (distance 10 cm, rotation speed: 1500 rpm), the 
electric field strength is in all three cases 2.5 kV/cm. 
 
While those fibers obtained at 15 kV and 60 mm distance between spinneret and rotating 
collector are relatively big in diameter (20 4µm) and show a high degree of orientation, the 
fiber diameter as well as the degree of orientation decreases with increasing voltage and 
distance. Fibers of the same material melt electrospun at 20 kV (and 80 mm distance) show an 
average fiber diameter of 14 4µm and a much lower orientation, even though the rotation 
speed of the collector was increased from 400 to 1000 rpm. A further increase of the 
electrospinning parameters, both voltage (to 25 kV) and distance (100mm), resulted in the 
smallest fiber diameter within this chapter. These fibers exhibits an average diameter of 5 2 
µm and the lowest fiber orientation. In order to avoid additional stretching of the fibers, 
leading to changes in the inner structure of the semi crystalline polypropylene fiber, low 
rotation speed of the target was used. In this case the speed of the jet was too high to orient 
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the fibers on the target. All investigated combination of voltages and distance were chosen to 
keep a constant effective electric field of 2.5 kV/10mm. For that reason, the force responsible 
for the fiber spinning was equal in all cases, even though more charges were introduced in the 
melt with higher voltages leading smaller fiber diameters. The three samples described 
previously were studied using synchrotron X-ray scattering. Figure 3A shows a 2D X-ray 
diffraction pattern recorded for a melt electrospun fiber produced at 15 kV (6 cm). 
 
Figure 3: Wide-angle X-ray diffractogram (WAXD) corresponding to an electrospun 
polypropylene fiber (Voltage 15 kV/6 cm). The fiber axis (FD) is indicated with a bar 
in the image. The Miller indices of the main peaks are indicated in the image. 
Calculated and experimental distances for the -crystal of iPP are given in the table. 
 
The fiber axis is indicated by a white and the letters FD on the image. The X-ray fiber 
diffraction data measured at room temperature is given in Figure 3B. The peak positions of 
the crystalline lattice can be indexed to a unit cell with a space group N9 CC and the 
parameters a = 6.65 Å, b = 20.96 Å, c = 6.50 Å, and  = 99.2°. Wide-angle X-ray 
diffractograms showed that all isotactic polypropylene fibers contained a mixture of the 
crystalline α-phase and the smectic phase at room temperature. Figure 4 shows 1D WAXD 
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curves calculated from 2D patterns of the iPP fibers electrospun at all three voltages (15, 20, 
and 25 kV). 
 
Figure 4: WAXS curves corresponding to isotactic polypropylene and polypropylene 
fibers electrospun at 15 kV (6 cm), 20 kV (8 cm), and 25 kV (10 cm). The black 
curves correspond to the of alpha-phase and smectic phase iPP. 
 
The black curves exemplify a 1D WAXD profile of alpha and smectic phase of iPP. The 
intensity of the peaks (110, 021, 040, 130, 111, 13-1 and 041) alters in dependence of the 
applied voltage during fiber production. Increasing of voltage and at the smae time the 
distance during electrospinning brings about a decrease of crystallinity and increase of the 
smectic phase fraction, visible in the evolution of the peaks shape. Longer distances and 
higher voltage leads to more wipping and significantly thinner jets. The lower degree of 
crystalinity might be due to a faster cooling of the thinner melt-jet and would result in faster 
solidification and less time for crystallization. The WAXD profile of the smectic phase of iPP 
is given for the sake of comparison (black pointed curve). The change in the WAXD pattern 
during heating with a rate of 10°C/min was monitored from 55°C to 180°C (see Figure 5A). 
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Figure 5: A.) Variable temperature WAXS corresponding to iPP electrospun at 25 kV 
(10 cm). For the color code used in the image the intensity increases from black to 
white. B.) 1D WAXS curves of iPP fibers electrospun at 25 kV measured at 55 and 
145°C. 
 
In this temperature range an increase in crystallinity was observed. The bright colors (white > 
blue > green > yellow > orange > brown > black) indicate an increasing intensity of the peaks. 
The smectic phase of iPP recrystallizes during the heating process before finally the melting 
of the fiber begins. The onset of the smectic phase recrystallization for all three samples is at 
about 90°C, as well as a maximum crystallinity at 145°C was observed. At temperatures 
above 145°C the crystallites start melting and the crystallinity decreases dramatically. All 
three samples showed similar recrystallization and melting behavior. Independently of the 
electrospinning conditions similar maximum crystallinities were observed in all three cases. 
Even though directly after melt electrospinning the ratio of the smectic phase to alpha phase 
differs, upon heating to 145°C similar crystallinities were achieved. Figure 5B shows two 
overlaid WAXD patterns of the melt electrospun polypropylene, produced at a voltage of 25 
A.) 3D 
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kV and monitored at 55°C and at 145°C. As these fibers showed the lowest crystallinity after 
their production, recrystallization for the PP 25kV sample was most pronounced. The 
recrystallization behavior of all three samples is shown in Figure 6A. 
 
 
Figure 6: A.) Intensity of the 040 diffraction peak of polypropylene fibers electrospun 
at 15 kV, 20 kV and 25 kV scanned from 55°C to 200°C (Onset of crystallization at 
90°C, Maximum crystallization rate at 145°C) and B.) –dI/dT of the peak intensity of 
the 040-reflex of the fibers melt electrospun at 25 kV. 
 
For all three samples (PP 15 kV, PP 20 kV, and PP 25 kV) the peak intensities of the 040-
reflex are shown from 55°C to 200°C. All three curves show an onset of crystallization 
around 90°, and a maximum at 145°C which is followed by a melting process. The melting 
results in a minimum peak intensity of the 040-reflex around 175°C, suggesting 
disappearance of all crystallites. Figure 6B shows –dI/dT of the peak intensity of the 040-
reflex for the fibers electrospun with 25 kV. The bending point –dI/dT = 0 gives the 
temperature at which maximum recrystallization of the smectic phase is obtained. Structural 
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features of the melt electrospun polypropylene fibers and their differences depending on the 
process parameters applied for production were investigated by SAXS. Figure 7 gives an 
overview over the different data processing steps used in the analysis of SAXS data. 
 
Figure 7: Different steps of analysis of variable temperature SAXS curves 
corresponding to polypropylene electrospun at 15 kV and 6 cm. A.) Lorentz-corrected 
SAXS intensity. B.) Correlation Function (CF). C.) Interface Distribution Function 
(IDF) used to analyze the size distributions of the amorphous and crystalline regions. 
 
The scattered intensity measured from the isotropic 3D object can be transformed to the 1-
dimensional intensity function I (s) by means of the Lorentz correction. 7A shows the 
Lorentz-corrected SAXS intensity of a melt elecrospun isotactic polypropylene fiber produced 
at 15 kV and 6 cm. The intensity I (violet > dark blue > light blue > green > yellow > orange) 
is plotted as a function of s. The value of s at which the intensity maximum is located 
decreases with increasing temperature. The use of the correlation function calculated from 
SAXS curves enables different representation of the microstructure. Therefore the SAXS data 
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was subjected to correlation function analysis in order to derive structural parameters 
corresponding to the sample. The correlation function is simply the Fourier Transform of the 
SAXS curve (7A) and is shown in Figure 7B. It is related to the electron density distribution 
within the sample. The long period LP, the thickness of the amorphous layer L2, and the 
crystalline layer L1 was calculated from the position of the maximum in the correlation 
function according to Strobl and Schneider [15]. The micro-structure of the sample can be 
also characterized by the interface distribution function (IDF) [16, 17]. The latter, denoted 
K’’(d), follows from the scattering cuve I(s) by applying a Fourier transformation: 
 
Here, s denotes the scattering vector, s = 2sin /λ, with  the Bragg angle and λ the 
wavelength. For crystallites with the thickness dc, K’’ (d) has a peak at d = dc which refers to 
the distance between the two surfaces of the lamellae [18]. The interface distribution function 
represents the probability of finding an interface along the density profile. Figure 7C shows 
the interface distribution function for melt electrospun isotactic polypropylene produced with 
an applied voltage of 15 kV. In general, we find the values of the long period calculated from 
different methods, such as conventional analysis by using the Bragg‘s law, the correlation 
function and the interface distribution function, to be different. However, their trends as 
functions of temperature are usually similar (as seen in Figure 7). Figure 8 shows the 
structural parameters that were obtained by interpretation of the correlation function for those 
fibers spun at 15 kV. The changes in the thickness of the crystallites L1, amorphous thickness 
L2, and the long period LP are plotted against the temperature. 
 
Figure 8: Long period, amorphous thickness and crystal thickness derived from the 
Interface distribution function over a temperature range from 55°C to 160°C. 
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With increasing temperature, the thickness of the crystallites remains almost unchanged, 
while long period LP and amorphous thickness L2 increase. This interpretation assumes that 
the sample has an ideal lamellar morphology i.e. it assumes that the sample consists of 
alternating crystalline and amorphous lamellae that are placed in stacks (see figure 8) of 
dimensions that are large enough to affect the small angle scattering. The model is assumed to 
be isotropic i.e. no preferred orientation of lamellae is accounted for. The IDF constitutes the 
relation between the scattering curve on one hand and the structural features of the layer 
thickness distributions on the other [19]. Figure 9 shows an overlay of the long periods of all 
three melt electrospun samples calculated from the correlation functions. 
 
Figure 9: SAXS long period of the polypropylene fibers electrospun at 15 kV (6 cm), 
20 kV (8 cm), and 25 kV (10 cm). 
 
In all three cases the long period increases with increasing temperature. However, small 
differences depending on the process parameter were observed. Especially at higher 
temperatures (above 140°C) those long periods corresponding to the higher applied voltages 
shift to higher values. Generally, PP 25 showed the smallest long period in this chapter. The 
monitored SAXS curves allow seeing the lamellar stacking for all three acceleration voltages. 
We conclude that the electrospinning conditions influence both the crystallinity (ratio of alpha 
phase to smectic phase) of the obtained fiber as well as their lamellar stacking. Higher applied 
voltages during melt electrospinning of isotactic polypropylene lead to thinner fibers reduced 
crystalline alpha phase and smaller values of the long period (corresponding to smaller 
distances between the lamellae). 
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Conclusion 
A series of isotactic polypropylene fibers was produced by variation of the process 
parameters. Three different voltages (15, 20, and 25 kV) and corresponding nozzle to target 
distances (6, 8 and 10 cm) were applied to the spinneret and the fibers were collected on a 
rotating aluminum cylinder at 60, 80, and 100 mm distance, respectively. The individual set 
of process parameters were chosen to keep electric field strength of 2.5 kV/10 mm. The 
collected fiber diameter reduces with increasing of the applied voltage and distance. The 
differences in the fiber structures were monitored using X-ray diffraction experiments at 
wide-angle and small-angle. All isotactic polypropylene fibers contained a mixture of the 
crystalline α-phase and smectic phase at room temperature. Distinct differences in 
crystallinity, respectively the ratio of alpha phase to smectic phase, were observed dependent 
on the process parameters. Increasing of voltage and at the same time distance during 
electrospinning resulted in a decrease of crystallinity and increase of smectic phase fraction. 
Annealing the fibers resulted in higher crystallinity. The observed onset for recrystallization 
of the smectic phase for all three samples was at about 90°C, while a maximum crystallinity 
was reached at 145°C. Similar maximum crystallinities were obtained at 145°C independent 
of the process parameters and fiber diameter. Recrystallization was most pronounced for the 
polypropylene fibers produced at 25kV and 10 cm, as these showed the lowest crystallinity at 
room temperature. Small-angle X-ray scattering curves allowed to detect the lamellar stacking 
for all three acceleration voltages, with small differences in the long period (determined from 
the correlation function) associated to the applied voltages. 
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 Chapter 5: Biofunctionalized nanofibers based on resorbable poly(ethylene 
glycol)-b-polyesters for tissue engineering 
 
Abstract 
Electrospun fibers with contrasting cell adhesion properties provided non-woven substrates 
with enhanced in vitro acceptance and controllable cell interactions. Poly(ethylene glycol)-
block-poly( -caprolactone) (PEG-b-PCL) based block copolymers with varying block length 
were synthesized in two steps and characterized by nuclear magnetic resonance and gel 
permeation chromatography. A cell-adhesive peptide sequence, GRGDS, was covalently 
coupled to the PEG segment of the copolymer in an additional step. The suitability of 
polymers with molecular weights ranging from 10 to 30 kDa for electrospinning and the 
influences of molecular weight, solvent, and concentration on the resulting morphologies 
were investigated. Generally, electrospun fibers were obtained by electrospinning polymers 
with molecular weight larger than 25 kDa and concentrations of 10 wt%. 
Methanol/chloroform (25/75, v/v) mixtures proved to be good solvent systems for 
electrospinning the PEG-b-PCL and resulted in hydrophilic, non-woven fiber meshes (contact 
angle 30°). In vitro testing of PEG-b-PCL meshes both with and without the immobilized 
GRGDS peptide showed contrasting differences. The mesh without cell adhesive GRGDS 
ligands showed no attachment of human dermal fibroblasts after 24 h cell culture 
demonstrating that the particular combination of the material and electrospinning conditions 
yielded protein and cell repellent properties. The GRGDS immobilized mesh showed 
improved cellular attachment. After 24 h the cells were viable and showed spread 
morphology. In the present chapter, for the first time, electrospun nanofibers based on block 
copolymers have been produced which are capable of specifically targeting cell receptor 
binding. Such surface-functionalized nanofibrous meshes are a promising material for tissue 
engineering and controlling cell-material interactions. 
 
Introduction 
Non-woven fiber meshes of microfibers – and more recently nanofibers – are used as tissue 
engineering scaffolds, whereby by the seeding and in vitro cultivation of cells onto the meshes 
precludes their implantation at the defect site. Such non-woven meshes are an important type 
of scaffold developed, aimed to provide a tissue analogue for a wide range of tissue types, 
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including bone, cartilage, vascular grafts and subcutaneous implants. [1]. In addition, oriented 
fibers are of interest in guiding regenerating nervous tissues, both in the peripheral and central 
nervous system [2, 3]. A significant bioresorbable material used in biomedical applications 
are the polyesters of the poly( -hydroxy acids) family [4]. Such polyester may have a range 
of degradation characteristics. Furthermore poly( -caprolactone) (PCL) is often used in tissue 
engineering for long-term implants in cases slow degradation is favorable. Approaches to 
improve biomaterials focus on the control of biomaterial tissue interaction. Control of 
material interaction with host tissue includes the reduction of non-specific protein adsorption.  
Such non-fouling properties can be supplemented with the enhanced adsorption of specific 
proteins, and material modification by immobilization of cell recognition motives to obtain 
controlled interaction between cells and synthetic substrates [5]. Pivotal among the materials 
with a reduced non-specific protein adsorption is poly(ethylene glycol) (PEG). A range of 
materials can be rendered resistant to non-specific protein adsorption by the surface 
modification or grafting of PEG to the substrate. While non-specific protein adsorption is an 
important property of biomaterials, functionalization of an intrinsically protein repellent 
material to control the cell scaffold interaction has been demonstrated by attaching natural 
proteins and small peptides such as RGD. Following this line the development of 
functionalized polymers that can elicit specific biological responses is a rather novel approach 
in scaffold engineering. Because the cell-material interaction, the cells proliferation and the 
consecutive tissue regeneration is also strongly effected by the 3D topology of the scaffold. 
Electrospun nanofibers attracted interest in biomedical applications. As they offer a means to 
construct nanometer scale dimensions there has been a surge in the use of electrospinning 
techniques to create nanofiber scaffolds as substrates from a wide range of different polymers. 
Electrospun fibers mimic the size scale of fibrous proteins (fibrils) found in extra cellular 
matrices and the three-dimensional nature of the matrix allows for cells to infiltrate the matrix 
and proliferate [6, 7]. Where a cell may adhere to only one microfiber in a typical biomedical 
textile, one cell can adhere to multiple electrospun fibers. Hence, there has been a surge in the 
use of electrospinning techniques to create nanofiber scaffolds as substrates, from a wide 
range of polymers, for tissue engineering [8]. Besides the small fiber diameter, nanofiber 
scaffolds offer high surface to volume ratio combined with the potential for high porosity and 
interconnected pores. Functionalization with biologically active ligands as well as 
minimization of unspecific protein adsorption remains challenging tasks for the preparation of 
electrospun fiber constructs. Here we report on electrospinning of poly(ethylene glycol)-
block-poly( -caprolactone) (PEG-b-PCL) copolymers, which enable the immobilization of 
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biologically active sequences (e.g. peptides, proteins and oligosacharides) in order to produce 
scaffolds with improved specific cellular interactions. Deprotection of the synthesized a-
acetal-PEG-b-PCL provides the respective functionality for immobilization of a peptide 
sequence. Figure 1 shows a schematic illustration of the interaction between functionalized 
and non functionalized electrospun fibers and a cell. 
 
Figure 1: Schematic illustration of the interactions between nanofibers and cells. 
Immobilized active molecules lead to cell adhesion to the nanofiber and cell survival 
(B), while cells remain detached on non-functionalized fibers, without immobilized 
adhesion promoting peptide (A). 
 
The covalently attached active molecule should be available on the fiber surface while 
maintaining it‘s bioactivity as cell mediator. Combining non-fouling properties and 
immobilization of cell recognition motifs should lead to controlled interactions between the 
nanofiber scaffold and cells. The aim of this chapter was to show a potential application of 
biologically functionalized nanofibers for tissue engineering. We attempt to make electrospun 
fibers with properties that exhibit diverse cellular interactions –from non- to strong cellular 
adhesion – with the introduction of a single peptide. As the literature on electrospinning is 
expansive and diverse, detailed information on the electrospinning process can be found 
elsewhere [9, 10, 11, 12, 13, 14, 15, 16]. Briefly, an electric potential is applied between a 
droplet of polymer solution (or melt) at the end of a capillary tube, and a grounded collector. 
A charged polymer jet is ejected when the charges overcome the surface tension and is 
accelerated towards the collector. On the path to the target, the jet is whipped by charge 
repulsion and strongly stretched, reducing the diameter, and the fiber solidifies before it is 
deposited on collector. 
Experimental part 
Materials 
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Ethylene oxide, 3, 3-Diethoxypropanol, ε-caprolactone, toluene, methanol, chloroform and 
diethyl ether were all purchased from Sigma-Aldrich (Germany) while GRGDS was supplied 
by Bachem (Switzerland). Ethylene oxide, 3, 3-diethoxypropanol, -caprolactone, and toluene 
were dried by distillation under nitrogen atmosphere. 
 
Chemical and morphological characterization 
The 
1
H-NMR and 
13
C-NMR spectra of polymer samples were measured at 25 °C in CDCl3, 
containing TMS as internal standard, with an Inova 300 spectrometer (300 MHz, Varian 
Associates Nuclear Magnetic Resonance Instruments, Palo Alto, USA). Gel permeation 
chromatography (GPC) measurements were performed at 35 °C using a high-pressure liquid 
chromatography pump (ERC HPLC 64200) and a refractive index detector (ERC-7215a). The 
eluting solvent was THF (HPLC grade) with 250 mg/mL 2, 6, di-tert-butyl-4-methylphenol 
and a flow rate of 1 mL/min and five columns with MZ gel were used. The length of the first 
column was 50 mm, 300 mm for the other four columns. The diameter of each column was 8 
mm, the diameter of the gel particles 5 mm, and the nominal pore widths were 50, 50, 100, 
1000 and 10000 Å, respectively. Calibration was achieved using poly(methyl methacrylate) 
(PMMA) standards. Infrared spectra were recorded using a Thermo Nicole Nexus 670 FT-IR 
spectrometer in transmission mode with a spectral resolution of 4 cm
-1
. The samples were run 
as KBr pellets. Contact angle was determined by sessile drop measurements with a 
goniometer microscope G40 (Krüss, Hamburg, Germany), using electrospun meshes as the 
substrate. The contact angle  is an average of 20 measurements. Resulting fibers were 
imaged with SEM (Cambridge S360, Leica) using an accelerating voltage of 15 KV. 
Microscope images were taken with a Zeiss Stemi 2000-C (Zeiss, Oberkochen, Germany). 
 
Polymer synthesis and chemical functionalization 
 
Figure 2: Structure of -acetal-PEG-b-PCL. 
 
PEG-b-PCL copolymers were synthesized in a two step synthesis (see Figure 2 for polymer 
structure) and the peptide was linked to the PEG-terminus in an additional step. Briefly, first 
the -acetal-poly(ethylene glycol) was synthesized starting from 3,3-diethoxypropanol, 
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potassium napthalide and ethylene oxide inside an UniLab Glovebox (Braun, Germany). For a 
detailed description of the macroinitiator synthesis see Jule et al [17]. The PCL block was 
synthesized using the -acetal-PEG-macroinitiator, pre-dried in an azeotropic distillation, and 
purified -caprolactone with catalytic amounts of tin 2-octoate at 145°C. The PEG-b-PCL was 
dissolved in DCM and then precipitated into a 50-fold excess of ice-cooled diethyl ether. 
Successful polymerization was confirmed by .
1
H-, 
13
C-NMR and GPC. 
1
H-NMR (300 MHz, CDCl3): 
 = 1.20 (t, J=7.00 Hz, 6H, 3x H-1, H-1‘), 1.39 (m, H-11), 1.58-1.72 (kB, H-10, H-12), 2.31 (t, 
J=7.42, H-9), 3.64 (s, H-6), 4.06 (t, J=6.68Hz, H-13), 4.15 (t, 1H, H-7) ppm 
13
C-NMR (75 MHz, CDCl3): 
 = 24.57 (C-10), 25.47 (C-11), 28.34 (C-12), 34.10 (C-9), 64.13 (C-13), 70.57 (C-6), 173.53 
(C-8) ppm 
The -acetal-group was deprotected by dissolving 500 mg polymer in 10 mL acetonitrile, 1 
mL distilled water were added and pH 2 was adjusted by adding 400 µL glacial acid. The 
solution was stirred for 3h at room temperature and neutralized to pH 5 by drop wise addition 
of 0.1 M NaOH. The deprotection of the acetal-group was confirmed by 
1
H-NMR.  A signal 
at δ = 9.81 ppm indicates the free aldehyde. One mole equivalent GRGDS was added and 
stirred over night at room temperature. The solution was freeze dried, the polymer taken up in 
dichloromethane. Sodium cyanoborohydride (NaBH3CN) was added in order to reduce the 
Schiff base into stable secondary amine. The solution was reprecipitated in an excess diethyl 
ether. The product was vacuum-dried and used for electrospinning. The product was 
characterized by 
1
H-NMR- and infrared spectroscopy. The disappearing of the aldehyde 
proton in the 
1
H-NMR as well as the observation of the characteristic signals of amid bonds at 
1656 and 1565cm
-1
 in the infrared spectra indicate the immobilized GRGDS (see Figure 3). 
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Figure 3: Infrared-spectrum of peptide functionalized PEG-b-PCL copolymer. 
 
Electrospinning 
For electrospinning experiments 2 and 10 wt% solutions of the polymers were prepared in a 
mixture of chloroform and methanol (75/25 v/v). The polymer solution was pumped to the 18-
gauge, flat-tipped, stainless steel spinneret at a rate of 0.15 mL/h connected to a voltage 
source of 25 kV. The fibers were collected on a grounded aluminum cylinder (diameter 80 
mm, length 25 mm), which rotated at 200 rpm, in a 200 mm distance from the tip of the 
spinneret [19, 20] 
 
Cell culture 
In vitro experiments were performed with human dermal fibroblasts (hdF) (patient: female, 38 
years, passage 8). After isolation, the cells were cultured in a basal medium consisting of 
Dulbecco‘s Modified Eagle Serum (DMEM) supplemented with 1% fetal bovine serum (FBS, 
Bio Whittaker, Verviers, Belgium) at 37°C, 5% CO2 and 95% humidity. Samples were fixated 
to glass slides (diameter 10 mm) with a biocompatible adhesive, brought into tissue culture 
vials and pre-incubated overnight in DMEM. The medium was carefully removed and the 
samples were incubated with 500 µL cell suspension (60000 cells/mL, hdF) for 24 h at 37°C. 
The cell morphology was visualized by haemalum staining whereas cell viability was 
measured with Live/Dead® staining kits (Invitrogen, Germany). 
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Results and discussion 
This chapter aims to produce non-woven electrospun scaffolds which can be tailored to 
specifically interact with cells. The successful synthesis of a block copolymer, consisting of a 
hydrophilic (PEG) and a bioresorbable hydrophobic segment (PCL), and consequent peptide 
immobilization is the first stage towards electrospinning functional nanofibers. Relatively 
large hydrophilic segments (10 to 13 kDa PEG) were combined with the bioresorbable ester 
segments. 
First, an -acetal protected diblock copolymer, based on biodegradable PCL and PEG was 
produced in a two step synthesis. Commencing with 3, 3-diethoxypropanol as an initiator, two 
different -acetal-PEG macroinitiators, with molecular weights of 10 and 13 kDa respectively 
were prepared by anionic ring-opening polymerization. In order to produce uniform length 
polymers, the -acetal-PEG macroinitiators had polydispersity indices (PMI) below 1.1. Five 
different -acetal-PEG-b-PCL copolymers were synthesized with good yields (≥ 86 %) using 
tin 2-octoate as catalyst (Table 1). 
 
Table 1: PEG-b-PCL copolymers characterized by NMR and GPC.  
 
 
Molecular weights were analyzed by GPC with THF as eluent and narrow molecular weight 
samples of PMMA as standard. In addition molecular weights were calculated from the end-
group analysis by NMR. The resulting PEG-b-PCL had molecular weights ranging from 13 to 
28 kDa and with relatively narrow molecular weight distributions (Mw/Mn below 1.72). 
Deprotection of the -acetal at acidic conditions resulted in the free aldehyde and was 
confirmed by 
1
H-NMR. The free aldehyde of the PEG-b-PCL was reacted with the amino-
group of GRGDS in order to obtain -functionalized PEG-b-PCL copolymers. The Schiff 
base was reduced to a stable secondary amine and after purification a colorless powder was 
obtained that could be used for electrospinning of functionalized nanofibers. The successful 
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immobilization of the peptide sequence GRGDS was confirmed by 
1
H-NMR and infrared 
spectroscopy. 
All five copolymers of PEG-b-PCL (Table 1) were electrospun to investigate the impact of 
the molecular weight and concentration on fiber formation. Figure 4 shows morphologies 
obtained by electrospinning a 10 wt% solution of PEG-b-PCL with (A) a molecular weight of 
14 kDa and (B) a molecular weight of 26 kDa. Chain entanglement in a good solvent depends 
on the molecular weight and its concentration. Above a critical concentration C
*
, the chain 
entanglement acts as force overcoming the Raleigh instabilities associated the break up of a 
fluid jet in droplets [18]. Only polymer droplets were observed of dilute solutions regime due 
to insufficient chain overlap. By electrospinning 2 wt% solutions only particles were formed 
independently of the polymer (Figure 4a). 
  
 
Figure 3: SEM images showing electrosprayed/electrospun morphologies from 10 
wt% solutions of different molecular weights resulting in (A) PEG10-b-PCL4 particles 
and aggregates, and (B) PEG10-b-PCL16 fibers. 
 
Polymers with molecular weights below 25 kDa lead predominantly to spraying even at 
higher concentrations. The polymer chains are too short for sufficient entanglement and can 
not prevent the break-up of the jet in droplets. With increased concentration, respectively 
chain entanglement, those polymers with molecular weights above 25 kDa droplets and 
beaded fibers were formed and further increases in solution concentrations resulted in fiber 
formation only. In this instance, homogeneous electrospun fibers were obtained with 
molecular weights higher than 25 kDa at concentrations of 10 wt% (Figure 4b). 
To characterize the surface properties in contact with water, sessile drop contact angle 
measurements were performed. The contact angle of electrospun PEG10K-b-PCL16K mesh (θ = 
30.9 °±1.85) is relatively small indicating the hydrophilic surface of the material. The use of 
A B 
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long PEG segments with molecular weights of 10, respectively 13 kDa, as macroinitiators is 
likely responsible for the hydrophilicity of these polymers. The PEG-b-PCL electrospun 
material is readily wetted with aqueous media, and is a useful property when working with 
frequent media changes in vitro. In comparison, the contact angle of pure PCL electrospun 
fibers is considerably higher with 119.5°±0.7, indicating the hydrophobicity of such a mesh. 
(Preparation of a PCL mesh is described elsewhere [19])  
In vitro tests with fibroblasts indicate the suitability of these electrospun fiber meshes for 
tissue engineering purposes. Either non-functionalized and GRGDS functionalized 
electrospun PEG10-b-PCL16 meshes were seeded with human-derived fibroblasts and kept in 
cell culture for 24 h. The cell morphology and viability was investigated. Figure 5 shows 
characteristic optical micrographs including fluorescence images for Live/Dead® staining. 
The non-functionalized PEG10-b-PCL16 meshes appear to suppress cell attachment. 
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Figure 4: Optical and fluorescence images of fibers with and without GRGDS. 
Fibroblasts after 24 h culture and haemalum staining on (A) PEG10-b-PCL16 and, (B) 
GRGDS-PEG10-b-PCL16. Fluorescence image of fibroblasts after 24 h culture and 
live/dead staining seeded upon (C) PEG10-b-PCL16 and (D) GRGDS-PEG10-b-PCL16, 
(E) fibroblasts after 24 h culture on TCPS (positive control). 
 
The fibroblasts did not adhere on the unfunctionalized mesh substrates (Figure 5A&C) and 
obviously underwent apoptosis. Since similar electrospun substrates allow some attachment 
with pure PCL fibers, it is possible that the cells can not adhere to the fiber surface due to its 
hydrophilicity. This is also regarded as an indication that the fibers were repellent against 
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protein adsorption either FCS from the serum or proteins produced by the cells. Adsorption of 
these proteins would alter the surface properties of the fibers and set up preconditions which 
lead to cell adhesion. Vital, spread fibroblasts were observed attached to all adjacent glass 
substrates independent of the functionalized or not functionalized meshes (see Figure 5E), 
demonstrating that cells cannot adhere, rather than a cytotoxicity issue with the polymeric 
fibers.  
Conversely, the fibroblasts on the electrospun GRGDS immobilized PEG10-b-PCL16 mesh 
showed spread morphologies high viability (see Figure 5D). These cells display the 
characteristic spread, flat morphology of fibroblasts on tissue culture plastic, indicating good 
adherence to the electrospun fibers. However only a 24h in vitro period was observed. The 
observed cell adherence confirms that the GRGDS and the PEG block were present on the 
fiber surface. These results are in agreement with the small contact angle and indicate the 
presence of the PEG segment and availability of biologically active peptide sequences at the 
fiber surface. 
The cytocompatibility of a material can be detected using a Live/Dead® staining with 
fluoresceine diacetate and propidium-iodide. This staining results in green-fluorescent viable 
cells and red-fluorescent dead cells. The PEG10-b-PCL16 mesh selectively prevents fibroblast 
attachment (no cells), while the GRGDS immobilized PEG10-b-PCL16 mesh shows only 
adherent cells which are viable, indicating cytocompatibility. 
In summary, we have demonstrated a route to bioresorbable nanofibers, that are repellent 
against nonspecific protein adsorption and cell adherence. This forms the prerequisite to 
specific and directed binding. The latter has been demonstrated by functionalization of the 
hydrophilic terminus of the constituent block copolymer with the integrin binding GRGDS 
peptide. 
 
Conclusion 
Electrospun fibers could be produced from block copolymers that were either functionalized, 
or prevented cell adhesion. This shows that the described production of electrospun fibers 
leads to scaffolds which provide biologically active sequences on the fiber surface. Block 
copolymers with low polydispersities and molecular weights from 10 to 30 kDa were 
synthesized and functionalized with GRGDS. The hydrophilic nature of the resulting fibers is 
associated with the relatively large hydrophilic component of the copolymers. Electrospinning 
10 wt% solutions of these block copolymers with molecular weights higher than 26 kDa 
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resulted in homogeneous electrospun fibers (both functionalized and non-functionalized). 
Contact angle measurements (30°) confirmed the hydrophilicity of the fibers and suggest that 
the hydrophilic block is oriented to the fiber surface. The strong adhesion of fibroblasts to the 
biofunctionalized PEG-b-PCL mesh in vitro shows the presence and availability of GRGDS, 
immobilized to the PEG segment, at the fiber‘s surface. The electrospun fiber meshes 
displayed contrasting differences in fibroblast attachment to non-functionalized and GRGDS 
immobilized mesh. While non-functionalized block copolymer meshes prevent cell 
attachment, the functionalized non-woven showed enhanced cell attachment, and a high 
viability is preserved. The synthesis procedure allows the incorporation of additional 
bioactive compounds at the last stage, and may be suitable for triggering a host of cell 
responses and potential applications as artificial scaffolds. 
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Chapter 6: Control of protein adsorption on functionalized electrospun 
fibers 
 
Abstract 
Electrospun fibers that are protein resistant and functionalized with bioactive signals were 
produced by solution electrospinning amphiphilic block copolymers. Poly(ethylene glycol)-
block- poly(D,L-lactide) (PEG-b-PDLLA) was synthesized in two steps, with a PEG segment 
of 10 kDa, while the PDLLA block ranged from 20 to 60 kDa. Depending on the PEG and 
PDLLA segment ratio, as well as solvent selection, the hydrophilicity and protein adsorption 
could be altered on the electrospun mesh. Furthermore, an -acetal PEG-b-PDLLA was 
synthesized that allowed the conjugation of active molecules, resulting in surface 
functionalization of the electrospun fiber. 
Electrospun material with varying morphologies and diameter were electrospun from 10, 20, 
and 30 wt% solutions. Sessile drop measurements showed a reduction in the contact angle 
from 120° for pure poly(D,L-lactide) with increasing PEG/PDLLA ratio. All electrospun 
block PEG-b-PDLLA fibers had hydrophilic properties, with contact angles below 45°. The 
fibers were collected onto six arm star-poly(ethylene glycol) (star-PEG) coated silicon wafers 
and incubated with fluorescently labeled proteins. All PEG-b-PDLLA fibers showed no 
detectable adsorption of bovine serum albumin (BSA) independent of their composition while 
dependence between hydrophobic block lengths was observed for streptavidin adsorption. 
Fibers of block copolymers with PDLLA blocks smaller than 39 kDa showed no adsorption of 
BSA or streptavidin, indicating good non-fouling properties. 
Fibers were surface functionalized with Nε-(+)-biotinyl-L-lysine (biocytin) or RGD peptide 
by attaching the molecule to the PEG block during synthesis. Protein adsorption 
measurements, and the controlled interaction of biocytin with fluorescently labeled 
streptavidin, show that the electrospun fibers are both resistant to protein adsorption and are 
functionalized. Fibroblast adhesion was contrasting between the unfunctionalized and RGD-
coupled electrospun fabrics, confirming that the surface of the fibers was functionalized. The 
PEG-b-PDLLA surface functionalized electrospun fibers are promising substrates for 
controlling cell-material interactions, particularly for tissue engineering applications. 
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Introduction 
Non-woven, fibrous meshes of biodegradable polymers are an important class of tissue 
engineering scaffolds. In the last few decades, fibers were developed for a wide range of 
biomedical applications including bone, cartilage, vascular grafts, subcutaneous implants, 
drug-release systems and wound dressings [1, 2, 3, 4, 5, 6]. Non-woven meshes, based on 
biodegradable polymers, provide promising tissue analogues, particularly when used as 
scaffolds targeting chronic wound repairs [7]. Among the biodegradable and bioabsorbable 
polymers, the polyesters of the poly( -hydroxy acids) family, and specifically poly(lactides), 
are important for various biomedical applications due to their degradation characteristics and 
the non-toxic degradation products [8]. 
The success of a tissue engineering scaffold is influenced by several parameters that range 
from the macro- to the nanoscale. Surface chemistry, surface energy, morphology and 
topology can affect the cellular response to the material, particularly in vitro. The adsorbed 
proteins on biomaterials implanted into the body provide surfaces that are recognized by 
various cellular constituents, effectively altering the biomaterial into a biologically 
recognizable object. Such protein adsorption and remodeling are complex phenomena driven 
by dynamic protein/surface interactions. However, while all proteins are known to have an 
inherent tendency to deposit rapidly onto surfaces, it is generally accepted that cell adhesion 
and subsequent cellular events are controlled by proteins adsorbed onto artificial surfaces. It is 
therefore believed that the surfaces properties determine the organization of the adsorbed 
protein layer, and the nature of this layer in turn determines the cellular response to the 
implant [9]. Many different surface preparations based on poly(ethylene glycol) (PEG) have 
been developed to prevent nonspecific adsorption of proteins and cells [10, 11, 12]. Although 
nonspecific protein adsorption is an important property determining the success of a 
biomaterial, it is only one component of a surface that can also be functionalized with 
bioactive motifs to control cell scaffold interactions [13, 14, 16]. While a protein resistant 
coating is often reported for 2-D substrates, extending this non-fouling property to tissue 
engineering scaffolds is less reported. 
In this framework, the development of functionalisable polymers that can elicit specific 
biological responses, but suppress nonspecific protein adsorption, is of great interest. 
Electrospun fibers in particular have been recently attracted great interest as scaffolds for 
tissue engineering [17, 18]. A detailed history and theory of the electrospinning process is 
described elsewhere [19, 4, 20, 21, 22, 23, 24, 25], 26, 27]. As biomaterials, electrospun 
nanofiber non-woven, or meshes, exhibit important advantages when compared with other 
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scaffolds; firstly, nanoscale fibers provide analogues physically similar to natural, fibriller, 
ECM. Secondly, electrospun fibers offer an unsurpassed surface/volume ratio among tissue 
scaffolds [28]. This latter point is expected to have important consequences on the availability 
and presentation of polymer bound signaling molecules. Due to these advantages, the 
generation of electrospun matrices with biological properties may permit the development of 
novel materials for use in wound healing and tissue engineering [29, 31]. We demonstrate that 
such biofunctionalized electrospun fibers with reduced nonspecific protein adsorption can be 
achieved by using PEG-b-PDLLA copolymers. 
Experimental part 
Materials: 
Ethylene oxide (EO), 3, 3-Diethoxypropanol, 3, 6-dimethyl-1, 4-dioxane-2, 5-dione (D,L-
lactide), toluene, methanol, chloroform, dichloromethane (DCM) and diethyl ether were 
purchased from Sigma-Aldrich (Germany). Zinc octoate (Zn(Oct)2; Zinc 2-ethyl hexanoate) 
was obtained by ABCR (Germany) and used without further purification. PDLLA (Resomer 
R 208) was donated by Boehringer Ingelheim (Germany). Rhodamine red labeled bovine 
serum albumin (BSA), streptavidin Texas red conjugate and Nε-(+)-biotinyl-L-lysine 
(biocytin) was purchased from Molecular Probes (Germany) and GRGDS were supplied by 
Bachem (Switzerland). Isocyanate-terminated six arm star-PEG was kindly donated by 
SusTech GmbH & Co.KG (Germany). Silicon wafer (n-type, dopant: phosphor) were 
obtained by CrysTec (Germany) and cut into squared 14 x 14 mm pieces. Mono-methoxy-
PEG (Mw=10000 g/mol) was obtained from Iris BioTech (Germany). Commercial 
tetrahydrofuran (THF), 3, 3-diethoxy-1-propanol (DEP), ethylene oxide, toluene, methanol, 
chloroform and diethyl ether were purified by conventional distillations under a nitrogen 
atmosphere. 3, 6-dimethyl-1, 4-dioxane-2, 5-dione (D,L-lactide) was recrystallized twice from 
ethyl acetate under a nitrogen atmosphere and sublimated under vacuum at 110 °C. Potassium 
naphthalene was used in a THF solution, the concentration of which was determined by 
titration with 3, 5-di-tert-4-butylhydroxytoluene (BHT). 
 
GPC: 
Gel permeation chromatography (GPC) measurements were carried out at 35 °C using a high-
pressure liquid chromatography pump (ERC HPLC 64200) and a refractive index detector 
(ERC-7215a). The eluting solvent was THF (HPLC grade) with 250 mg/mL 2, 6-di-tert-butyl-
4-methylphenol and a flow rate of 1 mL/min. Five columns with MZ gel were used with the 
length of the first column being 50 mm, and 300 mm for the other four columns. The diameter 
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of each column was 8 mm, packed with 5 mm gel particles, with nominal pore widths of 50, 
50, 100, 1000 and 10000 Å, respectively. Calibration was done with poly(methyl 
methacrylate) standards. 
 
NMR: 
The 
1
H-NMR and 
13
C-NMR spectra of polymer samples were established at 25 °C in CDCl3, 
containing TMS as internal standard, with an Inova 400 spectrometer (400 MHz, Varian 
Associates Nuclear Magnetic Resonance Instruments, Palo Alto, USA). 
 
XPS: 
XPS measurements were performed with an Ultra Axis
TM
 spectrometer, (manufacturer: 
Kratos Analytical, Manchester UK). The samples were irradiated with monoenergetic Al K
1,2 radiation (1486.6 eV) and the spectra were taken at a power of 144 W (12 kV x 12 mA). 
The aliphatic carbon (C-C, C-H) at a binding energy of 285 eV (C 1s photoline) was used to 
determine the charging. The spectral resolution - i.e. the Full Width of Half Maximum 
(FWHM) of the Ester carbon from PET - was greater than 0,68 eV for the elemental spectra. 
The elemental concentration is described in atom%. 
 
Polymer synthesis: 
The functionalized PEG-b-PDLLA copolymers were synthesized in a two step synthesis 
(Figure 1) and the peptide coupled in an additional step. 
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Figure 1: Schematic of the A.) the two step polymer synthesis, and B.) 
functionalization. 
 
Briefly, the -acetal-PEG was synthesized from 3, 3-diethoxypropanol, potassium napthalide 
and ethylene oxide inside an UniLab Glovebox (Braun, Germany). For a detailed description 
of the macroinitiator synthesis see Jule et al. [31]. The block copolymers were synthesized 
using these -acetal-PEG- or methoxy-PEG-macroinitiators, pre-dried in an azeotropic 
distillation. Reaction tubes were flame dried and evacuated to remove traces of humidity. 100 
mg catalyst was added to 1 g of the macroinitiator and various amounts of 3, 6-dimethyl-1, 4-
dioxane-2, 5-dione (D,L-lactide) (see Table 1). 
 
 
 
Table 1: Monomer masses used for synthesis, molecular weight and polydispersities 
of the block copolymers 
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The reaction tubes were evacuated for 2 h and closed. Afterwards the tubes were placed in a 
pre-heated oil bath at 145 °C for 24 h, while the reaction mixture was stirred. 
The PEG-b-PDLLA was dissolved in DCM and then precipitated into a 50-fold excess of ice-
cooled diethyl ether. The polymerization was confirmed by .
1
H-, 
13
C-NMR and GPC. The 
block copolymers were used for electrospinning experiments. 
1
H-NMR: 1.2 (t, CH3 [acetal-group]), 1.56 (s, CH3 [PDLLA-segment]), 3.64 (m, CH2 [PEG-
segment]), 5.2 (m, CH, PDLLA) ppm. 
13
C-NMR: 16.66 (CH3 [PDLLA-segment]), 69.01 (CH [PDLLA-segment]), 70.59 (CH2 
[PEG-block]) ppm. 
Deprotection of the -acetal group and immobilization of GRGDS, respectively biocytin, and 
characterization was described previously [32]. Briefly, for immobilization of biocytin and 
GRGDS, the -acetal-group was deprotected by dissolving 500 mg polymer in 10 mL 
acetonitrile, 1 mL distilled water were added and pH 2 was adjusted by adding 400 µL glacial 
acid. The solution stirred at room temperature, then brought back to pH 5 with a 0.1 M NaOH 
solution in a drop-wise manner. The deprotection of the acetal-group was confirmed by 
1
H-
NMR. One mole equivalent biocytin or GRGDS was added and stirred over night at room 
temperature. Sodium cyanoborohydride (NaBH3CN) was added in order to reduce the Schiff 
base and stirred. The mixture was freeze dried, dissolved in dichloromethane, filtered and 
recrystallized with an excess diethyl ether. The product was vacuum-dried and used for 
electrospinning. 
 
Silicon wafer preparation: 
As substrates for protein adsorption studies we used silicon wafers with an ultra thin star PEG 
coating. Therefore, ultra thin coatings from six-arm star-shaped isocyanate-terminated 
prepolymers on amino-functionalized silicon wafers were prepared as described previously 
[10]. The 14 x 14 mm silicon wafers were star-PEG coated and stored overnight in ambient 
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atmosphere so that crosslinking could take place. Such spin coating with star-PEG resulted in 
protein repellent substrates with a layer thickness below 30 nm [10]. 
 
Electrospinning: 
For electrospinning the polymers were, unless otherwise mentioned, dissolved in a mixture of 
chloroform and methanol (75/25, v/v) to make 10, 20 and 30 wt% solutions. In the case of the 
biocytin and GRGDS functionalized fibers, mixtures of 50 wt% functionalized block 
copolymer and 50 wt% non-functionalized block copolymer of the molecular weight was 
dissolved and proceeded. The polymer solutions were pumped to the 18-gauge, flat-tipped, 
stainless steel spinneret at a rate of 0.1 mL/h. The fibers were collected for 50 s on the 
prepared star-PEG-coated silicon wafers fixed to an aluminum SEM stub (diameter 12 mm) at 
a 200 mm distance from the tip of the spinneret. A voltage of 25 KV was applied to the 
polymer solution with a Series 205B high voltage power supply (Bertran, NY, USA). 
 
Contact angle measurements: 
Contact angle was determined by sessile drop measurements with a goniometer microscope 
G40 (Krüss, Hamburg, Germany), using electrospun meshes (collected on aluminum foil) as 
the substrates. The contact angle  is an average of 20 measurements. 
 
Protein adsorption: 
Electrospun fibers were incubated for 20 min in a 50µg/mL solution of the Rhodamine 
labeled bovine serum albumin (BSA) or Texas red labeled streptavidin (STRP) in PBS buffer. 
Afterwards the samples were incubated three times for 20 min. in PBS buffer. The samples 
were incubated another time for 60 min in PBS buffer and washed extensively with distilled 
water. All samples were kept in dark during all incubation and washing steps before analysis 
with fluorescence microscopy. 
 
In vitro experiments: 
For preliminary in vitro tests, human dermal fibroblasts (patient: female, 38 years, passage 8) 
were isolated and cultured in a basal medium consisting of Dulbecco‘s Modified Eagle Serum 
(DMEM) supplemented with 1% fetal bovine serum (FBS, Bio Whittaker, Verviers, Belgium) 
at 37°C, 5% CO2 and 95% humidity. Electrospun fibers on star-PEG substrates were pre-
incubated overnight in DMEM, and this medium exchanged with 500 µL cell suspension 
(60000 cells/mL) for 24 h at 37°C. The cell morphology was visualized by haemalum staining 
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and representative microscope images were taken. The cell viability was measured with 
Live/Dead® staining kits (Invitrogen, Germany). 
 
SEM and optical microscopy: 
The samples were imaged with SEM (S-4800 Ultra High Resolution Scanning Electron 
Microscope, Hitachi) using an accelerating voltage of 1 KV. Microscope images were taken 
with a Zeiss Stemi 2000-C. In order to observe the protein adsorption, a 20,000 ms exposure 
and 20X magnification was used for all fluorescence images. Optical microscope images 
(magnification 20X) of the same sample are presented as comparison. 
Results and Discussion 
Synthesis of PEG-b-PDLLA copolymers: 
PEG-b-PDLLA diblock copolymers were synthesized in two steps (see Figure 1). First, the -
acetal-PEG was polymerized in an anionic ring-opening reaction with good yields (95 %) and 
a low polydispersity index (Mw/Mn) of 1.08. A white, slightly yellowish, powder was 
obtained. In a second step, the poly(D,L-lactide) block was polymerized using the previously 
synthesized -acetal-poly(ethylene oxide) or methoxy-PEG as macroinitiator. Three different 
methoxy-PEG-b-PDLLA and one -acetal-PEG-b-PDLLA copolymers, with molecular 
weights ranging from 30 to 70 kDa, were synthesized using zinc 2-octoate as catalyst. The 
yellowish/white polymers were used either directly for electrospinning or further 
functionalized in an additional step. Since the PEG macroinitiators had a low polydispersity, 
the ring-opening reaction with zinc 2-octoate resulted in low Mw/Mn, reproducible molecular 
weights (see Table 1) and high yields (80-90 %). The correct synthesis and the conversion of 
the monomers into polymer were confirmed by 
1
H-NMR, 
13
C-NMR and GPC. 
 
Electrospinning and fiber morphology: 
Morphology of the collected electrospun material is strongly dependant on the processing 
parameters (flow rate, voltage and needle to target distance), ambient parameters (air 
humidity, pressure and temperature), and the solution parameters [33]. The latter influences 
the interaction of polymer chains during the spinning process. Chain entanglement 
distinguishes between spraying and spinning, and is directly associated to the molecular 
weight, concentration and viscosity, which are parameters that play key roles in producing 
electrospun fibers [34]. Chain entanglement can be influenced by polymer concentration, 
molecular weight and the polymer-solvent interaction – the hydrodynamic radius of the 
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polymer is affected by the solvent. The chain entanglement prevents the break-up into 
droplets caused by Raleigh instabilities, while the electrical properties will determine the 
stretching of the jet and influence the final fiber diameter. From the three different molecular 
weight block copolymers the influence of the solution concentration and solvent composition, 
on the fiber morphology and on protein adsorption were analyzed. PEG10K-b-PDLLA60K, 
PEG10K-b-PDLLA39K and PEG10K-b-PDLLA20K were electrospun from 10, 20, and 30 wt% 
solutions and characteristic features are summarized in Table 2. 
 
Table 2: Influence of molecular weight and solution concentration on fiber diameter 
and morphology 
 
 
 Polymer concentration  
The fiber diameter was significantly affected by polymer concentration of the solution from 
10 to 30 wt%, shown in Table 2. For all different molecular weight block copolymers 
(between 30 and 70 kDa), solutions below 10 wt% resulted in both the lowest diameter 
electrospun fibers, as well as bead formation. Increasing the solution concentration increased 
the fiber diameter, and also removed the occurrence of beading. Figure 2 shows SEM 
micrographs of PEG10K-b-PDLLA60K (Mw = 70 kDa) electrospun fibers from different 
polymer concentrations from identical electrospinning conditions. 
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Figure 2: SEM micrographs of PEG10K-b-PDLLA60K fibers electrospun at an applied 
voltage of 25 kV and 20 cm distance between spinneret and target from different 
solution concentrations: (a) 10 wt%, (b) 20 wt%, (c) 30 wt%. 
 
Figure 2A shows both fibers (210 nm) with beads, while beads did not result from 20 wt% 
solutions (Figure 2B). Electrospun 30 wt% solutions resulted in a further increase in fiber 
diameter (3.3 µm) (Figure 2C), fiber diameter and solution polymer concentration for 
PEG10K-b-PDLLA60K are summarized in (Table 2). It is believed that Raleigh instabilities 
causes the formation of beads along the jet‘s path to the target, and is related to surface 
tension of the jet. Raleigh instabilities cause beading within a fluid jet, and low polymer 
concentrations tend to congregate and adopt a spherical shape due to the low surface tension. 
Higher polymer concentrations lead to higher surface tensions, which results in a continuous 
jet that may be stretched under the influence of surface charges. 
 
 Molecular weight effect 
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The molecular weight of the polymer affects the fiber morphology as well as their quality. 
Figure 3 shows SEM images of fibers of PEG10K-b-PDLLA60K, PEG10K-b-PDLLA39K, and 
PEG10K-b-PDLLA20K electrospun from 20 wt% solutions. 
 
 
Figure 3: SEM-Images of PEG10K-b-PDLLAX spun from 20 wt% solutions at a 
constant applied voltage of 25 kV, and a distance of 20 cm. (A) PEG10K-b-PDLLA20K, 
(B) PEG10K-b-PDLLA39K, (C) PEG10K-b-PDLLA60K. 
 
Beads were formed only in those fibers with the lowest molecular weight (30 kDa) (Figure 
3A) and may be attributed to the lower solution viscosity and surface tension. The higher 
molecular weight polymers (49 and 70 kDa) lead to larger diameter, bead-free, fibers (Figure 
3B&C). The fiber diameter from 30 wt% solutions of the highest molecular weight polymer 
was the largest in this chapter (3.3 µm). During the stretching of the polymer solution, it is the 
entanglements of the polymer chains in the solvent, which act opposite to stretching forces, 
and prevent the jet from breaking up into droplets through Raleigh instabilities. Those fibers 
with the smallest molecular weight, respectively smallest chain length in the spinning solution 
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showed flat and melted morphologies. Generally, higher quality fibers are obtained by 
electrospinning higher molecular weight polymers (Figure 3). 
 
Surface properties and protein adhesion of the electrospun mesh: 
The hydrophobic/hydrophilic nature of a substrate has been a significant component of 
surface engineering for various applications. For example in the separation of protein 
solutions, hydrophilic membranes are favorable due to the minimized protein adsorption and 
similarly hydrophilic scaffolds are preferred for some tissue-engineering applications and as 
wound dressings. The non-protein adhesive/non–fouling properties of PEG are widely 
recognized, and are a component of both the electrospun fibers and the collection system 
utilized in this chapter. 
The assay for protein adsorption upon electrospun PEG-b-PDLLA fibers involved incubating 
fluorescent BSA or STRP on electrospun fibers collected onto a star-PEG-modified silicon 
wafer. The NCO-star-PEG has two purposes within the experimental design, schematically 
shown in Figure 4. 
 
Figure 4: A Star-PEG coated collector initially sticks the fiber to the substrate, and 
continues to react with water to produce a protein resistant surface. Protein adsorption 
will only occur on the collected PEG-PDLLA material. 
 
Initially, the star-PEG is chemically reactive coating, and will adhere the electrospun material 
to the substrate, allowing for frequent media changes without loss of the electrospun material. 
Secondly, the star-PEG surface provides non-fouling properties and resembles a substrate 
upon which protein adsorption is minimized. During incubation with fluorescent proteins, the 
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substrate will resist protein adsorption and provide a non-interfering - inert- background for 
imaging, with only adsorption onto electrospun fibers assayed. Figure 5 shows fluorescence 
and optical micrographs of PDLLA electrospun fibers after incubation with the fluorescent 
proteins. 
 
Figure 5: Micrographs and fluorescence images of PEG10K-b-PDLLA39K (A&B) and 
PDLLA (C&D) electrospun and incubated with BSA and streptavidin (STRP). 
 
The pure PDLLA electrospun fibers showed significant adsorption of both the BSA and 
streptavidin on the electrospun fiber surface. 
PEG-b-PDLLA copolymers (20 wt%) were electrospun in either pure chloroform or a 
chloroform/methanol (75/25 v/v) solution. The original solvent composition of the polymer 
solution affected the protein adhesion on the PEG-b-PDLLA (Figure 6) as well as 
morphology. 
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Figure 6: Micrographs and fluorescence images of PEG10K-b-PDLLA20 spun from 
methanol/ chloroform (A) and pure chloroform (B), incubated with fluorescent BSA or 
streptavidin (STRP). 
 
Figure 6A shows that no adsorbed proteins were found on the samples electrospun from the 
solvent mixture, while the polymers dissolved in chloroform adsorbed both proteins. Due to 
the lack of protein adsorption onto these particular PEG-b-PDLLA electrospun fiber surfaces, 
we believe that the hydrophilic segment is enriched at the fiber surface. An increased 
PEG/PDLLA ratio in the polymers should therefore decrease water contact angle of the 
electrospun meshes. Contact angle measurements on three different molecular weight 
copolymers (PEG10K-b-PDLLA20K, PEG10K-b-PDLLA39K, PEG10K-b-PDLLA60K) meshes and 
an electrospun poly(D,L-lactide) (Resomer R 208) mesh show a significant trend (Figure 7). 
 
Figure 7: Images of contact angle measurements on (A) an electrospun PDLLA mesh, 
(B) a PEG10K-b-PDLLA60K mesh, (C) a PEG10K-b-PDLLA39K mesh, and (D) a PEG10K-
b-PDLLA20K mesh. 
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Since the PEG macroinitiator is the same for all block lengths, increasing molecular weight is 
attributed to the PDLLA block. The contact angle of pure PDLLA electrospun fibers is large 
(119°±2) (Figure 7A), indicating the hydrophobicity of such a mesh. In contrast, the PEG-b-
PDLLA electrospun material is readily wetted with aqueous media. Figure 7B shows a water 
droplet on a PEG10K-b-PDLLA60K mesh with a contact angle of 45° and illustrates the 
hydrophilicity of the scaffold. The contact angle of the PEG10K-b-PDLLA20K mesh was below 
10° indicating a super-hydrophilic surface (Figure 7D), while the PEG10K-b-PDLLA39K fibers 
also had a contact angle below 20° (Figure 7C). This shows increased hydrophilicity of the 
sample with increasing PEG/PDLLA ratio, and the presence of a PEG block in the polymer 
resulted in electrospun fiber meshes with a reduction in contact angle greater than 80°. 
The atom content of the first few nanometer surface layers of the electrospun PEG-b-PDLLA 
meshes and a PDLLA mesh was determined by X-ray photoelectron spectroscopy. Figure 8 
illustrates the differences in the oxygen to carbon ratio of these meshes. 
 
Figure 8: Oxygen to carbon atom ratio for electrospun (A) PDLLA, (B) PEG10K-b-
PDLLA60K, (C) PEG10K-b-PDLLA39K, (D) PEG10K-b-PDLLA20K meshes determined by 
XPS. 
 
The pure PDLLA fibers show with 0.54 the highest oxygen to carbon ration. All PEG-b-
PDLLA meshes had reduced oxygen/carbon ratios. Generally, the oxygen to carbon ratio 
decreases with the molecular weight of the PDLLA-segment in the PEG-b-PDLLA block 
copolymer.  
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The reduction in contact angle and the XPS measurements show that the hydrophilic block of 
the PEG-b-PDLLA is enriched at the fiber surface. The use of relatively long PEG segments 
with molecular weights of 10 kDa, as macroinitiators is likely to play a role in the 
hydrophilicity of these polymers, while the inclusion of methanol promotes hydrophilic fibers. 
During electrospinning, the less volatile methanol drives the soluble PEG block to the fiber 
surface, while the PDLLA remains below the surface.  
Interestingly, electrospinning from methanol/chloroform solutions leads to the formation of 
fibers, whilst the pure chloroform as a solvent leads mainly to electrostatic spraying and the 
collection of particles. Generally, a solution with a higher dielectric constant reduces the 
formation of beads and particles as well as the fiber diameter. It is known that by adding 
solvents as methanol or DMF the dielectric property of a solution is increased in order to 
improve the fiber morphology [35, 36]. The bending instability of the jet also increases with 
higher dielectric constant. This results in an increased deposition area and an increased jet 
path [37]. However, if a solvent, such as methanol with a dielectric constant of 32.6 is added 
to a solution (with a low dielectric constant) to improve electrospinning, the interaction 
between the solvents and polymer blocks, such as solubility, will have not only an impact on 
the morphology, but on the surface properties of the mesh as well. Such dielectric constant for 
the solvent likely has an influence on surface migration of segments during electrospinning. 
All three block copolymers (PEG10K-b-PDLLA20K, PEG10K-b-PDLLA39K, PEG10K-b-
PDLLA60K) using 10, 20, and 30 wt% in methanol/chloroform (25/75, v/v) were electrospun, 
and incubated with buffer solutions containing fluorescence labeled proteins. No BSA 
adsorption was observed on any PEG-b-PDLLA electrospun fibers, independent of the 
concentration, or respective fiber diameter (Figure 9). 
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Figure 9: Micrographs and fluorescence images of different molecular weight PEG-b-
PDLLAx electrospun from a 20 wt% solution incubated with BSA or streptavidin 
(STRP), (A) PEG10K-b-PDLLA20K, (B) PEG10K-b-PDLLA39K, (C) PEG10K-b-
PDLLA60K. 
 
All electrospun meshes of the block copolymers PEG10K-b-PDLLA20K and PEG10K-b-
PDLLA39K were protein repellent. In the case of PEG10K-b-PDLLA60K no adsorption of BSA 
was observed, but STRP did adsorb onto electrospun PEG10K-b-PDLLA60K fibers (Figure 9C). 
Electrospun fibers with a larger ratio of PDLLA in the block copolymer partially lost protein 
resistance (streptavidin). Since the electrospinning of different molecular weight polymers 
lead to different collected material, the PEG10K-b-PDLLA20K was selected as a fiber with good 
resistance to protein adsorption. 
 
Fiber Functionalization and in vitro tests 
End-functionalized PEG-b-PDLLA was synthesized so that bioactive molecules can be 
introduced to the surface of the electrospun fiber via the PEG block (see Figure 1). The -
acetal group protective end-group is converted to an -aldehyde group under acidic 
conditions, confirmed by 
1
H-NMR spectroscopy by the disappearance of the CH-signal of the 
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acetal group as well as the appearing of the aldehyde proton. The reactive aldehyde can then 
be used to conjugate biocytin and peptides (GRGDS) to the block copolymer. 
Biocytin was immobilized to the PEG segment of the block copolymer and is intended to 
appear at the surface of the electrospun fiber, and react with streptavidin as shown in the 
scheme in Figure 10. 
 
Figure 10: Schematic illustration of the binding of streptavidin with biocytinylated 
fibers.  
 
Electrospun fibers of biocytin labeled PEG10K-b-PDLLA25K collected onto star-PEG 
substrates were incubated with streptavidin (STRP) or with BSA and representative 
fluorescence microscope images and optical microscope images are shown in Figure 11. 
 
Figure 11: Optical and fluorescence microscope images of biocytin functionalized 
electrospun fibers incubated with bovine serum albumin, and streptavidin. 
 
These fibers selectively bind fluorescently labeled STRP during protein adsorption 
experiments, while no adsorption of BSA was detected. This reinforces the hypothesis that the 
PEG block is attracted to the surface of the electrospun fibers. 
Figure 12 shows a schematic illustration of cell adhesion on unfunctionalized fibers and fibers 
functionalized with the cell adhesion promoting peptide RGDS. 
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Figure 12: Schematic illustration of cell adhesion on (A) unfunctionalized fibers and 
(B) fibers functionalized with RGD. 
 
While fibroblasts should respond to the presented adhesion motive on the fiber surface, 
unfunctionalized fibers remain non adhesive.  
In order to evaluate the cell attachment and proliferation on such electrospun fibers, human 
dermal fibroblasts were seeded for 24 h on the (PEG10K-b-PDLLA25K) substrates and their 
morphology investigated. Notably, there was no fibroblast adhesion to the non-modified 
meshes after 24h incubation, while adhesion on adjacent glass surfaces was seen. While it is 
known that cells adhere poorly to PEG modified substrates, these tend to be flat substrates, 
while the electrospun fiber substrates described here provide a morphologically ―rough‖, 
three-dimensional substrate for cells to grow upon. Cytotoxicity controls show that the 
polymer itself is not toxic, and that the lack of protein adhesion upon these substrates is 
translated into non-adhesive substrates for cell-adhesion [32]. 
When RGD peptides are coupled to the PEG end of the PEG-b-PDLLA and electrospun, the 
resulting cell adhesion is contrasting with the unconjugated polymer. Fibroblasts adhere to the 
fibers electrospun from the RGD-modified block copolymer (Figure 13B&D), and 
demonstrate 100% viability after 24h, while no cells (viable or non-viable) were observed on 
the non-functionalized fibers (Figure 13A&C). The cell adhesive properties of the electrospun 
fibers can therefore be altered by the functionalization of the PEG end of the PEG-b-PDLLA 
block copolymer. 
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Figure 13: (A) PEG10K-b-PDLLA20K block copolymer fibers, (B&C) GRGDS 
immobilized PEG10K-b-PDLLA20K block copolymer fibers after 24 h cell culture with 
human dermal fibroblasts (haemalum and Live/Dead®staining).  
Conclusion 
Protein resistant and surface-functionalized electrospun fibers based on resorbable block 
copolymers have been produced. Prevention of nonspecific adsorption of proteins onto the 
fiber surface may open new possibilities towards selective cell-nanofiber interactions and 
potential manipulation of the in-vivo acceptance for the scaffold. Protected diblock 
copolymers were synthesized in a two step synthesis based on biodegradable polyester and 
PEG. Electrospinning of these copolymers resulted in fibers with excellent non-fouling 
properties. The protein adsorption of electrospun PEG-b-PDLLA fibers was found to be 
dependent on the ratio hydrophilic to hydrophobic block, respectively the molecular weights 
of (the PEG and) the PDLLA segments. A high PEG to PDLLA ratio was responsible for 
suppression of nonspecific protein adsorption on electrospun meshes. The solvent used during 
the electrospinning process was also determined to play a key parameter controlling the 
adsorption behavior. By choosing a mixture of methanol/chloroform (25/75, v/v) as solvent, 
an in-situ orientation of the PEG-segment was achieved, preventing protein adsorption. 
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Preliminary cell culture experiments with human dermal fibroblasts for 24 h showed either no 
cell attachment with unmodified fibers, or excellent attachment with biofunctionalized 
polymers. Biotinylated electrospun polymers also resulted in strong streptavidin fluorescence, 
and no BSA adsorption. Electrospun PEG-b-PDLLA fibers are promising candidates for 
suppressing nonspecific adsorption for tissue engineering applications. 
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Chapter 7: Bioresorbable Electrospun Fibers for Immobilization of Thiol-
containing Bioactive Molecules as Tissue Engineering Scaffolds 
 
Abstract 
Current developments in medicine raise high demands on modern implants and tissue 
engineering scaffolds that exceed passive biocompatibility. Besides degradability, specific 
surface chemistry and a three-dimensional structure that matches the damages tissue are core 
challenges and prerequisites for the reconstruction of living cells to functional tissue. We 
produced fibrous scaffolds capable of controlling the cell/fiber interactions. Electrospun fibers 
that are protein resistant and at the same time can be functionalized with bioactive signals 
(e.g. adhesion promoting peptides) were produced. The in vitro results indicate strong and 
specific cell binding of fibroblasts to GRGDC functionalized bioactive fibers. Promissing 
scaffolds were obtained by solution electrospinning amphiphilic block copolymers (poly(D,L-
lactide)-block-poly(ethylene glycol)) with three different thiol-reactive end groups from a 
solvent mixture (methanol/chloroform). These fibers combine minimized non-specific protein 
adsorption with well-defined surface chemistries to immobilize peptides. Fibers of block 
copolymers with PDLLA blocks of 30 kDa showed no adsorption of fluorescently labeled 
BSA or streptavidin, indicating good non-fouling properties. Sessile drop measurements 
showed a reduction in the contact angle from 120° for pure poly(D,L-lactide) due to the 10 
kDa poly(ethylene glycol) segment. Electrospun block PDLLA-block-PEG fibers provided 
hydrophilic substrates, with contact angles below 45°, suitable for cell culture experiments. 
Contrasting to other electrospun poly(lactide) scaffolds, these fibers were easily wetted by cell 
culture medium. Hydrophilic 3D fibrous scaffolds presenting thiol-reactive groups on the 
fiber surface allowed immobilization of active molecules and showed promising in vitro 
results. Fibroblast adhesion was contrasting between the unfunctionalized and GRGDC-
coupled electrospun fabrics, confirming that the surface of the fibers was functionalized. 
Besides immobilization of the GRGDC peptide sequence and subsequent cell culture 
experiments with fibroblasts, a cystein terminated fluorescence dye was immobilized to the 
fiber surfaces. A homogeneous green fluorescence on the fiber surfaces indicated the presence 
of the immobilized molecule. These electrospun scaffolds uniquely combine well-defined 
surface chemistries to immobilize bioactive molecules, homogeneous presentation of 
immobilized ligands, and minimized non-specific adsorption of protein. 
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Introduction 
Current research on new and improved biodegradable polymers is focused on more 
sophisticated biomedical applications to solve patients‘ problems with higher efficiency and 
the least possible pain. One example is tissue engineering, in which a biodegradable scaffold 
seeded with an appropriate cell type provides a substitute for damaged human tissue while the 
natural process of regeneration is completed [1]. The requirements for a scaffold suitable for 
tissue engineering applications are complex and depend mainly on the tissue to be restored as 
well as the location and size of the defect to be treated. A number of biodegradable and 
bioresorbable materials, as well as scaffold designs, have been experimentally and/or 
clinically studied. Ideally, a scaffold should have the following characteristics: (i) three-
dimensional and highly porous with an interconnected pore network for cell growth and flow 
transport of nutrients and metabolic waste; (ii) biocompatible and bioresorbable with a 
controllable degradation and resorption rate to match cell/tissue growth in vitro and/or in 
vivo; (iii) suitable surface chemistry for cell attachment, proliferation, and differentiation and 
(iv) mechanical properties to match those of the tissues at the site of implantation [2]. 
However, it is well established that biodegradable polymeric biomaterials are valuable in 
many short term medical applications that require the temporary presence of an implant, 
because they do not have to be surgically removed after fulfilling their functions in the human 
body. Biodegradable polymers form a unique class of materials that created an entirely new 
concept when originally proposed as biomaterials. Biodegradable polymers used in clinical 
applications should have resorption rates which are compatible with the healing rates of 
biotissues or with the performance of a specific function, depending on the final application in 
the human body. It is well known that the healing rate is different for each biotissue 
depending on its location in the body, and can vary from days up to several months. Poly ( -
hydroxyl acids) such as poly(glycolic acid) and poly(lactic acid), are currently the most, 
widely investigated, and most commonly used synthetic biodegradable polymers. They are 
currently the gold standard of the market that any new candidate must beat. These polymers 
are in fact the current benchmark in the biomaterial industry. Poly(glycolic acid) is the 
simplest linear aliphatic polyester, is highly crystalline and possesses a high melting point as 
well as low solubility in organic solvents. Lactic acid is a hydrophobic polymer and exists in 
two stereoisomeric forms which rise four morphologically distinct polymers: poly(D-lactide), 
poly(L-lactide), and poly(D,L-lactide). The fourth morphological form poly(meso-lactide), is 
in practice rarely used. One of the disadvantages of these materials is that their degradation 
products reduce the local pH value, which may accelerate the polyester degradation rate and 
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induce inflammatory reaction [3]. Poly(D,L-lactide) is FDA approved, exhibits a tensile 
modulus of 35 GPa, a tensile strength of 60 MPa, a bending strength of 130 Mpa, and shows 
complete weight loss in 0.5 to 1 year. Block copolymerization with PEG improves 
hydrophilicity of the copolymer significantly. PDLLA block is still degraded under 
physiological conditions; the degradation process is even accelerated by copolymerization 
with PEG. Due to the different polarities of the two blocks, resulting copolymers show 
amphiphilic properties. If the molecular mass is not too high, the remaining PEG block is 
excreted via renal clearance and the degradable copolymer remains non-toxic and can still be 
regarded as harmless. Poly(ethylene glycol) (PEG) is known for its biocompatibility and has 
been used extensively as coating material to generate surfaces that resist non-specific protein 
adsorption. [4]. 
Besides the bioresorbability and biocompatibility, scaffolds have to provide a three-
dimensional structure supporting the organization of the living cells to functional tissue. 
Highly porous nonwoven meshes that show a remarkable morphological similarity to the 
ECM can be produced straightforward by electrospinning [5]. In the last twenty years, the 
process of electrospinning has attracted much interest as technique to produce polymer sub-
micron fibers that in specific cases may range down to only a few nanometers. The process 
itself is a variation of the longer known electrospray process, which produces small particles 
using electrical force. As the literature on electrospinning is expansive and diverse, detailed 
information on the electrospinning process can be found elsewhere [6, 7, 8, 9, 10, 11, 12, 13]. 
Briefly, during electrospinning a droplet of polymer solution (or melt) is subjected to an 
electric field. A charged polymer jet is ejected when the charges over come the surface 
tension and is accelerated towards the collector. On the path to the target, the jet is thinned by 
a series of processes (referred to as bending, whipping, splaying etc), reducing the diameter, 
and the fiber solidifies before it is deposited on collector. In contrast to electrospraying, the 
viscoelastic behavior of the polymer solution keeps the elongated jet from breaking into beads 
due to the surface tension. Several different collection systems are described in literature [5] 
and can be used for fiber collection, each determining the structure and shape of the scaffold. 
As many tissue engineering strategies require the penetration of cells into a scaffold, 
producing electrospun substrates with both a significant volume and large pore size will 
become necessary. Increasing the nanofiber mesh porosity for cell penetration can achieved 
by techniques such as electrospinning onto ice crystals [14]. Cells are inherently sensitive to 
local mesoscale, microscale and nanoscale patterns of topography and chemistry [15]. 
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An appropriate surface chemistry preventing protein adsorption, which is a prerequisite to 
prevent foreign body reactions, is a necessarity in order to introduce and control cell/scaffold 
interaction. The interactions between an implant and biological systems are crucial in terms of 
success or inflammatory body reactions leading to implant failure. In order to control these 
reactions, non-specific protein adsorption and subsequent cell adhesion on the material have 
to be prevented. The non-protein adhesive/non–fouling properties of hydrogels like PEG are 
widely recognized, and are a component of both the electrospun fibers and the collection 
system utilized in this chapter. Besides the prevention of protein adsorption, biological 
activity of the polymeric scaffolds is a prerequisite for the ultimate formation of functional 
tissue [16]. Therefore, synthetic materials must contain active molecules similar to those 
proteins and growth factors found within the natural ECM and on cell surfaces, supporting the 
cell development by triggering its responses. Research in the field of tissue engineering 
centered mostly on surface modifications e.g. on immobilization of biomolecules that are 
recognized by cells [17]. These biomolecules included adhesive proteins like collagen, 
fibronectin, RGD peptides and growth factors like bFGF, EGF, insulin, etc. Biomolecules 
were electrostatically adsorbed, self-assembled on biomaterial surfaces or covalently attached 
in order to improve their biocompatibility and performance. An alternative to the surface 
modification by physical adsorption is immobilization of active molecules. However, among 
these modification strategies, only the covalent immobilized biomolecules were capable of 
altering the implants biocompatibility permanently and lead to long term stability. Generally, 
there are only few examples dealing with surface modifications on electrospun scaffolds. First 
Casper et al. reported incorporation of an active substance into electrospun fibers for tissue 
engineering. This modification did not lead to long term stable scaffold modification but to 
release system, showing retarded release of the active compound over a certain period of time. 
They created a biologically active functionalized electrospun poly(lactide-co-glycolide) 
matrix to permit immobilization and long-term release of growth factors [18]. Another 
approach to successfully create surface functionalized electrospun fibers was reported more 
recent by Kim et al [19]. By electrospinning a mixture of biodegradable poly( -caprolactone) 
and poly(D,L-lactide-co-glycolide)-b-poly(ethylene glycol) block copolymer surface 
functionalized fiber meshes were produced. The resulting electrospun fibers with primary 
amino-groups were applied for immobilization of lysozyme by using a homofunctional 
coupling agent. None of these approaches is sufficient to control the cell/scaffold interactions.  
In this chapter, a surface functionalizable, biodegradable fibrous mesh was produced by 
electrospinning. Bioresorbable polymeric fibers composed of PDLLA-block-PEG with three 
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different thiol-reactive end-groups were produced. By means of simple incubation with buffer 
solution containing an active molecule allowed immobilization and resulted in highly active 
fiber scaffolds. Figure 3 is a schematic illustration showing the preparation of a tissue 
engineering scaffold with this approach. Firstly, the fibers are produced and collected on a 
substrate. In a second step, the bioactive molecules are immobilized on the fiber surface. In a 
last step, cells are seeded onto the fibers and cultured in-vitro. As the electrospun PDLLA-
block-PEG fibers showed reduced non-specific protein adsorption resulting from PEG 
molecules presented on their surface, further immobilization of active molecules leads to 
fibers with unique properties for biomedical applications. The combination of a three-
dimensional structure with minimization of non-specific protein adsorption and 
immobilization of biologically active molecules allows to control the cell/material interaction 
and to trigger certain desired body responses. 
 
Experimental part 
Materials 
Methanol (MeOH), chloroform, dichloromethane (DCM), acetone, toluene, propane-2-ol, 
ethyl acetate, dimethyl sulfoxide (DMSO) and diethyl ether were purchased from Sigma-
Aldrich (Taufkirchen, Germany). All standard solvents were used as received in analytical 
grades. -Hydro- -aminopoly(ethylene glycol) (Mw = 10 kDa) and -hydro- -
methoxypoly(ethylene glycol) (mPEG, Mw = 10 kDa) were purchased from IRIS Biotech 
(Marktredwitz, Germany). 3,6-Dimethyl-1,4-dioxane-2,5-dione was obtained from Aldrich 
(Taufkirchen, Germany), recrystallized twice from ethyl acetate, dried in vacuum and purified 
by sublimation at 110 °C. N-Succimidyl 3-(2-pyridyldithio)propionate (SPDP) and N-( -
maleimidobutyryloxy)succinimide (GMBS) were purchased from Fluka (Buchs, Switzerland). 
Zinc( ) 2-ethylhexanoate was purchased from ABCR (Germany) and used without further 
purification. BODIPY
®
 FL L-cystine, immobilized TCEP disulfide reducing gel (4 µmol/mL 
gel, 50% suspension in water) and N-succimidyl 2-iodoacetate (SIA) were purchased from 
Pierce (Rockford, IL, USA). BSA tetramethylrhodamin conjugate, 3.7 mmol dye/mol protein, 
was purchased from Invitrogen (Eugene, OR, USA). Silicon wafers (100) were obtained from 
CrysTec (Berlin, Germany), cut into squares of 14 mm × 14 mm and cleaned by successive 
sonication in acetone, water and propane-2-ol. Poly(D,L-lactide) (PDLLA, Resomer 208) was 
donated by Boehringer Ingelheim (Ingelheim, Germany) and used as received. Isocyanate-
terminated sPEG was kindly donated by SusTech (Darmstadt, Germany). 
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Chemical and morphological characterization 
1
H NMR spectroscopy was performed on Mercury 300 and Inova 400 spectrometers (Varian, 
Palo Alto, CA, USA) at 300 MHz or 400 MHz, respectively. All measurements were 
performed in CDCl3 at room temperature. TMS was used as internal standard. NMR data are 
provided as follows: signal (multiplicity, coupling constant, assignment). Multiplicities are 
abbreviated s (singulet), d (dublet), t (triplet), m (multiplet) and ca (complex area). 
Assignments refer to characteristic sequences in the formulas of the products. 
Average molecular weights and PDI (polydispersity indices) were determined by gel 
permeation chromatography (GPC). PMMA was used as external standard. Anhydrous THF 
containing 250 mg/L 2,6-di-tert-butyl-4-methylphenol was used as mobile phase at a flow rate 
of 1.0 mL/min. A column combination consisting of four columns (all MZ Analysentechnik, 
Mainz, Germany, d = 8.0 mm, L = 300 mm) with pore widths of 50 Å, 100 Å, 1000 Å and 
10000 Å, respectively, and a refractive index detector (Jasco, Groß-Umstadt, Germany) were 
used. GPC was performed at 20.0 °C. WinGPC Unity software (PSS, Mainz, Germany) was 
used for GPC data processing. 
Morphologies of the electrospun fibers were determined by scanning electron microscopy 
(SEM, S3000 N, Hitachi, Japan) at 15 kV and working distances of 5 to 15 mm after 
sputtering with gold for 90 seconds (S150B, Edwards). The SEM images were used to 
measure fiber diameters which are presented as the mean with ± standard deviation. 
Microscope images were taken with a MRc5 camera, an Axioplan2 and a N XBO 75 lamp 
(Zeiss, Oberkochen, Germany) microscope. In order to observe the adsorption of the BSA 
texas red conjugate, 20.000 ms exposure and 20× magnification was used for all fluorescence 
images to allow comparison (Filter 31/ Zeiss, Germany). Optical microscope images were 
taken using a polarization filter (Filter 2/ Zeiss, Germany). Images of those fibers 
functionalized with BODIPY
®
 FL L-cystine were taken using Filter 6 (AHF Analysentechnik 
AG, Tübingen, Germany) and 20× magnification. Exposure times of the fluorescence images 
are quoted in the pictures. The electrospun polymers are indicated on each picture and a scale 
bar indicates the magnification of each image. 
 
Polymer Synthesis 
PDLLA-block-PEG copolymers were synthesized in a two step synthesis. Firstly, reactive 
PEG macroinitiators (α-hydro-ω-3-(1-maleimido)propionamidopoly(ethylene glycol), α-
hydro-ω-3-(2-pyridyldithio)propionamidopoly(ethylene glycol) and -hydro-ω-2-
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iodoacetamidopoly(ethylene glycol)) were prepared by reaction of commercially available 
α-hydro-ω-aminopoly(ethylene glycol) with N-( -maleimidobutyryloxy)succinimide, 
N-succinimidyl 3-(2-pyridyldithio)propionate and N-Succinimidyl 2-iodoacetate, respectively. 
In a second step, PDLLA-block-PEG copolymerswith thiol-reactive end groups (see Figure 1) 
were synthesized using the PEG macroinitiators. All functionalized PEG macroinitiators and 
PDLLA-block-PEG copolymers were characterized by 
1
H NMR spectroscopy, and GPC. 
 
α-Hydro-ω-3-(1-maleimido)propionamidopoly(ethylene glycol) 
N-( -maleimidobutyryloxy)succinimide (GMBS, 42 mg, 100 µmol, 1.5 eq) in THF (33 mL) 
was added to a solution of α-hydro-ω-aminopoly(ethylene glycol) (M = 10 kDa, 1000 mg, 100 
µmol, 1.0 eq) in 50 mL DCM. After stirring at r.t. for 24 h, the solvent was reduced to 10 mL, 
and poured into cold diethyl ether (100 mL). The precipitate was filtered off, washed with 
diethyl ether (3 × 10 mL) and dried in vacuum. α-Hydro-ω-3-(2-pyridyldithio)-
propionamidopoly(ethylene glycol) was obtained as a white solid (860 mg, 84 µmol, 86%). 
1
H NMR (300 MHz, CDCl3): /ppm = 2.52 (t, J = 7.0 Hz, CH2CONH), 3.40 (ca, 
NHCH2CH2O), 3.65 (ca, CH2CH2O), 3.94 (t, J = 7.0 Hz, NCH2CH2CO), 6.73 (s, 
COCHCHCO). 
 
α-Hydro-ω-3-(2-pyridyldithio)propionamidopoly(ethylene glycol) 
N-Succinimidyl 3-(2-pyridyldithio)propionate (SPDP, 28 mg, 90 µmol, 1.5 eq) was added to a 
solution of α-hydro-ω-aminopoly(ethylene glycol) (M = 10 kDa, 600 mg, 60 µmol, 1.0 eq) in 
DCM (10 mL). After stirring at r.t. for 24 h, the solution was poured into diethyl ether (100 
mL). The precipitate was filtered off, washed with diethyl ether (3 × 10 mL), and dried in 
vacuum. α-Hydro-ω-3-(2-pyridyldithio)propionamidopoly(ethylene glycol) was obtained as a 
white solid (570 mg, 57 µmol, 93%). 
1
H NMR (300 MHz, CDCl3): /ppm = 2.62 (t, J = 7.0 Hz, COCH2), 3.09 (t, J = 6.9 Hz, 
CH2S), 3.65 (ca, CH2CH2O), 7.11 (t, J = 5.6 Hz, NCHCH-ar), 7.67 (t, J = 6.5 Hz, CH-ar), 
8.49 (d, J = 4.5 Hz, NCH-ar). 
 
-Hydro-ω-2-iodoacetamidopoly(ethylene glycol) 
N-Succinimidyl 2-iodoacetate (SIA, 25.5 mg, 90 µmol, 1.5 eq) was added to a solution of α-
hydro-ω-aminopoly(ethylene glycol) (M = 10 kDa, 600 mg, 60 µmol, 1.0 eq) in DCM (10 
mL). After stirring at r.t. protected from light for 24 h, the solution was poured into diethyl 
ether (100 mL). The precipitate was filtered off, washed with diethyl ether (3 × 10 mL) and 
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dried in vacuum. α-Hydro-ω-2-iodoacetamidopoly(ethylene glycol) was obtained as a white 
solid (552 mg, 55 µmol, 90%). 
1
H NMR (300 MHz, CDCl3): /ppm = 3.64 (ca, CH2CH2O), 3.72 (s, CH2I). 
 
Poly(D,L-lactide)-block-poly(ethylene glycol) 
Different PDLLA-block-PEG copolymers with thiol reactive groups as well as a methoxy-
terminated block copolymer as reference were synthesized via ring-opening polymerization of 
3,6-dimethyl-1,4-dioxane-2,5-dione (see Figure 2). For that reason, one of the three 
corresponding PEG derivatives (α-hydro-ω-3-(1-maleimido)propionamidopoly(ethylene 
glycol), α-hydro-ω-3-(2-pyridyldithio)propionamidopoly(ethylene glycol) and -hydro-ω-2-
iodoacetamidopoly(ethylene glycol)) or -hydro- -methoxypoly(ethylene glycol) was used 
as macroinitiator and zinc( ) 2-ethylhexanoate as catalyst. For the synthesis of low PDI 
PDLLA-block-PEG copolymers, the PEG derivates were dried in an azeotropic distillation. 
Pre-dried PEG macroinitiators, purified 3,6-dimethyl-1,4-dioxane-2,5-dione and catalytic 
amounts of Zinc( ) 2-ethyl-hexanoate were used for synthesis of the block copolymers. To 
remove last traces of moisture, the reaction tubes were flame dried and evacuated. For the 
synthesis of this block copolymers 100 mg catalyst were added to 4 g of a (1/3, mol/mol) 
mixture of the macroinitiator and 3,6-dimethyl-1,4-dioxane-2,5-dione (D,L-lactide). The 
reaction tubes were evacuated another time for 2 h and closed. Afterwards the tubes were 
placed in a pre-heated oil bath at 135 °C for 24 h while the reaction mixture was stirred. The 
resulting PDLLA-block-PEG was dissolved in DCM (10 mL), and then precipitated into a 50-
fold excess of diethyl ether. The block copolymers were obtained as off-white solids. 
Successful polymerization was confirmed by .
1
H NMR and GPC. Due to the high proportion 
of the polymer chains, the reactive groups could not clearly be identified and only the signals 
of the repeating units were observed after copolymerization. 
1
H NMR (300 MHz, CDCl3): /ppm = 1.56 (s, CH3-lactide), 3.65 (ca, CH2CH2O), 5.17 (m, 
CH-lactide). 
 
Electrospinning 
Unless otherwise mentioned, the polymers were dissolved in a mixture of chloroform and 
methanol (75/25, V/V) to make 25 wt% solutions. During the electrospinning, polymer 
solutions were pumped to an 18-gauge, blunt, stainless steel spinneret at a rate of 0.1 mL/h. 
The fibers were collected for 50 s on star-PEG-coated silicon wafers, which were fixed to an 
aluminum SEM stub (diameter 12 mm) at a 200 mm distance from the tip of the spinneret. 
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Therefore, coatings from isocyanate-terminated sPEG prepolymers on amino-functionalized 
silicon wafers were prepared as described previously [20]. These collectors provide the 
advantage of immobilizing the fibers and by this allowing frequent media changes as well as 
preventing unspecific adsorption of proteins. For electrospinning, the sPEG coated silicon 
wafers were fixed to a grounded SEM stub with cell culture tape. A voltage of 25 kV was 
applied to the polymer solution with a Series 205B high voltage power supply (Bertran, NY, 
USA). Fibers were collected for 50 s, the silicon wafers removed and further proceeded for 
cell culture experiments, protein adsorption studies and visualization of the thiol-reactive 
groups on the fiber surfaces. Storage overnight in ambient atmosphere assured that 
crosslinking of the sPEG molecules could take place. 
 
Fiber Properties and Functionalization 
For visualization of adsorbed protein on the fibers, samples were incubated with fluorescently 
labeled BSA. Solutions of 50 µg/mL BSA Rhodamine red conjugate were prepared in 
phosphate buffered saline (PBS). The substrates were incubated with 100 µL of the stock 
solution for 20 min, and immersed five times for twenty minutes in PBS buffer, washed 
thoroughly one time with deionized water and dried in a stream of nitrogen. After drying, the 
fiber samples are subjected to fluorescence microscopy. 
The thiol reactive groups on the surface of electrospun fibers were determined by using 
BODIPY
®
 FL L-cystine, a thiol-containing fluorescence dye which allows visualization. A 
mixture of BODIPY
®
 FL L-cystine in DMSO (10 µmol/mL, 100 µL), PBS (pH = 7.5, 900 µL) 
and immobilized TCEP disulfide reducing gel (500 µL, 2.0 eq) was incubated for 20 min at 
r.t.. After centrifugation at 1000 min
-1
 for 1 min, the supernatant solution (250 µL each) was 
used to incubate fiber samples on silicon wafers for 20 min at r.t. The samples were washed 
with PBS (1 mL), incubated in water (1 mL) twice for 20 min each and washed with EtOH 
(1 mL) twice. After drying, the fiber samples are subjected to fluorescence microscopy. A 
remaining green fluorescence on the fibers indicates immobilized BODIPY
® 
FL L-cystine and 
thus thiol reactive groups on the surface. 
A mixture of the peptide GRGDC in PBS (5 µmol/ml, 500 µL) and immobilized TCEP 
disulfide reducing gel (1250 µL, 2.0 eq) was incubated for 20 min at r.t. After centrifugation 
at 1000 min-1 for 1 min, the supernatant solution (250 µL each) was used to incubate the 
samples for 20 min at r.t. The samples were washed with PBS (1 mL), incubated in water (1 
mL) twice for 20 min each and washed thoroughly with distilled H2O. Afterwards, the 
samples were further used for in vitro cell culture experiments. 
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Cell Experiments 
Cell culture experiments were carried out with human dermal fibroblasts (hdF) (patient 
female, 38 years, passage 8). After isolation, the cells were cultured in a basal medium 
consisting of Dulbecco‘s Modified Eagle‘s Serum (DMEM) supplemented with 1 % fetal 
bovine serum (FBS, Bio Whittaker, Verviers, Belgium) at 37 °C, 5% CO2 and 95% rel. 
humidity. After fabrication, samples were immediately removed from the target and placed in 
a sterile dish. The silicon wafers carrying the electrospun fibers were thoroughly washed with 
sterile PBS buffer five times to remove any contaminations. The samples were pre-wetted in 
culture vials overnight (24 h) with DMEM. After carefully removing the medium, the samples 
were seeded with 500 µL cell suspension (60000 cells/mL) for 1 h. Afterwards, 2 mL of 
DMEM were added and samples incubated for 24 h at 37 °C. To observe the cell morphology 
after 24 h, the cells were fixed by incubation with 4 wt% paraformaldehyd, and stained using 
Mayer‘s haemalum before further analysis. The cell morphology was determined by optical 
microscopy using a polarization filter. Representative microscope images were taken. 
Results and Discussion 
Polymer Synthesis 
Three different reactive PEG derivatives were prepared by reaction of commercially available 
α-hydro-ω-aminopoly(oxyethylene) with N-( -maleimidobutyryloxy)succinimide (GMBS), 
N-succinimidyl 3-(2-pyridyldithio)propionate (SPDP) and N-succinimidyl iodoacetate (SIA), 
respectively (see Figure 1). 
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Figure 1: Three block copolymers based on poly(D,L-lactide) and poly(ethylene 
glycol) with different thiol-reactive groups, allowing conjugation of thiol-containing 
active molecules (e.g. peptides, enzymes; etc). 
 
The first step in the synthesis of these block copolymers, the reaction leading to 
functionalized PEG derivatives is shown in Figure 2. 
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Figure 2: Two step synthesis of thiol-reactive block copolymers starting with -
hydro- -aminopoly(ethylene glycol) and NHS active esters. As second step, the 
PDLLA block is polymerized using an -hydropoly(ethylene glycol) as initiator, 3,6-
dimethyl-1,4-dioxane-2,5-dione and the catalyst zink( ) 2-ethyl-hexanoate. 
 
In all cases, N-hydroxysuccinimide (NHS) is released as a by-product. All functionalized 
PEG derivatives were characterized by 
1
H NMR spectroscopy. The broad PEG peak is found 
at  = 3.65 ppm in all cases. In the case of α-hydro-ω-3-(1-
maleimido)propionamidopoly(ethylene glycol) characteristic signals are found at  = 2.52 
ppm,  = 3.40 ppm,  = 3.94 ppm and  = 6.73 ppm. For the macroinitiator α-hydro-ω-3-(2-
pyridyldithio)propionamidopoly(ethylene glycol), signals of the end-group are found at  = 
2.62 ppm,  = 3.09 ppm  = 7.11 ppm,  = 7.67 ppm and  = 8.49 ppm. Due to the high 
influence of the large PEG block, spectra interpretation is significantly complicated, 
especially in the case of the small iodacetae end-group of -hydro-ω-2-
iodoacetamidopoly(ethylene glycol). In this case, successful reaction is indicated by the two 
protons of the end-group which can be found at  = 3.72 ppm. 
PDLLA-block-PEG copolymers with different thiol-reactive groups as well as a methoxy-
terminated PDLLA-block-PEG polymer as a reference were synthesized via ring-opening 
polymerization of 3,6-dimethyl-1,4-dioxane-2,5-dione using the corresponding PEG 
derivative as macroinitiator and zinc(II) 2-ethylhexanoate as catalyst. All polymers were 
characterized by 
1
H NMR spectroscopy and GPC. NMR spectroscopic methods proved that 
the desired products were obtained. All obtained products showed the characteristic signals at 
 = 1.56 ppm,  = 3.65 ppm, and  = 5.17 ppm confirming the successful synthesis of 
- Chapter 7 - 
  143 
PDLLA-block-PEG polymers. Due to the high proportion of the polymer chains, the reactive 
groups could not be clearly identified after copolymerization. Table 1 shows Mw, Mn and PDI 
determined by GPC and the mass ratios of the PEG block and the PDLLA block of the 
synthesized block copolymers. 
 
Table 1: Synthesized PEG-block-PDLLA block copolymers 
 
 
The mass ratios of the PDLLA and PEG blocks were calculated from the integration results of 
the 
1
H NMR spectra. In all cases the ratios were slightly lower than the calculated 3:1 ratio: 
2.42:1 for PDLLA-block-PEG-PDP, 2.40:1 for PDLLA-block-PEG-MP and 2.34:1 for 
PDLLA-block-PEG-IA and PDLLA-block-PEG-OMe. In accordance, average molecular 
weights were also smaller than calculated. All molecular weights Mw determined with GPC 
using a PMMA calibration standard ranged between 28 kDa and 29 kDa, except the one of 
PDLLA-block-PEG-IA (which was with 25 kDa slightly smaller). All polymers showed 
relatively narrow molecular weight distributions, reflected in the PDI‘s ranging between 1.30 
and 1.45. Deviations of block mass ratio and molecular weight are reproducible and can be 
regarded as systematic (see table 1). 
 
Electrospinning 
These polymers were electrospun in order to produce fibrous scaffolds (see Figure 3). 
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Figure 3: Schematic illustration of the scaffold production process: 1.) 
Electrospinning PDLLA-block-PEG-MP fibers. 2.) Incubation with the thiol-
containing active molecule. 3.) In vitro cell culture. 
 
We used the by far most common electrospinning configuration, the single collector system, 
which results in nanofibrous mats exhibiting randomly oriented fibers, mechanically 
stabilized on the sPEG coated silicon wafers. The morphology of electrospun nanofibrous 
meshes can be influenced by various parameters including polymer solution property (surface 
tension, conductivity, and viscosity), applied voltage, feed rate, the used collector, and the 
distance between needle tip and collector. All investigated block copolymers (see Table 1) 
had molecular weights (Mw) ranging between 25 and 29 kDa. An influence of the molecular 
weight on the obtained morphologies can therefore be neglected as all polymers had similar 
molecular weights. In order to determine the optimum concentration to obtain defect free 
fibers, we electrospun 10, 20, 25, and 30 wt% PDLLA-block-PEG-OMe solutions in a 
mixture of chloroform/MeOH (3/1, V/V) and observed the achieved morphologies with SEM 
and optical microscopy. Electrospinning the two dilutes polymer solutions (10 and 20 wt%) 
resulted in collection of a mixture between particles, beaded fibers and fibers. When solution 
parameters such as molecular weight of the polymer, concentration, viscosity are not 
appropriate to fabricate continuous fibers, the liquid jet breaks up into droplets. Appropriate 
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concentrations, respectively viscosities, in a good solvent lead to sufficient chain 
entanglements, which avoid the breaking up of the jet into droplets by surface tension [21]. 
Figure 4 shows a SEM-image of PDLLA-block-PEG-MP fibers obtained by electrospinning 
the 25 wt% solution. 
 
Figure 4: SEM image of electrospun PDLLA-block-PEG-MP fibers collected on a 
star-PEG coated silica wafer. 
 
Increasing the spinning solution to 25 wt% led to the formation of defect free fibers, while 
further increasing the solution concentration just increased fiber diameter. The optimum 
concentration for electrospinning experiments was determined to be 25 wt% and resulted in 
average fiber diameter of 2.5 µm.  
As the fibers with average diameter of 2.5 µm are quite large, light microscopy has proven to 
be a suitable method for fiber characterization. Figure 5 shows light microscopy images of a.) 
PDLLA-block-PEG-OMe, b.) PDLLA-block-PEG-MP, c.) PDLLA-block-PEG-PDP and d.) 
PDLLA-block-PEG-IA. 
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Figure 5: Microscope images of electrospun A.) PDLLA-block-PEG fibers, B.) 
PDLLA-block-PEG-MP fibers, C.) PDLLA-block-PEG-PDP fibers and D.) PDLLA-
block-PEG-IA fiber fragments. 
 
Electrospinning of all polymers except PDLLA-block-PEG-IA resulted in fibers with 
comparable diameters. In contrast to these polymers electrospinning of PDLLA-block-PEG-
IA copolymers results in formation of short fiber segments. Most probably the slightly lower 
molecular weight (Mw = 25 kDa) the brought molecular weight distribution (reflected in the 
PDI of 1.45) are responsible for the breaking up of the jet into fiber fragments during the 
electrospinning process. Additionally this observation may be caused by electrostatic effects 
due to the iodine atom of the IA group which enhances polarity and thus charge density of the 
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polymer. Strangely electrospinning of PDLLA-block-PEG-IA resulted neither in collection of 
spherical particles and/or fibers, but in fiber fragments of several hundred micrometers length 
and diameters of only a few micrometers. This observation contrasts the usually observed 
break up of the jet in particles caused by surface tension. Instead of minimizing the surface, 
high aspect ratio fragments of various lengths are obtained. The observed fragments might be 
due to the increased charge density, which results in a kind of splitting process on the way of 
the jet to the collector in combination with the lower molecular weight. However, the 
PDLLA-block-PEG-IA fragments maintain their shape on remaining path to the collector, 
which indicates a late breaking of the jet with most solvent molecules already evaporated.  
 
Fiber Properties and Functionalization 
Besides the three-dimensional structure, the surface chemistry of these fibers plays an 
important role. Minimization of protein adsorption and at the same time the possibility to 
introduce biologically active molecules leads bioactive scaffolds which seem capable of 
controlling cell/scaffold interaction. Therefore, unspecific protein absorption on PDLLA-
block-PEG fibers and pure PDLLA fibers was investigated by incubation of the samples 
(PDLLA, PDLLA-block-PEG, PDLLA-block-PEG-MP and PDLLA-block-PEG-PDP) with 
BSA tetramethylrhodamine conjugate followed by fluorescence microscopy. BSA 
tetramethylrhodamine conjugate acts as a model compound for control of unspecific protein 
adsorption, because BSA is a protein which is well known for its inherent tendency to deposit 
on surfaces. Figure 6 shows fluorescence microscope images of electrospun PDLLA fibers 
(Figure 6A) and electrospun PDLLA-block-PEG fibers after incubation with BSA 
tetramethylrhodamine conjugate. 
 
Figure 6: Fluorescence microscope images of A.) electrospun PDLLA and B.) 
PDLLA-block-PEG incubated with BSA Rhodamine conjugate. Magnification 20×, 
exposition time 20.000 ms. While pure PDLLA shows absorbed BSA Rhodamine 
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conjugate (A.), no fluorescence indicated the minimized absorption on these block 
copolymer fibers (B.). 
 
While the fluorescence on pure PDLLA fibers shows absorbed BSA Rhodamine conjugate, no 
fluorescence indicated absence of the protein/dye-conjugate on these block copolymer fibers. 
The complete suppression of BSA tetramethylrhodamine conjugate adsorption is an indicator 
for a hydrogel-like, non-fouling, surface of the fibers. Another indication for the presence of 
PEG groups near the fiber surface is given by contact angle measurements. The contact angle 
(sessile drop) of a PDLLA-block-PEG is smaller than 20° and the contact angle of PDLLA-
block-PEG-PDP nonwoven is q = (32 ± 3)°. In comparison, for a pure PDLLA sample the 
contact angle is q = (122 ± 2)°. The enhanced hydrophilicity of these electrospun block 
copolymer meshes indicates an enrichment of PEG at the fiber surface which is attributing to 
the remarkable non-fouling properties of these polymers. Primary adsorption is driven by 
short-range attraction, while secondary protein adsorption occurs due to van der Waals 
attraction. Generally, attractive surface interactions are overcompensated by repulsive 
interactions with the PEG [22]. However, the process leading to this remarkable non-fouling 
property and enrichment of the hydrophilic PEG segment at the fiber surface is still not fully 
understood. These remarkable non-fouling properties due to the enrichment of the 
poly(ethylene glycol) segment at the fiber‘s surface are believed to dependent on the use of 
poly(ethylene glycol)-block-poly(D,L-lactide) copolymers in combination with the used 
solvent system. The original solvent composition of the polymer solution affects the protein 
adhesion on the PEG-block-PDLLA. The use of a mixture of methanol/chloroform (25/75, 
V/V) for electrospinning results in a phase separation process during the fiber formation. 
Whereas chloroform is a good solvent for both polymer blocks, methanol is just a good 
solvent for the poly(ethylene glycol) block. Generally, methanol is regarded as exceptional 
solvent for electrospinning [10]. It is known that by adding solvents as methanol (dielectric 
constant 32.6) or DMF the dielectric property of a solution is increased in order to improve 
the fiber morphology [23, 24]. Therefore, most probably as charges are induced during the 
step of jet formation, these charges are predominantly carried by the methanol. Similar phase 
separation processes during electrospinning have already been discussed for the formation of 
micro- and nanostructured surfaces on fibers [25].  
Electrospinning polymer solutions involves a rapid evaporation of the solvent while the jet is 
accelerated to the counter electrode [26]. Within milliseconds the surface area of the jet is 
increased dramatically. This could lead to a number of thermodynamically driven events. For 
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example, a crossing of phase boundaries and a resulting structure formation by phase 
separation can occur as noted by Bognitzki and co-workers [27]. 
In addition to phase separation, evaporative cooling at the surface of the fibers could lead to 
the condensation of moisture. Evaporative cooling due to rapid solvent evaporation therefore 
significantly cools the surface of the electrospinning jet as it travels from the syringe to the 
target. The hydrophilic poly(ethylene glycol) segment is additionally drawn to the fiber 
surface by the moisture accumulated on the fiber. A similar process was discussed by 
Srinivasarao et al. for the formation of porous fiber surfaces [28]. Porous fiber surfaces are 
obtained because the droplets remain as individual entities acting as hard spheres due to the 
convection currents on the surface of the jet. As the jet dries to form solid fibers, the water 
droplets leave an imprint on the surface of the fibers in the form of pores. In contrast to his 
observations, electrospinning PDLLA-block-PEG copolymers resulted in fibers with smooth 
surfaces. We believe that the differences in morphology are consequences of the different 
polymers and there glass transition temperatures. Both segments of the block copolymer have 
glass transition temperatures below r.t. Especially the poly(ethylene glycol) segment, which is 
enriched at the fiber surface has a low glass transition temperature, Tg, of -67 °C, and 
attributes to their smooth surfaces. 
Thiol-reactive PDLLA-block-PEG polymers were synthesized so that bioactive molecules can 
be introduced to the surface of the electrospun fiber via the PEG block in an incubation step. 
The reactive group can then be used to conjugate a thiol containing dye, like BODIPY® FL 
L-cysteine, or peptides, like the cell adhesion promoter GRGDC, and other active thiol-
containing molecules to the block copolymer. Incubation of the different reactive and the 
methoxy terminated PDLLA-block-PEG fiber samples with the thiol containing fluorescence 
dye BODIPY® FL L-cysteine was used as model to show the binding of active molecules to 
the incubated fibers. For example, Figure 7 shows fibers with diameters of about 4 µm (same 
fiber sample as shown in Figure 5a) electrospun from PDLLA-block-PEG-OMe after 
incubation with a BODIPY® FL L-cysteine solution. 
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Figure 7: Fluorescence microscope images of electrospun A.) PDLLA-block-PEG 
fibers, B.) PDLLA-block-PEG-MP fibers, C.) PDLLA-block-PEG-PDP fibers and D.) 
PDLLA-block-PEG-IA fiber fragments after incubation with BODIPY
®
 FL L-cysteine. 
Green fluorescence is only observed on functionalized samples indicating the thiol-
reactive groups (MP, PDP, IA). 
 
The black image indicated the absence of conjugated dye. As expected, PDLLA-block-PEG-
OMe shows no reaction with BODIPY® FL L-cystein indicated by the lack of fluorescence. 
In contrast to the methoxy terminated block copolymer fibers, the electrospun PDLLA-block-
PEG-MP fibers showed strong fluorescence, indicating the immobilized BODIPY® FL L-
cysteine on the surface of the incubated fibers (see Figure 7b). The maleimide end groups of 
the block copolymer, which were available at the fiber surface reacted with the thiol group of 
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the dye. The homogeneous fluorescence indicates the good coverage of the fiber surface with 
immobilized dye. The result of incubation of PDLLA-block-PEG-PDP fibers with BODIPY® 
FL L-cysteine is demonstrated in figure 7c. Comparison with Figure 5c (showing untreated 
PLA-block-PEG-PDP fibers) indicates that treatment of the fibers with EtOH during 
BODIPY® FL L-cysteine staining results in swelling of the fibers. PDLLA-block-PEG-PDP 
fibers show even stronger binding of BODIPY® FL L-cysteine compared to PDLLA-block-
PEG-MP and PDLLA-block-PEG-IA, indicated by stronger fluorescence and shorter 
exposition times. A significant difference between PDLLA-block-PEG-MP, PDLLA-block-
PEG-PDP and PDLLA-block-PEG-IA is the quality and morphology of the fibers. Under the 
same conditions, electrospun PDLLA-block-PEG-IA incubated with BODIPY® FL L-
cysteine is shown in Figure 7d. Light microscopy already showed that electrospinning of 
PDLLA-block-PEG-IA did not result in significant fiber formation. This observation may be 
caused by electrostatic effects due to the iodine atom of the IA group which enhances polarity 
and thus charge density of the polymer. The polymer shows strong binding of BODIPY® FL 
L-cysteine. For this reason, it might be suited for binding of thiols to electrosprayed particles 
or fiber fragments. 
 
Cell Experiments 
The PDLLA-block-PEG-MP was chosen as suitable candidate for the immobilization of the 
adhesion promoting peptide GRGDC and in vitro cell culture experiments. Electrospun 
PDLLA-block-PEG fibers and GRGDC functionalized PDLLA-block-PEG-MP fibers were 
collected on sPEG coated silicon wafers, and were used as substrates for in-vitro culture of 
human dermal fibroblasts (hdF). After 24 h the cells were fixated with 4% of 
paraformaldehyd, stained with Mayers‘ Haemalum and examined by optical microscopy. 
Human dermal fibroblasts on the GRGDC modified PDLLA-block-PEG-MP fibers adhered 
and showed typical spread morphologies. In Figure 8a&b optical microscope images of 
fibroblasts adhering to GRGDC modified fibers are presented. 
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Figure 8: Microscope image of GRGDC functionalized electrospun fibers after 24 h 
in cell culture with hdF, fixation with 4% formaldehyde and hamalum staining. A.) 
Magnification 50×, B.) magnification 10×. 
 
The fibroblasts attached to the fibers (see Figure 8a), spreaded and bridged the nearest fibers. 
In this chapter, cells seeded on the fibrous substrates were found to have appropriate 
interactions with their environment based on the following observations. First, the cells 
maintained a normal phenotypic shape, suggesting that these cells function as in their native 
environment in/on these scaffolds. Second, the human dermal fibroblasts favored this 
structure, and adhered to the fibers, packing the electrospun structure surface after only 24 h 
of in-vitro culture. Third, these cells crosslinked the fibers and integrate with the surrounding 
fibers to form a three dimensional network. The cells responded to these three-dimensional 
substrates and strongly adhered to the functionalized fibers within only 24 h. Figure 9 shows 
microscope images of electrospun PDLLA-block-PEG fibers and GRGDC functionalized 
PDLLA-block-PEG-MP fibers after 24 h in cell culture with hdF. 
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Figure 9: Microscope images of A.) GRGDC functionalized PDLLA-block-PEG 
fibers and B.) PDLLA-block-PEG fibers after 24 h in cell culture with hdF, fixation 
with 4% formaldehyde and hamalum staining. Magnification 20×. 
 
While many cells attached to the GRGDC functionalized sample, no attached cells were 
found to be present on the pure PDLLA-block-PEG fibers (see Figure 9b). Due to the 
hydrophilicity of the substrate and minimized protein adsorption from the FCS, or those 
proteins produced and secreted by the cells themselves, fibroblasts were not able to attach, 
kept floating in the medium and underwent apoptosis. 
All these evidences indicate that the biologically functionalized, electrospun PDLLA-block-
PEG fibers induce controlled cell/scaffold interactions. Besides of the possibility to control 
these interactions, the generated fiber meshes proved to be promising, suitable substrates for 
tissue engineering. 
Conclusion 
3-Dimensional fibrous scaffolds, combining minimized non-specific protein adsorption with 
the possibility for further bioactivation were developed. Prevention of nonspecific adsorption 
of proteins onto the fiber surface may open new possibilities towards selective cell-nanofiber 
interactions and potential manipulation of the in-vivo acceptance for the scaffold. Three 
different thiol-reactive diblock copolymers based on poly(D,L-lactide) and poly(ethylene 
glycol) were successfully synthesized. Electrospinning of these copolymers resulted in fibers 
with excellent non-fouling properties. Binding of two different active molecules was 
demonstrated. The protein adsorption of electrospun PDLLA-block-PEG fibers was found to 
be dependent on the hydrophilic PEG segment. By choosing a mixture of 
methanol/chloroform (25/75, v/v) as solvent, an in-situ orientation of the PEG-segment was 
achieved, preventing protein adsorption and resulting in hydrophilic scaffolds. In vitro cell 
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culture experiments with fibroblasts showed either no cell attachment with unmodified fibers, 
or excellent attachment with biofunctionalized polymers 24 h. These results indicate that the 
biologically functionalized, electrospun PDLLA-block-PEG fibers induce controlled 
cell/scaffold interactions. Such bioactive scaffolds with remarkable morphological similarity 
to natural ECM are promising substrates for tissue engineering as they exceed passive 
biocompatibility and allow organization of living cells to functional tissue. 
References 
[1] M. E. Gomes, R. L. Reis, Biodegradable polymers and composites in biomedical applications: from 
catgut to tissue engineering. Part 2 Systems for temporary replacement and advanced tissue regeneration, 
International Material Reviews, 2004, 49(5), 261-273. 
[2] Dietmar W. Hutmacher, Scaffolds in tissue engineering bone and cartilage, Biomaterials, 21(24), 2000, 
2529-2543 
[3] M. E. Gomes, R. L.Reis, Biodegradable polymers and composites in biomedical applications, from 
catgut to tissue engineering Part1. available systems and their properties, International Materials Reviews, 2004, 
49(5), 261-273. 
[4] P. Gasteier, A. Reska, P. Schulte, J. Salber, A. Offenhäusser, M. Moeller, J. Groll, Surface grafting of 
PEO-based star-shaped molecules for bioanalytical and biomedical applications, Macromeolecular Bioscience, 
2007, 7, 1010-1023. 
[5] Z.-M. Huang, Y. -Z. Zhang, M. Kotaki, S. Ramakrishna, A review on polymer nanofibers by 
electrospinning and their applications in nanocomposites, Composites Science and Technology, 63(15), 2003, 
2223-2253. 
[6] D. H. Reneker, A. L. Yarin, H. Fong, S. Koombhongse, Bending instability of electrically charged 
liquid jets of polymer solutions in electrospinning, J. Appl. Phys., 2000, 87, 4531. 
[7] Y. M. Shin, M. M. Hohman, M. P. Brenner, G. C. Rutledge, Electrospinning: A whipping fluid jet 
generates submicron polymer fibers, Appl. Phys. Lett., 2001, 78, 1149. 
[8] M. M. Hohman, M. Shin, G. C. Rutledge, M. P. Brenner, Electrospinning and electrically forced jets. I. 
Stability theory, Physics of Fluids, 2001, 13(8), 2201. 
[9] M. M. Hohman, M. Shin, G. C. Rutledge, M. P. Brenner, Electrospinning and electrically forced jets. II. 
Applications, Physics of  Fluids, 13(8) (2001) 2221. 
[10] S. V. Fridrikh, J. H Yu, M. P. Brenner, G. C. Rutledge, Controlling the Fiber Diameter during 
Electrospinning,  Phys. Rev. Lett., 2003,  90, 144 502. 
[11] J. J. Feng, The stretching of an electrified non-Newtonian jet: A model for electrospinning, Physics of 
Fluids, 2002, 14, 3912. 
[12] J. J Feng, Stretching of a straight electrically charged viscoelastic jet, J. Non-Newtonian Fluid 
Mechanics, 2003,116, 55 
[13] A. L Yarin, S. Koombhongse, D. H. Reneker, Bending instability in electrospinning of nanofibers, J. 
Appl. Phys., 2001, 90, 4836. 
- Chapter 7 - 
  155 
[14] Simonet M., Schneider O. D., Neuenschwander P., Stark W. J., Ultra porous 3D polymer meshes by 
low-temperature electrospinning: Use of ice crystals as a removable void template, Polymer Engineering and 
Science, 2007, 47(12), 2020-2026. 
[15] M. M. Stevens, J. H. George, Exploring and engineering the cell surface interface, Science, 2005, 310 
(5751), 1135-1138. 
[16] P.Y.W. Dankers, M.C. Harmsen, L.A. Brouwer, M.J.A. Van Luyn, E.W. Meijer, A modular and 
supramolecular approach to bioactive scaffolds for tissue engineering, Nature Materials, 2004,  4 (7), 568-574. 
[17] D. L., Elbert, J. Hubbell, Surface treatments of polymers for biocompatibility, Annual Review of 
Materials Science, 1996, 26, 365-370. 
[18] C. L. Casper, N. Yamaguchi, K. L. Kiick, J. F. Rabolt, Functionalizing Electrospun Fibers with 
Biologically Relevant Macromolecules, Biomacromolecules, 2005, 6, 1998-2007. 
[19] T. G. Kim, T. G. Park, Surface Functionalized Electrospun Biodegradable Nanofibers for 
Immobilization of Bioactive Molecules, Doi: 10.1021/bp060039t. 
[20] J. Groll, W. Haubensak, T. Ameringer, M. Moeller, Ultrathin coatings from isocyanate star PEG 
prepolymers: patterning of proteins on the layers, Langmuir, 2005, 21(7), 3076-3083. 
[21] S. L. Shenoy, W. D. Bates, H. L. Frisch, G. E. Wnek, Role of chain entanglements on fiber formation 
during electrospinning of polymer solutions: good solvent, non-specific polymer-polymer interaction limit, 
Polymer, 2005, 46(10), 3372-3384.. 
[22] A. Halperin, Polymer Brushes that Resist Adsorption of Model Proteins:  Design Parameters,  
Langmuir, 1999, 15 (7),  2525–2533 
[23] S. R Bhattarai, N. Bhattarai, H. K. Yi, P. H. Hwang, D. I. Cha, H. Y. Kim, Novel biodegradable 
electrospun membrane: scaffold for tissue engineering, Biomaterials, 2004, 25(13), 2595-2602. 
[24] H. Dai, J. Gong, H. Kim, D. Lee, A novel method for preparing ultra-fine alumina-borate oxide fibres 
via an electrospinning technique, Nanotechnology, 2002, 13, 674–677. 
[25] S. Megelski, J. S. Stephens, D. B. Chase, J. F. Rabolt, Micro- and Nanostructured Surface Morphology 
on Electrospun Polymer Fibers, Macromolecules, 2002, 35, 8456-8466. 
[26] J. Doshi, D. H. Reneker, Electrospinning process and applications of electrospun fibers, J. Electrost., 
1995, 35, 15. 
[27] M. Bognitzki, W. Czado, T. Frese, A. Schaper, M. Hellweg, M. Steinhart, A. Greiner, J. H. Wendorff, 
Nanostructured fibers via electrospinning, Adv. Mater., 2001, 13, 70. 
[28] M. Scrinivasarao, D. Collings, A. Philips, S. Patel, Three-Dimensionally Ordered Array of Air Bubbles 
in a Polymer Film, Science, 2001, 292, 79. 
 
- Chapter 8 - 
  156 
Chapter 8: A simple and versatile route to functionalized electrospun 
fibers: The use of isocyanate terminated six arm star poly(ethylene glycol) 
as additive 
 
Abstract 
The objective of this chapter was fabrication of a bioresorbable, biocompatible and 
functionalized fibrous scaffold for tissue engineering, and to examine cell morphology of 
induced cell-fiber interaction with the electrospun matrix. We demonstrate a simple route to 
produce electrospun fibers with immobilized biomolecules and minimized protein adsorption. 
A solution of biodegradable poly(lactide-co-glycolide) (PLGA) and isocyanate terminated star 
shaped poly(ethylene glycol) (sPEG) was electrospun to produce surface functionalized 
fibers. The resulting fibrous mesh showed no adsorption of fluorescently labeled bovine 
serum albumin, indicating its minimized nonspecific protein adsorption. As biomolecules 
either the adhesion promoting peptide sequence GRGDS or biocytin-L-lysine were 
immobilized to the sPEG. Two types of fibers, sPEG-co-PLGA and GRGDS immobilized 
sPEG-co-PLGA, were then used to investigate differences in biological responses in terms of 
cell morphology and viability using human dermal fibroblasts (HDF). While pure sPEG-co-
PLGA fibers did not induce adhesion of HDF, these cells strongly adhered to the GRGDS 
modified fibrous mesh. Good capability of the fibrous structure for supporting the cell 
attachment and spreading was observed as well as good cell viability. In the case of the 
biocytin-L-lysine modified fibers, the immobilized molecules were visualized by fluorescence 
microscopy after complexation with a streptavidin texas red conjugate. Homogeneous 
fluorescence indicated the presence and distribution of the molecules on the fibers surface. 
The combination of minimized nonspecific protein adsorption with immobilization of active 
molecules as well as the simplicity of the production of these three-dimensional fibrous 
scaffolds is unique features. The findings suggest that these electrospun fibrous meshes could 
be used as promising tissue engineering material for immobilizing a wide range of bioactive 
molecules and controlling the cell/material interactions. 
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Introduction 
New approaches and strategies to enhance dermal tissue regeneration have significant impact 
on patients suffering from chronic nonhealing wounds, such as diabetic ulcer, as well as on 
patients with large burn wounds. Much attention has been focused on designing implantable 
biodegradable polymer scaffolds that target accelerating wound repair and scaffolds for tissue 
engineering. Tissue engineering is an approach to reconstruction and/or regeneration of lost or 
damaged tissue [1]. Cells are seeded on tissue scaffolds, cultivated in-vitro and implanted at 
the human tissue defect sides. For these applications, only surface compatibility is not 
sufficient. To fabricate such implants, it is required that scaffolds are designed to both support 
cell-cell interactions as well as to direct cell alignment in mimicking this tissue structure [2]. 
Fabricating scaffolds with their functional characteristics closely resemble those of the tissues 
they aim to restore leads to a new generation of scaffolds in a more biomimetic approach. 
Ideally, scaffolds for tissue engineering should provide the seeded cells a metabolically and 
mechanically supportive environment with large void volume and large surface to volume 
ratio for maximal cell seeding, attachment, growth, extra cellular matrix production and other 
cell functions [3]. Besides all this requirements, scaffolds have to provide a three-dimensional 
structure supporting the organization of the living cells to functional tissue. As polymeric 
nanofiber substrates have similar structures as the nano-scaled nonwoven fibrous extra 
cellular matrix (ECM) proteins, they seem promising as candidates for ECM mimicking 
scaffolds. Although several different processes for the production of nanofibers are currently 
available (e.g. self-organization, template based processes etc.), electrospinning is the most 
cost-effective and straightforward one to generate continuous nonwoven meshes. 
Electrospinning offers the advantage that very thin fibers with diameters of less than 1 µm can 
be produced, and seem promising for biomedical applications, especially tissue engineering 
[4]. The structures, produced by an electrospinning process, are nonwoven, three-dimensional, 
and porous. As many tissue engineering strategies require the penetration of cells into a 
scaffold, producing electrospun substrates with both a significant volume and large pore size 
will become necessary. Increasing the nanofiber mesh porosity for cell penetration can 
achieved by techniques such as electrospinning onto ice crystals [5]. As biomaterials for 
tissue engineering, electrospun meshes exhibit important advantages when compared with 
other scaffolds. First, the interconnectivity of the voids available for tissue ingrowths is 
beneficial compared to foams and sponges. Second, ultra thin fibers produced by 
electrospinning offer an unsurpassed surface to volume ratio among established tissue 
scaffolds [3]. The latter is expected to have important advantages on the availability and activity of 
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immobilized molecules (e.g. peptides, lectines, enzymes etc.). Thus, electrospun fibers have been 
explored as extra cellular matrix mimicking tissue engineering scaffolds, novel carriers for bioactive 
drugs, and filtrations for biomolecules [6]. Besides the three-dimensional structure, biocompatibility 
and biological activity is required and remains a major challenge. 
To improve biocompatibilities of polymeric tissue engineering scaffolds research in the last 
thirty years centered mostly on surface modifications e.g. on immobilization of biomolecules 
that are recognized by cells [7]. These biomolecules included adhesive proteins like collagen, 
fibronectin, RGD peptides and growth factors like bFGF, EGF, insulin, etc. Biomolecules 
were covalently attached, electrostatically adsorbed or self-assembled on biomaterial surfaces 
in order to improve their biocompatibility and performance. Biocompatibility of vascular 
PTFE scaffolds for example was improved by adsorption of specific proteins prior to 
implantation [8]. The same modification strategy, physical adsorption of a protein layer onto 
the implants surface, was for modification of electrospun fibers as well. Ma et al. used this 
strategy to improve the spreading and proliferation of endothelial cells on electrospun PET 
fibers [9]. An alternative to the surface modification by physical adsorption is immobilization 
of active molecules. Methods such as plasma treatment followed by photochemical grafting of 
the GRGDS peptide sequences were investigated. One way to covalently attach protein 
molecules on polymer surface is grafting of poly(methacrylic acid) on the biomaterials 
surface to introduce carboxyl groups at first, followed by immobilization of the protein 
molecules using water soluble carbodiimide as coupling reagent [10, 11]. However, among 
these two modification strategies, only the covalent immobilized biomolecules were capable 
of altering the implants biocompatibility permanently and lead to long term stability. 
Generally, there are only few examples dealing with surface modifications on electrospun 
scaffolds. 
First Cheryl et al. reported incorporation of an active substance into electrospun fibers for 
tissue engineering. This modification did not lead to long term stable scaffold modification 
but to release system, showing retarded release of the active compound over a certain period 
of time. They created a biologically active functionalized electrospun poly(lactide-co-
glycolide) matrix to permit immobilization and long-term release of growth factors [12]. By 
incorporation of poly(ethylene glycol) with immobilized low molecular weight heparin 
electrospun from a 45 wt% poly(lactide-co-glycolide) solution, modified fibers were produced 
and the biological activity of the meshes shown. In this case, the functionalized scaffolds 
showed slow release of the active molecule. Another approach to successfully create surface 
functionalized electrospun fibers was reported more recent by Kim et al [13]. By 
electrospinning a mixture of biodegradable poly( -caprolactone) and poly(D,L-lactide-co-
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glycolid)-b-poly(ethylene glycol) block copolymer surface functionalized fiber meshes were 
produced. The resulting electrospun fibers with primary amino-groups were applied for 
immobilization of lysozyme by using a homofunctional coupling agent. None of these 
approaches is sufficient to control the cell/scaffold interactions. Besides immobilization of 
biologically active molecules, prevention of nonspecific protein adsorption, which inside a 
biological host is followed by cell adhesion on the material surface and triggers the foreign 
body reactions, is another key feature determining the success of a biomaterial. The 
combination of minimizing non-specific protein adsorption and immobilization of signaling 
sequences has not been reported yet. Materials used in biomedical applications have to be 
biocompatible, non-toxic and should not cause foreign body reactions. The implanted 
biomaterial interacts with proteins in the body which adsorb onto the surface of a biomaterial 
according their affinities and the surface properties like surface chemistry, energy and 
topology of the inserted object. A transform from an inert, foreign material to a biologically 
active and recognizable surface takes place within seconds to minutes [14]. Poly(ethylene 
glycol) (PEG) is known for its biocompatibility and has been used extensively as a coating 
material to generate surfaces that resist nonspecific protein adsorption [15]. Biofunctional 
hydrogel surface coatings of PEG on flat surfaces are well established and seem promising for 
biosensors, biomedical devices and implants. Changes in the molecular architecture of the 
polymer, from linear to star shaped PEGs, lead to higher polymer segment density and a 
higher density of functionalities. Thus, star shaped PEG polymers have been used widely for 
preparation of hydrogels with designated properties [15]. Even though most studies 
concentrated on two-dimensional, flat substrates, the possibility of coating biomedically 
relevant substrates in three-dimensional geometries has bee shown for poly(ethylene 
terephthalate) monofilament constructs. Following this approach, the three-dimensional 
implant was first activated via ammonia plasma treatment, followed by incubation of the 
substrate in aqueous sPEG solution. Immobilization of the adhesion promoting peptide 
GRGDS was achieved by simply mixing the peptide into the sPEG solution. While the 
scaffolds that were coated with sPEG only did not induce cell adhesion, the cells strongly 
adhered to the GRGDS modified scaffolds. The combination of prevention of nonspecific 
protein adsorption with introducing specific biomolecules leads to distinct control of the 
cell/material interaction. Besides the attempts to use functional coatings, either to suppress 
nonspecific protein adsorption or to immobilize bioactive molecules, on three-dimensional 
implants, the modification of electrospun fibers is much less investigated. Protein adsorption 
on nanofibers has not been analyzed in detail yet and was often neglected in cell adhesion 
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studies. However, protein adsorption is expected to play a key role in determining and 
triggering cell response to nanofibers as well. While there are many examples of surface 
modifications in tissue engineering in general, only few examples deal with modification of 
surface on electrospun scaffolds and none combines this approach with minimized protein 
adsorption. 
In this chapter, the surface of biodegradable fibrous mesh was functionalized with star shaped 
isocyanate terminated PEGs and used for immobilization of amino group containing 
biomolecules. Bioresorbable polymeric fibers composed of PLGA and sPEG were produced 
by electrospinning. By means of simply mixing the isocyanate terminated sPEG with PLGA, 
and addition of the bioactive molecule in one solution and electrospinning, a simple route to 
biofunctionalized scaffolds for tissue engineering was achieved. Figure 1 is a schematic 
illustration showing the preparation of a tissue engineering scaffold with this approach. 
 
Figure 1: Schematic illustration of the experiments. First a sPEG solution is mixed 
with the Polymer, then the active molecule is added and electrospun onto the sPEG 
coated target. Cells are seeded onto these substrates. A cell interacts with the 
immobilized integrin ligand, whereas unspecific adsorption is minimized. 
 
The combination of a three-dimensional structure with minimization of nonspecific protein 
adsorption and immobilization of biologically active molecules allows to control the 
R 
R 
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cell/material interaction and to trigger certain desired body responses. These biocompatible 
and biodegradable electrospun fibers immobilized with bioactive molecules could be 
potentially used as wound dressing material, implantable devices or tissue engineering 
scaffolds. 
 
Experimental part 
Materials: 
Diethylether, acetone, dichloromethane and dimethylsulfoxide were supplied by Sigma-
Aldrich (Germany). Acetone was dried with phosphorpentoxide and distillation, while 
dimethylsulfoxide was dried over 4-A molecular sieves. The peptide sequence GRGDS was 
purchased from Bachem (Switzerland). Rhodamine red labeled bovine serum albumin (BSA), 
neutravin texas red conjugate as well as streptavidin texas red conjugate (STRP), streptavidin 
labeled poly(styrene) beads (diameter 1 µm), biocytin-L-lysine and a Live/Dead®-staining kit 
were supplied from Mobitec (Germany). Silicon wafers (100) were purchased from CrysTec 
GmbH (Germany). Isocyanate terminated six arm star poly(ethylene glycol) (sPEG) of an 
average molecular weight of 12 kDa was donated by SusTech GmbH & Co KG (Germany) 
and stored inside a Braun Unilab Glovebox (Germany). The preparation of these isocyanate 
terminated prepolymers is described elsewhere [16]. Commercial THF and toluene were dried 
over LiAlH4 and purified by conventional distillation. N-[3-trimethoxysilyl)-
propolyl]ethylenediamine (Aldrich, 97%) was stored under inert gas atmosphere and filtered 
before use. PLGA (RG 504) was donated by Boehringer Ingelheim Pharma GmbH &Co.KG 
(Ingelheim am Rhein, Germany) and used as obtained. The PLGA used in this chapter had a 
molecular weight of approximately 45 kDa. Phosphate-buffered saline was purchased by 
Sigma-aldrich (Germany), 0.0027 M potassium chloride and 0.137 M sodium chloride, was 
dissolved in 1 L deionized water to obtain 0.01 M phosphate buffer (pH 7.4 at 25°C). 
 
Preparation of sPEG coated silicon wafers: 
The detailed preparation of the coatings has been previously described by Groll et al. [17]. 
Briefly, silicon wafers were cut to 15 x 15 mm pieces, cleaned thoroughly and activated by 
UV/ozone or oxygen plasma. For aminosilylation the activated substrates were treated with 
0.3 mL of N-[3-trimethoxysilyl)-propyl]ethylenediamine in 50 mL dry toluene for 2 h under 
nitrogen atmosphere (inside a glovebox). A solution of 10 mg/mL isocyanate terminated 12 
kDa – prepolymers was prepared in a mixture of THF/water (1/9, v/v). After 5 min the 
solution was filtered with a 0.2 µm filter and used for spin coating (2500 rpm, 40s) onto the 
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substrates. The resulting films showed about 30 nm layer thickness and were stored at 
ambient conditions before use. 
 
Electrospinning: 
Isocyanate terminated sPEG was dissolved in dry acetone under mechanical stirring at 5 wt% 
and stored under nitrogen atmosphere until further use. 25 wt% PLGA (RG 504) were added 
to the sPEG solution and mixed with an Ultra-Turrax® (IKA, Germany) at 22000 rpm for 
60s. The solution was immediately used for electrospinning. For electrospinning experiments 
polymer solutions were fed at 2.5 mL/h to a flat-tip stainless steel spinneret connected to a 
high-voltage power supply. An Eltex KNH35 (Germany) high voltage generator was utilized to 
charge the solutions at 20 kV while the collector remained grounded. The solutions were 
pumped to 18-gauche, flat-tipped; stainless steel spinneret located 200 mm from a conductive 
collector. Different collectors were used as targets for the fiber deposition. For SEM analyses, 
grounded aluminum stubs were used, while for protein adsorption studies and preliminary in-
vitro cell culture, previously sPEG coated silicon wafers (15 X 15 mm) were fixed with 
conductive carbon tape to a grounded aluminum SEM stub (diameter 12 mm). Using sPEG 
coated targets for fiber deposition on one hand prevents unspecific protein adsorption in the 
sample background and on the other hand immobilizes the fibers on the target. This allows 
frequent media changes without the loss of electrospun material during protein adsorption 
studies as well as in cell culture experiments. Thirty seconds of electrospinning onto these 
targets proved sufficient for a good coverage. Those samples suitable for contact angle 
measurements and the degradation studies, were collected on a rotating aluminum cylinder 
(diameter 80 mm, length 150 mm), which rotated at a constant rate of 200 rpm. To allow easy 
removal of the electrospun nonwoven, the cylinder was covered with a thin sheet of Teflon 
foil. Feed rate, distance and applied voltage remained as described, but in order to achieve a 
dense compact nonwoven suitable for wettability studies, fibers were collected over a time 
period of 20 min. 
Generally, functionalization of the electrospun sPEG-co-PLGA fibers can be achieved by two 
different routes [18]. Firstly, the active molecule (containing an amino- or hydroxy-group) 
can be mixed with the 5 wt% star-PEG solution prior to spinning. After addition of 25 wt% 
PLGA and electrospinning, functionalized fibers are gained in situ. Secondly, sPEG-co-PLGA 
fibers can functionalized in an additional step after the electrospinning. In this case, non 
reacted isocyanate groups on the fiber‘s surface are used for functionalization. The second 
procedure for fiber functionalization is out of the frame of this paper. In order to achieve fiber 
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functionalization, the amino or hydroxy terminated active molecules were mixed into the 
sPEG solution before adding the PLGA. Two equivalent of the active molecule (e.g. GRGDS 
or biocytin) were first dissolved in 0.2 mL dimethylsulfoxide and then added to the sPEG 
solution. The PLGA (25 wt%) was added and dissolved by mixing for 60 s using the Ultra-
Turrax® (22000 rpm). Following this procedure, statistically two of the six arms of the 
isocyantae terminated sPEG are functionalized with the active molecule. 0.2 mL diethylether 
were added to the solution and the polymer. The mixture was homogenized for another 60 s. 
All polymer solutions were preceded immediately after preparation and after maximum 20 
min replaced by fresh ones. 
 
Scanning Electron Microscopy and Optical Microscopy: 
To investigate their morphology, the fibers were characterized by scanning electron 
microscopy (SEM) and optical microscopy. For high-resolution images, the electrospun fibers 
were deposited onto scanning electron microscopy (SEM) stubs. Unless otherwise stated, all 
samples were imaged with an S-4800 Ultra High Resultion Scanning Electron Microscope 
(Hitachi) using an accelerating voltage of 1 KV and a working distance of 10-15 mm. All 
samples for optical microscopy were collected on sPEG coated silicon wafers. Microscope 
images were taken with a Zeiss Stemi 2000-C (magnification: 20 x; polarization filter (filter 
2)). In order to observe adsorption of the fluorescently labeled proteins on the fiber surface, 
images were taken with an exposure time of 20000 ms using a fluorescence filter (filter 31). 
Optical microscope images using a polarization filter with an exposure time of 5 ms of the 
same sample section are shown in comparison to the fluorescence images. Representative 
images are presented. 
 
Protein Adsorption: 
For visualization of adsorbed protein on the fiber‘s surface, we incubated the samples with 
fluorescently labeled model proteins. 50 mg/mL stock solutions of BSA Rhodamine red 
conjugate, streptavidin texas red conjugate and neutravidin texas red conjugate were prepared 
in phosphate buffered saline (PBS). These stock solutions were covered in aluminum foil, 
stored at -20°C and allowed to thaw before use. To further improve the non-fouling 
properties, sPEG-co-PLGA fiber samples, were immersed in a 1 mg/mL glycidol solution in 
bicarbonate buffer for 1 h and rinsed with deionized water. NH2 groups which remain after 
reaction of the isocyanate groups of the sPEG molecules with water can react with glycidol. 
The glycidol treatment, eliminates free polar NH2 groups at the fiber surface, hydrophilizes 
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the sample and therefore is able to further suppress nonspecific protein adsorption. Prior to 
incubation with the protein solutions, the substrates were stored 60 min in deionized water. 
Afterwards, the substrates were incubated with 100 µL of the stock solution for 20 min, 
immersed five times for 20 min with PBS buffer, washed thoroughly with deionized water 
and dried in a stream of nitrogen. 
 
Analysis of surface functionalization on sPEG-co-PLGA fibers: 
The functional groups on the surface of electrospun fibers were determined by using the 
biocytin/streptavidin complex and fluorescently labeled streptavidin. The 
biocytin/streptavidin complex is well characterized and has been used extensively for many 
applications [19]. Biocytin functionalized electrospun fibers were generated by mixing 2 
equivalent biocytin into the spinning solution (as described in the electrospinning section). 
Afterwards, the samples were incubated five times with PBS and thoroughly washed with 
distilled water. This procedure was followed by a glycidol treatment. Incubation of the 
biotinylated fiber samples with a solution of 50 µg/mL streptavidin Rhodamine red conjugate 
was used for visualization of the biocytin groups on the fiber surface. As negative control, 
fibers without further modification and sPEG-co-PLGA fibers after glycidol treatment were 
incubated with 50 µg/mL streptavidin Rhodamine red conjugate, and washed as previously 
described. Alternatively, a fiber sample functionalized with biocytin was incubated with 50µL 
of streptavidin labeled poly(styrene) beads in PBS and similar washing steps (see 
supplementary information). The resulting meshes were observed by optical microscopy. 
 
Examination of the wettability: 
The wettability of electrospun fiber meshes was examined by contact angle measurements. 
Sessile drop measurements with a goniometer G40 (Krüss, Hamburg) were performed using 
the electrospun meshes as substrates. Therefore, dense compact nonwoven meshes, collected 
on a grounded rotating drum, were cut into pieces of 25 X 15 mm and fixed onto an object 
slide using two small stripes of adhesive tape at the sides of the sample. To allow comparison 
between sPEG containing nonwovens and PLGA meshes, images of the water droplets on 
electrospun fiber meshes were taken at the moment of contact. After a few seconds all water 
droplets on sPEG containing meshes were gone, not allowing determination of exact 
equilibrium contact angles. Whereas, water droplets on an electrospun PLGA nonwoven 
remained stable for several hours. Therefore, we only present an equilibrium contact angle (5 
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min after contact with the water droplet) for the pure PLGA nonwoven. This contact angle is 
an average number of 20 individual measurements. 
 
Degradation studies: 
Degradation (mass loss and molecular weight changes) of electrospun PLGA and sPEG-co-
PLGA nonwovens were investigated at physiological conditions (PBS-buffer, pH 7.4 at 37°C) 
over a period of three months. Pieces of the nonwovens with a mass of 70 mg were incubated 
each with 1.5 mL PBS-buffer. The samples were kept in 1.5 mL Eppendorf-tubes on a 
Heidolph Polymax 1040 incubator (Germany) for 12 weeks (84 days) at 37°C and a rotation 
speed of 150s
-1
. The pH was checked weekly and in the case of alterations of more than 0.2 
the buffer was exchanged. Samples were taken after 0, 1, 3, 7, 14, 21, 28, 35, 63 and 84 days. 
The samples were centrifuged at 10000 rpm for 5 min, the PBS buffer carefully removed and 
the remaining samples incubated 3 times for 20 min with distilled water. After a second 
centrifugation the distilled water was removed and the samples were freeze-dried for 24 h. An 
average mass loss of three samples for each time point was determined. The resulting 
molecular weights (Mw, Mn) and Mw/Mn (PMI) were determined by gel permeation 
chromatography (GPC). GPC measurements were carried out at 35 °C using a high-pressure 
liquid chromatography pump (ERC HPLC 64200) and a refractive index detector (ERC-
7215a). The eluting solvent was THF (HPLC grade) with 250 mg/mL 2,6-di-tert-butyl-4-
methylphenol and a flow rate of 1 mL/min. Five columns with MZ gel were applied. The 
length of the first column was 50 mm, 300 mm for the other four columns. The diameter of 
each column was 8 mm, the diameter of the gel particles 5 mm, and the nominal pore widths 
were 50, 50, 100, 1000 and 10000 Å, respectively. Calibration was achieved using 
poly(methyl methacrylate) (PMMA) standards. 
 
Cell culture and bioassays 
 Cell culture experiments were carried out with human dermal fibroblasts (HDF) 
(patient female, 38 years, and passage 8). After isolation, the cells were cultured in a basal 
medium consisting of Dulbecco‘s Modified Eagle Serum (DMEM) supplemented with 1 % 
fetal bovine serum (FBS, Bio Whittaker, Belgium) at 37°C, 5% CO2 and 95% humidity. After 
fabrication, samples were immediately removed from the target and placed in a sterile 
polystyrene dish. The silicon wafers carrying the electrospun fibers were thoroughly washed 
with sterile PBS buffer five times to remove any contaminations. The samples were pre-
wetted in culture vials overnight (24 h) with DMEM. This hydration of the surface at room 
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temperature fully exposes the hydrophilic PEG block and the covalently attached peptide 
sequence in the block copolymer on the surface. After carefully removing the medium, the 
samples were pre-seeded with 500 µL cell suspension (60000 cells/mL) for 1 h. Afterwards, 2 
mL of DMEM were added and samples incubated for 24 h at 37°C in-vitro. For determination 
of cell survival, a Live/Dead® viability/cytotoxicity kit for mammalian cells (Molecular 
Probes) was used according to the manufacturer‘s protocol. To observe the cell morphology 
after 24 h, the cells were fixed with 4 wt% paraformaldehyd incubation before further 
analysis. The cell morphology was determined by optical microscopy using a polarization 
filter (filter 2) without any staining and high resolution SEM-pictures were imaged on a 
Hitachi S3000 N at 15 kV and working distances of 5 to 25 mm. 
 
Statistical analysis: 
In graphs, all data are presented as means ± standard error determined in three independent 
measurements. Average fiber diameters were obtained from the SEM-images, and are an 
average of 20 measured fibers. 
 
Results and Discussion 
Electrospinning and characterization of sPEG-co-PLGA fibers 
We used the by far most common electrospinning configuration, the single collector system, 
which results in nanofibrous mats exhibiting a high fiber density, mechanically stabilized as a 
sheet by fusion or overlapping between fibers. Electrospinning occurs when a polymer 
solution is charged to high voltage that generates an electrical force that can extrude out a 
polymer jet, which then breaks down to the sub-micron scale fibers through a complicated 
bending and whipping process [2]. The morphology of electrospun nanofibrous meshes can be 
influenced by various parameters including polymer solution property (surface tension, 
conductivity, and viscosity), applied voltage, feed rate, the used collector, and the distance 
between needle tip and collector [20]. Therefore, we electrospun 10, 15, 20, 25, and 30 wt% 
PLGA solutions in acetone and observed the achieved morphologies by SEM. Electrospinning 
the two dilutes polymer solutions (10 and 15 wt%) resulted predominantly in spraying. When 
solution parameters such as molecular weight of the polymer, concentration, viscosity are not 
appropriate to fabricate continuous fibers, the liquid jet breaks up into droplets. Appropriate 
concentrations, respectively viscosities, in a good solvent lead to sufficient chain 
entanglements, which avoid the breaking up of the jet into droplets by surface tension [21, 
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22]. Figure 2 shows SEM-images of PLGA fibers obtained by electrospinning the 20, 25 and 
30 wt% solutions. 
 
Figure 2: SEM-Images of electrospun PLGA fibers A.) 20 wt%, B.) 25wt%, C.) 30 
wt%. 
 
Beaded fibers were formed by electrospinning the 20 wt% solutions (see Figure 2A). Further 
increasing the spinning solution to 25 wt% led to the formation of defect free fibers (Figure 
2B), while electrospinning 30 wt% solutions just increased fiber diameter (Figure 2C). With 
increasing polymer concentration, respectively viscosity, the fiber diameter was increased. 
While the beaded fibers from the 20 wt% solutions showed average diameters of 250 nm, the 
diameter of those fibers obtained from the 30 wt% solutions was 2.3 µm, which is almost a 10 
fold increase. While, by increasing the solution polymer concentration from 20 to 25 wt% the 
fiber quality was significantly improved (elimination of beads as defect structures), further 
increase did not result in further improvement. The optimum concentration for 
electrospinning experiments was determined to be 25 wt%. To obtain suitable electrospun 
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fibers with amine and isocyanate functionalized surface and fibrous structure, a mixture of 5 
wt% isocyanate terminated six arm sPEG and 25 wt% PLGA was electrospun. Defect free and 
stable fibers were obtained (see Figure 3). 
 
Figure 3: SEM-Images of sPEG-co-PLGA fibers (27 wt% PLGA, 3 wt% sPEG). 
 
The average diameter of electrospun fibers increases from 2.4 µm to 2.5 µm due to the added 
sPEG. This is mainly caused by the increased viscosity of the electrospinning polymer 
solution with increase in the amount of the hydrophilic sPEG in the mixture. As interactions 
between artificial materials and biological systems are crucial and are mainly determined by 
nonspecific protein adsorption and cell adhesion, the first step towards control of these 
interactions is minimization/prevention of nonspecific adsorption. Poly(ethylene glycol), for 
example sPEG, is known for its biocompatibility and has been extensively used as coating 
material to generate surfaces that resist nonspecific protein adsorption [15]. 
In recent studies of electrospun fibers for tissue engineering applications, numerous 
techniques for their in-vitro study have been proposed. Here, the use of reactive nano-layered 
collections systems permits the investigation of ―dilute‖ quantities of fibers on a protein 
repellent substrate. For the protein adsorption studies and biological tests, silicon wafers were 
first coated with sPEG, a star shaped polyether crosslinked with water to a dense network. 
The electrospun fibers were collected on these targets suitable for protein adsorption studies 
as well as in-vitro culture. Such in-vitro systems provide insight into the response of cells to 
nanofibers, as both the fiber and substrate chemistry can be modified independently. Due to 
this sample preparation, detaching of the fibers and loss of electrospun material during the 
frequent media changes was avoided, while the advantages of the protein repellent properties 
of the ultra-thin sPEG coating was preserved. After collection, the electrospun sPEG-co-
PLGA fibers were incubated with 50 µg/mL containing fluorescently labeled protein solution. 
BSA Rhodamine red conjugate, streptavidin texas red conjugate and neutravidin texas red 
were investigated as model proteins. Figure 3 shows optical microscope and fluorescence 
images of electrospun fibers after incubation with BSA. 
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Figure 4: Optical microscope images and fluorescence microscopy images of PLGA 
(A) sPEG-co-PLGA (B.) and glycidol treated sPEG-co-PLGA (C.) incubated with 25 
µg/mL fluorescence labeled bovine serum albumin (BSA). 
 
While pure PLGA fibers showed strong fluorescence (see Figure 3A), no fluorescence was 
observed on the surface of the sPEG-co-PLGA and glycidol treated sPEG-co-PLGA fibers 
(see Figure 3B&C). Red fluorescence on the fiber surface, as seen for the pure PLGA fibers, 
indicates a homogeneously adsorbed protein layer. The hydrophilic sPEG already minimizes 
the amount of adsorbed BSA resulting in no fluorescence, while adsorption of the other two 
fluorescently labeled proteins, streptavidin and neutravidin, on the sPEG-co-PLGA fibers 
resulted in weak fluorescence located on their surface (Data not shown). An additional 
glycidol treatment of the fiber samples, before incubation with these proteins, was sufficient 
to suppress adsorption of all used model proteins. Due to the reaction of glycidol with amino 
groups on the fiber surface, hydrophilicity was increased and electrostatic interactions with 
these amino groups were eliminated. In order to show the hydrophilicity of electrospun 
meshes, sessile drop contact angle measurements were performed. Figure 5 shows images of 
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these wettability studies. In the case of all sPEG containing fiber samples, no equilibrium 
contact angle could be determined. 
 
Figure 5: Optical microscope images and fluorescence microscopy images of PLGA 
(A) sPEG-co-PLGA (B.) and glycidol treated sPEG-co-PLGA (C.) incubated with 25 
µg/mL fluorescence labeled bovine serum albumin (BSA). 
 
All sPEG-co-PLGA samples were extremely hydrophilic and water droplets were taken up by 
the samples during a few seconds. Figure 5 A.) shows a water droplet shortly before contact 
with the mesh, at the time of contact and five seconds later. The surface of this mesh is easily 
wetted and a droplet is taken up by the mesh, illustrating its hydrophilic nature. Due to this 
inability of determining correct equilibrium contact angles, images of the water droplets at the 
moment of contact with the meshes were taken in order to estimate differences in their 
wettability. Figure 5 B.) shows a water droplet on an electrospun PLGA mesh with an contact 
angle of 120°. The hydrophobicity of the material PLGA (contact angles between 70° and 80° 
[23]) was increased by the surface roughness, due to the small diameter fibers. The contact 
angle of a water droplet on this super-hydrophobic mesh remains unchanged for more than 30 
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min. Figure 5 C.) shows a water droplet on an electrospun sPEG-co-PLGA mesh at the 
moment of contact. No difference was observed whether 2 equivalent of the adhesion 
promoting peptide sequence GRGDS were present (see Figure 5 D) or not. Both water 
droplets showed angles of roughly 30° directly after contact and in both cases the droplet 
spreaded immediately. Glycidol treatment of the electrospun sPEG-co-PLGA meshes further 
increased the sample hydrophilicity (see Figure 5 E.). Upon contact, the droplet spreaded 
immediately and the whole surface of mesh was wetted. 
 
Evaluation of the degradation behavior of sPEG-co-PLGA fibers 
As the target applications of electrospun meshes are for tissue engineering applications, 
degradation and bioresorption over a defined time frame as well as biocompatibility and 
excretion from the body are key issues. While PLGA in the resulting fiber is responsible for 
its biodegradability, the sPEG is considered as bioinert. Due to its solubility, it is excreted 
from the body. Even though PLGA and PEG are FDA approved as materials for biomedical 
and pharmaceutical applications and considered as non-toxic [24], degradation time has to be 
considered for each application. Hydrolytic degradation of the electrospun meshes was carried 
out in phosphate buffer solution (pH = 7.4 and 37°C). Samples were taken out from the 
degradation medium, and characterized for weight loss and molecular weight change after 
washing with distilled water and freeze drying. Figure 6 shows the mass loss of electrospun 
PLGA and sPEG-co-PLGA meshes. 
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Figure 6: Mass loss of electrospun PLGA and sPEG-co-PLGA fibers over a period of 
10 weeks. Error bars are standard deviations. 
 
Continuous degradation started in both cases after 3 weeks, and leads to complete 
disintegration of the mesh (100% weight loss) during 3 months. 68 % of the weight loss and a 
decrease of Mw (see supplementary information Figure 3) from 5.8 x 10
4
 g/mol to 6.0 x 10
3
 
g/mol, were observed for the remaining polymer over 9 weeks degradation time. During the 
same time period 53 % of the weight loss and a decrease of Mw from 4.5 x 10
4
 g/mol to 2.3 x 
10
3
 g/mol occurred in the case of the pure PLGA mesh. The weight loss was after the first 
three weeks significantly higher for the sPEG-co-PLGA mesh. The faster degradation might 
be related to the increased hydrophilicity of these samples. The hydrolytic degradation 
behavior of both electrospun meshes depends on cleavage of hydrolytically unstable ester 
linkages and result in similar degradation times, with a slightly higher weight loss of the 
sPEG containing sample. 
 
Immobilization of active molecules and biological activity of the electrospun meshes 
Moreover, additional to minimization of the nonspecific protein adsorption, immobilization of 
biologically active molecules is necessary to trigger and control biological responses. One 
particular advantage of the sPEG is the slow change in reactivity from isocyanate groups, 
which are reactive towards amines and hydroxy groups, to amine groups in contact with water 
[15]. This allows functionalization at three different stages during the scaffold generation. 
Firstly, an amino or hydroxy containing active molecule can be mixed into the sPEG/PLGA 
solution prior to electrospinning. Secondly, the freshly prepared electrospun sPEG-co-PLGA 
fibers can be incubated with solutions of these active molecules. And last, the remaining NH2 
groups can be used for functionalization after crosslinking with water. This article mainly 
concentrates on the first two functionalization possibilities. While functionalization of fully 
crosslinked sPEG coatings has been reported [18], work on the functionalization of the amino 
groups on the fiber surface is still in progress, and will be reported separately. 
Biocytin functionalized electrospun sPEG-co-PLGA fibers were incubated with a solution of 
streptavidin Rhodamine red conjugate. Adsorption due to the polar amino end groups was 
prevented by additional glycidol treatment. While in the case of the unfunctionalized sPEG-
co-PLGA fibers no fluorescence was observed, the biocytin modified fibers showed a strong 
fluorescence, indicating the availability of the active molecule at the surface. The 
fluorescently labeled streptavidin complexes the available biocytin molecules at the surface 
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and therefore immobilizes the fluorescent tag. A strong fluorescence showed the present 
biocytin molecules located at the fiber surface (see Figure 7A). 
 
Figure 7: Optical microscope and fluorescence image of glycidol treated biotin-sPEG-
co-PLGA (A.) and glycidol treated sPEG-co-PLGA (B.) after incubation with 
Rhodamine red labeled streptavidin, illustrating the fiber functionalization. 
 
To clear the concern of nonspecific adsorption of streptavidin onto the hydrophilic surface of 
the mesh, pure sPEG-co-PLGA without a biocytin molecule was incubated with the same 
solution and did not show any significant fluorescence (see Figure 7 B.)). It was likely that 
nonspecific streptavidin adsorption was minimal due to the star shaped PEG chains at the 
fiber surface. The PEG chains reduce the streptavidin adsorption by steric repulsive action. 
Alternatively to the incubation with Rhodamine red labeled streptavidin, the fibers were 
incubated with 50µL of a solution containing streptavidin labeled polystyrene beads (diameter 
1µm). An extensive washing step and drying in a stream of nitrogen was added prior to 
observation with the optical microscope to remove particles which were not immobilized on 
the fibers. Beads attached to the fibers indicated the biocytin molecules on the fiber surface. 
Electrospun sPEG-co-PLGA fibers and GRGDS functionalized sPEG-co-PLGA fibers were 
collected on sPEG coated silicon wafers, and were used as substrates for in-vitro culture of 
human dermal fibroblasts (HDF). After 24 h the cells were fixated with 4% of 
paraformaldehyd and examined by optical microscopy. No attached cells were found to be 
present on the pure sPEG-co-PLGA fibers. Due to the hydrophilicity of the substrate and 
minimized protein adsorption from the FCS, or those proteins produced and secreted by the 
cells themselves, fibroblasts were not able to attach, kept floating in the medium and 
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underwent apoptosis. Human dermal fibroblasts on the GRGDS modified sPEG-co-PLGA 
fibers adhered and showed typical spread morphologies. In Figure 8 optical microscope 
images of fibroblasts adhering to GRGDS modified fibers are presented. 
 
Figure 8: Microscope image of human dermal fibroblasts (female, age 38, passage 8) 
after 24 h in cell culture on electrospun and GRGDS functionalized sPEG-co-PLGA 
fibers (A.), with higher magnification image (B.). 
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Cells first attached to one fiber, spread and finally bridged several fibers. The cells responded 
to these three-dimensional substrates and strongly adhered to the functionalized fibers within 
only 24 h. 
Additionally, morphological observations of the human dermal fibroblasts after 24 h of in-
vitro culture on the GRGDS functionalized sPEG-co-PLGA fibers were confirmed by SEM 
and are presented in Figure 9. 
 
Figure 9: SEM images of A.) a human dermal fibroblast on electrospun sPEG-co-
PLGA fibers with B&C.) higher magnification images of adhesion points to the fibers. 
 
The fibroblasts attached to the fibers (see Figure 9B&C), spreaded and bridged the nearest 
fibers. The SEM images reveal that human fibroblasts on the cellular level responded to this 
structure. In this chapter, cells seeded on the fibrous substrates were found to have appropriate 
interactions with their environment based on the following observations. First, the cells 
maintained a normal phenotypic shape, suggesting that these cells function as in their native 
environment in/on these scaffolds. Second, the human dermal fibroblasts favored this 
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structure, and adhered to the fibers, packing the electrospun structure surface after only 24 h 
of in-vitro culture. Third, these cells crosslinked the fibers and integrate with the surrounding 
fibers to form a three dimensional network. 
The fluorescence and optical microscope images shown in Figure 10 illustrate the cell 
viability. 
 
Figure 10: Fluorescence microscope images of human dermal fibroblasts after 24 h in 
cell culture on A.) GRGDS-sPEG-co-PLGA fibers (Live/Dead®-staining), with higher 
magnification (B.), and corresponding optical microscope image (C.). 
 
Only living cells, indicated by the green fluorescence, were observed on the GRGDS 
functionalized sPEG-co-PLGA fibers. These fibroblasts are strongly spread between the 
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different fibers they adhere to the fibrous structure (see Figure 10B&C). In comparison to the 
GRGDS functionalized mesh almost no cells were attached to the pure sPEG-co-PLGA mesh 
(see supplementary information). All these evidences indicate that the biologically 
functionalized, electrospun sPEG-co-PLGA fibers induce controlled cell/scaffold interactions. 
Besides of the possibility to control these interactions, the generated fiber meshes proved to 
be promising, suitable substrates for tissue engineering. Cell/scaffold interaction involves a 
series of proper biological responses to the substrate, including adhesion, cell morphology and 
growth. Scaffolds, like the GRGDS functionalized sPEG-co-PLGA, encouraging or sustaining 
such biological activities upon culturing can be called biologically active. 
Conclusion 
This chapter demonstrated the feasibility and efficiency of using synthetic, functionalized 
electrospun sPEG-co-PLGA fibers for controlling cell/scaffold interactions. We were able to 
produce electrospun fiber scaffolds with the possibility of introducing a variety of bioactive 
molecules as well as suppressing nonspecific interactions in a simple approach. The 
combination of bioresorbable PLGA, sPEG and bioactive molecules lead to electrospun fibers 
with unique properties. The electrospun scaffolds showed, minimized nonspecific protein 
adsorption, degraded over a period of 3 months and were able to induce certain cell responses 
due to the immobilized biomolecules. Immobilization of the adhesion promoting GRGDS 
peptide changed the inert fibrous substrate into a supporting growth substrate for human 
dermal fibroblasts. It showed enhanced cell adhesion, preserved the typical phenotype-like 
morphology and showed good cell viability. Therefore, we conclude that cell responses to the 
scaffolds can be triggered, suggesting the feasibility of constructing complex sets of cellular 
interactions with synthetic fibers as first step towards biomimetic scaffolds. These results 
provide a promising basis for future optimization of electrospun fibrous scaffolds for tissue 
engineering applications. 
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Chapter 9: Biofunctionalized electrospun fibers cultured with human 
keratinocytes: A composite material as approach towards artificial skin  
 
Abstract 
Nonwoven sub-micrometer fibers showed tremendous potential for biomedical applications 
such as tissue engineering and wound dressings. Ideally, these scaffolds should provide an 
appropriate surface chemistry as well as incorporated or/and immobilized bioactive factors 
additionally to the three-dimensional structure. However, the combined effects of three-
dimensional structures, surface chemistry and immobilized bioactive factors are yet not fully 
understood. In this chapter, we developed bioactive fibrous scaffolds by immobilizing a 
fibronectin fragment, a collagen IV fragment as well as a combination of both to cell 
adhesion-preventing fiber surfaces, simulating the extra cellular matrix found in human skin 
tissue. An appreciate surface chemistry on all three investigated electrospun fiber types 
(sPEG-co-PLGA, PDLLA-block-PEG, and PDLLA-block-PEG-MP) proved to prevent 
adhesion of keratinocytes without additional bioactivation, thus allowing to distinguish the 
isolated effect of the immobilized active molecules on the cellular response. By this approach 
complex cell/scaffold interactions can be reduced to the effect of the three-dimensional 
microstructure and the effect of bioactivation. Keratinocytes were found to selectively adhere 
to those fibers modified with the collagen IV segment GEFYFDLRLKGDK or a mixture of 
GEFYFDLRLKGDK and GRGDS (1:1) during the first 24 h. Cell numbers on all 
investigated scaffolds were determined. After 6 days the number adhering cells on these 
scaffolds was slightly reduced, whereas the spread and flattened morphologies indicated 
strong adherence. These keratinocytes developed in normal phenotypes. However, the 
decrease in average cell numbers on the bioactivated scaffolds after 6 days was attributed to 
the fact that keratinocytes in the human skin form layer structures and prefer flat surfaces. As 
the flat substrate on which all fibers were collected provides nonfouling properties, the cells 
can just adhere to the surrounding fibers in an appropriate distance. 
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Introduction 
Enhancing dermal tissue regeneration has significant implications for patients suffering from 
chronic non-healing wounds such as diabetic ulcer, venous ulcer as well as large area burn 
wounds [1]. Much attention has been focused on designing implantable compliant 
biodegradable polymer scaffolds that target accelerating chronic wound repair. Current short 
term biomedical applications of biodegradable polymers include orthopedic fixation devices, 
nerve guides, artificial veins and arteries, wound coverings and tissue engineering scaffolds 
among many others. Tissue engineering is a new approach to reconstruction and/or 
regeneration of lost and damaged tissue. 
A number of requirements are crucial in determining the success of a material for scaffolds 
used inside the human body. Most importantly the material must be biocompatible, meaning 
that it induces an appropriate response inside the host organism. Biodegradable materials have 
been the more popular choice due to the elimination of a second surgery to remove the 
scaffold. Toxicity, inflammatory and possible immune response of the material as well as its 
degradation products should typically be minimized. While processes such as protein 
adsorption and the inflammatory response will occur to some degree with any implant, a 
bioinert material will form very little interactions with the surrounding environment, 
including the body fluids and surrounding tissue. Furthermore, specific interactions with the 
biological environment are often accomplished through surface modifications allowing a large 
variety of synthetic, natural or hybrid materials to be used [2]. 
Poly ( -hydroxyl acids) such as poly(glycolic acid) and poly(lactic acid), are currently the 
most, widely investigated, and most commonly used synthetic biodegradable polymers. When 
poly (ethylene glycol) (PEG), a well-known biocompatible polymer, is coupled to the 
aforementioned homopolymers, many of the properties may transfer to the conjugate product. 
Hence, the block copolymers of poly(lactide) and PEG have received a lot of attention 
recently [3]. 
Nonwoven fibrous matrices have been widely used as scaffolds in tissue engineering, and 
modification of microstructure of these matrices is needed to organize cells in two-
dimensional and/or three-dimensional space with spatially balanced proliferation and 
differentiation required for functional tissue development [4]. A variety of porous materials 
have been used to produce three-dimensional cell composites by allowing individual cells to 
attach on the scaffold surface, promoting cell growth, and maintaining the differentiated cell 
phenotypes. For a tissue to be successfully regenerated, sufficient cell propagation, and 
appropriate differentiation must be achieved in the three-dimensional cellular composite. 
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Interest in potential biomedical applications of nanomaterials and nanostructured materials 
arises from the perception that they are able to interact with individual biomolecules, cells and 
their individual parts and other biological structures of similar size in the micrometer and 
nanometer range. Besides this, nanomaterials and nanofibers in particular are widespread in 
living nature. Such different materials as hair, connective tissue, bones, skin and blood vessels 
– to name just few – are all formed by some regular and repetitive arrangements of 
nanofibers, usually made up by proteins or polysaccharides [5]. Among those natural 
occurring nanofibrous structures are the fibrin(ogen) polymerization as part of the final stage 
of the blood coagulation cascade and fibrous protein structures (fibrils) formed in the extra 
cellular matrices responsible for the three-dimensional arrangement of cells into functional 
tissue. 
Electrospinning is a facile processing technique capable of converting polymers into inter-
connected flexible nanofibers structures, and it is particularly appealing for fabricating large 
sheets of scaffolds suitable for dermal implantation [6]. Furthermore, the electrospinning 
process affords the opportunity to engineer scaffolds with micro to nanoscale topography and 
controlled porosity similar to the natural extra cellular matrix [2]. By varying the process and 
solution parameters their fiber orientation and porosity/pore size of the scaffold can be 
altered. Initially, small pore size was seen a hindrance in many situations. However, small 
pore size can actually serve as an advantage in applications where cell infiltration is 
unwanted. Round cells and bacteria with diameters on the order of 10 µm cannot fit in 
nanofiber meshes with pores on the nanofiber scale, making these meshes particularly useful 
for barrier applications such as skin and endothelium. The temporary barrier takes the from of 
a thin polymeric sheet or a mesh-like device that can be placed between adhesion tissues at 
the time of surgery. Therefore, these materials should be flexible and though enough to 
provide a tight cover over the traumatized soft tissue and should biodegrade after the injured 
tissue is completely regenerated. Temporary barrier-type devices can serve as basis for the 
development of artificial skin for the treatment of burns and other skin lesions [7]. In fact, this 
is a widely investigated application, which has become the first tissue engineered product 
commercially available [8]. Thus, a nanofiber mesh will essentially behave as two-
dimensional sheets on which cells are able to migrate along the surface, rather than a three 
dimensional scaffolds which cells are capable of infiltrating. While the size scale and 
orientation of electrospun fibers can be used to influence cell functions such as adhesion, 
proliferation, and migration, even greater control of cellular response can be achieved by 
attaching bioactive molecules to the surface of the scaffold. 
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A scaffold used as artificial skin to cover or replace damaged tissue has to be constructed 
similar native human skin. The human skin is a complex living tissue (see figure 1), which is 
formed of well organized layers of functional tissues with the epidermis being its outermost 
layer. 
 
Figure 1: Histopathological image of dyshidrotic dermatitis, showing focal spongiotic 
change in the epidermis [9]. 
 
The epidermis is avascular and is nourished by diffusion from the dermis. The keratinocyte is 
the major cell type of the epidermis, making up about 90% of epidermal cells. The dermis is 
the layer of skin beneath the epidermis that consists of connective tissue and cushions the 
body from stress and strain. The dermis is tightly connected to the epidermis by a basement 
membrane and contains lymphatic vessels and vessels. It is composed of dense irregular 
connective tissue, and receives its name from the dense concentration of collagenous, elastic, 
and reticular fibers that weave throughout it. These protein fibers give the dermis its 
properties of strength, extensibility, and elasticity. 
Bioactivation of scaffolds leading to cell adhesion, spreading and proliferation requires 
specific adhesion promoting peptides as well as several soluble factors activating certain 
signaling pathways. One basic problem, the clear distinction between the different extra 
cellular matrix (ECM) constituents that participate in cellular adhesion and their 
corresponding signaling pathways was addressed by Salber et al. The immobilization of 
peptide sequences mimicking fibronectin, and collagen type IV, two major components of the 
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ECM, on flat surfaces and subsequent cell responses (fibroblasts and keratinocytes) were 
investigated [10]. 
While bioactivated electrospun scaffolds as substrates for cell culture of human dermal 
fibroblasts have been descried in previously [11, 12], in this chapter the interaction of 
keratinocytes (HaCaT) with electrospun fibers functionalized with two peptide sequences as 
well as a mixture (1:1, w/w) was investigated. To achieve this, sPEG-co-PLGA and PDLLA-
block-PEG-MP were electrospun and collected as randomly orientated nonwoven which 
prevent unspecific cell adhesion. Specific cell adhesion was achieved by functionalization of 
the fibers with the peptide sequences and their combinations. Bioactivation of the scaffold 
surfaces with the peptides led to a high density of these bioactive molecules due to the 
relatively high scaffold surface area. HaCaT keratinocytes were seeded on these bioactive 
scaffolds and were in culture for 24 h and 6 days. The cell numbers were quantified as well as 
the cell morphology observed. 
 
Experimental part 
Materials: 
Acetone, chloroform, methanol, diethylether and dimethylsulfoxide were supplied by Sigma-
Aldrich (Germany). Acetone was dried with phosphorpentoxide and distillation, while 
dimethylsulfoxide was dried over 4-A molecular sieves. All other standard solvents were used 
as received in analytical grades. The peptide sequence GRGDS and GEFYFDLRLKGDK 
were purchased from Bachem (Switzerland). A Live/Dead®-staining kit was supplied from 
Mobitec (Germany). Silicon wafers (100) were purchased from CrysTec GmbH (Germany). 
Isocyanate terminated six arm star poly(ethylene glycol) (sPEG) of an average molecular 
weight of 12 kDa was donated by SusTech GmbH & Co KG (Germany) and stored inside a 
Braun Unilab Glovebox (Germany). The preparation of these isocyanate terminated 
prepolymers is described elsewhere [13]. Commercial THF and toluene were dried over 
LiAlH4 and purified by conventional distillation. N-[3-trimethoxysilyl)-
propolyl]ethylenediamine (Aldrich, 97%) was stored under inert gas atmosphere and filtered 
before use. PLGA (RG 504) was donated by Boehringer Ingelheim Pharma GmbH &Co.KG 
(Ingelheim am Rhein, Germany) and used as obtained. The PLGA used in this chapter had a 
molecular weight of approximately 45 kDa (THF-GPC measured with PMMA standard). 
Phosphate-buffered saline was purchased by Sigma-aldrich (Germany), 0.0027 M potassium 
chloride and 0.137 M sodium chloride, was dissolved in 1 L deionized water to obtain 0.01 M 
phosphate buffer (pH 7.4 at 25°C). -Hydro- -aminopoly(ethylene glycol) (Mw = 10 kDa) 
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and -hydro- -methoxypoly(ethylene glycol) (mPEG, Mw = 10 kDa) were purchased from 
IRIS Biotech (Marktredwitz, Germany). 3,6-Dimethyl-1,4-dioxane-2,5-dione was obtained 
from Aldrich (Taufkirchen, Germany), recrystallized twice from ethyl acetate, dried in 
vacuum and purified by sublimation at 110 °C. N-( -maleimidobutyryloxy)succinimide 
(GMBS) was purchased from Fluka (Buchs, Switzerland). Zinc( ) 2-ethylhexanoate was 
purchased from ABCR (Germany) and used without further purification. The preparation of 
PDLLA-block-PEG-MP (poly-D,L-lactide)- -3-(1-maleimidopropionamidopoly(ethylene 
glycol)) was described previously. Immobilized TCEP disulfide reducing gel (4 µmol/mL gel, 
50% suspension in water) was purchased from Pierce (Rockford, IL, USA).  
 
Preparation of sPEG coated silicon wafers: 
The detailed preparation of the coatings has been previously described by Groll et al. [14]. 
Briefly, silicon wafers were cut to 15 x 15 mm pieces, cleaned thoroughly and activated by 
UV/ozone or oxygen plasma. For aminosilylation the activated substrates were treated with 
0.3 mL of N-[3-trimethoxysilyl)-propyl]ethylenediamine in 50 mL dry toluene for 2 h under 
nitrogen atmosphere (inside a glovebox). A solution of 10 mg/mL isocyanate terminated 12 
kDa – prepolymers was prepared in a mixture of THF/water (1/9, v/v). After 5 min the 
solution was filtered with a 0.2 µm filter and used for spin coating (2500 rpm, 40s) onto the 
substrates. The resulting films showed about 30 nm layer thickness and were stored at 
ambient conditions before use. 
 
Electrospinning: 
For electrospinning the polymers were, unless otherwise mentioned, dissolved in a mixture of 
chloroform and methanol (75/25, v/v) to make 25 wt% solutions. The polymer solutions were 
pumped to the 18-gauge, flat-tipped, stainless steel spinneret at a rate of 0.1 mL/h. A voltage 
of 25 KV was applied to the polymer solution with a Series 205B high voltage power supply 
(Bertran, NY, USA). During the electrospinning, polymer solutions were pumped to an 18-
gauge, blunt, stainless steel spinneret at a rate of 0.1 mL/h. Fibers were collected for 60 s. The 
collector was positioned at a 200 mm distance from the tip of the spinneret. 
Isocyanate terminated sPEG was dissolved in dry acetone under mechanical stirring at 5 wt% 
and stored under nitrogen atmosphere until further use. 25 wt% PLGA (RG 504) were added 
to the sPEG solution and mixed with an Ultra-Turrax® (IKA, Germany) at 22000 rpm for 
60s. The solution was immediately proceeded. For electrospinning experiments polymer 
solutions were fed at 2.5 mL/h to a flat-tip stainless steel spinneret connected to a high-
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voltage power supply. An Eltex KNH35 (Germany) high voltage generator was utilized to 
charge the solutions at 20 kV while the collector remained grounded. The solutions were 
pumped to 18-gauche, flat-tipped; stainless steel spinneret located 200 mm from a conductive 
collector. Thirty seconds of electrospinning onto these targets proved sufficient for a good 
coverage. 
Samples for in-vitro cell culture were collected on previously sPEG coated silicon wafers (15 
X 15 mm), which were fixed with conductive carbon tape to a grounded aluminum SEM stub 
(diameter 12 mm). Storage overnight in ambient atmosphere assured that crosslinking of the 
sPEG molecules could take place. These substrates allow frequent media changes without the 
loss of electrospun material during cell culture experiments. 
 
Biofunctionalzation of the fibrous scaffolds: 
The electrospun fibrous scaffolds were functionalized by incubation with adhesion promoting 
peptide solutions. The thiol-reactive polymer PDLLA-block-PEG-MP was incubated with 
cystein terminated adhesion promoting peptide. Therefore, a mixture of the peptide GRGDC 
in PBS (5 µmol/ml, 500 µL) and immobilized TCEP disulfide reducing gel (1250 µL, 2.0 eq) 
was incubated for 20 min at r.t. After centrifugation at 1000 min
-1
 for 1 min, the supernatant 
solution (250 µL each) was used to incubate the samples for 20 min at r.t. The samples were 
washed with PBS (1 mL), incubated in water (1 mL) twice for 20 min each and washed 
thoroughly with distilled H2O. Afterwards, the samples were further used for in vitro cell 
culture experiments. 
Generally, functionalization of the electrospun sPEG-co-PLGA fibers can be achieved by two 
different routes [15]. Firstly, the active molecule (containing an amino- or hydroxy-group) 
can be mixed with the 5 wt% star-PEG solution prior to spinning. After addition of 25 wt% 
PLGA and electrospinning, functionalized fibers are gained in situ. This way of gaining 
functionalized fibers is out of the frame of this paper and was described previously. Secondly, 
sPEG-co-PLGA fibers can functionalize in an additional step after the electrospinning. In this 
case, non reacted isocyanate groups on the fiber‘s surface are used for functionalization. We 
incubated the electrospun scaffolds directly after production with a solution of 5 µmol/mL 
peptide (GRGDS, GEFYFDLRLKGDK, and a mixture of GRGDS & GEFYFDLRLKGDK 
[1:1]) in PBS for 1 h. The peptide solution was exchanged with fresh PBS (1 mL), the 
samples afterwards incubated in water (1 mL) twice for 20 min each and washed thoroughly 
with distilled H2O. The functionalized samples were further used for in vitro cell culture 
experiments. 
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In vitro experiments: 
The spontaneously immortalized human keratinocyte cell line HaCaT [16] was kindly 
provided from Prof. N. Fusenig (German Cancer Research Institute, Heidelberg, Germany). 
HaCaT cells were cultured in carbonate-buffered Hank‘s medium supplemented with 5% fetal 
calf serum (PAA, Coelbe, Germany) and 1% penicillin–streptomycin (Biochrom KG, Berlin, 
Germany) at 37°C in a 5% CO2 atmosphere. The culture medium was changed twice a week. 
The silicon wafers carrying the electrospun fibers were thoroughly washed with sterile PBS 
buffer five times to remove any contaminations. The samples were pre-wetted in culture vials 
overnight (24 h) with cell culture media. This hydration of the surface at room temperature 
fully exposes the hydrophilic PEG and the covalently attached peptide sequence in the 
copolymer on the surface. Cells were seeded on each substrate with a cell density of 60000 
cells per sample and mL. Afterwards, 2 mL media were added and samples incubated for 24 h 
at 37°C in-vitro. For determination of cell survival, a Live/Dead® viability/cytotoxicity kit for 
mammalian cells (Molecular Probes) was used according to the manufacturer‘s protocol. To 
quantify the cell density after 24 h or 6 days on the modified samples, six spots on each 
sample were chosen, photographically reported with fluorescence microscopy images, and 
cells within an area of 500 µm X 500 µm were counted. The numbers presented are given as 
average numbers counted on 6 images per sample and two samples per fiber type. Therefore, 
each number represents an average of 12 randomly chosen positions. The resulting cell 
number was considered to be representative for the cell settlement on the substrates. To 
observe the cell morphology after 24 h or 6 days, the cells on these samples were immediately 
fixed with 4 wt% paraformaldehyd incubation before further analysis. The red fluorescence 
indicating the fixed cells allowed identifying the cells without using any additional staining. 
Cell growth and adhesion were investigated microscopically. Microscope images were taken 
with a MRc5 camera, an Axioplan2 and a N XBO 75 lamp (Zeiss, Oberkochen, Germany) 
microscope. 20.000 ms exposure and 20× magnification was used for all fluorescence images 
to allow comparison (Filter 31/ Zeiss, Germany). Optical microscope images were taken using 
a polarization filter (Filter 2/ Zeiss, Germany). 
 
Results and Discussion 
For the development of a scaffold used as artificial skin, a three-dimensional fiber matrix was 
produced by electrospinning, modified with relevant bioactive peptide sequences and tested in 
vitro. This chapter concerns the fabrication of electrospun nonwoven substrates that prevent 
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unspecific cellular adhesion but can be modified with different ECM-derived peptide 
sequences that act as integrin binding partners. As skin is a complex organ constituted of 
seven different layers, of which in five keratinocytes are the predominant cell type and the 
two lowest layers formed by fibroblast, both cell types have to remodel the scaffold to 
functional tissue. Keratinocytes originate in the basal layer from the division of keratinocyte 
stem cells. They are pushed up through the layers of the epidermis, undergoing gradual 
differentiation. While they move to the surface of the skin the keratinocytes are enucleated, 
flattened and highly keratinized. Eventually they die off and form the stratum corneum. It 
consists of lipid bilayers with alternating hydrophilic and hydrophobic areas. This is an 
efficient barrier against chemicals that are insoluble in fat and against those which are 
insoluble in water and minimizes moisture loss. For the skin, the basement membrane is an 
important part as it functions as a substratum for the keratinocytes forming the upper layers 
and a surrounding matrix for the cells in the dermis. Thus, peptide sequences derived from 
fibronectin (FN), and collagen IV (Col IV), two major components of the ECM, have been 
used in this chapter. Therefore, this chapter concentrates on the production of a fibrous 
scaffold structure suitable as three-dimensional environment for cells present in the dermis (as 
for example fibroblasts) and at the same time allowing formation of layers of keratinocytes, a 
substitute for the basement membrane connecting dermis and epidermis. 
Electrospinning sPEG-co-PLGA and PDLLA-block-PEG-MP resulted in degradable fibers 
that prevented nonspecific protein adsorption as well as cell attachment. Thus, by 
immobilization of biologically active peptide sequences cell responses can be triggered and 
controlled. Subsequently the fibers were biofunctionalized by covalently binding peptide 
sequences derived from fibronectin (GRGDS), and collagen IV (GEFYFDLRLKGDK), two 
of the major constituents of the ECM [17]. These peptides are known to interact directly with 
connective tissue cells (e.g., fibroblasts) and epithelial cells (e.g., keratinocytes), which are 
two typical cell types found in the epidermis and dermis of human skin, as well as they play a 
role in self-assembly of fibronectin fibrils, heparin, and cell-binding sites. The response of 
fibroblasts to electrospun fibrous scaffolds with immobilized has already been described 
previously [11, 12] and is out of the frame of this chapter. In this chapter, peptide sequences 
are embedded into the coating by reaction between the amino terminuses of the peptide chain 
with the isocyanate groups (in the case of sPEG-co-PLGA) or the maleimide-groups (in the 
case of the block copolymer PDLLA-block-PEG-MP) on the fiber surface and cultured with 
HaCaT keratinocytes over a period of 6 days (see Figures 2 and 3). 
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Figure 2: Fluorescence images of the scaffolds after 24 h in vitro cell culture with 
keratinocytes and Live/Dead staining. 
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Figure 3: Fluorescence images of the scaffolds after 6 days in vitro cell culture with 
keratinocytes and Live/Dead staining. 
 
The maleimide end groups of the block copolymer, which are available at the fiber surface, 
react with the thiol group of the peptide sequence. A peripheral thiol group, like in the 
GRGDC peptide sequence, can be used to immobilize the peptide without loss of its activity. 
By this reaction, the peptide sequence is covalently coupled to the PEG blocks of the PDLLA-
block-PEG-MP block copolymer. A thioester is formed between the polymer and the peptide. 
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The 10 kDa PEG block functions as flexible spacer and guaranties cells can recognize and 
interact with the active molecule. Covalent attachment to the fiber surface allows long-term 
immobilization, with release of the active molecule only being possible by degradation of the 
polymer. 
Due to the slow hydrolysis of the isocyanate groups, the crosslinking process requires at least 
24 h for the isocyanate groups to be completely hydrolyzed. Thus, a convenient time window 
remains in which the isocyanate functionality of the surface can be used for covalent 
immobilization of compounds. Ideally, these compounds bear amino groups so that they react 
preferentially with the isocyanate groups with respect to hydrolysis [10]. In order to assure 
bioactivation of the fibers, the sPEG-co-PLGA nonwovens were wetted with peptide-
containing aqueous solutions directly after they have been prepared. In this state, the fibers 
are still isocyanate-functionalized, so that the peptides are preferentially immobilized on the 
fibers surface. Since the peptides are bound by reaction with isocyanate groups that are 
positioned at the ends of a star-shaped molecule on the fiber surface, each immobilized 
peptide is automatically immobilized with a PEG spacer with a molecular weight of 2000 
g/mol (12000g/mol divided by the six arms). Thus, accessibility of the peptide sequences for 
the cells is assured. The collagen IV-derived peptide sequence contains two lysines close to 
the C-terminus of the peptide. The lysine residues can react with the sPEG molecules in the 
same way as the N-terminus. Due to the peripheral position of the two lysines, a significant 
effect on the biochemical properties of the peptide is, however, not expected. The peptide 
sequences are derived from different proteins that play an important role in the ECM, the 
native three-dimensional environment into which cells are embedded in the living organism. 
The overall peptide concentration used for the functionalization of the sPEG-co-PLGA and 
PDLLA-block-PEG-MP scaffolds was 5 mmol/ml in all cases to ensure identical network 
structure and density. This however means that the concentrations of the single peptides 
decreases from 5 mmol/mL to 2.5 mmol/mL when the peptide is used alone, together with the 
other peptide, respectively. 
Figure 2 shows representative fluorescence microscope images of the substrates with the 
different fibers and peptides after 24 h cell culture with HaCaT keratinocytes and Live/Dead 
staining taken with a magnification of 5X and exposure times of 20000 ms. The sPEG coated 
silicon wafers as well as most unmodified fibers showed no adhering cells. The HaCaT 
keratinocytes did not respond to the immobilized fibronectin sequence (GRGDS). Only those 
fibers with the immobilized GEFYFDLRLKGDK peptide showed larger keratinocyte 
quantities. 
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Figure 3 shows fluorescence images of the substrates substrates with the different fibers and 
peptides after 6 days cell culture with HaCaT keratinocytes and Live/Dead staining taken with 
a magnification of 5X and exposure times of 20000 ms. Figure 4A&B is a higher 
magnification image of keratinocytes after 24 h in vitro cell culture on electrospun 
GEFYFDLRLKGDK modified sPEG-co-PLGA fibers. 
 
Figure 4: Microscope images of keratinocytes after 24 h in vitro cell culture on 
electrospun GEFYFDLRLKGDK modified sPEG-co-PLGA fibers. 
 
On these samples the HaCaT keratinocytes behaved similar to the 24 h samples. Cells were 
only observed on bioactivated fibers, with the highest affinity to GEFYFDLRLKGDK. 
However, over time at least a few keratinocytes adhered to those fibers only modified with 
GRGDS. The cell numbers on the different substrates were quantified. 
Figure 5 presents the results of static cell-culture experiments with HaCaT keratinocytes. 
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Figure 5: Average cell numbers (6 per sample type) counted on 500 µm X 500 µm are 
of the different substrates. 
 
No cells were found to adhere on the sPEG coated silicon wafer. Cells can barely adhere 
nonspecifically onto unmodified PDLLA-block-PEG fibers, PDLLA-block-PEG-MP fibers 
and sPEG-co-PLGA fibers after 24 h and 6 days, even though the fibers provide a three-
dimensional substrate with a certain roughness and curvature. Interestingly, the RGD 
sequence (as GRGDC or GRGDS) also does not show a significant effect on cell adhesion 
when compared to the unmodified fibers. Even if the PDLLA-block-PEG-MP is bioactivated 
by immobilization of GRGDC, no HaCaT were observed on the samples. Even though almost 
no cells adhered to the GRGDS modified sPEG-co-PLGA fibers primarily (after 24 h), some 
cells were found to adhere to the fibers after 6 days. In contrast, the collagen IV sequences 
significantly induce cell adhesion and proliferation. These observations are in agreement with 
the situation in the skin, where the basement membrane is positioned in between the dermal 
(fibroblasts) and the epidermal (keratinocytes) cells and connects these layers. While 
fibronectin is an important constituent of the extra cellular matrix of the dermis, collagen IV 
plays a major role at the epidermal layers and is thus crucial for the adhesion and proliferation 
of keratinocytes. As a result, keratinocytes freshly harvested from human skin do not spread 
and migrate on fibronectin coated surfaces but develop this ability during the first week after 
placing the cells in culture. This is in good agreement with the observation on the electrospun 
GRGDS modified sPEG-co-PLGA fibers, as the HaCaT keratinocytes begin to adhere after a 
certain gap time. It is believed that due to the binding of the peptide sequences into a cell-
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adhesion-preventing environment, this effect is even more pronounced, resulting in much less 
cells adhering to the GRGDS modified samples.  
The effects of sPEG-co-PLGA functionalized with combinations of the two different peptides 
(GRGDS and GEFYFDLRLKGDK) induce even stronger cell adhesion after 24 h. It is 
important to stress again that the overall peptide concentration used for all surfaces presented 
is identical. Although the concentration of single peptides decreases, cell adhesion generally 
increases. This combination induces primarily more cell attachment than modification with 
only GEFYFDLRLKGDK, which typically is part of the natural environment of keratinocytes 
in the human tissue. After six days in static cell culture, the initially high number of adherent 
cells decreases to about 10% of the value after 24 h. Thus we suggest that only the collagen 
derived GEFYFDLRLKGDK peptide sequence is capable of supporting cell attachment and 
proliferation. This decrease in the number of attached cells was also observed for the 
GEFYFDLRLKGDK modified scaffold during six days of cell culture. However, this effect 
was by far not as pronounced as with the combination of peptides. 
The microscope images reveal that HaCaT keratinocytes respond to the GEFYFDLRLKGDK 
modified electrospun fibers. After 24 h the cells adhere with filaments to the fibers while 
beginning to spread on the underlying sPEG coated silicon wafer. After these first 24 h the 
cells did not yet reach a fully spread, flattened state as seen on these images. Figure 6 shows 
microscope images of HaCaT keratinocytes on sPEG-co-PLGA fibers which were modified 
with a mixture of GEFYFDLRLKGDK and GRGDS (see figure 6A) in comparison to purely 
GEFYFDLRLKGDK modified fibers. 
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Figure 6: Microscope images of keratinocytes after 24 h in vitro cell culture on 
A&B.) GEFYFDLRLKGDK/GRGDS (1/1, W/W) modified sPEG-co-PLGA fibers 
and C&D.) GEFYFDLRLKGDK modified sPEG-co-PLGA fibers. 
 
Fluorescence images of these cells with Live/Dead-staining after paraformaldehyd fixation 
are additionally given to identify the positions of the otherwise unstained cells. In the case of 
the fibers functionalized with the peptide mixture, the cell morphology is even less spread. 
The typical rounded shape of cells not able to strongly attach and spread is still preserved. In 
contrast to this, the keratinocytes on the GEFYFDLRLKGDK modified fibers already begun 
to spread to a much greater extend, attaching there focal adhesions contacts to the fiber while 
the cell body spreads on the nonfouling background. Nanoscaled assembly of integrins to so-
called ―focal adhesion contacts‖ are known to be crucial in cell adhesion. 
A comparison of the typical HaCaT morphology after 24 h and 6 days is presented in figure 7. 
After 24 h the cells are still in the process of spreading, their contacts to the surrounding 
fibers can be seen on the image and are taken as evidence for the peptide/integrin receptor 
mediated attachment (see figure 7A). After 6 days, the cells are spread and flattened to a 
much higher extend (see figure 7B).These cells maintained a normal phenotypic shape, 
suggesting that cells function biologically in this structure. As cells are unable to attach to the 
sPEG coating as well as to these fibers without proper biological activation, the cells favor 
this structure, so they adhere onto the fibers. 
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Figure 7: Microscope images of keratinocytes after A.) 24 h and B.) 6 days in vitro 
cell culture on GEFYFDLRLKGDK modified sPEG-co-PLGA fibers. 
 
From this evidence, it indicates that these electrospun bioactivated fibers are recognized as 
matrix. On the other hand, the fact that the cell body‘s are mainly positioned on flat surfaces, 
while adhering to the fibers indicate that keratinocytes prefer to adhere to flat substrates, as in 
natural skin. In human skin for example, fibroblasts are located in the connective tissue, 
surrounded by their extra cellular matrix, while the keratinocytes for cell layer on top of this 
tissue. One possibility to enhance proliferation and cell attachment might be to use these 
scaffolds in fibroblast/keratinocyte co culture [18], or by preseeding fibrobast in these three-
dimensional scaffolds, keeping them in cell culture for several days and later cultivating 
keratinocytes in an additional step.  
Adhesion of HaCaT keratinocytes strongly depends on the peptides, their combinations and 
the morphology. Firstly, sequences derived from collagen IV lead to pronounced cell 
adhesion, whereas the fibronectin sequences barely promote the adhesion of HaCaT 
keratinocytes. Secondly, two-dimensional flat substrates promote the adhesion of 
keratinocytes, whereas cells of the connective tissue like fibroblasts prefer a three-
dimensional fiber matrix. The decrease in average cell numbers on the bioactivated scaffolds 
after 6 days may be attributed to the fact that keratinocytes in the human skin form layer 
structures and prefer flat surfaces. As the flat substrate on which all fibers were collected 
provides nonfouling properties, the cells can just adhere to the surrounding fibers in an 
appropriate distance. Cells without direct contact to fibers and only substrate were removed 
with the cell culture media. However, this bioactivated, degradable electrospun fibers proved 
capable of selectively interacting with certain cell types. The cell selectivity can be introduced 
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by immobilizing a proper adhesion promoting peptide sequence to the cell-adhesion-
preventing fiber surface and allows control over the scaffold/cell interaction. This effect 
determining cell attachment was strongly enhanced by the fibrous structure, which in the case 
of keratinocytes suppresses cell attachment. 
 
Conclusion 
On the basis of this results, we conclude that the architecture of electrospun scaffolds with 
bioactive molecules immobilized on a cell adherence-preventing and protein adsorption-
preventing fiber surface can be regarded as simplified extra cellular matrix. Cells respond 
specifically to a combination of the fibrous structure, the surface chemistry and the 
bioactivation. The collagen IV sequences GEFYFDLRLKGDK as well as a combination of 
GEFYFDLRLKGDK and GRGDS proved to promote cell attachment. Since this studies have 
not optimized the physical properties like fiber orientation, porosity and pore size distribution 
for specific cell types, the scaffolds can still be further optimized specifically for keratinocyte 
attachment, growth and proliferation. This chapter provides a basis for the development of 
scaffolds used in tissue engineering. 
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Chapter 10: Quasi-monodisperse microparticles and nanoparticles by 
electrostatic spraying: Parameters affecting the spraying process and 
structure formation 
 
Abstract 
Electrostatic processes have many applications such as electrospray ionization in mass 
spectroscopy, electrospray deposition of thin films, electrospinning for many different 
applications, and polymeric particle fabrications for drug encapsulation. In this chapter, an 
electrostatic process was used to produce biodegradable polymeric micro- and nanoparticles. 
Governing parameters, limits and opportunities for particle production were identified and 
discussed. Particles on the basis of PLGA and PDLLA-block-PEG polymers with various 
molecular weights were generated. The effects of processing parameters such as polymer 
concentration, used solvent and polymer, feed rate, voltage, configuration specific parameters, 
and surfactants on the particle size as well as their surface morphology were investigated 
systematically. Particle size and surface morphology can be controlled by carefully choosing 
parameter combinations suitable for the desired structural features. Mainly the group of 
solution parameters determines the formed structures. These solution parameters determine 
whether thin polymeric layers, particles or fibers are achieved. If the polymer had an 
appropriate molecular weight and concentrations were suitable, the jet broke-up into droplets 
and particles were formed. Changing influence parameters directly related to these governing 
parameters, like viscosity, surface tension, and conductivity, gives further control over the 
spraying process. Solvent related parameters like volatility and dielectric constant showed 
tremendous influence on particle sizes and morphology. For example, higher solvent volatility 
favored formation of bigger particles. Solid and/or hollow particles can be produced by 
control of the solvent evaporation during electrospraying. Applied voltage, feed rate and 
nozzle to target distance are another set of dependent parameters and are as important as the 
solution parameters. These parameters showed influence on the particle size and especially on 
the homogeneity of the electrosprayed samples. One combination of voltage and 
corresponding feed rate at a given nozzle to target distance enables the production of quasi-
monodisperse particles. Besides the suitability of electrospraying for particle generation of 
different polymeric materials and controllable particle size, these particles can be easily 
modified with amino group containing molecules. This simple modification allowed 
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immobilization of a fluorescence dye and generation of fluorescently labeled particles. 
Furthermore, degradation of electrospun particles was studied over a period of 14 days under 
physiological conditions. In short, electrospraying is promising, simple and reproducible 
technique for the fabrication of sprays. Various polymeric microparticles and nanoparticles 
for medical, biological and pharmaceutical applications can be produced, while particle size 
and morphology can be precisely controlled by alteration of certain parameters. 
 
Introduction 
The ability to produce distinct structures of biodegradable polymer provides an opportunity to 
develop enhanced biological, pharmaceutical and medical devices. Electrostatic processes 
provide a simple and cost-effective mean for the production of a wide variety of defined 
nanostructures and microstructures. Since the polymer solution is charged before deposition, 
the desired submicron-structures can be selectively patterned forming the required macro-
structure for a particular application [1, 2]. In addition, electrospraying provides efficient 
encapsulation and protection of large fragile therapeutic drugs. A whole variety of different 
model drugs has already been successfully encapsulated by electrospraying processes 
including proteins, DNA, RNA, taxol as well as other drugs used for cancer therapies. All 
these example of successful encapsulation in biodegradable and bioresorbable polymers 
demonstrated the suitability for retarded release applications. Besides these applications, 
particle sizes generated by electrospraying seem promising for pulmonary delivery as a large 
fraction of the microparticles between 1 and 5 µm are deposited in the deep lung (especially 
the alveoli) upon inhalation. Especially for inhalation therapy there exists interest in control 
over particle size, particle size distribution and particle surface morphology combined with 
simple and straight forward production technique. Therefore, understanding and controlling 
the effect of governing parameters on particle formation (or generally structure formation) as 
well as the limits of the electrospraying process provides a need. 
Abe Nollet as early as 1750, showed the efficiency of electrostatic spraying [3]. Besides these 
first observations, the basis for theoretical understanding of the electrospraying process was 
developed by Lord Rayleigh. He first described the formation of a charged jet as 
3231
22
9
I
F
rj , where I is the injection current, F is the solution flow rate,  is the 
permittivity of the solution, and  is the surface tension [4, 5]. Typically electrospraying 
(electrostatic spraying) operates by inducing a surface charge on the fluid being sprayed using 
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an applied voltage. Emitted droplets appear unstable with regard to their charge and 
disintegrate ejecting hundreds little droplets that are approximately two orders of magnitude 
smaller. In many cases, however, the residual electric conductivity of the fluid is inadequate 
to produce the large surface charge necessary for the formation of increasingly fine structures 
as in the case of most organic solvents applicable to spraying polymers such as polylactide-
co-glycolide and poly(ethylene glycol)-block-poly(D,L-lactide) [6]. However, attempting to 
generate fine sprays (particles) and to control and understand the influence of the governing 
parameters and limits remains a major challenge.  
Drug release systems are one major application of microparticles and nanoparticles. Various 
examples ranging from medical and biological to pharmaceutical applications are reported. 
These delivery systems offer numerous advantages compared to conventional dosage forms, 
which include improved efficacy, reduced toxicity, and improved patient compliance and 
convenience. Such systems often use macromolecules as carriers for the drugs. Biodegradable 
polymers have advantages over other carrier systems in that they do not need to be surgically 
removed when drug delivery is completed and that they can provide for example direct drug 
delivery to the systemic circulation. Drugs and polymers have been combined in a number of 
different ways depending upon the application of interest. Microparticulate formulations have 
the widest applicability to the widest variety of formulation needs: oral delivery, 
intramuscular injection, subcutaneous injection, pulmonary delivery, and targeted delivery. 
An example for successful targeted drug delivery of microparticles into the lungs by 
inhalation has been reported by Sharma et al. as persistent, high blood levels of antitubercular 
drugs resulting from prolonged oral administration of anti-tubercolosis drugs may be neither 
necessary nor sufficient to kill mycobacteria residing in macrophages; direct targeting of 
alveolar macrophages was a straight forward strategy. Inhalable biodegradable microparticles 
containing two of the first-line anti-tuberculosis drugs, isoniazid, and rifampicin, were 
prepared and tested for phagocytosis by mouse macrophage, administration as a dry powder 
inhalation to rats, and targeting alveolar macrophages with high drug doses when 
administered to rats [7]. Among the first active targeting attempts nanoparticles with either 
aldehyde groups or hydroxyl groups on their surface were produced. Aldehyde groups on the 
surface of particles can react with the lysine residues of cell‘s proteins. On the other hand, 
aldehyde groups on the particle surface may be used for attachment of the amino-containing 
ligands. The hydroxyl groups on the surface of such particles can be further derivatized and 
conjugated with molecules capable to pilot these modified carriers to specific sites of living 
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organism. Such spheres have already been tested as vehicles for delivery of anti-inflammatory 
and anti-tumor drugs [8, 9].  
Besides the bioactivation of microparticles, researchers focused on immobilization of tracer 
molecules like fluorescent dyes on drug carriers.  Fluorescently labeled microparticles can be 
used to study the uptake of particulates by cells (in vitro or in vivo). Such fluorescent, 
degradable microparticles can be traced after varying time periods inside the tissue. For 
example Pinkerton et al. used fluorescent microspheres to study particle deposition in site-
specific regions of the lung with confocal laser scanning microscopy. They used a nebulizer to 
aerosolize microspheres followed by passage through a heated discharging column to reduce 
static charge and to remove water surrounding each microsphere. Precoating of microspheres 
with albumin helped to minimize displacement during vascular fixation of the lungs. Confocal 
laser microscopy facilitated visualization of microspheres throughout the bronchial tree, 
ducts, and alveoli of the lungs [10]. Fluorescently labeled microparticles can be used as model 
particles to trace their pathway after application. 
Besides the active targeting by immobilization of certain bioactive molecules, the use of PEG-
coatings to stealth the carrier in order to prevent natural occurring clearance mechanisms was 
reported. It has been pointed out that PEG coating of nanospheres provides protection against 
interaction with the blood (as example for body fluids in general) components, which induce 
removal of the foreign particles from the blood. It prolongs, therefore, their circulation in the 
blood stream. In consequence, thus coated spheres may function as circulation depots of the 
administered drugs [11, 12]. PEO chains provide a steric barrier, which hinders the adsorption 
of certain plasma proteins onto the surface of such particles. On the other hand, the PEG coat 
enhances adsorption of certain other plasma compounds. In consequence, the PEG-coated 
spheres are not recognized by macrophages as foreign bodies and are not attacked by them 
[13]. A simple one-step generation of such particles containing a high PEG ratio as well as 
PEG enriched at the particle surface may prove interesting for drug delivery.  
In this chapter, the influence of parameters on the structure formation by electrostatic 
processing, especially particle formation by electrospraying was investigated. We identified 
governing parameters, limits and opportunities of this method. Degradable, quasi-
monodisperse spherical particles of PLGA and PDLLA-block-PEG were generated. A 
strategy for immobilization of amino group containing molecules to these particles has been 
developed and as model a fluorescent molecule was immobilized to the particles. 
Fluorescently labeled PLGA and PDLLA-block-PEG particles were produced. Furthermore, 
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degradation behavior of small electrospun particles was compared to degradation of polymer 
foils. 
 
Experimental part 
Materials: 
Two commercially available poly(lactide-co-glycolide)s (PLGAs) having intrinsic viscosities 
of 0.18 dl/g (MW ~ 18,000-23,000 g/mol; trade name: Resomer RG 502 H) and 0.38 dl/g 
(MW ~28,000-35,000 g/mol; trade name: Resomer RG 503 H) with 51:49 (mol%:mol%) 
lactide:glycolide ratio as well as sorbitan trioleat (Span 85
®
) and lecithin were supplied by 
Boehringer Ingelheim Pharma GmbH & Co.KG (Ingelheim am Rhein, Germany) and used as 
received. HPLC grade tetrahydrofuran (THF), toluene, acetone, dichloromethane and 
acetonitrile as well as 4‘-fluoresceinamine, 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide 
hydrochloride, 3, 3-diethoxy-1-propanol, ethylene oxide and 3, 6-dimethyl-1, 4-dioxane-2, 5-
dione were obtained from Sigma-Aldrich (Taufkirchen, Germany). Tetrahydrofuran, 3, 3-
diethoxy-1-propanol (DEP), ethylene oxide, toluene, and methanol were purified by 
conventional distillations under a nitrogen atmosphere. 3, 6-dimethyl-1, 4-dioxane-2, 5-dione 
(D,L-lactide) was recrystallized twice from ethyl acetate under a nitrogen atmosphere and 
sublimated under vacuum at 110 °C. α-methoxy-ω-hydroxy-poly(ethylene glycol) (MW = 
10000 g/mol) was obtained from Iris BioTech (Germany). -acetal-ω-hydroxy-poly(ethylene 
glycol) was synthesized from 3, 3-diethoxypropanol, potassium napthalide and ethylene oxide 
inside an UniLab Glovebox (Braun, Germany). For a detailed description of the 
macroinitiator synthesis see Jule et al. Different poly(D,L-lactide)-block-poly(ethylene 
glycol) copolymers with molecular weights ranging from 30,000-70,000 g/mol (MW = 30,000 
g/mol, 35,000 g/mol, 49,000 g/mol and 70,000 g/mol) were synthesised using the above 
mentioned poly(ethylene glycol) macroinitiators (see Table 1). 
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Table 1: Different polymers synthesized and further used for electrospraying 
experiments 
 
The detailed synthesis of these block copolymers and their characterization is described 
elsewhere [14]. Briefly, reaction tubes were flame dried, and afterwards 100 mg catalyst were 
added to 1 g of the macroinitiator and various amounts of 3, 6-dimethyl-1, 4-dioxane-2, 5-
dione (D,L-lactide). The reaction tubes were evacuated for 2 h, closed and placed in a pre-
heated oil bath at 145 °C for 24 h, while the reaction mixture was stirred. The resulting PEG-
b-PDLLA was dissolved in DCM and then precipitated into a 50-fold excess of ice-cooled 
diethyl ether and vacuum dried. 
 
Analytical methods: 
The 
1
H-NMR and 
13
C-NMR spectra of polymer samples were established at 25 °C in CDCl3, 
containing TMS as internal standard, with an Inova 400 spectrometer (400 MHz, Varian 
Associates Nuclear Magnetic Resonance Instruments, Palo Alto, USA). GPC measurements 
were carried out at 35 °C using a high-pressure liquid chromatograpy pump (ERC HPLC 
64200) and a refractive index detector (ERC-7215a). The eluting solvent was THF (HPLC 
grade) with 250 mg/mL 2,6-di-tert-butyl-4-methylphenol and a flow rate of 1 mL/min. Five 
columns with MZ gel were applied. The length of the first column was 50 mm, 300 mm for 
the other four columns. The diameter of each column was 8 mm, the diameter of the gel 
particles 5 mm, and the nominal pore widths were 50, 50, 100, 1000 and 10000 Å, 
respectively. Calibration was achieved using poly(methyl methacrylate) (PMMA) standards. 
Viscosities of the polymer solutions were measured using an Ostwald-viscosimeter with an 
electrical pump and an electronic microchronometer controlled by a photoelectric relay. For 
measuring the acetone-solutions a capillary type 1A (Schott, Germany) and for measuring the 
dichloromethane-solutions a capillary type 0A (Schott, Germany) were used. Viscosities have 
been calculated according to the following equation: 
 = K (t - ) 
with  = kinematic viscosity, K = as capillary specific constant, t as processing time for the 
solution to pass the photoelectric barrier, and  = time specific correction factor. Surface 
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tensions were determined using a Wilhelmy-tensiometer (plate configuration) with a platinum 
standard sample. This standard sample with known surface energy was used to determine the 
surface energies of the solutions from the contact angles at the solid/liquid/gas interface. 
Surface energy was obtained from the measured forces with the dynamic Wilhelmy-method, 
which is a simple and reliable way to determine the contact angle hysteresis. Conductivity of 
the polymer solutions was determined with a conductometer (Metrohm 66 conductometer, 
Germany), a Teflon metering chamber and two silver electrodes. After filling the metering 
chamber with the liquid to be tested, conductivity is directly and continuously obtained. 
 
Electrostatic spraying as method for particle production: 
The basic set-up for electrostatic spraying (electrospraying, or electro-hydro-dynamic 
atomization (EHDA)) is equipped with a capillary connected to a high voltage power supply 
through which a liquid to be atomized is pumped. Two different experimental configurations 
were designed to study the effects of particle formation (see Figure 1A&B). 
 
Figure 1: Schematic illustration of the used electrospraying configurations. A.) is a 
simple set-up consisting of a nozzle through which a polymer solution is fed with 
applied high voltage and a grounded collector, B.) shows a configuration consisting of 
a spraying chamber, a nozzle (connected to the high voltage) through which the 
solution is pumped, and a needle as grounded target. An air stream is pumped through 
the chamber a cyclone-type particle collector. This air current transports the particles 
from the chamber to the collector and allows continuous collection without building 
up charges at the grounded target. 
 
Setup A.) is a simple, straight forward electrospraying setup consisting just of a nozzle to 
which a voltage is applied high voltage supply, a syringe pump to control the feed rate, and a 
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grounded aluminum target for particle collection. Setup B.) was designed with a glass 
chamber enclosing the nozzle, and a grounded needle, connected to a cyclone type particle 
collector (Respirable Dust Aluminum Cyclone, SKC Inc., USA) and a vacuum pump 
(Vakuumbrand, Germany). The vacuum pump provides an air current of 28 l/min through the 
glass chamber and transports the particles from the spraying nozzle to the collector. In both 
systems, a HA 11 plus (Harvard Apparatus, purchased from Hugo-Sachs Elektronik GmbH, 
March-Hugstetten, Germany) was used to pass polymer solutions through various nozzle 
types at slow, well controlled flow rates (0.02-1.5 ml/h). The polymers (PLGA Type 1 [MW ~ 
18,000-23,000 g/mol], PLGA Type 2 [MW ~ 28,000-35,000 g/mol], PDLLA20k-b-PEG10k 
[MW ~ 30,000 g/mol], PDLLA25k-b-PEG10k [MW ~ 35,000 g/mol], PDLLA39k-b-PEG10k 
[MW ~ 49,000 g/mol], PDLLA60k-b-PEG10k [MW ~ 70,000 g/mol]) were dissolved in 
acetone, dichloromethane, or acetonitrile. Concentrations ranging from 1to 10 wt% were used 
for the spraying experiments. Higher concentrations led in all cases to significant fiber 
formation. The amount of surfactants in this chapter was taken as the percentage of the 
solution weight. The high voltage (ranging from 10 kV to 35 kV) was applied to the nozzle by 
an Eltex KNH34 (purchased from Eltex Elektrostatic GmbH, Weil am Rhein, Germany) high 
voltage power supply. Particles were produced using various flow rates between 0.02 mL/h 
and 1.5 mL/h. Furthermore, setup A.) allowed to determine the optimum distance between 
nozzle and collector by alteration between 100 and 300 mm. The influence of the inner 
diameter of the nozzle on the obtained particles was by spraying from various flat-tipped 
(blunt) needles (18-30 ga). Additionally, the influence of different surfactant types and 
concentrations on particle formation was studied. At the tip of the nozzle, a liquid cone was 
formed and a thin jet was ejected from the apex of the cone. Single spray cone was achieved 
by adjusting the electric potential of the nozzle. The thin jet than broke up into monodisperse 
droplets. As the solvent evaporated from the surface of the liquid droplets, smaller solid 
particles were obtained. As only the solvent evaporates, the initial polymer mass in each 
droplet determines the final particle mass. 
 
Fluorescence labeling: 
To fluorescently label 0.05 mmol of the PLGA type polymers, 0.06 mmol 4‘-
fluoresceinamine and 0.07 mmol 1-ethyl-3-(3dimethylaminopropyl)-carbodiimide 
hydrochloride (EDC) in 30 mL acetonitrile were stirred for 2 h at room temperature. 
Afterwards the solvent was removed by distillation under reduced pressure at 30°C. The 
residue was dissolved in 15 mL dichloromethane and washed four times with 20 mL distilled 
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water. The solution was added slowly to 500 mL ether. The product was filtered and washed 
with ether and dried. Successful immobilization of the fluoresceinamine molecules was 
confirmed by fluorescence microscopy and 
1
H-NMR spectroscopy (see figure 2). 
 
Figure 2: Fluorescence labeling of the PLGA-type polymers. A.) 
1
H-NMR spectra of 
fluoresceineamine-labeled PLGA type polymer, B.) Fluorescence microscope image 
of pure PLGA, and C.) Fluorescence image of FITC-labeled polymer. The strong 
fluorescence indicates the immobilized FITC. 
 
For immobilization of fluoresceinamine to the PDLLA-block-PEG copolymers, the α-acetal 
group has to be converted into an aldehyde group before the fluoresceinamine is coupled. The 
-acetal-group was deprotected by dissolving 500 mg polymer in 10 mL acetonitrile, 1 mL 
distilled water was added and pH 2 was adjusted by adding 400 µL glacial acid. The solution 
stirred at 30°C for 5 h, then brought back to pH 5 with a 0.1 M NaOH solution in a drop-wise 
manner. The deprotection of the acetal-group was confirmed by 
1
H-NMR. One mole 
equivalent 4‘-fluoresceinamine was added and stirred over night at room temperature. Sodium 
cyanoborohydride (NaBH3CN) was added in order to reduce the Schiff base and stirred. The 
mixture was freeze dried, dissolved in dichloromethane, filtered and recrystallized with an 
excess diethyl ether. The product was vacuum-dried and used for electrospinning. 
Deprotection of the α-acetal group as well as later the disappearing of the aldehyde and the 
formation of the product was confirmed by 
1
H-NMR-spectroscopy. Additionally the 
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fluorescence resulting from the immobilized 4‘-fluoresceineamine was confirmed by 
fluorescence microscopy using a GFP-filter (see Figure 3). 
 
Figure 3: Fluorescence-labeled PDLLA-block-PEG block copolymers. A.) 
1
H-NMR-
spectra of PDLLA-block-PEG after conversion of the -acetal into an aldehyde. B.) 
1
H-NMR-spectra of PDLLA-block-PEG-FITC. C&D.) Fluorescence microscope 
images of pure PDLLA-block-PEG and PDLLA-block-PEG-FITC. E.) Coupling of 
fluoresceinamine to PDLLA-block-PEG-aldehyde. 
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Polymer degradation and particle degradation: 
Degradation (mass loss and molecular weight changes) of electrosprayed PLGA particles and 
melt-pressed foils was investigated at physiological conditions (PBS-buffer, pH 7.4 at 37°C) 
over a period of two weeks. Samples of 10 mg particles or foils were incubated with 1.5 mL 
PBS-buffer over the desired time period. The samples were kept in 1.5 mL Eppendorf-tubes 
on a Heidolph Polymax 1040 incubator (Germany) at 37°C and a rotation speed of 150s
-1
. The 
pH was checked every second day and in the case of alterations of more than 0.2 the buffer 
was exchanged. Samples were taken after 0, 1, 3, 7, and 14 days. The samples were 
centrifuged at 10000 rpm for 5 min, the PBS buffer carefully removed and the remaining 
samples incubated 3 times for 20 min with distilled water. After a second centrifugation the 
distilled water was removed and the samples were freeze-dried for 24 h. An average mass loss 
of three samples for each time point was determined. The resulting molecular weights (Mw, 
Mn) and Mw/Mn (PMI) were determined by gel permeation chromatography (GPC). 
Additionally morphological changes were observed by scanning electron microscopy. 
For melt-pressing of the foils, 2 g of the polymer were positioned between two Teflon sheets 
on the apparatuses for melt-pressing. A temperature of 10°C more than the melting point of 
the polymer was adjusted at the two heating plates. The plates were closed, and pressed with a 
pressure of 2 tons for 1 min. The pressure was released the foil was cooled to room 
temperature before the foil was cut into samples of the desired weight. 
 
Scanning electron microscopy and optical microscopy: 
To investigate their morphology, the particles were characterized by scanning electron 
microscopy (SEM) and optical microscopy. For high-resolution images, the electrosprayed 
particles were deposited onto scanning electron microscopy (SEM) stubs. The electrosprayed 
material on the aluminum SEM stubs were gold-coated (Sputter Coater S 150 B, Edwards, 
Germany) and imaged with a Cambridge S360 (Leica, Germany). All samples were imaged 
with an S-4800 Ultra High Resultion Scanning Electron Microscope (Hitachi, Germany) or a 
Stereo Scan 360 Cambridge Scanning Electron Mikroscope (Carl-Zeiss-NTS GmbH, 
Germany) using an accelerating voltage of 2-15 kV, and a working distance of 10-15 mm. 
Samples for optical microscopy were collected on glass object slides. Microscope images 
were taken with a MRc5 camera, an Axioplan2 and a N XBO 75 lamp (Zeiss, Oberkochen, 
Germany) microscope. In order to observe particle fluorescence, a GFP-filter (Filter 6/ Zeiss, 
Germany) was used for all fluorescence. Exposure times of the fluorescence images are 
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quoted in the pictures. The electrospun polymers are indicated on each picture and a scale bar 
indicates the magnification of each image. Representative images are presented. 
 
Results and Discussion 
Fundamentally, electrospraying and electrospinning are identically processes with an obvious 
difference – electrospraying generates droplets/particles whereas electrospinning results in 
fibers. Based on empirical evidence the many parameters affecting and controlling the 
structure formation during electrostatic processing are known to be: choice of the solvent, 
choice of the polymer, solution concentration, polymer molecular weight, solution viscosity, 
solution conductivity, surface tension, applied voltage, distance between nozzle and target, 
electric field, feed rate (or flow rate), temperature, humidity, and solvent volatility, as well as 
nozzle diameter. 
However, not all not all the variables mentioned above are fundamental control parameters 
nor are they independent of each other. For example solution viscosity is a function of the 
solvent, the molecular weight of a polymer, and the concentration (among other factors like 
temperature). In addition, applied voltage, nozzle to target distance, electric field, and feed 
rate are interrelated. Therefore we group the first set of parameter as solution parameter and 
the latter ones as process parameters. Whereas apparatus specific parameter (like nozzle 
diameter) and independent parameter are discussed separately.  
Generally, by electrostatic processing a variety of distinctly different morphologies and 
structures can be obtained depending on the solution parameters. Five different structures and 
morphologies can be achieved by choosing the appropriate concentration range. Experimental 
observations in electrospinning/electrospraying confirm that for fiber formation to occur, a 
minimum polymer concentration in a certain solvent or solvent mixture is required. Below 
this critical value, application of voltage results in electrospraying or bead formation primarily 
due to Rayleigh instability. At these low concentrations, an insufficient deformable entangled 
network of polymer chains exists. As the solution concentration is increased, a mixture of 
beads and fibers is obtained. Further increase in concentration results in the formation of 
continuous fibers, and although it is not typically reported, at even higher concentrations 
uniform fibers are no longer obtained due to the high solution viscosity. The formation of 
chain entanglements has been acknowledged as primary effect in this progression [15]. In 
order to optimize the electrostatic processing for particle production we investigated the 
influence of solution parameters, process parameters and certain independent or configuration 
specific parameters.  
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Solution parameters 
One of the most effective means of defining a particular electrosprayed/spun structure is 
through control of the fluid properties. Multiple factors concerning the fluid composition are 
important including the dissolved polymer and its molecular weight, the polymer 
concentration, and especially the solvent. 
 
Concentration 
Various concentrations of PLGA type 1 and PLGA type 2 in both solvents (acetone or 
dichloromethane) were sprayed to illustrate the effect of polymer solution concentration, the 
molecular weight of the dissolved polymer as well as the used solvent (see Figure 4A). 
 
Figure 4: Particle sizes of particles electrosprayed with different polymer 
concentrations, respectively molecular weights, from acetone and dichloromethane 
(DCM). A.) shows the linear dependence of particle size and solution concentration 
ranging from 1 to 9 wt%. For one certain polymer and solvent, the polymer 
concentration in the sprayed droplet determines the resulting particle diameter. The 
rate of increase depends on the molecular weight of the dissolved polymer. Bigger 
particles show larger size deviations. B.) scanning electron microscope images of 
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electrosprayed PLGA type 2 particles sprayed from acetone solutions containing 1 - 9 
wt% polymer. 
 
By increasing the concentration from 1wt% to 9 wt% particle diameter increased 
significantly. Within this concentration range the particle diameter (of a given polymer and a 
given solvent) increased linear with the solution concentration. In this concentration range 
polymer chain overlap is minimal and allows to electrospray the solutions. The initiated jet 
beaks-up under the influence of the surface tension. Further increasing the solution 
concentration resulted in beads interconnected by fibers (10 wt%- 20 wt%), and continuous 
fibers (above 20wt%). In these two regimes, chain entanglements are present to fully stabilize 
the jet and prevent its breaking-up. Electrospraying solution concentrations below 10 wt% 
allowed the production and collection of particles. Lower concentrations resulted in fewer 
entanglements and smaller particles (see Figure 4B). According to Festag et al., chain 
entanglements within a drop limit the subdivision of the drops. As the solvent evaporates 
polymer concentration increases and entanglements commence which stabilize the droplet 
from further subdivision (even if at the same time the surface charge increases) [16]. 
However, since chain disentanglement in strong elongational flow field is occurring under the 
influence of the applied voltage it is still uncertain how many entanglements exactly prevent 
the breaking-up of the jet. Polymer solution concentration can be used to enhance control over 
jet break-up during spraying. It is well known that for a given molecular weight, the 
entanglement density increases with concentration. Chain entanglements are one of many 
parameters that can influence structure formation during electrostatic processing of a polymer 
solution.  
 
Polymer 
Alternatively, the same result is achieved at a fixed homopolymer concentration by increasing 
the molecular weight. Molecular weights MW and composition of the investigated polymers 
are shown in table 1. Two poly(lactide-co-glycolide) polymers and two poly(D,L-lactide)-
block-poly(ethylene glycol) copolymers with different molecular weights were used for the 
electrospraying experiments. Increasing the molecular weight of the electrosprayed PLGA 
from 23.000 g/mol to 35.000 g/mol resulted to an increase of the particle diameter of up to 75 
% (from 3.2 µm to 5.5 µm in the case of DCM, and from 0.8 µm to 1.5 µm in the case of 
acetone, both sprayed from 9 wt% polymer solutions). The Size of particles electrosprayed 
from solutions of a given polymer concentration in one solvent is depend on the molecular 
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weight. Therefore, those polymers with the higher molecular weight (PLGA type 2) always 
resulted in larger particles if all other parameters were kept constant (see Figure 4A). SEM-
images of electrosprayed particles from different polymers are shown in Figure 5. 
 
Figure 5: SEM-images of electrosprayed PLGA and PDLLA-block-PEG particles. A.) 
PLGA type 1 (MW ~ 20,000 g/mol), B.) PLGA type 2 (MW ~ 30,000 g/mol), C.) 
PDLLA39k-b-PEG10k (MW ~ 50,000 g/mol) PDLLA60k-b-PEG10k (MW ~ 70,000 
g/mol). 
 
Different particle sizes, shapes and morphologies were observed by changing the sprayed 
polymer. In the case of PLGA, those particles with the higher molecular weight resulted in 
bigger particles. In the case of PDLLA-block-PEG copolymers, changing the molecular 
weight from 50,000 g/mol to 70,000 g/mol changed the generated morphology from 
aggregated particles to dry particles. As only the length of the PDDLA segment was 
increased, the Tg of the used polymer increased as well. Due to the higher Tg and the higher 
molecular weight, more defined structures were obtained. For copolymers the situation may in 
some cases become more complex as the Tg values and the hydrodynamic radius of the 
macromolecule depend on its design and the length and nature of the different segments. In 
this case the overall molecular weight will only be a first approximation. Besides this 
observation, both Gupta et al. and Jun et al. have investigated the effect of molecular weight 
on fiber formation during electrospinning at a given concentration [17, 18]. They found that 
increased chain entanglements and longer relaxation times, as a consequence of increased 
- Chapter 10 - 
  214 
molecular weight, were responsible for increased fiber formation and increased fiber 
diameter.  
 
Solvent 
Another component influencing the solution parameters is the solvent itself. For a given 
polymer, solvents can be classified either as good or poor solvents. A good solvent causes the 
polymer chains to expand and reduces the overall Gibbs free energy. While a polymer 
dissolved in a good solvent will expand, the same polymer will collapse in a poor solvent at 
the same temperature. However, if the polymer is in expanded or in a collapsed state 
determines the hydrodynamic radius of the macromolecule and will therefore determine if the 
polymer chains can entangle. Similarly, as the solvent quality decreases, effects of polymer-
polymer interactions on solution viscosity become increasingly important and must be taken 
into account [19]. Therefore, choice of the solvent was expected to have an influence on the 
obtained structures. Besides the solubility of a given polymer in a certain solvent, physical 
properties like surface tension, conductivity, dielectric constant and the vapor pressure will 
influence the electrospray process. We electrosprayed solutions of PLGA dissolved in 
acetonitrile, acetone and dichloromethane with keeping all other parameters constant. Figure 6 
shows SEM-images of the obtained particles and their morphologies. 
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Figure 6: SEM-images of electrosprayed PLGA type 1 particles electrosprayed from 
A.) acetone, B.) acetonitrile, and C.) dichloromethane showing their different sizes and 
morphologies. 
 
While those particles sprayed from acetonitrile and acetone solutions were generally smaller 
and showed porous surfaces, particles generated from dichloromethane were larger and 
showed smooth surfaces. Additionally, those samples sprayed from acetonitrile showed the 
largest particle diameter deviations, whereas both samples generated from acetone and 
dichloromethane were homogeneous (quasi-monodisperse). However, while spraying under 
the same conditions, variation of the solvent type produced a variety of distinctly different 
particle morphologies (see Figure 6). Besides the polymer solubility, this should be 
comparable for all three solvents, additional solvent properties result in these differences. 
Even though, solvent properties are not an exact representation of the polymer solution 
properties, solvent is typically more than 90 % of the polymer solution. Taking this into 
account, solution properties can be assumed to be closely related to these pure solvent 
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properties at least for comparison purposes. Table 2 shows physical properties of acetonitrile, 
acetone and dichloromethane. 
 
Table 2: Physical solvent properties 
 
Some solvent properties like e.g. dielectric constant, solvent vapor pressure, the surface 
tension, and conductivity determine the properties of the electrosprayed solution and directly 
influence the resulting particles. The two main parameters influencing the particle size and 
morphology of a spray, out of this parameter set, are the dielectric constant and the vapor 
pressure of a polymer solution. The dielectric constant of the polymer solution characterizes 
how much charge a non-ionized solution will hold and how fine a spray will be. The bending 
instability of the jet increases with the dielectric constant of the used solvent, leading to an 
increased deposition area and smaller structures. The dielectric constant of an uncharged 
polymer in solution is mainly determined by the dielectric constant of the solvent used. 
Therefore, acetonitrile (dielectric constant: 37.5) and acetone (dielectric constant: 20.7) result 
in much finer sprays compared to dichloromethane with a dielectric constant of 8.93. This 
result is in good agreement with the experimental observations. Additionally, taking the vapor 
pressure of the used solvents into account may explain the observed differences in the 
morphology of the particle surfaces. Acetonitrile, with a vapor pressure value of 11.9 kPa, is a 
solvent which evaporates much slower than acetone with a vapor pressure of 24.6 kPa and 
dichloromethane with 46.6 kPa. Therefore solvent evaporation should be the fastest for those 
sprays generated from dichloromethane solutions. Solvents having high vapor pressure are 
more likely to produce distinct structures since the spray typically solidifies during the flight 
resulting in hollow and solid particles. Low vapor pressure solvents are better for forming 
melted or continuous structures as they still contain residual solvent upon reaching the 
deposition surface (collector). As Evaporation of a solvent usually occurs at the surface of a 
droplet, fast evaporation leads to the formation of a solid polymer skin and later on in big 
hollow particles. In this case the hollow shells can collapse, resulting in cornflake or donut 
shaped particles. Slower evaporation of a solvent leads to much smaller particles and irregular 
surface morphologies. The distance from nozzle to collector can be adjusted to increase or 
decrease drying time. 
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The viscosities of all three pure solvents range from 0.36 to 0.44 X10
-3
 Pa*s. Therefore, 
differences in the solution viscosities can not be attributed to the pure solvents, but to the 
concentration and molecular weight of the dissolved polymer and the solvent. Increasing both, 
the molecular weight and the concentration, results in a corresponding increase in solution 
viscosity. The ability of a polymer jet to break-up into droplet is a function of solution 
viscosity, and therefore depends on these parameters and the chosen solvent. The dependence 
of viscosity and particle diameter for both PLGA type polymers and both solvents (acetone 
and dichloromethane) are shown in Figure 7A. 
 
Figure 7: Influences of solvent properties on generated particle sizes. A.) Viscosity 
vs. Particle size, B.) surface tension vs. particle size, and C.) solution conductivity vs. 
particle size. 
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As expected, from the dependence between particle size and polymer concentration, a linear 
dependence between solution viscosity and particle size for given polymers and given 
solvents was observed. 
Figure 7B illustrates the influence of surface tension on particle size. With increasing surface 
tension, particles become smaller. As the jet travels towards the collector, the surface tension 
causes the formation of beads along the jet and finally in break-up into droplets. Surface 
tension has the effect of decreasing the surface area per unit mass of a fluid. In this case, when 
there is a high concentration of free solvent molecules, there is a greater tendency for the 
solvent molecules to congregate and adopt a spherical shape due to surface tension. Therefore, 
higher surface tension usually results in smaller droplet sizes and particles. A higher viscosity 
means that there is gerater interaction between the solvent and polymer molecules thus when 
the solution is stretched, the solvent molecules will tend to spread over the entangled polymer 
molecules thus reducing their tendency to come together under the influence of surface 
tension [20]. 
Figure 7C illustrates the alterations of the average particle sizes with increasing solution 
conductivity. Stretching of the liquid jet is mainly caused by repulsion of the charges at its 
surface. Thus, if the conductivity of the solution is increased, more charges can be carried by 
the liquid. Therefore, particle size decreases with increasing conductivity (see Figure 7C). 
At this point it has to be stated that the solution parameter have the biggest influence on the 
resulting structures and morphologies. However, for one particular system (a certain polymer, 
one solvent and a given concentration) particle size and the particle size distribution can be 
further controlled by adjusting the process parameter (voltage, feed rate and distance). 
 
Process Parameters 
Applied voltage 
Increasing the current (I) carried by the polymer solution will decrease jet diameter. By 
increasing the applied voltage, the current was effectively controlled since V is proportional to 
I, holding other variables constant. According to the Fowler-Nordheim equation, the 
relationship between I and V follows
V
B
VAI exp2 , where A and B are constants that 
depend on the geometry and material of the charge injection electrode (their value depends on 
the specific design of the apparatus). Therefore, increasing applied voltage produces finer 
spray as already indicated by Rayleigh‘s equation (equation 1). Figure 8A shows the 
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dependence between the applied voltage and the average particle diameter for the two PLGA 
type polymers and both solvents (acetone and dichloromethane). 
 
Figure 8: Graphs showing the influences of the process parameters. A.) Dependence 
of particle size and applied voltage [at constant flow rate and distance], B.) particle 
size and flow rate [at constant voltage and distance], as well as C.) particle size and 
nozzle to target distance [at constant voltage and flow rate]. 
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Above a certain critical voltage the spraying process is initiated. At low voltages, smooth 
surfaces could be produced (data not shown) since the emerging jet formed large drops that 
still contained solvent upon deposition. Increasing the applied voltage resulted in the 
formation of increasingly rough and porous structures. At approximately 15 kV, the applied 
voltage is sufficient to initiate jet formation and the subsequent break-up of this jet into 
droplets, followed by evaporation of the solvent on their way to the target, where the resulting 
particles are collected. Higher voltages resulted in a decreased average particle diameter. 
Increasing the applied voltage from 15 to 35 kV resulted in reduction of the particle size from 
4 µm to 600 nm. 
 
Feed rate  
The effect of changing polymer solution feed rate was not as pronounced and clear as the 
effect of the other previously mentioned variables. According to Rayleigh‘s equation 
(equation 1) we expect that an increase in feed rate causes an increase in jet radius, the 
opposite effect of increased current. We investigated the influence of increased feed rate using 
an 20 ga blunt tip needle, an applied voltage of 20 kV and a needle to collector distance of 20 
cm. Figure 8B shows the dependence of particle size and solution feed rate for the two PLGA 
type polymers and both solvents (acetone and dichloromethane). As the flow rate increased 
from 0.02 mL/h to 0.45 mL/h, there was an increase in the average particle size as predicted 
by Rayleigh‘s equation. Larger flow rates often produced very large drops resulting in very 
non-homogeneous samples. At the same time, feed rates that were to slow resulted in sprays 
producing a non-homogeneous surface. According to A. I. Gregor‘ev et al [21] a certain 
combination of the parameters voltage and feed rate should result in samples consisting of 
monodisperse particles. Depending on the values of the feed rate at a certain applied voltage, 
the emitted droplets are stable with regard to both their own charge and the external electric 
field of the spraying configuration. In Figure 8A&B the most homogeneous samples are 
indicated by the smallest standard deviation, indicating that the variability of the particle 
diameters was minimal. For each electrospraying system (polymer dissolved in a solvent to 
make a certain concentration) monodispersity, and a most homogeneous sample, was obtained 
at a specific combination of the two parameters voltage and feed rate as described by 
Gregor‘ev et al. Therefore, optimization of the feed rate according to the other working 
parameters allows producing the most homogeneous surface structure.  
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Distance 
In order to determine the influence of the distance between nozzle and collector (in this case 
the collector is the target) at constant feed rate and constant applied voltage, the particles were 
produced using distances ranging from 100 to 300 mm (see Figure 8 C). If the distance is to 
short, the flight time of the particles on their way to the collector is too short to fully 
evaporate the solvent and particles agglomerate resulting in porous structure. Distances larger 
than 15 cm resulted in the collection of dry particles. Further increasing the distance within 
the investigated range resulted only in small variations which are not significant and can be 
neglected. 
 
Apparatus specific parameters and independent parameter 
 
Internal needle diameter 
The internal diameter of the needle has a certain effect on the electrostatic processing. In 
order to evaluate the influence of the nozzle size on the resulting particle size and particle size 
distribution we used stainless steel blunt needles with inner diameters between 20 ga and 30 
ga. Figure 9A shows the influence of the needle diameter on the diameter of the resulting 
particles. 
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Figure 9: Graphs illustrating the influence of A.) the inner nozzle diameter on the 
diameter of the produced particles and B.) changes in particle diameter during 
continuous spraying over a period of 120 min. 
 
No significant difference in particle size was found when using needle diameters between 20 
ga and 30 ga. Just a slight decrease of the average particle diameter with decreasing inner 
needle diameter may indicate a trend. Comparing this slight decrease with the standard 
deviation of the particle diameter makes conclusions difficult and trends uncertain. The 
geometry and the material of the electrode/needle influences the current introduced to the 
polymer solution to be sprayed, as reflected by the apparatus specific constants A and B in 
equation 2. According to Ramakrishna et al. a decrease in the internal diameter of an orifice 
was also found to cause a reduction in the diameter of electrospun fibers. When the size of the 
droplet at the tip of the orifice is decreased, such as in the case of a smaller inner diameter of 
the needle, the surface tension of the droplet increases. For the same voltage supplied, a 
greater columbic force is required to cause jet initiation. As a result, the acceleration of the jet 
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increases and flight times before collection decreases. However, if the diameter of the needle 
is too small, it may not be possible to extrude a droplet [20]. 
 
Spraying time 
For larger amounts of particles, continuous spraying over certain time periods may be 
necessary. Therefore, electrosprayed particle samples were collected at certain time points 
over a period of 120 min and analyzed by scanning electron microscopy. Figure 9 B shows 
the particle diameter in dependence of the collection time. As the particle size does not 
change with time particles can be produced in a continuously. By changing from 
electrospraying configuration shown in Figure 1A to the configuration shown in Figure 1B 
particles can be collected over longer time periods (up to several days). While the simple 
device allows changing the parameters like distance, voltage and feed rate very easy, particles 
can not be collected continuously. As the charged particles deposit on the target, charges may 
accumulate and change the electric field over time. Additionally, the flight time of the 
particles and therefore the time for the solvent to evaporate are directly given by the nozzle to 
target distance. The second device allows continuous collection of particles without 
accumulation of charges at the target. One major advantage of this configuration is that flight 
time of the particles and nozzle to target distance are independent. While the particles are 
carried from the spraying chamber to a cyclone by an air current provided with a vacuum 
pump. In this case the target, a needle with a small surface, is separated from the collector, 
which is a cyclone type particle collector. The second configuration allowed collection of 
larger particle amounts. Particle size and size distribution did not vary over this time frame 
and reproducible results were obtained with both apparatuses. 
 
 
Addition of surfactants to the spraying solution 
 
If a drug is not soluble in the same solvent as the biodegradable polymer, these drugs can only 
be encapsulated by electrospraying or electrospinning using a coaxial configuration or by 
processing emulsions and dispersions. Dispersions and emulsions are usually stabilized with 
small amounts of surfactants. Surfactants and stabilization agents like sorbitan trioleant (Span 
85) or lecithin are surface active molecules. In order to study the effect of different surfactants 
on particle formation by electrospraying various amounts of Span 85 and lecithin were added 
to the polymer solutions and electrosprayed. Figure 10 A shows SEM-images of 
- Chapter 10 - 
  224 
electrosprayed PLGA type 1 particles, particles generated with PLGA type 1 solutions 
containing 0.15 wt% Lecithin, and particles generated with PLGA type 1 solutions containing 
0.15 wt% Span 85. 
 
 
Figure 10: Influence of the two surfactants Span 85 and lecithin on particle formation. 
A.) SEM-images of pure PLGA type 1 particles and those sprayed from solutions 
containing 0.15 wt % Span 85 or Lecithin. B.) Influence of lecithin concentrations (0 
to 0.15 wt%) on the diameter of the sprayed particles. C.) Influence of Span 85 
concentration on the resulting particle diameter. 
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Both surfactants do not alter the particle size and surface morphologies significantly. Figure 
10 B shows the influence of various amounts surfactant on the resulting particle sizes. 
Addition of lecithin did not lead to significant changes of the particle diameter. Similar to 
these observations, Figure 10 B illustrates the influence of various Span 85 amounts on the 
resulting particle diameters. Likewise by adding Span 85 into the solution no effect on the 
diameter or surface morphology of these electrosprayed particles was observed. 
 
Fluorescently labeled particles 
In order to show the possibility to immobilize active molecules to the electrosprayed particles 
we coupled fluoresceinamine to both polymers. Therefore, we generated electrosprayed 
fluorescently labeled particles by electrospraying those polymers with covalently coupled 
fluoresceinamine. SEM-images and fluorescence microscope images of pure PLGA-type 1 
particles and fluorescently labeled particles are shown in Figure 11. 
 
Figure 11: SEM-images of A.) electrosprayed PLGA type 1 particles and C.) FITC 
labeled PLGA type 1 particles. B.) Fluorescence microscope images of PLGA 
particles, and D.) FITC labeled PLGA type 1 particles using a GFP-filter. Exposure 
times: 500 ms, magnification: 50X. 
 
The SEM-images reveal that no difference in particle size or surface morphology is induced 
by the modified polymers. The fluorescence microscope image of the fluoresceinamine 
modified PLGA particles show typical green fluorescence and might prove useful to track 
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particles after application. As the fluorescence dye is immobilized to the polymer covalently, 
degradation and cleavage of the polymer macromolecule is necessary to release the 
compound. 
 
 
Particle degradation at physiological conditions and comparison to melt-pressed foils 
Biodegradable polymers find widespread use in drug delivery as they can be degraded to non-
toxic monomers inside the body. Depending on the application and the administration route 
the degradation rate has to be adjusted in order to avoid accumulation. In order to evaluate if 
degradation of small electrosprayed particles would differ from degradation of macroscopic 
foils, samples were incubated over 14 days under physiological conditions and analyzed by 
scanning electron microscopy and gel permeation chromatography. Figure 12A&B show the 
observed molecular weight changes. 
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Figure 12: Degradation of electrosprayed PLGA type 1 particles in comparisons to 
melt pressed foils. A.) MW changes and B.) Mn changes over a degradation period of 
14 days. C.) SEM-images showing the morphological changes of electrosprayed 
particles and melt pressed foils before degradation (t=0 days), after 3 days, and after 
14 days.  
 
As the melt-pressed foils were heated to 70°C and pressed with a pressure of 2 bar, a slight 
degradation was observed resulting in lower molecular weights than the electrosprayed 
particles. Both degradation curves run parallel. Therefore, melt-pressed foils can be taken as 
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first model for the degradation of electrosprayed particles. After 14 days degradation resulted 
in molecular weights below 10,000 g/mol, corresponding to complete resorption as PLGA-
fragments around 3,000 g/mol become soluble. Figure 12 C shows SEM-images illustrating 
the morphological changes of the investigated samples. The morphology of the electrosprayed 
particles changes after incubation. Isolated individual particles agglomerate within 3 days and 
after 14 days only a polymer film remains. A complete loss of the original shape and 
morphology was observed. Similar observations were obtained from the foil samples as after 
14 days the sample shape disappeared and a gel residue remained. 
 
Conclusion 
In conclusion, using an electrospraying technique, we successfully prepared quasi-
monodisperse and size controllable microparticles. This technique proved suitable for 
production of biodegradable PLGA and PDLLA-block-PEG particles. Several parameters 
influencing the electrospraying process and determining the resulting structures were 
identified. Carefully orchestrating these parameters allowed precise control of particle size 
and surface morphology. Narrow size distributions were obtained in a reproducible and 
simple manner. Modification of the polymer particles with active molecules was shown by 
covalently attaching a fluorescence dye. As a result, quasi-monodisperse biodegradable 
polymer particles showing green fluorescence were generated. In addition, due to the ability 
to generate homogeneous sprays of controlled particle sizes in the inhalable size range and the 
easy immobilization of active molecules, the electrospinning may prove potentially useful for 
pulmonary drug delivery as well as to validate deposition after particle application. 
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Chapter 11: Encapsulation of lipophilic and hydrophilic model-drugs in 
monodisperse micro- and nanoparticles by electrostatic spraying as drug 
reservoir 
 
Abstract 
Electrosprayed microparticles are potential candidates for pulmonary drug delivery. In this 
chapter, we prepared polymer-coated drug crystals and drug-loaded degradable microspheres 
in the inhalable size range by electrospraying. Commonly used anti-asthmatics such as 
fenoterol hydrobromide, salbutamol sulphate, salbutamol free base and budesonide were used 
as model drugs to investigate three different encapsulation approaches. Firstly, dispersions of 
drug crystals in polymer solutions were electrosprayed to form particles. These particles 
proved to have a core-shell structure typical for coated drug crystals. Secondly, solutions 
containing the dissolved drug and polymer were electrosprayed to form matrix-type particles. 
A variation of the latter was electrospraying of emulsions of the drug dissolved in one solvent 
and the polymer dissolved in a second immiscible solvent. All approaches led to particles with 
diameters between 0.5 and 5 µm. Morphology, surface structure drug loading, and release 
behavior was strongly influenced by the composition of the liquid precursor, while particle 
size and size distribution were controlled by optimization of the electrospraying parameters. 
Dependent on the encapsulation approach totally different release behaviors were achieved. 
While polymer-coating led to a very fast release and minor retardation, matrix-type particles 
showed retardation over several hours and controlled release. Moderate burst releases (release 
in the first 30 min) seem promising in order to achieve formulations suitable to reduce the 
delivery frequency. Salbutamol free base, fenoterol hydrobromide, and budesonide loaded 
microparticles were produced by electrospinning. The lipophilic budesonide showed much 
lower burst releases independent of the used polymers. Salbutamol free base and budesonide 
was released from the particles under physiological conditions for more than 12 h. 
Electrospraying of emulsions led to particle showing various morphologies and surface 
structures. Mixtures of different resorbable polymers in various ratios were tested. Wrinkled 
particles, as well as particles with smooth surfaces were obtained. Morphology and release 
behavior was controlled by variation of the polymer composition. Particle formulations with 
various release behaviors, morphologies and surface structures can be produced by 
electrospraying these different liquid precursors. The particle properties can be tailored for the 
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treatment. Therefore electrospraying seems a promising and simple technique for 
encapsulation of various drugs as well as microparticle formation. Due to their size and the 
quasi-monodispersity of the samples these formulation seem suitable for pulmonary delivery 
by inhalation. 
 
Introduction 
Inhalation therapy is predominantly used for medical treatment of the airways with gases, 
liquid droplets or powders. If the demanded drug can not be delivered as gas, most common 
inhalers are used in order to disperse the powder or liquid as fine particles in a gas. The low 
efficiency of conventional inhalation equipment is related to the less optimal size distribution 
of the particles released, although recently developed inhalers can show improved 
distributions [1, 2]. Research has shown that in adults, monodisperse 2.8 µm bronchodilator 
particles were optimal in terms of efficiency [3, 4]. These experiments point to the fact that 
the range of optimal aerosol particles sizes might be much smaller 2-3.5 µm than currently 
assumed 1-5 µm. It was also shown that administration of these monodisperse aerosols 
opened the way to reduce the dose emitted from metered or dry powder inhalers by 80% 
without losing any clinical effect [5]. Large particles are less efficacious; therefore, they may 
be eradicated from the emitted dose without reducing the therapeutic effect. Smaller particles 
are exhaled directly or deposited in the alveoli, where they are not effective due to the lack of 
smooth muscle. They are most probably rapidly adsorbed into the systemic circulation and 
might be responsible for fast-emerging side effects such hypokaliema [6]. As a result of these 
findings, an interest in producing monodisperse aerosols has emerged as a means to improve 
therapeutic quality [7]. In order to decrease the numbers of inhalation times for the comfort of 
the patient formulations with retarded drug release seem promising. To achieve retarded 
release, the drug has to be encapsulated in a degradable and resorbable material. Several 
bioresorbable polymers with suitable degradation kinetics as well as non-toxic degradation 
products are based on polyesters or polyester-b-polyether copolymers. In order to avoid 
accumulation of polymers in the lungs and subsequent inflammations, the polymeric material 
has to be fully degraded within the release time or to be removed by the two possible 
clearance mechanisms. If the material is deposited in the bronchi, it is removed by mucucilliar 
clearance. The mucus is transported upwards by the beating cilia out of the lungs. If the 
particles reach the alveoli, they are removed by activated lung macrophages. Several different 
drugs with completely different physical properties as well as different action mechanisms are 
commonly used in inhalation therapy for pulmonary delivery in the treatment of various 
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diseases.  Asthma is the most well known disease directly treated by inhalation. The following 
three drugs with different physical properties and action mechanisms are all used in the 
treatment of asthma. Fenoterol hydrobromide is bromine containing hydrophilic form of 
fenoterol commonly used to evoke bronchodilatation in asthmatic patients. Fenoterol ((RS)-1-
(3,5-Dihydroxyphenyl)- 2-[(RS)-2-(4-hydroxyphenyl)- 1-methylethylamino]ethanol; MW: 
303.35 g/mol) is an asthma medication designed to open up the airways to the lungs. It is 
classed as a beta agonist. Salbutamol sulphate (4-[2-(tert-butylamino)-1-hydroxyethyl]-2-
(hydroxymethyl)phenol; MW: 239.311 g/mol) is a short-acting β2-adrenergic receptor agonist 
used for the relief of bronchospasm in conditions such as asthma and chronic obstructive 
pulmonary disease. It is usually delivered by the inhalation for direct effect on bronchial 
smooth muscle. In this form of delivery, the maximal effect of salbutamol can take place 
within five to twenty minutes of dosing, though some relief is immediately seen. Salbutamol 
can also be given orally, as an inhalant or intravenously. Budesonide (16,17-
(butylidenebis(oxy))-11,21-dihydroxy-, (11-β,16-α)-pregna-1,4-diene-3,20-dione; MW: 
430.534 g/mol) is a glucocorticoid steroid commonly used for the treatment of asthma, non-
infectious rhinitis (including hay fever and other allergies), and for treatment and prevention 
of nasal polyposis. Additionally, it is used for inflammatory bowel disease. The drug is a 
lipophilic water insoluble molecule. Polymeric drug delivery systems can be classified 
according to their composition (reservoir or matrix system) or by release mechanisms 
(diffusion, degradation or interactions with the solvent). In the case of a matrix- or reservoir-
type system, the time of release is controlled by diffusion through the polymeric matrix. For 
degradation controlled systems the drug release by polymer degradation is predominant. The 
release by degradation in these cases is an order of magnitude higher than release by 
diffusion, which almost can be neglected. The smaller particle sizes get, the smaller the 
diffusion distance gets, the faster the drug is release and the more effects like charge 
interactions become important for incorporation of a certain substance in order to achieve 
sustained release. Among the different techniques for encapsulation of drug in a polymeric 
matrix, electrospraying is one of the lesser known. Particle sizes, size distribution, 
morphology, surface structure, drug loading and release behavior can be controlled. The used 
solvent is one of the key parameters which influences the formation and size of particles. In 
order to carry out electrospraying, the polymer must first be in a liquid form, either as a 
molten polymer or as a solution. The property of the solution plays a significant part in the 
electrospraying process. The electrical property of the solution, surface tension, viscosity, as 
well as the rate of evaporation will have an influence on particle formation. Surface tension 
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plays a major role in the first step of electrospraying, the jet formation and the generation of 
droplets. Droplet size and the polymer concentration determine the resulting particle size. As 
the solution jet accelerates from the tip of the needle to the collector, the solution is stretched 
while the surface tension causes the solution to break up into droplets. Whether a liquid jet 
breaks up into droplets is related to the extend of polymer molecule chains entanglement 
within the solution. When a small drop of a liquid falls through the air, the droplet generally 
takes a spherical shape caused by surface tension. Therefore, high surface tension favors the 
formation of particles. For the electrospraying process to be initiated, the solution must gain 
sufficient charges. Generally the electric conductivity of solvents is very low as they contain 
very few free ions which are responsible for the electric conductivity of the solution. The 
presence of acids, bases and salts increase the conductivity of the solvent. Therefore, the used 
drug component determines the electric conductivity of the solution rather than the solvent 
itself and might influence the electrospraying process significantly. The process parameters 
voltage, distance and flow rate can not be considered as independent parameters. A minimum 
voltage is needed to cause the solution drop at the tip of the needle to distort into the shape of 
a Taylor Cone and eject a liquid jet. If a higher voltage is applied, a smaller less stable Taylor 
Cone is formed. As result of an unstable Taylor Cone, different particle sizes are formed. The 
flow rate determines the amount of solution available for electrospraying. For each voltage, 
there is a corresponding flow rate to maintain the Taylor Cone stable. Varying the distance 
between the tip and the collector has a direct influence in both the flight time and the electric 
field strength. All these parameters allow to influence the formulation properties and to 
optimize the particles for a certain application. 
Aim of this current work was to develop formulations of a drugs used in asthma therapy in 
particles in the inhalable size range showing retarded release. In this chapter the solvents 
acetone, dichloromethane and acetonitrile were used for preparation of the solution 
precursors. The drugs fenoterol hydrobromide, salbutamol sulphate, salbutamol free base and 
budesonide were encapsulated. For these encapsulations different resorbable polymers based 
on polyesters and polyester-b-polyether copolymers and different liquid precursors were used. 
As liquid precursors dispersions of drug crystals in a polymer solution, and solutions of drug 
and polymer, as well as emulsions of a solution containing the drug and an immiscible second 
solution containing the polymer used for drug encapsulation by electrospraying. 
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Experimental part 
Materials: 
Acetone, acetonitrile, dichloromethane (DCM), and dimethylformamide (DMF) were 
purchased from Sigma-Aldrich (Germany) and used without further purification. The model-
drugs budesonide, fenoterol hydrobromide, salbutamol sulphate, and salbutamol free base 
were donated by Boehringer Ingelheim Pharma GmbH & Co. KG (Ingelheim am Rhein, 
Germany). The polylactide-co-glycolide based polymers PLGA 1 poly(lactide-co-glycolide) 
with carboxylic acid groups and a molecular weight of 23,000 g/mol (Resomer RG 502H, 
polymer composition 48:52 to 52:48 molar ratio, inherent viscosity 0.16-0.24 dl/g), PLGA 3 
polylactide-co-glycolide with dodecyl groups and a molecular weight of 23,000 g/mol 
(Resomer RG 502S polymer composition 48:52 to 52:48 molar ratio, inherent viscosity 0.16-
0.24 dl/g,), PLGA 2 polylactide-co-glycolide with carboxylic acid groups and a molecular 
weight of 35,000 g/mol (Resomer RG 503H, polymer composition 48:52 to 52:48 molar ratio, 
inherent viscosity 0.32-0.44 dl/g), as well as PLGA-b-PEG 1 poly(L-lactide-co-glycolide)-
block-poly(ethylene glycol) a triblock copolymer with one 6,000 g/mol poly(ethylene glycol) 
segment and two 300,000 g/mol poly(L-lactide-co-glycolide) segments (Resomer LGP t 7016, 
polymer composition of the poly(L-lactide-co-glycolide) segment 70:30), and PLGA-b-PEG 2 
a triblock copolymer with one 6,000 g/mol poly(ethylene glycol) segment and two 75,000 
g/mol poly(L-lactide-co-glycolide) segments (Resomer LGP t 7046, polymer composition of 
the poly(L-lactide-co-glycolide) segment 70:30) were donated by Boehringer Ingelheim 
Resomer GmbH & Co.KG (Ingelheim am Rhein, Germany) and used as received. The 
detailed synthesis of the two lactide based block copolymers PDLLA-b-PEG 1 poly(D,L-
lactide-block-ethylene glycol) a diblock copolymer with a 10,000 g/mol molecular weight 
poly(ethylene glycol) segment and a 40,000 g/mol poly(D,L-lactide) segment, and PDLLA-b-
PEG 2 poly(D,L-lactide-block-ethylene glycol) a diblock copolymer with a 10,000 g/mol 
molecular weight poly(ethylene glycol) segment and a 60,000 g/mol poly(D,L-lactide) 
segment has been described previously [8]. The macroinitiator used for the synthesis of these 
block copolymers -methoxy, -hydroxyl poly(ethylene oxide) with a molecular weight of 
10,000g/mol was purchased from Iris Biotech GmbH & Co.KG. Briefly, 1 g (0.1 mmol) -
methoxy, -hydroxyl poly(ethylene oxide) and 62.5 respectively 90.27 mmol D,L-lactide 
were first dried in a reaction tube, 1 equivalent Sn(Oct)2 was added, and the tube evacuated 
for 3 h. The closed tube was heated up to 135°C under stirring and kept inside the oil-bath for 
24 h. The resulting waxy polymer was purified by recrystallization (dichloromethane/ ether), 
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solvents were removed by filtration and the white product dried for 24 h. The products were 
obtained with yields ranging from 70-89%. The obtained products were characterized with 
1
H-NMR and 
13
C-NMR spectroscopy. 
1
H NMR (CDCl3): 
  = 1.20 (t, J = 7.05 Hz, 6H, CH3), 1.68 (d,  J = 6.68 Hz, CHCH3), 3.64 (m, OCH2CH3, 
CHCH2O, OCH2CH2O, CH2OH), 4.50 – 4.60 (m, CHCH2), 5.10 – 5.27 (m, CHCH3) 
13
C NMR (CDCl3): 
  = 70.57 (OCH2CH2O) 
The synthesis of the polyglycidol based copolymers PG-g-PCL 1, a poly(glycidol)-graft- -
caprolactone) copolymer consisting of 24 glycidol repeat units and a total molecular weight of 
22,000 g/mol, and PG-g-PCL 2, a poly(glycidol)-graft- -caprolactone) copolymer consisting 
of 24 glycidol repeat units and a total molecular weight of 43,000 g/mol, was performed as 
described by Hans et al. [9].  
Briefly, the macroinitiators, protected polyglycidols with a linear architecture were obtained 
via anionic ring-opening polymerization of protected glycidol in diglyme with potassium as 
counter ion. Removal of the protecting groups leads to poly(glycerols) which were further 
used as macroinitiators for chemical catalyzed ring-opening polymerization of -caprolactone. 
For chemical synthesis, 1 mmol polyglycidol and 180 (PG-g-PCL 1) or 360 (PG-g-PCL 2) 
mmol -caprolactone were heated to 80 °C in order to obtain a homogenous solution. The 
catalyst Sn(oct)2 the mixture was stirred 24 h at 130 °C. The polymer was isolated by 
dissolution in dichloromethane and precipitation in hexane. After drying in vacuum a white 
powder was obtained with a yield of 96%. Successful polymerization was confirmed by 
1
H- 
and 
13
-C NMR spectroscopy.  
1
H NMR (DMSO-d6):  
 = 0.70-0.95 (m, CH3CH2), 1.20-1.42 (m, CH3CH2, OCOCH2CH2CH2), 1.42-1.62 (m, 
CH2CH2CH2), 2.27 (t, J = 7.2 Hz, OCOCH2CH2), 3.05-3.27 (m, CCH2O), 3.27-3.80 (m, 
OCH2CH(CH2O)O), 3.98 (t, J = 6.4 Hz, CH2OCO), 4.07-4.40 (m, CHCH2O), 4.40-4.60 (s, 
not converted CHCH2OH groups) ppm.  
13
C NMR (DMSO-d6):  
 = 7.4, 22.0, 24.0, 24.4, 24.9, 25.0, 27.8, 32.2, 33.3, 33.5, 60.5, 63.4, 172.7, 172.7 (the peaks 
of the polyglycidol backbone are not distinguishable from the noise of the baseline). 
 
 
Particle production by electrostatic spraying: 
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The basic configuration for electrospraying is equipped with a nozzle connected to a high 
voltage power supply and supplied with a liquid to be sprayed. In the electrostatic field a 
droplet hanging beneath the nozzle changes its shape to conical and, if the voltage is high 
enough, a liquid jet is ejected from a cone apex. The liquid jet breaks up to the mist of 
uniform droplets [10]. Depending on the strength of the electric stresses in the liquid surface 
relative to the surface tension, different spraying modes will be obtained. For the production 
of pharmaceutical microparticles, the so called cone-jet mode seems the most appropriate. In 
this mode the process is very stable and small monodisperse droplets are formed [11]. The 
configuration used in this chapter consists of a spraying chamber, a capillary, through which a 
polymer solution is fed, connected to a high voltage supply; a grounded target and a cyclone 
type particle collector (see Figure 1). 
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Figure 1: Electrospraying configuration used for particle production: A.) schematic 
drawing, B.) air flow simulation for the geometry of a spraying chamber, C.) 
photograph an electrospraying device. 
 
The spraying chamber consists basically of a cylindrical glass tube (inner diameter 170 mm) 
with tapered ends. One end acts as inlet for filtered air and the other end ducts the produced 
particles to the cyclone type particle collector. Figure 1B illustrates the calculated air flow and 
velocities in such a device for a pump transporting 28 L/min  air through the device. Particles 
are collected on a filter membrane (0.2 µm cellulose filter membrane, Millipore, Germany) 
- Chapter 11 - 
  238 
inside the cyclone type particle collector (Respirable Dust Aluminum Cyclone, SKC Inc, 
USA) downstream of the set-up. The distance between the nozzle-tip and the grounded target 
is 120 mm. With this device the particles were separated by size. Large particles are collected 
inside the cyclone (cut off approximately 1 µm), while small particles are not sedimented but 
collected on a filter membrane on top of the cyclone. Air is drawn through the filter by a 
vacuum pump (Vakuumbrand, Germany) maintaining a small under-pressure in the spraying 
chamber. As a precursor for the production of drug-loaded particles, a dispersion, solution, or 
emulsion of the drug with addition of polymer is supplied to the spraying nozzle. The flow 
rate of the liquid was kept at 1.5 mL/h using a syringe pump of type HA 11 plus (Harvard 
Apparatus, purchased from Hugo-Sachs Elektronik GmbH, March-Hugstetten, Germany). A 
high voltage of 25 kV was applied to the nozzle. This device allows continuous collection of 
particles and avoids aggregation by long flight times respectively complete solvent 
evaporation. Figure 1C shows an image of the electrospraying configuration used in this 
chapter. All presented particles were made in the set-up described above. In order to evaluate 
the suitability of electrospraying for formulation with retarded release three different 
encapsulation approaches were investigated. 
 
1.) Coating of a drug with a polymer layer 
The drugs salbutamol sulphate or fenoterol hydrobromide were dispersed in different polymer 
solutions and sprayed with the electrospraying device described above. Particles were 
collected over a period of 12 h. The polymers were dissolved in dichloromethane to make 
2.0% (w/w) concentrations and a small amount of the stabilizer Lecithin was added (0.2% 
[w/w]). To those solutions 8.0% (w/w) [2.0% (w/w) in the case of fenoterol hydrobromide] 
micronised drug were added and the crystals dispersed with an Ultrathorax (18000 rpm) for 
approximately 1 min. Dispersions prepared according to the procedure above were stable for 
approximately 24 h before sedimentation was visible. After 24 h, particles were collected and 
further proceeded. The particle fractions were weighted, investigated by SEM and further in-
vitro degradation studies carried out. 
 
2.) Drug-loaded polymer matrix 
The model drugs (salbutamol sulphate, salbutamol free base, fenoterol hydrobromide, or 
budesonide) were dissolved in different polymer solutions. The polymers were dissolved to 
make 1% (w/w) solution concentrations and 0.1% (or 0.25%) of the drug were added. The 
solution was stirred for 1 min with an Ultrathorax (18000 rpm) to make sure of complete 
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dissolution. The prepared solutions were sprayed with the electrospraying device described 
before. The particles were collected over a period of 12 h. The particle fractions were 
weighted, investigated and further in-vitro degradation studies were done. 
 
 3.) Spraying of emulsions 
The two model drugs salbutamol sulphate and fenoterol hydrobromide were dissolved in a 
small amount of water. Polymer solutions with concentrations of 1% (w/w) were prepared and 
a small amount of the stabilizer Lecithin was added (0.1% [w/w]). To 2 mL of those solutions 
0.2 mL of a 2% (w/w) salbutamol sulphate solution in water were added and emulsified with 
an Ultrathorax (18000 rpm) for 1 min. Emulsions prepared according to this procedure were 
stable for approximately 24 h before phase separation was visible. Emulsions of this drug 
solution in different polymer solutions were prepared and sprayed with the electrospraying 
device described above. The particles were collected over a period of 12 h. The particle 
fractions were weighted, SEM-pictures were taken and in-vitro degradation studies were done 
performed. 
 
Scanning Electron Microscopy (SEM) and Transmission Electron Microscopy (TEM): 
To investigate their morphology, the particles were characterized by scanning electron 
microscopy (SEM) and transmission electron microscopy. For high-resolution images, the 
electrosprayed particles were deposited onto aluminum scanning electron microscopy (SEM) 
stubs. The electrosprayed material on the aluminum SEM stubs were gold-coated with an 
Sputter Coater S 150 B (Edwards, Germany) and imaged with an S-4800 Ultra High Resultion 
Scanning Electron Microscope (Hitachi, Germany) or a Stereo Scan 360 Cambridge Scanning 
Electron Mikroscope (Carl-Zeiss-NTS GmbH, Germany) using accelerating voltages of 2-15 
kV, and a working distances of 10-15 mm. Bright field transmission electron microscopy 
measurements were performed using a Philips electron microscope CM10 PW6020/10 
(Germany). Particle samples were directly collected on formvar coated copper TEM-grids 
(diameter 3.05 mm, 200 respectively 400 mesh) over a period of 5 min. Therefore, the TEM-
grids were used as grounded target and placed inside the spraying chamber. 
 
In-Vitro drug release: 
Since controlled and sustained release is key issues for the development of new 
pharmaceutical formulations, assays quantifying release of model drugs are of great 
importance. In order to evaluate the electrosprayed formulations an in-vitro drug release assay 
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was developed. The amount of the drug released from the formulation into the buffer solution 
was detected and quantified by HPLC. Samples were analyzed with an Agilent 1100 HPLC 
with a series 1200 auto sampler (Agilent, Germany). The in-vitro allows comparison between 
the different formulations and indicates if these particles are suitable for retarded release 
applications. In order to determine the total amount of salbutamol sulphate respectively 
salbutamol free base loaded in/on the microparticles, the particles were processed as followed. 
1mg of the formulation was dissolved in 1mL chloroform. The precipitated salbutamol was 
dissolved in 1mL PBS-buffer and analyzed measured by HPLC analysis. In order to 
determine the amount of salbutamol sulphate respectively salbutamol free base released from 
the formulation into PBS-buffer the particles were processed as followed. 1 mg electrosprayed 
particles are weighted into a 2 mL Eppendorf-cup. 1.5 ml of PBS was added and the cup was 
turned several times for particle dispersion. To ensure constant incubation temperature (37°C 
± 0.2) the particles were placed in an incubation chamber (Heidolph Polymax 1040). The 
Eppendorf cups were incubated over 0 min, 30min, 1 h, 2 h, 6 h, 12 h 24 h, 48 h and longer if 
no complete drug release had occurred. After incubation the Eppendorf cups were centrifuged 
for 5 min at 1000 rpm. The PBS-buffer solution was removed from the sedimented particles 
and the concentration of released salbutamol sulphate respectively salbutamol free base in the 
PBS-buffer was determined by HPLC (Mobile phase: 650 ml buffer [2.88 g sodium dodecyl 
sulphate ad 2000 ml purified water, adjust the buffer at pH 2.6 by using attenuated phosphoric 
acid] and 350 ml acetonitrile; column: Aquasil C18, 5 µm, 250 x 4.6 mm; temperature: 40°C; 
detection wavelength: 220 nm; flow rate: 1,5 ml / minute; injection volume: 20 µl (loop 
overfill 50 µl), run duration: 12 min, retention time: ~ 7.56 min salbutamol sulphate; drug 
solvent: phosphate buffer saline (PBS): phosphate buffer saline tables (P-4417) from Merck; 
calibration standards: 50 mg Salbutamol sulphate reference, 50,0 ml PBS (stock solution); 
STD 1: 10 µg/ml, STD 2: 50 µg/ml; STD 3: 100 µg/ml, STD 4: 500 µg/ml; STD 5: 1000 
µg/ml). In order to determine the loading and release of budesonide, a mixture of the 1 mg 
electrosprayed particles, 625 µL of 1.8x PBS-buffer, and 375 µL ethanol were prepared. This 
totals 1.5 mL, consisting of 75% PBS and 25% ethanol (drug loading and encapsulation 
efficiency were measured using separate samples from the same preparation). Samples were 
incubated at 37°C, and at specified time points (0, 0.5, 1, 2, 6, 12, 24 hours) a sample was 
collected and frozen in liquid nitrogen. Each sample was allowed to thaw before it was 
centrifuged (1000 rpm for 5 min) and the supernatant was collected for determination of 
budesonide release into the buffer. Samples were analyzed by HPLC and the amounts of 
budesonide quantified (Mobile phase: 650 ml buffer [1.32 g (NH4)2HPO4  (Merck) ad 1000 ml 
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purified water, use concentrated phosphoric acid to adjust at pH 3.2] and 350 ml Acetonitrile; 
column: Aquasil C18, 5 µm 250 x 4.6 mm; temperature: 36°C; wavelength: 240 nm; flow 
rate: 2 ml / minute; injection volume: 50 µl (loop overfill 150 µl); run duration: 12 min; 
retention time: ~ 8.6 min budesonide; drug solvent:  600 ml buffer (1.32 g (NH4)2HPO4  
(Merck) ad 1000 ml purified water, use concentrated phosphoric acid to adjust at pH 3.2) and 
400 ml acetonitrile; calibration standard: 10 mg Budesonide reference ad 100,0 ml drug 
solvent (stock solution), STD 1: 0.1 µg/ml, STD 2: 1 µg/ml, STD 3: 10 µg/ml, STD 4: 100 
µg/ml). Budesonide analysis standards were prepared in a solution containing 75% PBS and 
25% ethanol. For mass balance, the amount of budesonide remaining with the particles in the 
centrifuged pellet was determined by centrifuging a second time, discarding most of the 
supernatant, and then lyophilizing. The dried particle remnants were weighed and dissolved in 
acetonitrile for analysis by HPLC with separate budesonide standards prepared in acetonitrile. 
Described drug release experiments with water-ethanol solution do not reflect the situation in 
the natural fluid environment. But in the natural environment inside a human body a lot of 
fatty cellular walls or blood vessel walls covered by fatty structures are present, and they are 
good solvents for lipophilic drugs like budesonide. Because a direct mimicking of such 
conditions was difficult to achieve, we decided to use ethanol addition which substantially 
increases budesonide solubility in the media. 
 
Results and Discussion 
Electrostatic spraying provides an easy tool for the production of quasi-monodisperse 
particles. Morphology, particle sizes (diameter) and particle size distribution strongly depend 
on the solution precursor and the process parameters used. Particles sizes ranging from the 
nanometer to the micrometer scale were generated. Evaporation speed of the solvent 
determines whether hollow or solid particles will be formed [12]. By means of electrostatic 
spraying, various precursor solutions were converted to drug containing particles. The 
precursor solutions are not limited to one component but can contain various drugs and 
polymers or polymer mixtures. Choice and composition of the precursor solution determines 
the particle properties and their release behavior. In this chapter we investigated the suitability 
of electrospraying to encapsulate the model drugs fenoterol hydrobromide, salbutamol 
sulphate and budesonide. Figure 2 shows the molecular structure of these model drugs. 
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Figure 2: Molecular structure of the model drugs, A.) fenoterol hydrobromide, B.) 
salbutamol sulphate, C.) budesonide. 
 
Besides being used in asthma therapy, all these model drugs differ in their physical properties 
as well as in their mechanism of action. We investigated different encapsulation strategies, 
respectively different precursor liquids, for particle generation by electrospraying.  Besides 
the capability to form quasi-monodisperse particulates, drug release of these drug loaded 
particles was studied. First aim was the production of drug loaded polymer particles with sizes 
between 0.5 and 5 µm, the inhalable size range, by electrospraying. These particles can either 
be coated drug crystals or matrix type particles containing the hydrophilic or hydrophobic 
model drug. A variety of synthesized and commercially available polymers were used for 
encapsulation and therefore electrosprayed. Particle size was determined by carefully 
orchestrating the process parameters, e.g. polymer, surfactants, solvent properties, viscosities, 
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concentrations, voltage and flow rate. The detailed influences of these parameters have been 
discussed previously [Chapter 10]. In this chapter we primarily concentrate on the effects of 
the used model drug, polymer (as well as polymer mixtures) and the type of the liquid 
precursor. We distinguish mainly two types of liquid precursors leading to distinctly different 
particles (see Figure 3). 
 
 
Figure 3: Schematic drawing illustrating two different encapsulation ways: A.) coated 
drug particle, B.) matrix particle (drug molecular dispersed in polymer matrix). 
 
Firstly, the micronised drug crystals are dispersed in a solvent containing the polymer and a 
stabilization agent. Spraying these dispersions leads to coated drug crystals, with their size 
closely related to the size of the initial drug molecule (see Figure 3A). Secondly, the drug 
molecule and the polymer are dissolved. In this case, either one solvent dissolves both (drug 
and polymer), or two immiscible solvents (one containing the drug and the other one 
containing the polymer) are emulsified using a stabilizing agent. Spraying both solutions leads 
to matrix-type particles. In this case, the drug is molecular dissolved in the polymer matrix 
(see figure 3B). Dependent on the composition and type of precursor, different particle 
morphologies and different release behavior can be achieved. The morphology of different 
electrosprayed particles was investigated with SEM and TEM, and their release behavior was 
studied in an in vitro assay. 
 
 
Coated drug particle 
Electrospraying the two model drugs salbutamol sulphate and fenoterol hydrobromide 
dispersed in the polymer solutions containing PLGA 1, PLGA 2 and PLGA-b-PEG 2 particles 
were obtained. Table 1 gives an overview of the sprayed particles, the used polymer, the 
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incorporated drug, the drug loading, their sizes, and their drug release after 30 min (R30), as 
well as the time after which 90% of the drug are released (T90). 
 
Table 1: Characteristics of coating-type particles (1-3 theoretical drug loading 80 
wt%,  4 theoretical drug loading 50 wt%) 
 
Morphologies and particle sizes were investigated with scanning electron microscopy. Figure 
4 shows the SEM-images of the micronised model drugs fenoterol hydrobromide, salbutamol 
sulphate and budesonide. 
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Figure 4: SEM-images of the different micronised drug particles: A.) fenoterol 
hydrobromide, B.) salbutamol sulphate, C.) budesonide. 
 
Electrospraying of these drug crystals in dispersion containing the dissolved polymer as liquid 
precursors resulted in the particles shown in Figure 5. 
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Figure 5: Different coating-type particles produced by electrospraying: A.) fenoterol 
hydrobromide coated with PLGA 1, B.) fenoterol hydrobromide coated with PLGA 2, 
C.) salbutamol sulphate coated with PLGA 1, D.) salbutamol sulphate coated with 
PLGA 2, E.) salbutamol sulphate coated with PLGA-b-PEG 2. 
 
The SEM-pictures seen in Figure 5A&B show particles generated with fenoterol 
hydrobromide dispersions. Figure 5A shows fenoterol crystals coated with PLGA 1, while 
Figure 5B  shows fenoterol hydrobromide coated with PLGA 2. In both cases, transmission 
electron microscopy images are inserted to illustrate the core-shell structures obtained by 
these coatings. The dark areas on these TEM-images indicate the drug crystal, as the drug 
crystals contain bromine, while the brighter corona indicates the polymer shell. In both 
images the core-shell structure, respectively the polymer coated drug crystal, is clearly visible 
and in rather good agreement with the expected structure (compare Figure 3).  In both cases, 
the shape of these particles is irregular, yet they have a quasi-monodisperse size distribution. 
The morphology shows various pores. Spraying of the polymer with the larger molecular 
weight resulted in larger particles (see Figure 5B). Figure 5C,D&E show a SEM-picture of 
those particles obtained from spraying dispersed salbutamol sulphate in different polymer 
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solutions. Those particle formed by spraying salbutamol sulphate dispersed in PLGA 1 (see 
Figure 5C) show quite monodisperse particle sizes and porous morphologies. In comparison 
to these, the particles obtained from the drug dispersed in the solution containing the polymer 
with the higher molecular weight (PLGA 2) seem to have more irregular shapes; most 
particles are elongated, which indicates the higher viscosity of the solution. The longer 
polymer chains of this statistic copolymer lead to more entanglements than the shorter ones of 
PLGA 1 at similar concentration. This effect creates a force which acts together with the high 
salt content oppositely to the surface tension and results in the formation of elongated 
particles. The size distribution of those particles is much less monodisperse. Figure 5C shows 
a SEM-image of particles generated by spraying salbutamol sulphate dispersed in a solution 
containing PLGA-b-PEG 2. The obtained particles present ―red blood cell‖ like disk shapes 
and has a highly porous surface morphology. The highly porous surface might be related to 
the poly(L-lactide) as similar surface structures have already been described for electrospun 
fibers [14]. The disk like shape was predominantly observed when PLGA-b-PEG triblock 
copolymers were sprayed. The cause of the disk shape has not been fully understood yet and 
is still under investigation. The particle sample is quite inhomogeneous and contains of 
particles of various sizes. Particles with the polymers PLGA-b-PEG 1, PG-g-PCL 1, PG-g-
PCL 2, PDLLA-b-PEG 1 and PDLLA-b-PEG 2 have not been obtained. The molecular 
weight of PLGA-b-PEG 1, respectively the viscosity of the solution, is too high and prevents 
the break-up of the jet. Instead of particles, fibers were formed. The polymers PG-g-PCL 1, 
PG-g-PCL 2, PDLLA-b-PEG 1 and PDLLA-b-PEG 2 have low glass transition temperatures. 
Therefore, in all cases a spray is formed but the formed droplets loose their shape completely 
upon collection and form a polymer layer. The release of various particulates has been tested 
by incubation with PBS-buffer solution in Eppendorf-tubes at 37°C. Figure 6 shows the 
salbutamol sulphate release over a period of 24 h. 
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Figure 6: Salbutamol sulphate release from electrosprayed coating-type particles. 
 
For comparison, pure salbutamol sulphate is included in this figure. The dissolution speed of 
the salbutamol sulphate crystals shown in Figure 4B determines the availability in the buffer 
medium. As a negative control these crystals show release without any retardation. The 
released amount of salbutamol sulphate was determined by GPC. Under physiological 
conditions (pH = 7.4 and 37°C) and constant stirring on an incubator the release is very fast. 
Upon contact with the buffer medium more than 80 wt% of the encapsulated drug were 
released independently of the polymer used as coating.  Compared to the pure salbutamol 
sulphate crystals, all three coatings lead to certain retardation. PLGA 1 coated salbutamol 
sulphate shows the fastest release of all three formulations. Within 30 min more than 95wt% 
of the coated drug was already released into the buffer solution. The release behavior of 
PLGA 2 coated drug crystals was similar. No positive influence of the higher molecular 
weight of this polymer on the retardation was observed. After 30 min more than 98wt% of the 
coated drug were released into the buffer and were detected by HPLC. The particles coated 
with PLGA-b-PEG 1 showed the slowest drug release. Even this formulation released more 
than 94wt% of the coated salbutamol during the first 30 min. All coated drug crystals showed 
very fast release behavior and almost no significant retardation. With drug burst release over 
90 % in all cases, these formulations will lead to an immediate effect. All coated particles 
achieved by electrospraying were in the inhalable size range and might be useful for 
application were a short term response is useful. 
 
Particles with drug homogeneously distributed in polymer matrix 
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Electrospraying solutions containing both, drug and polymer, results in particles with the drug 
homogeneously distributed in a polymer matrix. Table 2 gives an overview of the 
electrosprayed matrix-type particles, the used polymers, the incorporated drugs, the drug 
loading, the particle sizes, and their drug release after 30 min (R30), as well as the time after 
which 90% of the drug are released (T90). 
 
Table 2: Characteristics of matrix-type particles (1-10 theoretical drug loading 10 
wt%) 
 
Morphologies and particle sizes were investigated with scanning electron microscopy. Figure 
7 shows particles containing salbutamol sulphate molecular dispersed in different polymers. 
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Figure 7: Salbutamol sulphate molecular dispersed in electrosprayed particles: A.) 
PLGA-b-PEG 2, B.) PLGA 2, C.) PLGA 1, D.) PLGA 3, E.) PDLLA-b-PEG 2. 
 
Figure 7A shows an SEM-image of PLGA-b-PEG 2 particles containing salbutamol sulphate. 
Figure 7B&C show electrosprayed PLGA 2 and PLGA 1 particles. In Figure 7B 
electrosprayed particles produced by spraying a solution of 0.1% (w/w) salbutamol sulphate 
and 1% (w/w) PLGA 2 in dichloromethane are shown. These particles are larger than those 
obtained under similar conditions with PLGA 1 (see Figure 7C). The main difference between 
these particles is their diameter. The bigger particles were electrosprayed from the solution 
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containing the polymer with the larger molecular weight (PLGA 2). Figure 7D shows an 
SEM-image of electrosprayed PLGA 3 particles containing salbutamol sulphate. 
Morphologies and particle sizes of the PLGA 3 particles are similar to the PLGA 1 particles. 
As the molecular weight and composition of both polymers is similar and only the end-group 
various, similar sizes and morphologies are obtained. Exchanging the COOH end-group with 
a dodecyl end-group leads to slower degradation but does not effect the particle formation 
significantly. Figure 7E shows an SEM-image of electrospun PDLLA-b-PEG 2 particles 
loaded with salbutamol sulphate. All particles were electrosprayed from acetone solutions 
containing 0.1% (w/w) salbutamol sulphate and 1% polymer. While the obtained particle 
sizes depend on the chosen polymer, all particles show smooth surfaces. Particle size directly 
depends on the molecular weight of the polymer and the solution viscosity (for one specific 
solvent; like in this case acetone). The shape of these particles is perfectly spherical. Surfaces 
are smooth and quasi-monodisperse particulates are obtained. Besides an influence on the size 
of electrosprayed particles the choice of the polymer is expected to have impact on the drug 
encapsulation and release. Besides the influence of the polymer on particle formation, a 
significant influence of the chosen solvent on particle morphology and size was observed. 
Figure 8 illustrates the differences observed on electrosprayed matrix-type PLGA 1 particles 
generated using different solvents: A.) dichloromethane, B.) acetone, C.) acetonitrile, and D.) 
DMF / DCM (1/1; V/V). All particles shown in Figure 8 were obtained by electrospraying 
solutions of 0.1% [w/w] budesonide and 1% (w/w) PLGA 1 in the different solvents. 
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Figure 8: Electrosprayed matrix-type PLGA 1 particles generated using different 
solvents: A.) dichloromethane, B.) acetone, C.) acetonitrile, and D.) DMF / DCM (1/1; 
V/V). 
 
Different particle sizes and morphologies were obtained by variation of the solvent or solvent 
system. The largest particles were produced from dichloromethane. These particles seem to be 
collapsed; their shape is rather irregular and their surface is wrinkled. Changing the solvent to 
acetone reduces the obtained particle diameter. The particles obtained from dichloromethane 
show irregular shapes (almost ―donut‖-like), while those electrosprayed from acetone show 
smooth surfaces and almost perfectly spherical particles. While dichloromethane evaporates 
fast and leaves a hollow polymeric shell behind which deforms and implodes later (leading to 
the ―donut‖ shaped particles), the slower evaporating leaves much smaller solid spherical 
- Chapter 11 - 
  253 
particles. Acetonitrile leads to similar small spherical particles as acetone. Figure 8C shows an 
SEM image of particles electrosprayed from a solution of 1% PLGA 1 and 0.1% budesonide 
in a mixture of the two solvents DMF and dichloromethane (50/50[v/v]). The particles on this 
image have a regular spherical shape and smooth surfaces. Addition of DMF to 
dichloromethane increases conductivity and the dielectric constant of the solvent, while the 
solvent evaporates slower. The addition of DMF as co-solvent to dichloromethane decreases 
the diameter of electrosprayed particles dramatically. Besides the chosen polymer and solvent 
the chosen drug has shown to influence the size and morphology of the electrosprayed 
particles. Figure 9 shows SEM-images of electrosprayed matrix-type particles loaded with 
different drugs. 
 
Figure 9: Electrosprayed matrix-type particles loaded with different drugs: A.) PLGA 
3 with budesonide, B.) PLGA 3 with salbutamol free base, C.) PDLLA-b-PEG with 
budesonide, D.) PDLLA-b-PEG with salbutamol free base, E.) PLGA 1 with 
budesonide, and F.) PLGA 1 with fenoterol hydrobromide. 
 
In the first row PLGA 3 as polymer matrix was loaded with budesonide (Figure 9A) and with 
salbutamol free base (Figure 9B). The two SEM-images in the middle show matrix type 
PDLLA-b-PEG loaded with budesonide (Figure 9C) and salbutamol free base (Figure 9D). 
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The SEM-images in the last row show PLGA 1 matrix type particles loaded with budesonide 
(Figure 9E) and with fenoterol hydrobromide (Figure 9F). A TEM-image was included to 
illustrate the homogeneous fenoterol hydrobromide distribution in the electrosprayed matrix-
type particles. Only a minor influence of the used drug on particle size and morphology was 
observed. Exchanging budesonide with salbutamol free base does not change the particle size 
and morphology significantly. In the case of exchanging budesonide with fenoterol 
hydrobromide, particle size and morphology was changed as well. As fenoterol hydrobromide 
is not soluble in dichloromethane, water was added as co-solvent. Therefore the differences in 
particle size and morphology might as well be attributed to the solvent variation. All samples 
consisted of quasi-monodisperse particles. The drug release of all particulates was 
investigated by incubating samples in the required buffer media and quantifying the released 
drug with HPLC. For the hydrophilic salbutamol free base, a PBS-buffer solution was used, 
while for the release studies of the hydrophobic budesonide a mixture of PBS-buffer and 
ethanol was used. The ethanol increased the solubility of the lipophilic budesonide. Figure 10 
illustrates the release of encapsulated budesonide in various matrix-type particles. 
 
Figure 10: Budesonide release from different electrosprayed matrix-type particles. 
 
All particles showed retarded release over a period of 24 h. Dependent on the chosen polymer 
and the solvent used for electrospraying; different release behavior and burst release was 
achieved. Both PLGA 1 particles and PLGA 2 particles loaded with 10 wt% budesonide and 
produced from dichloromethane solution showed approximately 40 wt% release after 30 min 
and 90 wt% after 10 to 12 h. The particles produced with the higher molecular weight 
polymer (PLGA 2) showed more retardation. Compared to these particles produced from 
dichloromethane solution, particles electrosprayed from acetone showed smaller diameters 
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and much slower release. The PLGA 1 particles and PLGA 2 particles electrosprayed from 
acetone solutions showed between 20 and 25 wt% release after 30 min and retardation over 
more than 24 h. These particles with their smooth particle surfaces encapsulate the 
budesonide more effectively than those obtained from dichloromethane. Both particulates 
electrospun form acetone and a block copolymer (PDLLA-b-PEG 1 or PLGA-b-PEG 1) 
showed retarded release over more than 24 h. The budesonide loaded PLGA-b-PEG 1 
particles had with a release of approximately 15 wt% the lowest burst release in this chapter.  
All formulations of the lipophilic budesonide obtained from acetone solutions seem very 
promising for pulmonary delivery as the particle sizes were in a suitable range, the burst 
releases were below 30 wt% and release over a period of 24 h was achieved. Figure 11 
illustrates the release behavior of salbutamol free base encapsulated in various matrix-type 
particles. 
 
Figure 11: Salbutamol free base release from different electrosprayed matrix-type 
particles. 
 
All encapsulations of the hydrophilic molecule, salbutamol free base, by electrospraying were 
much less effective than those of the lipophilic drug. After 30 min under physiological 
conditions between 40 and 65 wt% of the encapsulated drug were already released into the 
buffer. The only formulation showing 40 wt% release of encapsulated salbutamol free base 
was obtained from a PLGA-b-PEG 2 solution in acetone. All other particles independent from 
the polymer or solvent used showed salbutamol free base release of more than 60 wt% in the 
first 30 min. Even though the release in these first minutes is high, a retarded release was 
observed in all cases. The release of 90 wt% of the encapsulated drug molecule takes more 
than 12 h. Therefore, these formulations might be useful in applications were a combination 
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of direct effect and retardation is needed. Generally, encapsulation of the lipophilic model 
drug was much more effective and led to much lower immediate drug release and higher 
retardation than those of hydrophilic drug molecules like salbutamol free base. Dependent on 
the disease to be cured an appropriate treatment (drug concentration and time of action) both 
encapsulations and their release behavior might be useful. These first results show that release 
behavior as well as particle size can be easily controlled by carefully tuning the precursor 
composition and the electrospraying parameters. 
 
Electrospraying emulsion of a drug dissolved in one solvent and a polymer dissolved in a 
second immiscible solvent 
 
Table 3 gives an overview over the characteristics of particles generated from spraying 
emulsions and polymer mixtures (1-10 theoretical drug loading 10 wt%).  
 
Table 3: Characteristics of particles generated from spraying emulsions and polymer 
mixtures (1-10 theoretical drug loading 10 wt%) 
 
Figure 12 shows electrosprayed matrix-type particles containing salbutamol sulphate in 
different polymer mixtures. 
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Figure 12: Electrosprayed matrix-type particles containing salbutamol sulphate in 
different polymer mixtures: A.) PLGA-b-PEG 1/PLGA 1, B.) PLGA-b-PEG 2/PLGA 
1, C.) PLGA-b-PEG 2/ PLGA 1, D.) PDLLA-b-PEG/PLGA 1, E.) PG-g-PCL 1/ 
PLGA 1, and F.) PG-g-PCL 2/PLGA 1. 
 
Figure 12A shows electrosprayed particles containing a mixture of PLGA-b-PEG 1 and 
PLGA 1. These particles were generated by spraying an emulsion of both polymers (50/50 
[w/w]) and salbutamol sulphate in a methylene chloride water mixture (10/1 [v/v]). The 
particles obtained show regular spherical shape and slightly collapsed morphologies. The 
particle surface is smooth without pores or holes. These electrosprayed particles are quasi-
monodisperse. The particles in Figure 12 B consist of the two polymers PLGA-b-PEG 2 and 
PLGA 1. The SEM-Image shows particles electrosprayed from an emulsion containing 
PLGA-b-PEG 2 and PLGA 1 (50/50 [w/w]) in dichloromethane and water (10/1 [v/v]). In 
contrast to other particles made with the same polymers but different ratios this particles are 
spherical. Beside their different shape they present a much smoother surface. However, the 
particles differ in size. Figure 12C shows electrosprayed particles of a mixture of the two 
polymers PLGA-b-PEG 2 and PLGA 1 (75/25 [w/w]). These particles were generated by 
electrospraying emulsions of the polymer mixture and salbutamol sulphate in 
dichloromethane and water (10/1 [v/v]). The collected particles have blood cell like flat shape 
which was already observed previously. These particles are similar in shape and morphology 
as those obtained when coating salbutamol sulphate with PLGA-b-PEG 2. Especially the high 
fraction of PLGA-b-PEG 2 in the polymer mixture favors the disk shaped particle formation 
during electrospraying. The particles in Figure 12 D consist of the polymers PDLLA-b-PEG 1 
and PLGA 1. The SEM-image shows electrosprayed particles produced by spraying an 
- Chapter 11 - 
  258 
emulsion of the polymers and drug in dichloromethane and water (10/1 [v/v]). The particle 
shape is irregular and the morphology relatively smooth. Neither big holes nor small pores 
can be seen. The particle sizes are inhomogeneous. Besides small particles larger ones are 
found in this sample. The particles in Figure 12E were electrosprayed from a polymer solution 
containing PG-g-PCL 1 and PLGA 1(55/45 [w/w]). These particles shown were sprayed form 
emulsions containing the polymers and salbutamol sulphate. The shape of the particles is 
irregular. The morphology shows significant signs of collapsed particles. The surfaces are not 
smooth, but the particle sizes look homogeneous. Electrospraying a solution containing PG-g-
PCL 2 and PLGA 1 resulted in the particles shown in Figure 12F. These particles were 
electrosprayed from an emulsion containing both polymers, salbutamol sulphate in a mixture 
of dichloromethane and water (10/1[v/v]). The SEM-picture shows particles of irregular 
shape, a collapsed wrinkled morphology and a relatively large size distribution. Spraying 
emulsions containing only the polymers PG-g-PCL 1, PG-g-PCL 1, and PDLLA-b-PEG 1 did 
not result in particles. In these cases, electrospraying resulted in the formation of a polymeric 
layer. The release of encapsulated salbutamol sulphate from these electrosprayed particles 
was investigated by incubation in PBS-buffer under physiological conditions. Figure 13 
shows the release of all particles obtained by electrospraying emulsions of salbutamol 
sulphate dissolved in water and the polymer dissolved in dichloromethane. 
 
Figure 13: Salbutamol sulphate release from electrosprayed matrix-type solutions. 
 
Most formulations show only short retardation. The only formulation which took more than 6 
h for release of 90 wt% of the encapsulated salbutamol sulphate contained a combination of 
PLGA 1 and a PLGA-b-PEG triblock copolymer. The particles contain 45 wt% PLGA-b-PEG 
2 showed even after 24 h less than 90 wt% release, whereas those particles containing 45 wt% 
PLGA-b-PEG 1 released 90 wt% of the encapsulated salbutamol sulphate after 12 h. Even 
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though these two formulations showed a slow release over longer time periods most of the 
drug is already released in the first 30 minutes. Most particles released more than 50 wt% of 
the encapsulated drug in the first 30 min. The only formulation which showed a salbutamol 
sulphate release of approximately 25 wt% after 30 minutes consisted of 15 wt% PG-g-PCL 1 
and 75 wt% PLGA 1. These particle released 90 wt% of the encapsulated salbutamol sulphate 
after 6 h. These examples show that the release behaviors of particles obtained by 
electrospraying emulsions were influenced by changing the polymer composition. Especially 
adding different ratios of other polymers to PLGA 1 allowed tuning the release behavior of 
the particles. Besides the release behavior, particle size, morphology and surface structure 
were altered by changing the polymer composition. The particle size and the release of the 
hydrophilic drug salbutamol sulphate can be controlled by tuning the polymer composition of 
the precursor emulsion in order to develop a formulation as therapeutic for a certain medical 
treatment.  
 
Conclusion 
In this chapter, three different encapsulation approaches based on a modified electrospraying 
technique for commonly used asthma therapeutics have been investigated. Three model drugs 
with different physical properties were encapsulated, the particles characterized and their 
release behavior studied. Firstly, dispersions of drug crystals in polymer solutions were 
successfully electrosprayed to form particles. These particles proved to have a core-shell 
structure typical for coated drug crystals and showed very fast drug release. Secondly, 
solutions containing the dissolved drug and polymer were electrosprayed to form matrix-type 
particles. This approach led to particles showing a unique combination of quasi-monodisperse 
particles in the inhalable size range and controlled release over more than 24 h.  A variation of 
the latter was electrospraying of emulsions of the drug dissolved in one solvent and the 
polymer dissolved in a second immiscible solvent. By adjusting the electrosprayed polymer 
mixture, respectively the ratio of the different polymers, release behavior was altered. To 
summarize, all approaches led to particles with diameters useful for pulmonary delivery 
(between 0.5 and 5 µm). Morphology, surface structure drug loading, and release behavior 
was strongly influenced by the composition of the liquid precursor, while particle size, and 
size distribution were controlled by optimization of the electrospraying parameters. Especially 
the narrow size distributions and homogeneous sample qualities (see Figure 14) seem 
promising for inhalation therapy of various diseases where a retarded drug release is useful. 
Electrospraying is a simple and handy tool for the production of microparticles and allows 
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control over those particle properties determining release behavior as well as their deposition. 
These results suggest the suitability of the electrospraying as encapsulation technique for 
various medical and pharmaceutical applications. 
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Chapter 12: Electrospraying: a versatile method for preparing inhalable 
microspheres from biodegradable polymers 
 
Abstract 
A rapid, viable and safe one-step method for monodisperse drug loaded nano- and 
microparticle production is reported using a simple electrospraying technique. We 
demonstrate the generation of non aggregated particulates suitable for pulmonary delivery. 
Neutral positively charged and negatively charged biodegradable and bioresorbable polymers 
were tested for the encapsulation of dexamethasone, salbutamol free base and budesonide. 
Particle sizes were tunable between 0.5-5 µm. Spherical particles with surface morphologies 
ranging from smooth to porous have been observed. The charged polymers proved to be 
advantageous for the encapsulation of dexamethasone and budesonide. Reduced drug release 
during the first 30 min as well as enhanced retardation was observed for these formulations. 
In the case of salbutamol free base slightly lower primary release was observed using 
hydrophobic uncharged polymers like PLGA. Drug loadings between 3.9 and 8.7% were 
achieved for all three drugs. Formulations showing retarded release over 24 h and average 
particle diameters in the inhalable size range showed to be redispersable using a commercially 
available inhalation system. Cascade impactor experiments illustrated the aerodynamic 
diameter of the particles and their deposition pattern. A Fine Particle Fraction containing 
28.35 % of the encapsulated drug was determined by analyzing the deposited particles and 
quantifying the encapsulated drug with HPLC. Therefore, electrospraying seems a simple but 
versatile one-step method for the production of drug delivery systems showing retarded 
release for pulmonary drug delivery. 
 
Introduction 
In the treatment of asthma and other chronic obstructive lung diseases, inhalation therapy is 
the most frequently applied method to administer drugs. Direct local administration into the 
lungs leads to an immediate effect, and smaller doses are needed compared to oral 
administration. However, with the use of conventional inhalation devices, only a small 
fraction of the inhaled drug reaches the lower airways, where it has direct therapeutic effect. 
The low efficiency of the inhalation equipment is related to the less optimal size distribution 
of the particles released, although recently developed inhalers can show improved 
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distributions. Research has shown that in adults, monodisperse 2.8 µm bronchodilator 
particles were optimal in terms of efficiency [1, 2]. These experiments point to the fact that 
the range of optimal aerosol particle sizes might be much smaller than currently assumed and 
show the importance of a preparation method which is capable of producing monodisperse 
particles of controllable and well-defined size. Also, the size of the polymeric particles can 
affect its pathway and fate after administration [3, 4, 5]. Even the particle morphology and 
surface properties might have an influence on the efficiency of a formulation for pulmonary 
delivery. Porous particles have some advantages for pulmonary drug delivery due to their low 
mass density [3]. Administration of monodisperse aerosols also has the potential to reduce 
total dose and size effects, but the optimal formulation still needs to be defined. To improve 
the therapeutic quality of formulations for inhalation purposes, interest in new methods to 
produce monodisperse particles in the inhalable size range has emerged. Besides the 
production of monodisperse drug formulations of a certain size, considerable attention has 
been given to controlled delivery of pharmacological agents to their targets at a 
therapeutically optimal rate and dosage by encapsulating them with biodegradable and 
bioresorbable polymers [7]. In general, the release rate increases with a larger surface to 
volume ratio of the particles and is enhanced by surface diffusion or surface erosion. Thus, the 
ability to control the size of drug-loaded particles provides a means to control drug release 
profiles [8]. Therefore, an increasing interest has arisen to develop methods for producing 
defined micro- and nanoparticles. Solvent evaporation, single emulsion and double emulsion 
methods are commonly employed to fabricate biodegradable polymeric micro- and 
nanoparticles. Additionally, novel techniques including ultrasonic atomization and 
electrospinning have been employed to encapsulate, immobilize, or release drugs [9, 10]. 
Among these different encapsulation techniques, the multiple emulsion method is the most 
popular with poly(lactic-co-glycolic acid) (PLGA) being the most studied polymer for 
controlled release [11]. However, the size distribution is usually broad and the process is 
difficult to scale up. Recently, electrospraying has attracted more interest in producing drug-
loaded micro- and nanoparticles for controlled release applications. 
Electrospraying generates quasi-monodisperse droplets whose size can be varied between a 
few hundred nanometers to hundreds of micrometers. Electrospraying is commonly used for 
ionization and characterization of substances in mass spectrometry, or deposition of thin films 
[12, 13]. Conventional electrospraying and coaxial electrospraying, a variation of 
conventional electrospraying, primarily focus on encapsulation of proteins [14]. If exposure to 
harmful organic solvents, like dichloromethane, may cause denaturation and the loss of 
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activity coaxial electrospraying, a process where two concentric capillaries are used, and two 
different immiscible liquids can be pushed through these two capillaries proved advantageous 
[15]. Although there are a few reports of electrospraying for encapsulation [16], these reports 
focus mainly on PLGA and PLA; the use of resorbable charged polymers in such applications 
has not been investigated previously. 
In this work, electrospraying was employed to produce biodegradable polymeric micro- and 
nanoparticles and the effects of processing parameters were investigated. We focus on the 
encapsulation of three different model drugs (dexamethasone, salbutamol free base, and 
budesonide) in neutral, positively charged, and negatively charged biodegradable polymers. 
Those processing parameters which are important for generating quasi-monodisperse particles 
and also the release behavior of the various drug formulations are presented. A cascade 
impactor was used to study the deposition of the particles. The relatively large fine particle 
fraction of these electrosprayed drug-loaded particles and their drug release behavior are 
promising advances for pulmonary drug delivery. 
 
Experimental part 
Materials 
The solvents acetone, chloroform, and acetonitrile were obtained from Sigma-Aldrich 
(Germany) in analytical grade quality. Salbutamol free base and dexamethasone were 
purchased from Sigma-Aldrich (Germany). Budesonide was donated by Boehringer 
Ingelheim Pharma (Ingelheim, Germany). All the chemical substances were used without 
further purification or processing. 
 
Polymers 
Five polymers were investigated to test the present hypotheses.  These polymers, which are 
listed below in more detail, include traditional PLGA, poly(vinyl alcohol)-grafted-PLGA, 
three varieties of a positively-charged amine-modified polymer, and a negatively-charged 
polymer bearing sulphonate groups.  The chemical structures of these polymer types (except 
for PLGA) were presented previously [17]. 
 
 
Poly(lactic-co-glycolic acid) [PLGA] 
Resomer RG502H (provided by Boehringer Ingelheim, Germany) is a poly(D,L-lactide-co-
glycolide) (PLGA) having a molecular weight (Mn) of 12.2 kDa. Resomer RG 502 H consists 
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of a 50:50 mixture of lactic acid: glycolic acid and an inherent viscosity between 0.16 – 0.24 
dl/g.  This polymer is uncapped, meaning that it has free carboxylic acid groups.   
 
Poly(vinyl alcohol)-graft-poly(lactic-co-glycolic acid) [PVA-g-PLGA-10] 
This polymer, abbreviated as PVA-g-PLGA-10, was synthesized by grafting lactide and 
glycolide monomers onto poly(vinyl alcohol) [18].  The number 10 in the polymer name 
indicates that a 10:1 mass ratio of PLGA:PVA was employed in the synthesis (yield = 
78.7%).  The molecular weight (Mn) of PVA-g-PLGA-10 was measured by GPC/MALLS to 
be 132.4 kDa (Mw/Mn = 1.59), the mass ratio of PLGA:PVA after synthesis was determined 
by 
1
H NMR to be 10.6, and the lactide:glycolide ratio (LA:GA) was 49:51.  The glass 
transition temperature (Tg) of this polymer was measured as 35.5°C by differential scanning 
calorimetry. 
Diethylaminopropylamine-poly(vinyl alcohol)-graft-poly(lactic-co-glycolic acid) [DEAPA-
PVA-g-PLGA-39-10, DEAPA-PVA-g-PLGA 39-20, and DEAPA-PVA-g-PLGA 52-20] 
These positively-charged polymers, abbreviated as DEAPA-PVA-g-PLGA-39-10, DEAPA-
PVA-g-PLGA-39-20, and DEAPA-PVA-g-PLGA-52-20, were synthesized as described 
previously [19].  The numbers 39 and 52 in the polymer name indicate the number of 
positively-charged diethylaminopropylamine groups attached to the PVA backbone during the 
synthesis; for example, for the DEAPA-PVA-g-PLGA-39-10, the amine substitution was 
determined by NMR to be 12.9%, i.e., 39 of the estimated 300 hydroxyl groups on the PVA 
backbone are substituted with the amine groups.  The number 10 or 20 at the end of the 
polymer name designates the mass ratio of PLGA grafting, as mentioned above.  The actual 
grafting mass ratio for DEAPA-PVA-g-PLGA-39-10 was determined by 
1
H NMR to be 8.7, 
LA:GA = 49:51, Mn = 147.3 kDa, Tg = 11.3°C, and the yield was 76.7%.  For DEAPA-PVA-
g-PLGA-39-20, the grafting ratio was 21.4, LA:GA = 50:50, Mn = 333.0 kDa, Tg = 25.8°C, 
and the yield was 77.5%.  For DEAPA-PVA-g-PLGA-52-20, the grafting ratio was 17.4, 
LA:GA = 50:50, Mn = 261.5 kDa, Tg = 18.9°C, and the yield was 77.2%. 
 
Poly(vinyl sulphonate-co-vinyl alcohol)-graft-poly(lactic-co-glycolic acid) [P(VS-VA)-g-
PLGA-2-10] 
This is a negatively-charged polymer, abbreviated as P(VS-VA)-g-PLGA-2-10.  The 
synthesis and characterization of this polymer was described previously [20].  The number 2 
indicates the ratio of vinyl sulphonate:vinyl acetate used during synthesis (2:8), and the 
number 10 designates the mass ratio of grafted PLGA, following the patterns for the 
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aforementioned polymers.  The Mn of P(VS-VA)-g-PLGA-2-10 is 8.9 kDa (Mw/Mn = 1.64) 
and Tg = 35.1°C.  [20]. 
 
Particle production by electrospraying  
The principal of electrospraying is that the high electrical field applied stretches the liquid 
droplet at the capillary tip, which subsequently deforms to a cone, and small droplets are 
ejected from the apex of this cone. A droplet on the nozzle will grow until its mass is large 
enough to escape the surface tension at the capillary-droplet interface in the absence of an 
electric field. When a high electric field is applied, the solution forms a conical meniscus. The 
meniscus deforms further and breaks up into droplets with small sizes and narrow size 
distributions due to the pull of the electrostatic force. Columbic repulsion between the highly 
charged droplets results in circumvention of coalescence. For the preparation of drug-loaded 
polymeric microparticles a ―Delft-type‖ electrospraying device was used. The set-up consists 
of a glass chamber (i.d. = 18 cm) with tapered ends (see Figure 1). 
 
Figure 1: Electrospraying configuration used for particle production. A pump 
transports air through the glass chamber o the cyclone type particle collector. The high 
voltage is connected to the capillary, through which the drug and polymer containing 
solution is fed, while the grounded target is positioned in 12 cm distance opposite to 
this capillary. The sprayed droplets respectively particle are carried by the air current 
to the particle collector. 
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One end acts as inlet for air which guides the produced particles to the collection area. The 
spraying nozzle (18 gauge) is positioned in the main cylinder opposite the grounded target 
and perpendicular to the direction of the air flow. For the production of drug-loaded particles, 
we proceeded as follows: 
A polymer solution was prepared by dissolving 100 mg of the specific polymer in 10 mL dry 
acetone or acetonitrile and stirring for 30 min at room temperature. To this solution 0.1% 
(w/w) of the drug (dexamethasone, salbutamol free base, or budesonide) was added, and the 
sample was homogenized using an UltraTurrax (22 000 rpm) for 1 min and then stirred using 
a magnetic stirrer for another 10 min at room temperature. The solution was drawn into a 10 
mL syringe attached with a blunt tip 18-gauge stainless steel needle. The syringe was placed 
in a syringe pump (Harvard Apparatus 11 Plus, Harvard Apparatus, USA) and a high voltage 
supply, with the range of 0-30 kV and a limiting current of 5µA (Eltex KNH 34, Germany) 
was applied. The positive electrode of the power supply was connected to the nozzle, while 
the target was grounded. The solution was sprayed using a voltage of 25 kV and a flow rate of 
1.5 mL/h. The collector was positioned 12 cm away from the needle tip and a permanent air 
stream of 28 L/min transported the particles to a Respirable Dust Aluminum Cyclone (SKC 
Inc., USA) equipped with a filter membrane with an average pore diameter of 0.2 µm 
(Millipore, Germany). Particles were collected for 12 h, characterized, and then investigated 
for release behavior. 
 
Particle characterization with Scanning Electron Microscopy (SEM) 
The morphology and size of the drug-loaded particles were investigated using scanning 
electron microscopy (SEM) at a voltage of 1-15 kV (S-4800 Ultra High Resultion Scanning 
Electron Microscope, Hitachi, Germany) with a Cambridge S360 camera (Leica, Germany). 
Before testing, the samples were mounted on aluminum SEM stubs with double-sided carbon 
adhesive tape. To calculate particle size, a random sampling of 20 individual particles was 
taken. Microscope images were taken with an MRc5 camera, an Axioplan2 and an N XBO 75 
lamp (Zeiss, Oberkochen, Germany) microscope using a polarsation filter (F2). 
 
Drug-release assay, detection and quantification 
To measure the total amount of drug loaded with the electrosprayed microparticles, the 
particles were processed as followed. Due to the electrospraying process the formulations 
were not completely homogeneous. Therefore, 5 samples per formulation were investigated.  
For each sample, 5 mg of the formulation were dissolved in 10 ml acetonitrile.  Polymer and 
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drug standards were also dissolved in acetonitrile and were analyzed with HPLC equipped 
with a pre-column.  
For the detection and quantification of dexamethasone release from the particles, 1 mg of the 
electrosprayed particles and 1 mL PBS (Merk P-4417, Germany) were filled into 1.5 mL 
Eppendorf tubes and incubated on a Heidolph 1100 Incubator at 37°C. At specified time 
points (0, 1, 2, 4, 8, 24 hours) a sample was collected and frozen in liquid nitrogen.  Each 
sample was allowed to thaw before it was centrifuged and the supernatant was collected for 
determination of dexamethasone release into the buffer.  Samples were analyzed by HPLC.  
Dexamethasone analysis standards were prepared in PBS. For mass balance, the amount of 
dexamethasone remaining with the particles in the centrifuged pellet was determined by 
centrifuging a second time, discarding most of the supernatant, and then lyophilizing.  The 
dried particle remnants were weighed and dissolved in acetonitrile for analysis by HPLC 
equipped with a pre-column, with separate dexamethasone standards prepared in acetonitrile. 
As mobile phase, 650 ml buffer (2.88 g Sodium dodecyl sulphate ad 2000 ml purified water, 
adjust the buffer at pH 2.6 by using attenuated phosphoric acid) and 350 ml acetonitrile were 
used. A column type Intersil ODS-2, 5 µm (Merck, Column-No. 302184), 250 x 4.6 mm, a 
temperature of 40°C, wavelength of 220 nm, and a flow rate of 1.5 mL/min were used for the 
detection of dexamethasone. 
In order to quantify the budesonide content of the electrosprayed particles, a mixture of 
nanoparticles, PBS, and ethanol was prepared containing 1 mg of particles loaded with 
budesonide (drug loading and encapsulation efficiency were measured using separate samples 
from the same preparation), 750 µL of 1.8 X PBS (Merck P-4417, Germany), and 250 µL 
ethanol. This totals 1 mL, consisting of 75% PBS and 25% ethanol.  Previous solubility 
studies showed that sink conditions should be maintained when employing 25% ethanol. 
Samples were incubated at 37°C, and at specified time points (0, 1, 2, 4, 8, 24 hours) a sample 
was collected and frozen in liquid nitrogen.  Each sample was allowed to thaw before it was 
centrifuged and the supernatant was collected for determination of budesonide release into the 
buffer.  Samples were analyzed by HPLC.  For calibration, budesonide analysis standards 
were prepared in a solution containing 75% PBS and 25% ethanol. For mass balance, the 
amount of budesonide remaining with the particles in the centrifuged pellet was determined 
by centrifuging a second time, discarding most of the supernatant, and then lyophilizing.  The 
dried particle remnants were weighed and dissolved in acetonitrile for analysis by HPLC 
equipped with a pre-column (acetonitrile dissolves both the polymer and budesonide), with 
separate budesonide standards prepared in acetonitrile. 
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As mobile phase, 650 ml buffer (1.32 g (NH4)2HPO4  (Merck) ad 1000 ml purified water, use 
concentrated phosphoric acid to adjust to pH 3.2) plus 350 ml acetonitrile was used. The 
HPLC was equipped with a Toso Haas TSK-Gel Super ODS 2 µm, 100 x 4.6 mm column. A 
temperature of 40°C, a detection wavelength of 240 nm and a flow rate of 2 mL/min was 
used. 
In order to determine the salbutamol free base release from the particles, a mixture of 
nanoparticles and PBS was prepared containing 1 mg of the electrosprayed particles loaded 
with salbutamol free base (drug loading and encapsulation efficiency were measured using 
separate samples from the same preparation) and 1000 µL of 1 X PBS (Merck P-4417, 
Germany). Samples were incubated at 37°C, and at specified time points (0, 1, 2, 4, 8, 24 
hours) a sample was collected and frozen in liquid nitrogen.  Similar to the procedure 
described above, each sample was allowed to thaw before it was centrifuged, and the 
supernatant was collected for determination of salbutamol release into the buffer.  Samples 
were analyzed by HPLC.  Salbutamol analysis standards were prepared in PBS. For mass 
balance, the amount of salbutamol remaining with the particles in the centrifuged pellet was 
determined by centrifuging a second time, discarding most of the supernatant, and then 
lyophilizing.  The dried particle remnants were weighed and dissolved in chloroform.  The 
precipitated salbutamol was dissolved in PBS and analyzed by HPLC, using the same 
conditions that were used for the detection of dexamethasone.  
 
Particle deposition 
As the particle sizes were determined from the SEM images, cascade impactor experiments 
were utilized to determine the effective aerodynamic diameter of the particles and their 
deposition. The procedure used in this chapter is based on the impaction principle whereby 
the particles of a powder aerosol are separated by inertia into size ranges on the basis of their 
mass and shape. The apparatus consists of a sample induction port (SIP), a preseperator, 
8 separation stages with Brij35 coated collection plates and a final filter. The inhaler 
(Handihaler ) is connected to the SIP of the impactor via an adapter. The airflow through the 
impactor is set to a constant rate of 39 l/min. The apparatus timer is operated so that air is 
drawn through the inhaler for a defined period of 6.15 sec, and the powder aerosol is released. 
The Fine Particle Fraction (FPF) is defined as the amount of drug deposited on the collection 
plates 2-7 plus the filter; these represent aerodynamic diameters ≤ 5.2 µm. The delivered dose 
(DD) is defined as amount of drug deposited on all collection stages plus the filter, SIP, and 
preseparator. 
- Chapter 12 - 
  269 
The FPF and DD of spray dried and electrosprayed microparticles, as well as microparticle-
lactose mixtures, could be determined. Due to particle interaction, it may be expected that the 
lactose mixtures lead to higher FPF and DD. Therefore, 10 mg particles (loading 5-30%) were 
weighed into a poly(ethylene) capsule. Each FPF and DD determination was repeated 3 times. 
After particle deposition, the SIP and preseparator were washed with 20 mL chloroform in the 
case of salbutamol free base and dexamethasone, respectively, 6 mL acetonitrile for 
budesonide. Afterwards the plates were washed a second time, but this time with 20 mL, 
respectively, 9 mL PBS. Both solutions (the aqueous solution and the organic solution) were 
collected in 50 mL Falcon Tube and vortexed for 2 min. Three 1.5 mL aliquots of this 
solution were transferred into three Eppendorf cups which were centrifuged for 5 min at 
13,000 rpm. The aqueous phases of these samples were collected and further analyzed with 
HPLC as described previously. In order to quantify the drug amount deposited, the collection 
plates were put into basins and 10 mL chloroform (or 6 mL acetonitrile for budesonide) were 
added. The basins with collection plates were treated for 5 min in an ultrasonic bath. 
Afterwards 10 mL PBS (9 mL for budesonide) were added and the mixture was shaken 
several times and vortexed for 2 min at maximum speed.  Three 1.5 mL aliquots of these 
mixtures were transferred into three Eppendorf cups and centrifuged for 5 min at 13,000 rpm. 
The drug amounts in the aqueous phase were determined with HPLC as described previously. 
 
Results and Discussion 
In electrospraying, the dispersion of the liquid is driven primarily by electric forces, so that 
atomization and gas flow processes are relatively uncoupled. Such a system can be 
implemented by feeding a liquid with sufficient electric conductivity through a small capillary 
maintained at several kilovolts relative to a ground electrode positioned a few centimeters 
away. The electrospraying configuration was equipped with pump, which maintained a 
continuous air stream of 28 L/min perpendicular to the two previously described electrodes 
and transported the particles to a cyclone type particle collector (see Figure 1). Similar 
electrospraying chambers with tapered ends and a constant air-flow are known as Delft-type 
electrospraying devices as they were developed at University of Delft during the 1990s. The 
liquid meniscus at the tip of the capillary takes a conical shape under the action of the electric 
field, with a thin jet emerging from the cone tip. This jet breaks up further downstream into a 
spray of fine, charged droplets. In the so-called cone-jet mode, monodisperse droplets over a 
wide size range can be produced, from molecular dimensions to hundreds of micrometers, 
depending on the process parameters. The influences of the different process parameters on 
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the particle sizes and morphologies have been described previously and will not be discussed 
in detail [21]. After electrospray dispersion, the solvent evaporates leaving behind nano- and 
micrometric residues, which can be further used for specific applications. Since the particles 
are highly charged, in a conventional electrospray set-up they are very efficiently collected by 
objects connected to the electrical ground. In the electrospraying device, the air current is 
sufficient to diffract the pathway of the particles. Instead of being directed towards the 
grounded target, the particles are carried by the air stream. The provided air current enlarges 
the flight time of the droplets and guarantees complete removal of the solvent and the 
subsequent collection of solid particles. This way, a fine powder of quasi-monodisperse nano- 
and microparticles can be generated, which can be easily redispersed later. The particles are 
collected in a cyclone type particle collector, where they are sedimented or collected on a 
filter membrane (pore diameter 0.2 µm) depending on their size. Larger particles (~1 µm) are 
sedimented, while the small particles (>0.2 µm and < 1 µm) are collected in the filter 
membrane. Figure 2 shows an optical microscope image of electrosprayed poly(lactide-co-
glycolide) particles loaded with budesonide (sedimented fraction). 
 
Figure 2: Optical microscope image of budesonide encapsulated in electrosprayed 
PLGA particles. 
 
For the image, the tip of a spatula was used to transfer a small amount of the sample onto a 
glass object slide. Isolated particles show the absence of bigger aggregates and agglomerates 
and give an overview of the sample quality. To evaluate the individual particles and their 
surface or morphology, an optical microscope image is not sufficient. Scanning electron 
microscopy (SEM) images also reveal submicron particles that cannot be observed using 
conventional microscopy. In general, electrospraying is the nanoscale equivalent of spray 
drying that finds wide industrial applications for converting liquids into powders [22]. 
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In this chapter we focused on the encapsulation of the three model drugs: dexamethasone, 
budesonide, and salbutamol free base. The molecular structures of these model drugs are 
shown in Figure 3. 
 
Figure 3: Molecular structures of A.) dexamethasone, B.) salbutamol free base, and 
C.) budesonide. 
 
Solutions of both drugs and polymers were electrosprayed and the generated particles were 
collected and further analyzed. Table 1 gives an overview of the electrosprayed particles, 
explaining the studied drug/polymer combinations, achieved particle sizes, drug loadings, 
drug recoveries, their release after 30 min as well as the time needed to achieve 90% release 
of the encapsulated drug. 
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Table 1: Electrosprayed particles as drug-release systems. 
 
In this chapter we especially focused on comparing the effects of charges (positive and 
negative) vs. neutral biodegradable polymers. In the following sections we discuss the 
different particles in the order of encapsulated model drug. All particles were generated from 
solutions containing a 1:10 ratio of drug: polymer. This way, the release behaviors of the 
different particle formulations containing one drug can be compared and the influence 
polymer type can be directly evaluated. 
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Dexamethasone 
Dexamethasone was successfully encapsulated in PLGA (neutral polymer), P(VS-VA)-g-
PLGA-2-10 (negatively charged polymer) and DEAPA-PVA-g-PLGA-39-10 (positively 
charged polymer). Figure 4 shows SEM images of the electrosprayed particles. 
 
Figure 4: SEM-images of electrosprayed particles containing dexamethasone. 
Dexamethasone was encapsulated in A.) a neutral polymer [PLGA ], B.) a positively 
charged polymer [DEAPA-PVA-g-PLGA-39-10], and C.) a negatively charged 
polymer [P(VS-VA)-g-PLGA-2-10]. 
 
Average particle sizes ranged from 0.94 to 1.32 µm. All three particle types showed smooth 
surfaces and spherical shapes. Those particles containing the neutral PLGA had the smallest 
average diameters (0.94 µm). The particles containing the negatively charged P(VS-VA)-g-
PLGA-2-10 showed diameters of 1.06 µm. The largest particle diameters resulted from 
spraying the positively charged DEAPA-PVA-g-PLGA-39-10 (1.32 µm). Even though the 
particle sizes did not show much difference, the sample morphologies and the aggregation 
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behavior of the electrosprayed particles showed distinct differences. While the particles 
electrosprayed using the neutral PLGA were collected as isolated particles, the positively 
charged DEAPA-PVA-g-PLGA-39-10 particles form aggregates (see Figure 4 B). This 
aggregation was only observed with the positively charged polymer. As aggregation of the 
particles limits the application of the positively-charged formulation for pulmonary delivery 
via a conventional inhalation device, the negatively charged P(VS-VA)-g-PLGA-2-10 
particles and the neutral PLGA particles seem to be promising candidates for further 
investigations. Besides the aggregation behavior, no other differences can be seen in the SEM 
images. Independent of the polymer, drug loadings between 7.3 and 8.5 wt% were achieved. 
The highest drug loading was obtained for PLGA with 8.5 wt%. For the two charged 
polymers, no significant difference in the drug loading was observed. The positively charged 
DEAPA-PVA-g-PLGA-39-10 particles contained 7.8 wt% dexamethasone, while the 
negatively charged  P(VS-VA)-g-PLGA-2-10 particles contained 7.3 wt% drug. The release 
behavior of all three formulations was investigated in a release assay under physiological 
conditions (see Figure 5). 
 
Figure 5: Dexamethasone release from electrosprayed particles over a period of 24 h 
under physiological conditions. Dexamethasone was encapsulated in a neutral polymer 
[PLGA], a positively charged polymer [DEAPA-PVA-g-PLGA-39-10], and a 
negatively charged polymer [P(VS-VA)-g-PLGA-2-10]. 
 
A retarded release was observed for all three formulations, and drug was released from the 
particles into the buffer medium for more than 24 h. While the release profiles of both the 
positively charged and negatively charged polymer show equal release rates, the neutral 
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PLGA particles release their dexamethasone load much faster. Both charged polymer particles 
show comparable release rates. In both cases, between 15 to 20 % of the encapsulated 
dexamethasone was released in the first 30 min. Just 45 to 50 % are released into the buffer 
media during the first 24 h. At each time point comparable dexamethasone levels were 
detected in the buffer solution for these two formulations. In contrast to these particles, the 
PLGA particles already released 44.1 % of the encapsulated dexamethasone during the first 
30 min and released approximately 70% after 24 h. The charges on the polymer chains seem 
to contribute to a slower release of dexamethasone. As both polymers show fast 
biodegradation – complete mass loss within two weeks - (data not shown), both might be 
suitable candidates for the development of drug delivery systems for pulmonary delivery 
showing retarded release with different release profiles, and corresponding different local 
drug levels. 
 
Salbutamol free base 
Five different polymers in combination with salbutamol free base were used for the 
electrospraying experiments. PLGA and PVA-g-PLGA-10 are neutral biodegradable 
polymers. The three polymers DEAPA-PVA-g-PLGA-39-10, DEAPA-PVA-g-PLGA-39-20, 
and DEAPA-PVA-g-PLGA-52-20 were positively charged polymers. Electrospraying of 
DEAPA-PVA-g-PLGA-52-20 did not result in particles but in the collection of a polymer 
layer. With all other polymers it was possible to generate particles. Figure 6 shows SEM 
images of salbutamol free base loaded PLGA particles, PVA-g-PLGA-10 particles, and 
DEAPA-PVA-g-PLGA-39-20 particles. 
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Figure 6: Electrosprayed particles loaded with salbutamol free base. Salbutamol free 
base encapsulated in A.) PLGA, B.) PVA-g-PLGA-10, and C.) DEAPA-PVA-g-
PLGA-39-20. 
 
 As those particles obtained from spraying DEAPA-PVA-g-PLGA-39-10 did not significantly 
differ from the DEAPA-PVA-g-PLGA-39-20 particles, SEM images are not shown. The 
average particle sizes varied between 1.12 and 1.38 µm. The salbutamol free base loaded 
PLGA particles showed average diameters of 1.38 µm, porous surfaces and a relatively large 
polydispersity. The particles generated by electrospraying a solution of the other neutral 
polymer (PVA-g-PLGA-10) showed average diameters of 1.25 µm and smooth surfaces. The 
smallest particles were produced by electrospraying a solution containing the positively 
charged DEAPA-PVA-g-PLGA-39-20. In this case, the average particle diameter was 1.12 
µm while the surface was smooth. All particles generated by electrospraying salbutamol free 
base and these polymers resulted in spherical particles. The drug loadings achieved were in all 
cases much lower than those obtained for dexamethasone. While DEAPA-PVA-g-PLGA-52-
20 samples did not contain significant drug amounts (drug loading 0.33 wt %), all other drug 
loadings ranged between 3.8 and 4.7 wt%. Both neutral polymers encapsulated slightly higher 
drug amounts. For PLGA a drug loading of 4.7 wt% and for PVA-g-PLGA-10 a drug loading 
of 4.2 wt% was achieved. The two formulations containing the positively charged polymer 
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and salbutamol free base showed drug loadings of 3.9 and 3.8 wt%. Figure 7 illustrates the 
release behavior of salbutamol free base loaded electrosprayed particles. 
 
Figure 7: Salbutamol free base release from different electrosprayed particles. 
 
According to their release behavior, the five different formulations can be grouped in three 
groups. Firstly, electrospraying of the positively charged polymer DEAPA-PVA-g-PLGA-52-
20, which did not lead to particles but to a polymer layer, directly released 100 % of the drug 
upon water contact. From the release curve we conclude that no drug was encapsulated, but 
some residual drug was present at the surface. This led to immediate dissolution. Secondly, 
PVA-g-PLGA-10, DEAPA-PVA-g-PLGA-39-10, and DEAPA-PVA-g-PLGA-39-20 show 
similar release behavior. All formulations showed between 81 and 93 % salbutamol free base 
release during the first 30 min. After this tremendous primary release, almost no further 
release was observed. Thirdly, those particles obtained by electrospraying PLGA and 
salbutamol free base showed much better release profiles. Even in this formulation, 61 % of 
the encapsulated salbutamol free base were released into the buffer solution after 30 min, but 
after 24 h not even 90 % were released. These particles were the only ones in this chapter for 
which a retarded salbutamol release was observed. In general, hydrophilic substances like 
salbutamol free base did not prove suitable for encapsulation by electrospraying. Using 
positively-charged polymers did not bring any advantage; more likely neutral hydrophobic 
polymers like PLGA seem best suitable to achieve a salbutamol free base delivery system 
showing retarded release. 
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Budesonide 
Budesonide was encapsulated in PLGA (neutral), PVA-g-PLGA-10 (neutral), and DEAPA-
PVA-g-PLGA-39-10 (positively charged). Figure 8 shows SEM images of the different 
budesonide containing formulations. 
 
Figure 8: Electrosprayed particles loaded with budesonide. Budesonide was 
encapsulated in A.) PLGA, B.) PVA-g-PLGA-10, and C.) DEAPA-PVA-g-PLGA-39-
10. 
 
Electrosprayed PLGA particles showed the largest average particle diameters with 2.37 µm. 
The particle size distribution is quite narrow. The observed particles had spherical shape and 
smooth surface morphologies. The PVA-g-PLGA-10 particles were slightly smaller with 
average diameters of 1.1 µm. These spherical particles showed smooth surfaces as well. Due 
to the particle sizes, all three formulations are suitable candidates for pulmonary delivery, 
especially the positively charged DEAPA-PVA-g-PLGA-39-10 particles. On the SEM image 
shown in Figure 8 B the particles seem to be slightly aggregated. Those particles obtained 
when electrospraying the positively charged DEAPA-PVA-g-PLGA-39-10 showed the 
smallest average diameters (0.78 µm). Again, spherical particles with smooth surfaces were 
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obtained. All particles showed drug loadings between 7.9 and 8.7 wt%.  The neutral PLGA 
particles showed the highest drug loading (8.7%). The positively charged DEAPA-PVA-g-
PLGA-39-10 particles had comparable drug loadings with 8.5 wt%. PVA-g-PLGA-10 
particles showed the lowest drug loadings with 7.9 wt%. The drug loadings achieved with the 
hydrophobic budesonide were comparable to those previously described for dexamethasone. 
This result might be related to the molecular structures of both, which show a certain 
similarity and only differ in the side groups. Figure 9 shows the budesonide release behavior 
for the three described budesonide encapsulations. 
 
Figure 9: Budesonide release from different electrosprayed particles. The three 
polymers PVA-g-PLGA-10, DEAPA-PVA-g-PLGA-39-10, and pure PLGA were 
dissolved together with the drug in dichloromethane and particles were produced by 
electrospraying. 
 
All electrosprayed particles showed retarded release. Equally low release rates were observed 
for all three formulations. For the two neutral polymers PLGA and PVA-g-PLGA-10, 20 to 
24 % of the encapsulated budesonide were detected in the buffer solution after 30 min. The 
positively charged DEAPA-PVA-g-PLGA-39-10 particles showed the lowest release in the 
first 30 min. Only 8.3 % of the encapsulated budesonide was released within this time period, 
which was the lowest value achieved in this chapter. The slowest release overall was observed 
for the positively charged DEAPA-PVA-g-PLGA-39-10 particles. All three formulations 
released approximately 50 % of the encapsulated budesonide during a 24 h period. In general, 
hydrophobic drugs like budesonide encapsulated by electrospraying seem to be promising 
formulations showing controlled release. 
 
On the basis of the previously described results we decided to further investigate the 
electrosprayed PLGA particles containing budesonide. As a model for pulmonary drug 
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delivery with a conventional inhaler, we used a cascade impactor [23, 24] in combination with 
a Handihaler®. Deposition patterns dependent on the aerodynamic properties of the 
formulation were achieved. Depending on the aerodynamic particle diameter the particles 
impact on a certain impactor level. Particles with smaller aerodynamic diameters impact on 
impactor plates further down in the impactor (higher numbers), above the filter. In similarity 
to the human lung, smaller particles penetrate further down the airways. Particles between 1 
and 5 µm are deposited in the deeper lung, mainly the smaller bronchi and alveoli. Much 
smaller particles are exhaled from the lung. This event is not reflected in the impactor model. 
The particle fraction which would be exhaled is collected in the filter in the cascade impactor. 
Only those particles collected on the impactor plates located on levels 2 to 7 resemble the 
particle fraction which would be deposited in the deep lung upon optimal delivery with an 
inhaler. The cascade impactor experiment gives a first impression on the formulation 
properties and the deposition pattern expected in vivo. Figure 10 shows the SEM images of 
the particle fractions found on the impactor plates on the different impactor levels. 
 
Figure 10: Particle distribution on the different impactor levels. The PLGA particles 
shown on the images are loaded with budesonide and were produced by 
electrospraying drug and polymer dissolved in dichloromethane. The aerodynamic 
radius of the particles determines their distribution in the cascade impactor. 
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Larger particles and aggregates or agglomerates are deposited in SI, Presep, level 0 (< 10 
µm), and level 1 (< 9 µm). These particles would impact in the throat. All other levels 
resemble particles with aerodynamic diameters < 5.8 µm. As can be seen on the images, a 
large fraction of the electrosprayed particles are deposited on the impactor levels 3 to 5. These 
particles have an optimal size for inhalation. The budesonide amounts on the impactor plates 
were quantified with HPLC. Figure 11 illustrates the budesonide distribution over the 
different impactor levels. 
 
Figure 11: Aerodynamic size of electrosprayed particles and corresponding 
budesonide dose on the different impactor levels. The PLGA particles shown on the 
images are loaded with budesonide and were produced by electrospraying drug and 
polymer dissolved in dichloromethane. The fine particle fraction determines the 
administered dose. 
 
The Fine Particle Fraction [25] is the fraction of the budesonide found on all impactor plates 
detected on the impactor levels 2 to 7. In this case 28.35 % of the budesonide encapsulated in 
electrosprayed particles belong to the Fine Particle fraction. This fraction of the encapsulated 
drug would be delivered into the deep lung. Only this part of the encapsulated budesonide can 
unfold its full activity; still, 28.35 % of a dry powder formulation with retarded drug release 
for local delivery into the deep lung is a very promising result. Therefore, electrospraying is 
an innovative, simple one-step method for the production of drug loaded particles. As 
demonstrated, particle sizes of electrosprayed formulations can be controlled and adjusted to 
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the inhalable size range, and should be very suitable for retarded and targeted drug delivery 
into the human lungs. 
 
Conclusion 
All generated particles had spherical shapes and showed diameters between 0.5 and 5 µm. To 
summarize, we employed a simple one-step electrospraying technique for the production of 
drug loaded polymeric particles in the inhalable size range. Commonly used drug molecules 
like dexamethasone, salbutamol free base and budesonide have been incorporated in a 
biodegradable and bioresorbable polymer matrix. Dependent on the combination of drug and 
polymer, drug delivery formulations showing a retarded release have been achieved. We 
found that in some cases, like for the encapsulation of dexamethasone or budesonide, charged 
polymers were advantageous.  By using either positively charged or negatively charged 
polymers, the release into buffer at physiological conditions was significantly reduced in the 
first 30 min. In contrast, all generated salbutamol free base loaded particles showed fast 
release. The particle size can be further adjusted by carefully changing the process 
parameters. Dependent on the polymer and drug combination, different surface morphologies 
ranging from smooth to rough and porous have been generated. The suitability of such 
formulations for pulmonary delivery was shown for a budesonide containing PLGA 
formulation by administering particles with a Handihaler® into a cascade impactor. Particle 
deposition on the different cascade impactor levels allowed estimation of the actual 
aerodynamic diameters of the electrosprayed particles. The formulation showed to be 
dispersible and a large Fine Particle Fraction containing of 28.35 % of the encapsulated 
budesonide was determined on impactor levels 2 to 7. In general, electrospraying seems a 
suitable technique for the production of a new generation of retarded drug delivery 
formulations for pulmonary drug delivery. Due to the similarity to the industrially widely 
applied spray drying and these promising results, further investigations should allow 
conclusions regarding the applicability of such formulations in vivo. 
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Appendix A: Development and optimization of an electrospraying device 
for the continuous collection of nano- and microparticles for biomedical 
and pharmaceutical applications including pulmonary drug delivery 
 
Abstract 
The development, fabrication and testing of a compact electrospray device are presented with 
the dual goal of increasing yields and total particle amounts by orders of magnitude and 
retaining the monodispersity of the generated polymeric particles. A new and optimized 
electrospraying device producing 285 mg/24h monodisperse micro-sized particles with a yield 
of 79.2% was developed and tested. The new design allows continuous particle production 
and collection. By optimization of the chamber design, high velocities in combination with 
reduced turbulences lead to increasing yields. In comparison to a simple electrospraying 
configuration, the new device enables collection 14.25 times more particles in 24h. Besides 
this significant increase in particle amounts and numbers, collection effectiveness increased as 
well. While a basic electrospraying device allowed collection of only 34.7% of the generated 
particles, the yields determined for the new device were 79.2%. We report a 2.28 times 
increase in effectiveness combined with the potential to generate continuously particles with 
enhanced productivity while maintaining monodispersity of the particles. This modified 
electrospraying device may facilitate the production of micro- and nano-sized particles for 
biomedical and pharmaceutical applications in relevant amounts and reduced losses inside the 
device. 
 
Introduction 
The incorporation of drug into a biodegradable polymer matrix to prepare drug-loaded 
polymer micro/-nanospheres has been of interest primarily in creating drug delivery vehicles. 
Drug loaded monodisperse microparticles with sizes (aerodynamic radius) ranging from 1 to 5 
µm proved suitable for pulmonary delivery and have tremendous potential for the treatment of 
several chronic diseases including asthma. Novel microparticle formulations as drug delivery 
systems showing controlled and retarded release have been developed. Degradable and 
biocompatible microparticles with entrapped dugs are of great interest as well as the 
development of simple and cost-effective techniques to produce them. Especially aliphatic 
polyesters with hydrolysable backbones are promising candidates to control the release of 
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drugs entrapped into microparticulate systems. Among them, one of the most commonly 
employed systems is microparticles fabricated from poly(D, L-lactide-co-glycolic acid) 
(PLGA). These copolymers are attractive for this application due to many favorable 
characteristics such as good biocompatibility, their ability to degrade into natural metabolites 
and their safety profile for human use [1]. Electrospraying, or elctrohydrodynamic 
atomization, is a process that relies on a high electrostatic force to break liquid into fine 
charged droplets. Electrospraying has been applied to many fields, ranging from the 
generation of monodisperse spray of ultra-fine drops to analysis of proteins by mass 
spectroscopy as well as industrial varnishing processes (paint spraying). More recently, the 
exploration of electrospraying to manufacture micro- and nanoparticles for drug delivery is 
becoming a new focus of attention [2]. With this technique different structural drug loaded 
microparticles, e.g. matrix-drug microparticles, drug-encapsulated core-shell particles, can be 
produced. At the same time this technique also presents some interesting advantages. For 
example, Xie et al. have electrosprayed paclitaxel/PLGA microparticles [3], whose diameter 
can be well controlled using the scaling laws of electrospraying [4]; Ijsebaert et al. have firstly 
demonstrated that the aerosol microparticles with right diameters are potentially useful as the 
inhalation devices of pulmonary drug delivery, which can be achieved using a modified 
electrospraying technique [5]. Still, this technique in the area of preparing the drug-loaded 
particles has not been fully developed. Since electrospraying was first systematically studied 
by Zeleny [6, 7] and theoretical explained by Taylor [8], many researchers have investigated 
the mechanisms that induce an electric charge on the surface of a liquid and stretch the 
meniscus in the direction of the electric field. The physical process when the liquid meniscus 
is subjected to a strong electric field and electrostatic forces elongate the liquid to form a 
cone-jet, has been studied and reported by several groups and can be found elsewhere [9, 10, 
11, 12]. Briefly, in DC electrospraying charge separation takes place in the liquid meniscus 
upon application of an electric field between the tip of a capillary from which the liquid 
meniscus emanates and a grounded electrode placed in a distance. Tangential ion conduction 
then occurs along the electric double layer formed at the interface thus resulting in co-ion 
accumulation and hence a singular electric field at the meniscus tip. The repulsion between 
the co-ions at the meniscus tip then results in Columbic fission wherein a thin liquid jet 
emanates from the tip once the repulsive force exceeds the surface tension. The co-ion 
accumulation at the meniscus tip is also the reason why the drops produced as a result of 
various instabilities suffered by the jet carry a net charge [13]. 
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Several electrospraying modes have been observed [9], the predominant mode being the cone-
jet mode in which liquids meniscus assumes the shape of a sharp cone, obtained by balancing 
the electrostatic and capillary pressure acting on a conical surface for ideal, static equilibrium 
conditions [8]. For a perfectly conducting liquid, Taylor showed by considering the static 
equilibrium balance between the capillary and Maxwell stresses that a conical meniscus with 
a half angle of 49.3° is produced. 
Besides the previously described simple electrospraying configuration several more 
elaborated devices have been developed. A special nozzle system allowing control over the 
surface nano-structure has been reported by Berkland et al. [14]. A thin sharped tungsten 
electrode inside a glass capillary is responsible for increased process control in the flow-
limited field-injection electrostatic spraying (FFESS) configuration. Another nozzle 
modification especially for micro- and nano-encapsulation is the use of coaxial 
electrospraying configurations [15]. A coaxial electrospraying nozzle basically consists of a 
larger outer capillary through which a polymer solution can be fed and a smaller inner 
capillary through which the material to be encapsulated is supplied. If both liquids have 
appropriate physical properties (viscosity, conductivity etc.) and are immiscible core-shell 
particles can be obtained. Recently, Yeo et al. [16] described an electrospraying configuration 
using high-frequency AC electric fields above 10 kHz. They report on the potential of this 
method for scalability to both portable in-situ delivery devices and mass production lines. 
Applications are focused on two major areas, namely, micro/nano-encapsulation for drug 
delivery and on the other hand fiber synthesis for tissue/orthopedic engineering and wound 
healing. Several different electrode designs and collection chambers have been developed and 
proposed over the years. For example, the use of a ring-electrode for the production of 
cholesterol microparticles has been reported by Reyderman et al. [17]. In this case, the ring-
electrode was positioned directly on the opening of the collection tube. More recently, an 
electrospraying configuration sometimes referred to as ―Delft-type‖ since it was constructed 
for the first time in the Technical University of Delft (Netherlands) has been reported [18]. 
The set-up consists of a cylindrical glass tube with tapered ends. One end acts as an inlet for 
air and the other end ducts the produced particles via a heater to the collection side. The 
spraying nozzle is positioned in a glass side tube in which also the counter electrode ring is 
placed close to the main cylinder. The distance between the nozzle-tip and the ring is 10 mm. 
The discharge needle is inserted in the glass cylinder opposite to the spraying nozzle. The 
airflow through the system equals 30 L/min. Particles are collected on a membrane filter 
placed downstream of the set-up [19]. The two major advantages of this electrospraying 
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configuration are continuous collection of particles and neutralization of the charges on 
generated droplets and resulting powder formulations. In order to increase and gain better 
understanding of the potential of electrospraying for encapsulation, the objective of this 
chapter was to optimize the electrospraying device in a step-wise manner. Starting from a 
simple configuration, we modified the chamber design and introduced a cyclone-type particle 
collector. The main objective was to develop a device suitable for continuous particle 
collection, higher yields and collection of isolated particles, and non-aggregated powder 
formulations for medical and pharmaceutical applications. 
 
Experimental part 
Materials and Methods 
Acetone was purchased from Sigma-Aldrich GmbH & Co. KG. (Taufkirchen, Germany). 
Resomer RG502H (provided by Boehringer Ingelheim, Germany) is a poly(D,L-lactide-co-
glycolide) (PLGA) having a molecular weight (Mn) of 12.2 kDa. Resomer RG 502 H is a 
poly(D,L-lactide-co-glycolide) consists of a 50:50 mixture of lactic acid: glycolic acid and an 
inherent viscosity between 0.16 – 0.24 dl/g. This polymer is uncapped, meaning that it has 
free carboxylic acid groups. The electrospraying devices consisted of the following three main 
parts: An Eltex KNH35 (Germany) high voltage generator was utilized to charge the solution, 
a cyclone type particle collector (Respirable Dust Aluminum Cyclone, SKC Inc., USA) and a 
vacuum pump (Vakuumbrand, Germany). All other parts were manufactured at the DWI 
workshop and tailored for each device. In all three electrospraying configurations, a HA 11 
plus (Harvard Apparatus, purchased from Hugo-Sachs Elektronik GmbH, March-Hugstetten, 
Germany) was used to pass polymer solutions through the nozzles at controlled flow rates. 
 
Electrospraying experiments with the simple configuration (Device I) 
The basic electrospraying configuration consisting of a syringe through which a polymer 
solution was pumped at a constant rate and which is connected to a high voltage power supply 
and a grounded target for collection of the particulate is shown in Figure 2. 
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Figure 2: Basic electrospraying configuration consisting of a syringe through which a 
polymer/drug solution is pumped at a constant rate and which is connected to a high 
voltage power supply, and a grounded target for collection of the particles. 
 
Target and spraying nozzle are enclosed in a 450 X 450 X 800 mm PMMA box to eliminate 
the possibility of any contamination of the environment. After electrospraying and 
disconnecting the high voltage supply, the box was opened and the sample removed. In the 
simplest electrospraying experiments, a polymer solution (1-3 wt% poly(lactide-co-glycolide 
in acetone) was supplied to the spraying nozzle at a constant rate of 0.08 mL/h. The distance 
between the spraying nozzle and the grounded collector was 200 mm and an applied voltage 
of 25 kV proved to be optimal for production of monodisperse spherical polymer particles in 
nano- to micrometer scale. Particles were collected for 20 min and the collector was 
exchanged by a new one. Particles collected over a period of 24 h were transferred into 
1.5 mL Eppendorf tubes and the yield was determined. Average particles yields are presented, 
which result from three independent production cycles. 
 
Electrospraying experiments with a configuration for continuous collection (Device II) 
In addition to the three main elements of the basic configuration, this set-up consists of a 
spraying chamber and a cyclone-type particle collector (see Figure 3). 
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Figure 3: Electrospinning configuration for continuous particle production and 
collection. In addition to the elements of the basic configuration, this set-up consists of 
a spraying chamber and a cyclone-type particle collector. 
 
The experimental basically consists of a syringe filled with a polymer solution and a grounded 
electrode encapsulated in commercial PMMA tubing. A PMMA tubing with a length of 680 
mm and a diameter of 170 mm is used with adequate closure heads for this purpose.  A round 
air inlet of 30 mm is concentrically recessed in one of the two closure heads, while a Teflon 
Tubing with an outer diameter of 10 mm (inner diameter 8 mm) was fixed at the second 
closure head. The length of this Teflon tubing connecting the spraying chamber and the 
Respirable Dust Cyclone (SKC Inc, USA) was 300 mm. Both, nozzle and ground electrode 
are positioned 200 mm from the air inlet opposite to each other. The distance between the tip 
of the electrospraying nozzle and the ground electrode was fixed at 120 mm. A constant air-
flow of 28L/min through the device and cyclone was applied with a vacuum pump 
(Vakuumbrand, Germany). A polymer solution (1 wt% poly(lactide-co-glycolide) in acetone) 
was fed to the spraying nozzle at a constant rate of 1.5 mL/h. Particles are collected in 
cyclone-type particle collector. Particles were produced over a period of 24 h and collected 
continuously on a filter membrane (0.2 µm cellulose filter membrane, Millipore, Germany). 
Afterwards the particles were transferred into 1.5 mL Eppendorf tubes and the yields 
determined. 
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Electrospraying experiments with the optimized configuration for continuous collection 
(Device III) 
In contrast to the previously described electrospraying configuration, this device consisted of 
a glass chamber with optimized geometry and design. All described measures except the 
spraying chamber have been retained unchanged. A glass separation funnel was modified with 
two glass tubings (length: 60 mm) with ground neck NS 29. As shown in Figure 10, the 
tubings are fixed to the separation funnel at the place of maximum diameter in opposing 
positions. 
 
Figure 10: Images of the electrospraying device. A.) Overview of the electrospraying 
configuration consisting of a chamber, syringe with syringe pump, high voltage 
connections, vacuum pump, tubing and a cyclone-type particle collector. B.) Detailed 
view on the electrospraying chamber showing the syringe connected to the high 
voltage, the grounded electrode, the air-inlet and the connection to the particle 
collector. 
 
As precursor for the production of particles, a solution of polymer is supplied to the spraying 
nozzle. Poly(lactide-co-glycolide) was dissolved in dry acetone to make a 1 wt% solution. 
The flow rate of the solution is usually in the range of 1.5 mL/h. High voltage power supply 
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set on 20-25 kV is connected to the nozzle while the second electrode positioned opposite to 
this one remains on ground potential. The applied voltage was adapted to a current of 0.3 µA 
through the device. Particles are collected on a filter membrane (0.2 µm cellulose filter 
membrane, Millipore, Germany) inside the cyclone type particle collector (Respirable Dust 
Aluminum Cyclone, SKC Inc, USA) downstream of the set-up. All presented particles on the 
SEM-Images (see Figure 1) were generated in the set-up shown in Figure 10. 
 
Air-flow simulations and calculation of isolated particle tracks 
All simulations have been computed by the Institut für Textiltechnik of RWTH Aachen 
University (Eilfschornsteinstraße 18, D-52062 Aachen, Germany) and were kindly provided 
for comparison with the experimental results. The finite volume method has been used for 
simulation of the air-flow and the corresponding velocities. As precondition for the simulation 
of droplet/particle tracks after injection into the air-flow we assumed every particle hitting the 
wall as loss. This assumption seems realistic as every droplet or particle in a non-dry state 
sticks to the wall due to the adhesiveness and viscousness of the material swollen in acetone. 
In addition the non-neutralized charges of the particles attribute to the stickiness as well. Only 
dry particles can detach from the walls and reach the place of collection. Although the 
Reynolds number is about 250 in the tube of device II, a turbulence model (k-e) was used as 
the flow was not developed. Therefore, some turbulent areas, which have also been observed, 
could be simulated. 
 
Results and Discussion 
To obtain particles of narrow size distribution, voltage and liquid flow rate were fixed in such 
a way that the system operates in cone-jet mode. When electrospraying operates not in the 
cone-jet mode the process itself is not stable. One method of cone stability control is 
monitoring the voltage of the electric current flowing through the nozzle. When 
electrospraying operates in the cone-jet mode, the electric current is stable, usually in the 
range of one to tens of microampere [19]. For the production of certain particle sizes, a final 
tuning of the system by changing the liquid flow or voltage is necessary as the particle sizes 
may vary with the device used. While morphology and internal structure of particles produced 
depend strongly on the precursor type and solvent properties, yields and aggregation depend 
on the device used. To obtain solid, non-porous particles, precursor polymer should be very 
well dissolvable in the solvent which is used. Especially polymers with large molecules have 
low diffusion coefficients and tend to build a solid shell structure. For the production of small 
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solid particles, evaporation rate should be kept as small as possible and no additional heating 
should be applied. Unfortunately, this leads to long drying times corresponding to long flight 
distances. The common parameters used for the production of all particles are given in table 1. 
 
Table 1: General electrospraying conditions used for the generation of PLGA 
particles. 
 
 
Exemplary, the system used in this chapter is poly(lactide-co-glycolide) dissolved in acetone 
to make concentrations of 3 wt%, respectively 1 wt%. The polymer used in this chapter was 
kept identical independent of the device used for better comparison. A voltage of 25 kV and 
needle diameter of 24 ga was used. All three parameters, concentration, flow rate, and nozzle 
to collector distance had to be adapted to the devices in order to obtain monodisperse particles 
in the inhalable size range. The optimum conditions for the particle generation were 
determined for each configuration and device used. Figure 1 shows SEM images of 
electrosprayed poly(lactide-co-glycolide) particles produced in this study. 
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Figure 1: Electrosprayed PLG particles. A.) Magnification X=1000, B.) magnification 
X=2000, and C.) magnification X=5000. 
 
Different magnifications are shown to illustrate the homogeneity and monodispersity of the 
generated particles. All particles show spherical shape and smooth surface morphologies. The 
most simple electrospraying configuration (Device I) is schematically shown in Figure 2. The 
advantage of such a simple configuration, being easily adjustable distances has to be 
highlighted. For determination of sprayability and in order to obtain a first set of processing 
parameter experiments with such a configuration are necessary. The detailed electrospraying 
parameters are given in table 2. 
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Table 2: Apparatus specific electrospraying conditions. (Flow rate, collection time, 
particle diameter, yields, comments – for all three configurations) 
 
 
A nozzle to collector distance of 120 mm and a flow rate of 0.8 mL/h proved to be best 
suitable for the production of homogeneous sprays. As alumina SEM-stubs were used for 
collection and the surface area of such a collector is very limited, they had be exchanged 
approximately every 20 min. This is a clear disadvantage as for the production of 20 mg over 
a period of 24 h the collector had to be exchanged 72 times. Besides being unpractical and 
time consuming, collection on 72 different collectors leads to higher material losses when the 
particles are merged to one batch in an Eppendorf tube. During a 24 h time period, 1.92 mL 
corresponding to 57.6 mg polymer are electrosprayed. As only 20 mg were collected, 34.7% 
of the theoretical yield was obtained. The rest of the particles was distributed in the whole 
PMMA-box and could not be located nor collected. For biomedical and pharmaceutical 
applications such yields and total particle amount are not sufficient and a scale-up is needed. 
In order to be able to collect particles continuously over longer time periods and to increase 
yields and productivity, the electrospraying configuration was modified. For this reason 
several modifications and changes had to be introduced. Firstly the place of collection and the 
other electrode had to be separated. Secondly, a more efficient collector had to be introduced. 
Thirdly, the chamber size had to be decrease in order to minimize surface for particle 
deposition. Figure 3 shows an electrospraying device for continuous particle collection 
(Device II). In order to separate the place of collection and the grounded electrode, we 
introduced a second capillary connected to ground potential and applied constant air-flow of 
28 L/min to transport the particles to the collection place downstream. As more sufficient 
collector a Respirable aluminum dust cyclone commonly used for environmental sampling 
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and analysis was introduced. Dependent on the air-flow and particle size, particles are either 
sedimented in a collection flask or collected on a membrane with 0.2 µm pores size. In order 
to decrease the inner surface of the electrospraying device, a tube with an inner diameter of 
170 mm and a length of 680 mm was used. In this second device the particles are generated at 
the spraying nozzle, attracted by the target (grounded electrode) and carried to the cyclone-
type particle collector placed downstream by the air-flow. This modified device allows 
continuous collection of non-agglomerated particles. The device specific process parameters 
are given in Table 2. Especially the air-flow leads to faster solvent evaporation and less 
aggregation. The optimum conditions for the generation of spherical solid particles proved to 
be altered significantly from the one described previously for device I. Best results were 
achieved using concentrations of 1 wt%, a nozzle to target distance of 120 mm, and solution 
flow rates of 1.5 mL/h. Total particle amounts of 200 mg were achieved over a period of 24 h. 
In comparison to the particle amounts produced with device I this is means a ten times 
increase of collected particles. Theoretical 36 mL of the polymer solution corresponding to 
360 mg of polymer have been generated over a period of 24 h. As only 200 mg (55.56 %) 
have been collected, 44.44 % of the particles were not located and contribute to loss. Besides 
an improved comfort, particle amounts in the gram scale can be produced within a few days. 
In comparison to the previously described results this first modification already means a 
significant increase. As mentioned previously, approximately 45 % of the electrosprayed 
particles have not been transferred to the collection side. In order to identify the reason for 
these losses, simulations of the air flow inside device II were performed. We underline the 
qualitative nature of these calculations since the electric field and interactions between 
charges are not considered. 
We assume the flow to be turbulent despite of the low volume flow. Taking the given volume 
flow into account for  calculation of the Reynolds‘ number for the air flow in the spraying 
chamber and the Teflon tubing, values of  250 and 5000 were determined. Even though the 
Reynolds number determined for the spraying chamber is lower than the critical value of 
2300, the assumption of a turbulent flow is justified due to the turbulences induced by the 
sharp edges at the air-inlet. Inside the spraying chamber these turbulences continue as a 
relaminization doesn‘t occur in the short distance. The simulated air-flow inside the spraying 
chamber and the tubing and corresponding velocity vectors are shown in Figure 4. 
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Figure 4: Simulation of the air-flow and local velocities in the electrospraying 
chamber connected to a vacuum pump transporting the air at a rate of 28 L/min. The 
place where the needle and the spray enter the chamber is marked with circle. 
 
At the inlet the air is transported with velocities of approximately 0.1 m/s into the spraying 
chamber. The entering air-stream expands until it collapses after 200 mm. It partially flows 
back near the chamber walls so that a recirculation area builds up. In the rest of the spraying 
chamber very low velocities of 0.03 m/s were calculated. The turbulences induced by the 
sharp edges at the air-inlet together with the low velocities cause a high turbulence intensity, 
which means that the velocity fluctuation is in the same size as the average velocity. The air is 
pumped out of the spraying chamber at the outlet through the Teflon tubing. The air is 
transported with approximately 9.4 m/s through the tubing to the respirable aluminum 
cyclone. As we expected the turbulent air flow to be the main reason for the particle losses, 
we examined the inside of the spraying chamber and the deposition pattern after 24 h of 
continuous electrospraying. When opening the tubular spraying chamber, it was visible that 
some areas are covered with a thin whitish layer. The deposition pattern was inhomogeneous 
and showed areas of increased deposition and almost no deposition. While the surface around 
the position were the spraying nozzle and the target are introduced in the tube (±50 mm) was 
covered with a larger number of particles (visible by the white color), the inner surface 
between the air-inlet and this position did show almost no particles. The area towards the 
Teflon tubing connecting the spraying chamber and the cyclone was covered with a thinner 
whitish layer. The closure head on the collection side itself and especially the area around the 
out-let showed most deposited particles. In a next step the particle flow inside the spraying 
device with the previously described air-flow was calculated. Figure 5 illustrates the 
simulated particle tracks inside the electrospraying chamber. 
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Figure 5: Simulated particle tracks in the electrospraying chamber. Every particle 
hitting the wall is expected to stick to the wall. These particles attribute to losses and 
lower yields. Approximately half of the generated particles hit the wall 
 
We assumed that every particle hitting the wall on its flight adheres. Electrostatic interaction 
between the particles and with the surface of the electrospraying chamber has been ignored in 
the simulation. The trajectories of several particles were simulated. The differences in the 
particle motion can be explained by the turbulences. Half of the generated particles hit the 
wall of the spraying chamber during their flight. From the calculations, provided that every 
particle hitting the wall does not reach the collection side, we can conclude that approximately 
half of the generated particles reach the collector. This result is in good agreement with the 
experimental results. Figure 6 shows the distribution of the particles on the wall. 
 
Figure 6: Simulated Particle distribution inside the electrospraying chamber. 12 % of 
the produced particles hit the wall at the wall on the collection side where the tube to 
the cyclone-type particle collector is located (indicated with 0). Another place where a 
high particle concentration is predicted is in the area of the entering needle (400 to 500 
mm). 
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The distances on the center line represent the distances from the out-let and the Teflon tube 
connecting the spraying chamber and the cyclone. The simulation results show particles 
distributed almost over the whole inner surface. A higher particle concentration can be found 
in the areas where the particles are produced, and where the back flow was calculated as well 
as on the head closure with the outlet. Approximately 12% of the generated particles are 
deposited around the out-let and the Teflon tubing. In order to minimize particle losses and to 
increase the yields turbulences inside the spraying chamber had to be decreased. Generally, 
avoiding sharp edges as well as corners may diminish these turbulences. Figure 7 shows a 
schematically drawn design of a spraying chamber with optimized geometry for minimal 
turbulences. 
 
Figure 7: A new chamber geometry with reduced air currents and reduced local air-
velocity 
 
Especially the funnel like shape of the spraying chamber leads to a homogeneous velocity 
distribution with most velocity vectors directed towards the collector side. One clear 
disadvantage of this modified geometry is the lower velocities in the area of particle 
generation. Just by moving the spraying nozzle 50 mm in the direction of the collector, 
particle yields drop down dramatically (approximately 40 mg/24h). In this position of 
electrospraying device II velocities of approximately 0.03 m/s are insufficient to deflect the 
particles from their trajectories towards the grounded electrode and carry them to the collector 
downstream of the device. Combination of higher velocities and less turbulence can be 
combined by designing a smaller chamber with less dead volume. The schematic drawing in 
Figure 8 reflects on possible new design. 
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Figure 8: Schematic drawing of a new chamber design for optimized air-flow. Due to 
the reduced inner volume, higher local air-velocities are expected. Additionally, due to 
the conical shape reduced currents should be obtained. 
 
The funnel-like shape of the spraying area of the chamber, the tube like air-inlet and the two 
added tubings for the two capillaries (spraying nozzle and grounded electrode) combine 
higher air-velocities and less turbulence, respectively current. The calculated contours of 
velocity inside the spraying chamber and corresponding velocity vectors are shown in Figure 
9. 
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Figure 9: Simulation of the air-flow in the optimized chamber geometry. Higher local 
air-velocities and fewer currents in the center region of the electrospraying chamber 
are predicted. 
 
At the inlet the air is transported with velocities of approximately 0.1 m/s into the spraying 
chamber. The velocity of the air flow in the center area of the spraying chamber keeps 
constantly that high. No significant differences between the air inlet and the connection to the 
Teflon tubing can be identified. The velocity of the air in the area of the two capillaries drops 
down to 0 m/s. Therefore, the particles generated at the spraying nozzle are firstly attracted by 
the grounded electrode, enter the area of high air velocity, are distracted and carried towards 
the collector. The residual solvent evaporates during their flight and solid particles are 
collected. Figure 10 is an image of the optimized electrospraying configuration (device III). 
The spraying chamber has a length of 250 mm and is made of glass. The overview image of 
the set-up illustrates how all parts are connected while Figure 10B gives a detailed impression 
of the spraying chamber. The shown device has been used for the generation of poly(lactide-
co-glycolide) particles. The highest flow rate at which a stable monodisperse electrospray 
could be sustained was again 1.5 mL/h, which corresponds to a production rate of 360 
mg/24h. At larger flow rates, on the order of 2 ml/h it was still possible to stabilize the conical 
meniscus but monodispersity was compromised. Still higher flow rates resulted in unstable 
behavior of the conical meniscus and were not examined. 285 mg particles were collected 
during a 24h period, which corresponds to a yield of 79.2%. Optimization of the chamber 
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design clearly increased particle amounts and yields. In a next step a concept for the 
combination of several spraying chambers to one electrospraying device was developed. A 
schematic drawing of this scale-up is presented in Figure 11. 
 
Figure 11: Concept for further up scaling of the electrospraying. Combination of 
several electrospraying chambers to one cyclone and a vacuum pump leads to 
collection of larger particle amounts. The polymer/drug solution can be supplied from 
one pump and reservoir located in the center of the device. 
 
The Figure shows six individual chambers combined into one device. By equally supplying 
the precursor solution and the high voltage from the center of the device to all individual 
spraying chambers, equal particles should be generated in each chamber. The grounded 
electrodes are inserted into each chamber opposite to the spraying nozzles. A vacuum pump 
transports these particles through a tubing system to a cyclone-type particle collector, where 
the particles are collected as dry powder. Further increase of the particle amounts and yields 
should be achieved following this concept. 
 
Conclusion 
A new electrospraying device for the continuous production of increased particle amounts and 
higher yields of polymeric materials has been developed. This device utilizes several 
improvements over the commonly used electrospraying configurations including continuous 
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collection over long time periods via separation of the grounded electrode and the place of 
particle collection. Using an aerodynamic transport system for the particles to the cyclone-
type particle collector leads to the collection of solid, non aggregated and agglomerated 
sprays. Optimization of the chamber design further increased the obtained yields. 
Minimization of turbulences in the spraying chamber while maintaining relatively high air 
velocities of 0.1 m/s led to yields of 79.2% corresponding to 285 mg/24h. By discretely 
varying chamber and device design, efficiency in terms of particle amounts and yields are 
realized. Thus relevant amounts for biomedical and pharmaceutical applications can be 
produced, for example formulations for controlled drug-delivery devices. Used to create 
specific formulations or coating existing drug particles, electrospraying technology provides a 
simple and robust technique for fabrication of dry powder formulations consisting of 
monodisperse particles with precisely define size range and defined nano-structures (as voids 
or porous and wrinkled surfaces) from a broad range of biocompatible polymeric materials. 
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Appendix B: Evaluation of protein adsorption behavior on nanofiber 
surfaces  
 
Abstract 
Adsorption of two model proteins (bovine serum albumin [BSA] and streptavidin [Strp]) on 
the surface of electrospun fibers was visualized using microscopy. To evaluate the adsorption 
of proteins on the surface of a nanofiber mesh collected onto a silicon wafer coated with a 
protein repellent star-PEG layer, samples were immersed in solutions of fluorescent labeled 
proteins. The fluorescence intensity depends on the material and size of the fibers and is 
directly comparable if protein solutions of a fixed concentration are used. The combination of 
collection on protein repellent substrates, incubation with fluorescence labeled proteins and 
fluorescence microscopy provides an easy and handy tool for determination of the protein 
adsorption behavior of electrospun nanofibers. 
 
Introduction 
Electrospun nanofibers have attracted great interest in biomedical applications. The 
nanometer scale dimensions are of similar magnitude to the fibrils often found within extra 
cellular matrix, and so far electrospinning experiments demonstrate great promise in tissue 
engineering. Depending on the application field, the polymer fibers have to fulfill different 
requirements. As tissue scaffold for bioengineering applications for example biocompatibility 
and biodegradability as well as hydrophilicity and other surface properties have to be 
optimized in order to achieve acceptance in the body. The development of a scaffold is 
affected by several parameters that range from the macro- to the nanoscale. Surface 
chemistry, surface energy, morphology and topology can affect the cellular response to the 
material, particularly in vitro. The adsorbed proteins on biomaterials implanted into the body 
provide surfaces that are recognized by various cellular constituents, effectively altering the 
biomaterial into a biologically recognizable object. Besides the polymer used the effects of 
various processing parameters of electrospinning such as concentration, applied voltage, 
distance from needle to collector has dramatic impact on the morphology (e.g. fiber diameter.) 
of nanofiber mesh.  Such a difference on surface morphology of electrospun nanofiber mesh 
under various processing parameters and materials will show different protein adsorption on 
the surface in contact with body fluid. 
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Experimental part 
Materials and Methods 
As substrates for protein adsorption studies we used silicon wafer with an ultra thin star PEG 
coating. Therefore, ultra thin coatings from six-arm star-shaped isocyanate-terminated 
prepolymers on amino-functionalized silicon wafers were prepared as described previously 
[1]. The 14 x 14 mm silicon wafers were star-PEG coated and stored overnight in ambient 
atmosphere so that crosslinking could take place. Such spin coating with star-PEG resulted in 
protein repellent substrates with a layer thickness below 30 nm. For electrospinning 
experiments the polymers were, unless otherwise mentioned, dissolved in a mixture of 
chloroform and methanol (75/25, v/v) to make 10% solutions. The polymer solutions were 
pumped to the 18-gauge, flat-tipped, stainless steel spinneret at a rate of 0.1 mL/h. The fibers 
were collected for 50 s on the prepared star-PEG-coated silicon wafers fixed to an aluminum 
SEM stub (diameter 12 mm) at a 200 mm distance from the tip of the spinneret. A voltage of 
25 KV was applied to the polymer solution with a Series 205B high voltage power supply 
(Bertran, NY, USA). Electrospun fibers were incubated for 20 min in a solution of 50µg/mL 
Rhodamine labeled bovine serum albumin (BSA) or texas red labeled streptavidin (Strp) in 
PBS buffer. Afterwards the samples were incubated three times for 20 min. in PBS buffer, 
incubated another time for 60 min in PBS buffer and washed extensively with distilled water. 
The samples were kept in dark during all incubation and washing steps before analysis with 
fluorescence microscopy. 
 
Results and Discussion 
The assay for protein adsorption upon poly( -caprolactone) [PCL], poly(D,L-lactide) 
[PDLLA], Poly(lactide-co-glycolide) [PLGA] and poly(ethylene glycol)-b-poly(D,L-lactide) 
[PEG-b-PDLLA] fibers was through incubating fluorescent BSA or Strp on electrospun 
material deposited onto an isocyanate-terminated star-PEG-modified silicon wafer. The NCO-
star-PEG has two purposes within the experimental design. Initially, the Star-PEG is 
chemically reactive coating, and will stick the electrospun material to the silicon wafer, 
allowing for frequent media changes without loss of the electrospun material. Secondly, the 
star-PEG surface will continue reacting with water to become a substrate upon which protein 
adsorption is minimized. During incubation with fluorescent proteins, the substrate will resist 
protein adsorption and provide a good imaging background, with only adsorption onto 
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electrospun fibers being assayed. Microscope images taken at constant exposure time (20000 
ms) allow the comparison of the different materials. 
Figure 1 shows fluorescence and optical micrographs of PCL, PLGA, PDLLA and PEG-b-
PDLLA electrospun fibers after incubation with fluorescent BSA. Low adsorption of the BSA 
on electrospun PEG-b-PDLLA, contrasted with the electrospun fibers of all other polymers 
that showed significant adsorption on the electrospun fiber surface. The star-PEG coating on 
collector did not adsorb the fluorescent BSA.  
 
Figure 1: Optical and fluorescence micrographs of BSA adsorption on electrospun 
PCL, PDLLA, PLGA and PEG-b-PDLLA fibers. 
 
Figure 2 illustrates the contrasting differences observed upon incubation of electrospun PCL 
fibers with BSA or STRP. While the BSA does adsorb in significant smaller amounts on the 
fiber surface, Strp shows a much higher adsorption and stronger fluorescence. This two model 
proteins show the differences in the adsorption of miscellaneous proteins and points the 
extremely versatile situation inside a host organism, with a huge number of different proteins. 
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Figure 2: Optical and fluorescence micrographs of electrospun PCL fibers after 
incubation with fluorescently labeled BSA and Strp. 
 
Conclusion 
Fluorescence microscopy is a handy tool for the determination of protein adsorption behavior 
of electrospun fibers which show no auto fluorescence. The contrasting adsorption properties 
of various electrospun fibers were visualized on fluorescence microscope images. The 
adsorption of fluorescence labeled proteins on different electrospun samples can be compared 
in order to provide a first estimation for the adsorption behavior of those fibers in contact with 
body fluids inside the body. 
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